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EXECUTIVE SUMMARY
ES.1

Background and Introduction

The Centers for Medicare & Medicaid Services (CMS) has undertaken a major initiative
to evaluate and realign the incentives for inpatient and post-acute services provided under the
Medicare program. Currently, about a fourth of all beneficiaries are admitted to a general acute
care hospital each year; almost 35 percent of them are discharged to additional care in a longterm care hospital (LTCH), an inpatient rehabilitation facility (IRF), a skilled nursing facility
(SNF), or a home with additional services provided by a home health agency (HHA). Many
beneficiaries use more than one service following hospital discharge (Gage et al., 2008).
Although these services constitute a continuum of care for the patient, the current measurement
systems do not allow Medicare to examine the effects of these continuing services on the
patient’s overall health and functional status.
The Medicare program currently mandates that IRFs, SNFs, and HHAs each submit
assessment data on the beneficiary’s medical, functional, and cognitive status. CMS uses this
information in both its payment and quality monitoring efforts. Hospitals, both general acute
care and LTCHs, also submit data on medical conditions being treated as they are reported under
the Medicare Severity-Diagnosis Related Group (MS-DRG) based on a case-mix system used to
pay and monitor these providers. Despite the inclusion of these factors in the existing systems,
four of the five case-mix systems were developed independently and use different items to
measure each set of concepts. As a result, the Medicare program has not been able to measure
changes in patients’ health status as they progress across their episode of care. Further, this lack
of standardized measurement makes it difficult to understand the extent to which patient costs
and program costs differ across the settings.
The Deficit Reduction Act of 2005 (DRA) directed CMS to develop methods for
consistently measuring Medicare beneficiaries’ health status across acute and post-acute care
(PAC) settings. This contract addresses this issue by testing the use of a standardized set of
items for measuring medical, functional, cognitive, and social support factors in the acute
hospital, LTCH, IRF, SNF, and HHA. These items are based on the science underlying currently
mandated assessments in the Medicare payment systems, including the IRF-Patient Assessment
Instrument (PAI), Minimum Data Set (MDS), and Outcome and Assessment Information Set
(OASIS) instruments. Over the past few years, RTI International has been working with the
Office of Clinical Standards and Quality and the research and clinical communities associated
with acute and PAC services, including clinicians, case-mix measurement experts, accreditation
bodies (such as The Joint Commission and the Commission on the Accreditation of
Rehabilitation Facilities), provider associations, and others, to identify a select set of items that
would be appropriate for measuring beneficiary severity of illness, regardless of site of care.
Input was collected through numerous stakeholder meetings, including several open-door forums
(ODFs) and technical expert panels (TEPs). The results of these panels were submitted for
publication in the Federal Register and underwent two sets of public comment periods. The
results led to the development and pilot testing of the Continuity Assessment Record and
Evaluation (CARE) Item Set. The items were revised following the pilot test and the resulting
changes were implemented for use in the Post-Acute Care Payment Reform Demonstration
(PAC-PRD). Data were collected in the PAC-PRD from 2008 to 2010. Over 53,000
1

assessments were collected in acute hospitals, LTCHs, IRFs, SNFs, and HHAs. Volume 1 of this
set of reports reviews the development of the CARE tool, including justification of the item set,
pilot testing, and item edification processes.
Two types of reliability tests were conducted and profiled in Volume 2. The first is a
traditional interrater reliability test, which examines how well the assessment items measure
specific concepts when two clinicians are measuring the same patient at the same time. The
second reliability test examines how discipline and provider setting affect assessment item
scoring. Additional analyses of the internal consistency of the functional status subscales in the
standardized CARE items were also examined. As expected, most of the items performed
reliably, as similar items were already in use and found to be reliable within some PAC settings,
but had not necessarily been tested in use across the other settings. Given that patient assessment
applies to patients across settings, it is not surprising that items found to be reliable in one setting
were also reliable in other settings. The exception was in some of the instrumental activities of
daily living (IADLs) such as shopping and laundry, which were more subjective in nature than
the clinical items.
Volume 3 provides an additional set of analyses comparing the standardized CARE items
with analogous items in the mandated assessment instruments being collected at the time of the
PAC-PRD data collection. The purpose of this analysis is to examine item and coding
differences between each of the three CMS assessment instruments and CARE and to consider
how these differences affect relative coding on the comparable assessment tool items for the
same patient.
Volume 3 has several sections. Section 12 introduces the volume and provides a
roadmap to other reports in the three-volume set. The next three sections discuss the item
definitions and coding differences between the standardized CARE items and the mandated
assessment instruments—IRF-PAI, MDS 2.0, and OASIS-B—that Medicare-certified providers
were using at the time of data collection. These three sections also present data from cases in the
CARE sample to show how the standardized items relate to the mandated items and to highlight
expected similarities and differences between items. Section 13 examines the comparability of
the standardized CARE items to those items currently in the IRF-PAI assessment tool.
Section 14 compares the CARE items to the MDS 2.0 items for each patient in the CARE sample
who was admitted to a SNF. While the MDS 3.0 went into effect in 2010, the results are
compared with the assessment data used at the time of data collection (MDS 2.0). Due to the
close collaboration of the CARE development team with the MDS 3.0 development team, many
of the CARE items are intentionally similar to those items in the MDS 3.0. Section 15 reviews
the CARE items relative to the OASIS-B items. OASIS-C has gone into effect since the data
collection. However, OASIS-B was used during the time of the reliability tests. The CARE
items also were based on discussions with the OASIS-C developers to create consistency in item
modifications.
As described throughout the reporting of these results, we did not expect a one-to-one
match between CARE item responses and the mandated assessment instruments. The item
definitions differ as do the definitions of the coding categories. Understanding how the
standardized items compare to those items already used in the respective health communities to
monitor the quality of care and adjust payment policies for differences in patient severity or case2

mix characteristics will be important. Most important, the high reliability results reported in
Volume 2 suggest that the standardized items work well in each setting. The information
presented here in Volume 3 is important for understanding the expected differences in rating
between the current items and the standardized items.
ES.2

CARE Item Set and IRF-PAI: Overview, Background, and Methods

Comparisons are made between selected items from the CARE Item Set and the FIM®
1
Instrument items on the IRF-PAI. The IRF-PAI, which is the current assessment tool for the
inpatient rehabilitation setting, includes FIM® items and function modifiers. For each
beneficiary in the CARE sample who was admitted to an IRF, the analysis compares admission
scores between the existing IRF-PAI/FIM® items that are used for payment (12 motor items)
with conceptually similar CARE items. These analyses focused on items capturing concepts
used in the current Medicare IRF prospective payment system (PPS) to determine payments.
To conduct these analyses, we merged the January 2010 extract of the CARE data with
2
IRF-PAI/FIM® assessments available through December 31, 2010. The merge was based on the
beneficiary identification number and a match on admission or discharge dates on each
assessment. We successfully matched 93 percent of the CARE assessments with IRF-PAI/FIM®
Instrument data and have a total of 9,481 assessments: 4,890 admission assessments and 4,591
discharge assessments. The analyses included in this report focus on the admission assessment
items.
ES.2.1 Purpose of Analyses
As previously noted, these analyses focus on items capturing concepts used in the current
Medicare IRF PPS to determine payments. The CARE Item Set includes items in the
Impairments and Functional Status sections that are similar in concept to the IRF-PAI/FIM®
items. The comparable concepts in the Impairments section include the bladder and bowel
management items. The comparable concepts in the Functional Status section include items in
Section A (the Core Self-Care items), Section B (the Core Functional Mobility items), and
Section C (the Supplemental Functional Ability items). The results are organized by these
sections. Some of the CARE and IRF-PAI/FIM® items are similar, but for others, the
comparable concepts are more distal and may include more than one variable in the comparison.
Finally, not all CARE items have an equivalent IRF-PAI/FIM® and vice versa. For example, the
eating items in the CARE Item Set and IRF-PAI/FIM® Instrument are similar, but not exactly the
same. The CARE Item Set has separate items for eating and administration of tube feedings. In
the IRF-PAI/FIM® Instrument, these activities are reported in a single item, eating. Walking is
also measured very differently in the two data sets, making it difficult to compare items across
the CARE Item Set and the IRF-PAI/FIM® Instrument.
1 FIM® is a trademark of Uniform Data System for Medical Rehabilitation, a division of UB Foundation Activities,

Inc.

2 CARE extract date 01/28/2010. Data shown in this chapter were generated with the req_lc008_v3, req_lc012,

req_lc013, and req_lc014 programs.
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ES.2.2 Reasons for Expected Differences in Item Response Codes (CARE vs. IRFPAI)
ES.2.2.1

Overview

There are several reasons why FIM® scores on the IRF-PAI Instrument and CARE Item
Set scores for similar items will not match, including the following:
Time Frame: The assessment time frame for most of the FIM® items on the IRF-PAI is
3 calendar days, whereas the CARE Item Set time frame is 2 calendar days (if the patient is
admitted before noon) or 3 calendar days (for patients admitted after noon). The only CARE
Item Set time frame exception is for the CARE Mood items that use a 14-day look-back period.
Most Dependent Episode vs. Usual Performance: If the patient’s functional
performance varies during the assessment time frame, the instructions for completing the IRFPAI/FIM® direct the clinician to report the patient’s most dependent episode. For the CARE
Item Set, clinicians are instructed to report the patient’s usual performance during the CARE
assessment time frame.
Implication: In general, these differences are likely to result in FIM® scores that reflect
a lower level of independence than the CARE Item Set’s assessment scores for the same patient.
We would expect that some FIM® scores will be lower than CARE scores for some items.
Differences in Rating Scales: The CARE functional item rating scale has a range of 6
(Independent) to 1 (Dependent), and the FIM® items on the IRF-PAI/FIM® Instrument have a
range of 7 (Complete Independence) to 1 (Total Assistance). The definitions at each level differ
across each rating scale. The CARE scale was designed to provide better specificity at the
lowest level and remove differences associated with use of a device at the higher level, in
keeping with the International Classification of Function approach.
Figure ES-1 shows how FIM® scores generally map to CARE Item Set scores. Note that
the IRF-PAI/FIM® Instrument instructs the clinician to determine the assessment code based on
what percentage of the task the patient can perform safely and independently. The CARE Item
Set instructs the clinician to determine what amount of assistance the helper provides for the
patient so that the patient can safely complete the activity.
Differences in Item Definitions: Each instrument defines items differently, specifically
what is and what is not included in each of the items. For example, the CARE Item Set has
separate items for eating and administration of tube feedings. In the IRF-PAI/FIM® Instrument,
these activities are reported in a single item, eating. When the functional assessment items in the
CARE Item Set were developed, the objective was to have definitions that would be relevant to
assessing all PAC patients. Additionally, CARE items were designed to focus on discrete
activities; some FIM® items may capture multiple concepts or activities. Thus, the definitions of
items on the IRF-PAI/FIM® Instrument and the CARE Item Set are often different. There are
important distinctions between these two instruments. For each activity on the CARE and IRFPAI/FIM® instruments, there are unique differences in task inclusion. Each instrument includes
items that the other instrument does not.
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Figure ES-1
General relationship between IRF-PAI/FIM® Instrument levels and CARE Item Set levels

IRF-PAI FIM®
Instrument Level

CARE Item Set Level

7 - Complete Independence
(Without a device)

6 - Independent

(With or without a device)

6 - Modified Independence
(Device used)

5 - Set up or clean up assistance

(Helper sets up or cleans up only)

5 - Supervision or Set Up

(Pt. only needs cues, standby,
no physical contact)

4 - Supervision or Touching Assistance
(Helper provides verbal cues or
touching /steadying assist)

4 - Minimal Assistance

(Pt. performs 75% or more of tasks)

3 - Partial/Moderate Assistance

(Helper does less than half the effort)

3 - Moderate Assistance

(Pt. performs 50%-74% of tasks)

2 - Maximal Assistance

2 - Substantial/Maximal Assistance

(Pt. performs 25%-49% of tasks)

(Helper does more than half the effort)

1 - Total Assistance

1 - Dependent

(Pt. does less than 25% of tasks)

(Helper does all of the effort)
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Error: Some disagreement between the CARE and IRF-PAI items may be attributable
to clinician reporting errors on one of the tools. As noted in the interrater reliability section in
Volume 2, and in prior evaluations of IRF-PAI items, some items have lower reliability than
others.
ES.2.2.2
results.

Clinical Examples

We provide the following clinical examples to assist with the interpretation of the data

Example of CARE score 6 and FIM® scores 6 & 7
•

The CARE Item Set and IRF-PAI/FIM® Instrument use distinct codes to reflect the
most independent patients. The CARE score 6–Independent is similar to merging the
FIM® scores of 7–Complete Independence and 6–Modified Independence. The
CARE score 6–Independent is reported for the patient who completes an activity with
or without an assistive device. The CARE Item Set includes separate items that
collect data about the patient’s use of mobility devices and aids. The IRF-PAI/FIM®
score 7–Complete Independence is used for the patient who completes the activity
with reasonable time, without a device, and without concern for the patient’s safety.
The IRF-PAI/FIM® score 6–Modified Independence is used for patients who need
more than a reasonable amount of time, who use a device, or for whom there is a
safety concern.
–

Example: A patient can safely feed him/herself without assistance and does not use
any devices; however, he/she requires more than a reasonable amount of time to
complete this activity. The clinician using the CARE Item Set codes 6–Independent
(the highest independence rating). The clinician using the IRF-PAI/FIM®
Instrument uses code 6–Modified Independence (the second highest independence
rating).

Example of CARE scores 5 & 4 and FIM® score 5
•

If the patient needs only setup or clean-up assistance and can be safely left to
complete the activity, the CARE item score is 5–Setup or Clean-up Assistance. The
IRF-PAI/FIM® Instrument scores this patient as 5–Supervision or Setup.
–

Example: The use of CARE score 5–Setup or Clean-up Assistance and IRFPAI/FIM® score 5–Supervision or Setup is reported if the patient needs a helper to
gather clothes for upper body dressing and the patient does not need any
supervision with the activity. If the helper provides setup assistance and then leaves
the room while the patient completes upper body dressing, then the scores for the
FIM® and the CARE data set may be the same—a score of 5. However, if a patient
needs supervision in addition to setup assistance, then the CARE score of 4–
Supervision or Touching Assistance is reported and indicates the need for the helper
to remain with the patient. The IRF-PAI/FIM® score for the patient who needs
supervision is scored 5–Supervision or Setup.
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Example of CARE score 4 and FIM® scores 5 & 4
•

The CARE score for a patient who needs only setup assistance differs from the
CARE score for a patient requiring supervision, verbal cueing, or touching/steadying
assistance to complete an activity. The CARE item is scored as 4–Supervision or
Touching Assistance for patients who need supervision, verbal cueing, or
touching/steadying. The IRF-PAI/FIM® Instrument rating scale uses one score for
these assistance levels.
–

•

Example: If a patient needs verbal cues to complete upper or lower body dressing,
the clinician reports CARE score 4–Supervision or Touching Assistance. When
using the IRF-PAI/FIM® to assess the same patient, a score of 5–Supervision or
Setup is reported (as long as no hands-on assistance is used for the patient during
any portion of the activity). However, if the patient requires steadying/touching
(e.g., steadying the patient while she pulls up her pants), the clinician will report the
IRF-PAI/FIM® Instrument score as 4–Minimal Assistance.

Clinician feedback favored the CARE Item Set’s ability to make clinically important
distinctions between the patient’s need for supervision (CARE score 4) and Setup or
Clean-up Assistance (CARE score 5). The need to provide supervision (CARE
score 4) often means that the clinician is present intermittently or throughout the time
that the patient performs an activity (such as eating or walking). In contrast, Setup or
Clean-up (CARE score 5) often means that the clinician can leave (and attend to other
responsibilities) while the patient performs the remaining tasks. The clinician may
return to the patient at the end of the activity to provide any clean-up assistance.
Clinician feedback indicated that these distinctions have major implications regarding
the time needed to provide care for these higher-level patients.

Example of CARE score 4 and FIM® score 4
•

An additional example shows some of the similarities in coding. A patient who needs
touching/steadying assistance would be coded on the CARE as 4–Supervision or
Touching Assistance because the patient is unsteady upon rising from sit to stand and
requires the clinician to place his/her hand on the patient to steady him/her during this
activity. When assessing this same patient using the IRF-PAI/FIM®, score 4–
Minimal Assistance is also used because the patient performed 75 percent or more of
the task.

Example of CARE score 3 and FIM® scores 3 & 4
•

If the helper assists with less than half of the effort, the CARE item score is 3–
Partial/Moderate Assistance. This patient may be scored on the IRF-PAI/FIM®
Instrument as either a 4–Minimal Assistance (patient performs 75 percent or more of
the task) or 3–Moderate Assistance (patient performs 50 to 74 percent of the task),
depending on the patient’s need for assistance.
–

Example: A patient transfers to and from his bed with the helper providing lifting
assistance, but less than half the effort. The CARE coding for this patient is 3–
Partial/Moderate Assistance. The IRF-PAI/FIM® coding requires the clinician to
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determine what percentage of the task the patient performs. If the patient performs
75 percent or more of the task, then the patient is scored a 4–Minimal Assistance,
but if the patient performs 50 to 74 percent of the task, then the FIM® score 3–
Moderate Assistance is reported.
Example of CARE scores 1 & 2 and FIM® scores 1 & 2
•

The CARE coding distinguishes between a patient who contributes a small amount of
effort (rated as level 2) and a patient who is totally dependent (rated as level 1).
These scores differ from the IRF-PAI/FIM® Instrument scores. If the helper assists
the patient with more than half of the effort, the CARE item score is 2–
Substantial/Maximal Assistance. This patient may be scored on the IRF-PAI/FIM®
Instrument as either 2–Maximal Assistance if the patient performs 25 to 49 percent of
the task or 1–Total Assistance if the patient performs less than 25 percent of the task.
–

Example: A patient is assessed using the CARE while transferring into and out of
bed. The helper does all of the effort to complete this activity upon admission to
the facility and scores the patient 1–Dependent. Upon discharge, the same patient
contributes a bit of effort while performing the activity and is scored 2–
Substantial/Maximal Assistance to document the patient’s progress in performing
this activity. If the patient performed less than 25 percent of the task, then the IRFPAI/FIM® score would be 1–Total Assistance at both admission and discharge.
Clinician feedback during the CARE Item Set training indicated that it is important
to distinguish between patients who are unable to participate in an activity and
patients who are beginning to participate in an activity. Clinicians also emphasized
that there are fundamental, relevant, and measurable distinctions among lowerfunctioning patients.

Example of CARE scores 1 & 2 and FIM® score 1
•

The IRF-PAI/FIM® score 1–Total Assistance (patient performs less than 25 percent
of effort) includes a broader range of patient performance than the CARE score of 1.
The FIM® Instrument’s lowest score includes patients who perform less than
25 percent of the activity, including patients who require total assistance. The CARE
rating scale differentiates between level 1–Dependent and level 2–
Substantial/Maximal Assistance (helper does more than half the effort).
–

Example: The CARE approach is based on whether the patient can do more than
half or less than half the activity and, given that information, how much assistance
is needed. If the patient can do more than half the activity, does the clinician need
to stay and supervise or can they set up and walk away, safely leaving the patient?
If the patient does less than half the activity, must the helper do all the effort or just
more than half the effort?

ES.2.2.3

Summary

The differences between the IRF-PAI/FIM® Instrument and the CARE Item Set,
including the administration and rating scales, are essential to recognize while interpreting the
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results of the data comparison. It is not expected that a one-to-one comparison can be made
between IRF-PAI/FIM® and CARE items for these and other reasons that are highlighted in the
following section. For each comparison, we note where the expectation for the most overlap
should occur. When data appear inconsistent, we are unable to determine the patient’s true
status.
ES.2.3 Selected Results of the CARE Item Set and IRF-PAI/FIM® Instrument
Analysis
Corresponding assessment instrument items were chosen from CARE and the IRF-PAI®
instruments. The analysis used scores from the 4,890 admission assessments collected.
ES.2.3.1

Bowel and Bladder Items

This complex grouping of comparison items from the CARE and IRF-PAI assessment
instruments was most challenging in the items’ distinct definitions and coding scales. The
Bladder item in CARE corresponded best to the FIM® Bladder Management item and two related
function modifier items (Bladder Level of Assistance and Bladder Frequency of Accidents). The
IRF-PAI/FIM® and CARE instruments both measure the level of assistance the patient requires
for managing the use of equipment/devices related to bladder (with a separate item for bowel
care); however, the FIM® uses a scale of 7 through 1 to indicate the amount of assistance needed,
whereas the CARE uses “Yes” or “No,” resulting in the inability to use cross-tabulation
comparison analyses. Instead, frequency tables are provided and indicate that 61 percent of
patients assessed using CARE had a bladder or bowel impairment upon admission. Within the
same sample, nearly 50 percent of the patients assessed with the IRF-PAI/FIM® required “Total
Assistance” for Bladder Level of Assistance.
Cross-tabulation comparisons were possible for CARE Frequency of Incontinence and
IRF-PAI’s Frequency of Accidents. The IRF-PAI item defines “accidents” as the act of wetting
linen or clothing with urine, including urinal or bedpan spills. The CARE Item Set reports
bladder incontinence as the involuntary leakage of urine. Successful use of incontinence
pads/undergarments (diapers) results in the patient’s being incontinent without any urine spilling
onto linen or clothing. The FIM® item does not collect data on the frequency of the patient’s
“successful use” of incontinence pads/undergarments (diapers); thus, the FIM® item reflects not
the number of times a patient is incontinent when using incontinence pads/undergarments
(diapers), but instead the frequency with which the patient had a FIM®-defined “bladder
accident.” The same corresponding items for Bowel were used for item comparison in the
analysis. The distinct difference in each instrument’s use of “incontinence” (CARE) and
“accidents” (IRF-PAI) affected the level of agreement noted between these two items in the
analysis. The expected areas of highest overlap between the CARE and FIM® bladder items did
occur. For example, there was 85 percent agreement between the instruments when CARE was
coded as “continent” for Frequency of Incontinence and IRF-PAI was coded as 6–No Accidents
With Device or 7–No Accidents Without Device. As previously noted, we expected differences
in score match rates due to the differences in the definitions of these items.
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ES.2.3.2

Selected Activities of Daily Living Items

Eating Item
Each instrument’s distinct definition of the Eating item impacted the analysis percentage
of agreement. For example, the eating items in the CARE Item Set and IRF-PAI/FIM®
Instrument are similar, but not exactly the same. The CARE Item Set has separate items for
eating and administration of tube feedings. In the IRF-PAI/FIM® Instrument, these activities are
reported in a single item, Eating. The cross-tabulations show that the CARE codes of 1, 2, 3, 4,
and 5 tended to overlap with the IRF-PAI/FIM® codes, as expected. The highest agreement was
between a CARE value of Dependent and an IRF-PAI/FIM® value of Total Assistance, where
both groups are included in the highest dependency group. Other group matches were affected
by the absence of the tube feeding cases in the CARE numbers and their inclusion in the IRFPAI numbers.
Toilet Hygiene/Toileting Item
Influencing the level of agreement between the instruments for this item were the similar
definitions yet distinct coding differences. The CARE values of 1, 2, 3, and 4 overlapped with
the FIM® values on the IRF-PAI as expected. The most agreement was between a CARE value
of Dependent and the IRF-PAI/FIM® value of Total Assistance (90 percent), followed by a
CARE value of Substantial/Maximal Assistance with the IRF-PAI/FIM® values of Total
Assistance (42 percent) and Maximal Assistance (45 percent).
Upper Body Dressing and Lower Body Dressing Items
Both the IRF-PAI/FIM® and the CARE instruments’ Upper Body Dressing items are
defined similarly. The Lower Body Dressing item definition on each instrument is similar
except the CARE item excludes footwear; putting on and taking off footwear and orthotics is a
separate item on the CARE Item Set.
Comparing the Upper Body Dressing item from each instrument, all CARE values
overlapped with the IRF-PAI/FIM® values as expected, with the exception of CARE level 6–
Independent, which overlapped most with an IRF-PAI/FIM® level of Supervision/Setup
(34 percent). This overlap may have been due to the IRF-PAI’s emphasis on rating the patient’s
most dependent versus CARE’s usual performance criteria. The most agreement was between a
CARE value of Substantial/Maximal Assistance and IRF-PAI/FIM® values of Total Assistance
(26 percent) and Maximal Assistance (60 percent). There was also high agreement among
patients with CARE values of Dependent and IRF-PAI/FIM® values of Total Assistance
(83 percent).
For the Lower Body Dressing item used from each instrument, all CARE values
overlapped with the IRF-PAI/FIM® values as expected. The most agreement was among patients
with a CARE value of Substantial/Maximal Assistance and IRF-PAI/FIM® values of Total
Assistance (33 percent) and Maximal Assistance (57 percent).
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Chair/Bed-to-Chair Transfer Item
The transfer item definitions were similar; however, the IRF-PAI definition includes the
wheelchair as one of the surfaces on which the patient is assessed. The CARE values of 1, 2, 3,
and 4 overlapped with the IRF-PAI/FIM® values as expected, except CARE’s code Setup or
Clean-up Assistance, which overlapped the most with the IRF-PAI/FIM® levels Minimal
Assistance/Touching (44 percent) and Supervision/Setup (31 percent). Patients coded as
Independent on the CARE item were most often coded as needing supervision (35 percent) and
minimal assistance (31 percent) on the IRF-PAI/FIM® Instrument. The most agreement was
among patients with a CARE value of Dependent and an IRF-PAI/FIM® value of Total
Assistance (93 percent).
Toilet Transfer Item
Each instrument defines toilet transfer differently. The CARE Item Set includes transfer
on and off a toilet or commode, whereas the IRF-PAI/FIM® item defines toilet transfer as getting
on and off a standard toilet (potentially a more difficult transfer without height adjustment). All
CARE values overlapped with the IRF-PAI/FIM® values as expected except for the CARE value
of Independent, which overlapped most with an IRF-PAI/FIM® level of Minimal
Assistance/Touching (33 percent). This overlap may have been due to the different definitions
allowing toilet seat height adjustment. The most agreement was among patients with a CARE
value of Substantial/Maximal Assistance and IRF-PAI/FIM® values of Total Assistance
(29 percent) and Maximal Assistance (49 percent). There was also substantial overlap between
patients with CARE values of Dependent and IRF-PAI/FIM® values of Total Assistance
(76 percent).
Shower/Bathe Item
Both the IRF-PAI/FIM® and the CARE instruments’ Shower/Bathe items are defined
similarly. CARE values overlapped with the IRF-PAI/FIM® values as expected. The most
agreement was among patients with a CARE value of Partial/Moderate Assistance and IRFPAI/FIM® values of Moderate Assistance (52 percent) and Minimal Assistance (25 percent).
ES.2.3.3

Mobility Items

Walking is measured so differently in the two data sets that data cannot be easily
compared across the CARE Item Set and the IRF-PAI/FIM® Instrument, thus not allowing for
cross-tabulation analysis. Frequency data are presented for each instrument.
Mode of Mobility—Walking/Wheelchair Items
The CARE instrument requires coding the patient’s performance for the walking or
wheeling item, and only one distance of this mode of mobility is coded. On the CARE Item Set,
all walking items are left blank if the patient usually uses a wheelchair. The IRF-PAI/FIM®
Instrument requires selection of the mode of locomotion by anticipating the patient’s mode of
mobility at discharge or, if the clinician is uncertain, the clinician completes at admission both
scores for wheelchair mobility and the walking items. Both walking and wheelchair scores are
reported for each IRF-PAI, whereas the CARE Item Set codes one score for the patient’s
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performance using the most frequently used mode of mobility (walking or wheeling) during the
admission assessment period.
Less than half (43 percent) of the patients in the sample assessed with the CARE Item Set
primarily used a wheelchair for mobility upon admission. Results on the IRF-PAI showed that,
upon admission, the most frequent distance walked was coded as Less Than 50 Feet and the most
frequent distance wheeled was coded as Activity Does Not Occur. The walk item most often
coded was Total Assistance, and the most frequent codes for the wheelchair item were Activity
Does Not Occur and Total Assistance.
Up and Down Stairs Item
The CARE Item Set has two distinct items for assessing a patient’s level of assistance
needed to go up and down 12 or 4 steps. The IRF-PAI/FIM® Instrument uses one item to assess
the patient’s ability to go up and down 12 to 14 steps. The IRF-PAI/FIM® Instrument has an
exception code that is used if the patient can perform “household ambulation” (going up and
down four to six steps independently, with or without a device), if the activity takes more than a
reasonable amount of time, if there are safety considerations, or if the patient requires
supervision. The data analysis revealed that going up and down stairs was a challenging activity
for many patients on admission, and codes indicating that the activity did not occur were
common on both instruments. The CARE Item Set has a skip pattern for the stair items if the
patient primarily uses a wheelchair. Nearly 43 percent of all patients were coded as Coded on
Other Item or Missing for the CARE item, and 74 percent were coded as Activity Does Not
Occur on the IRF-PAI/FIM® Instrument.
ES.2.3.4

CARE Correlations with IRF Length of Stay

The correlations between the CARE Item Set and IRF-PAI/FIM® Instrument functional
items with length of stay (LOS) are used to address predictive validity. Correlations between a
subset of the CARE Item Set’s function items and IRF LOS are displayed side by side with
correlations between the IRF-PAI/FIM® Instrument items and IRF LOS.
Although LOS is not equivalent with resource intensity, it provides general information
on the expected direction and relationship between functional items and a measureable outcome
that represents length of treatment. LOS is used as a proxy to look at the relative effects of
CARE Item Set and IRF-PAI/FIM® Instrument items and their association with the amount of
rehabilitation treatment received.
The correlations with the IRF LOS with the CARE items and IRF-PAI/FIM® Instrument
items are generally similar. There are some instances where the absolute value of the correlation
is slightly higher on the CARE items. For example, the CARE toilet hygiene item correlation
with IRF LOS is −0.377, whereas the IRF-PAI/FIM® Instrument toileting correlation is −0.364.
For other items, the correlation with IRF LOS was higher for the IRF-PAI/FIM® Instrument item
than for the CARE item. Overall, it appears that the CARE Item Set’s capacity to explain LOS is
comparable to that of the IRF-PAI/FIM® Instrument.
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ES.2.4 Summary of the CARE Item Set and IRF-PAI/FIM® Instrument Analysis
There was generally good agreement between CARE Item Set and IRF-PAI/FIM®
Instrument scoring levels where agreement was expected, that is, for areas where the item
definition was similar. Specifically, because of similarities between task performance definitions
across the CARE and IRF-PAI self-care items, agreement was excellent and predictable based on
the altered structure of the measure response levels. This pattern was remarkably consistent
across the self-care items, as well as those supplemental items with similar activity definitions.
When items were conceptually similar but definitions were very different, agreement was
not expected. For example, definition differences for bowel and bladder items and for walking
items challenged comparisons. Our preliminary analyses showed that the relationship between
LOS and individual CARE items was comparable to correlations between individual IRF-PAI
items and LOS, even though the latter assessment was tailored to fit the IRF setting.
ES.3

CARE Item Set and MDS 2.0 Instrument: Overview, Background, and Methods

These analyses compare the CARE Item Set items relative to MDS 2.0 prospective
payment items (resource utilization group [RUG]-III V5.20). Analyses are based on CARE
assessments matched with MDS 2.0 assessments. CARE and MDS 2.0 assessment data were
merged using Medicare beneficiary identification number (HICN), gender, and birth date. In
summary, 93.3 percent of the CARE admission assessments collected in participating SNFs were
successfully matched with MDS 2.0 data, for a total of 3,977 assessment pairs.
ES.3.1 Expected Differences in Response Item Codes between CARE and the
MDS 2.0
Selected items from both the MDS 2.0 Instrument and CARE Item Set were compared
for this analysis. As with the IRF-PAI–CARE comparison, items were selected based on
concepts used in the SNF PPS for case-mix adjustment. Although many CARE items address
activities that are also included on the MDS 2.0, there are several key differences between the
two assessment instruments that may have resulted in differences in data reported on the two
assessments. Key differences between the assessment instruments affecting all item-by-item
comparisons include the following:
Time Frame: The assessment time frame for the CARE Item Set is 2 calendar days (if
the resident is admitted before 12 noon) or 3 calendar days (for residents admitted after 12 noon).
The MDS 2.0, 5-day PPS assessment was used for patients who are covered by Medicare Part A.
Most MDS 2.0 items are assessed during a 7-day look-back period. The assessment allows up to
3 additional grace period days for the 5-day PPS instrument, during which the resident is
assessed by “looking back over the last 7-day assessment period.” Other MDS 2.0 items have a
14-day look-back period.
Implication: Patients may be assessed at different acuity levels on the MDS 2.0 and
CARE Item Set. When preadmission days are included in the 7-day look-back period and when
only one instrument uses the 14-day look-back period, the resident’s prior acuity level can affect
the data comparison of the two instruments. These status differences may occur at preadmission
or post-admission to the SNF.
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Item Rating Scales: Differences between CARE and MDS 2.0 in item rating scales
exist, and a comparison and alignment of the rating scales are noted with each item comparison.
The functional item rating scale differences are detailed in the following sections prior to the
selected item analysis discussion.
Item Definitions: Although similar concepts are compared in this analysis, specific item
definitions may not be identical, and specific item definitions are described before each
comparison.
Administration Differences: Another source of potential variation between the CARE
Item Set and MDS 2.0 items may be due to different types of clinicians conducting the CARE
assessment and the MDS assessment.
Error: Some disagreement between the CARE and MDS 2.0 items may be attributable to
clinician reporting errors on one of the tools. As noted in the interrater reliability section in
Volume 2, and in prior evaluations of MDS 2.0 items, some items have lower reliability than
others.
ES.3.2 Selected Results of the CARE Item Set and MDS 2.0 Instrument Analyses
ES.3.2.1

Items in the Major Treatments Section

A subset of Major Treatments items in the CARE Item Set were paired with
corresponding items on the MDS 2.0 and analyzed using the admission patient data sample of
3,977 patients. Within the 12 Major Treatments assessment items analyzed for this report, three
item pairings were assessed by the MDS 2.0 over a 7-day assessment period compared with the
CARE 2-day assessment period. Nine item pairings were assessed by the MDS 2.0 over a 14day assessment period compared with the CARE 2-day assessment period (the only exception is
the 14-day look-back period for the CARE Mood items). There was very high agreement (89 to
99.8 percent) between 9 out of 12 of the Major Treatments item pairings. These nine paired
items assessed the patient as not having received the comparable Major Treatments item
described by the MDS 2.0 and CARE.
For most of these items, the MDS 2.0 identified a small quantity of patients as having
received the Major Treatments item when CARE assessed the patient as not having received it.
This discrepancy is likely due to the broader MDS 2.0 assessment period of 7 or 14 days (e.g.,
Pressure Relieving/Specialty Surface, Complex/Surgical Wounds, and Oxygen). Also, the
definitions between the instruments varied with the MDS 2.0 capturing a much broader range of
patients within the definition of these items compared with the CARE Item Set definition. For
example, CARE item Specialty Surface or Bed was assessed as “No Treatment Received” and
MDS 2.0 assessed as “Yes, Treatment Received” 79 percent of the time for this item pairing,
exemplifying the more inclusive definition used in the MDS 2.0. See Table ES-1 for a
breakdown of CARE and MDS 2.0 agreement on Major Treatments items.
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Table ES-1
CARE agreement with MDS 2.0 for Major Treatments items

CARE & MDS 2.0:
Major Treatments Items;
CARE 2-Day Assessment;
MDS 2.0 7-Day or 14-Day Assessment

Item coded
“treatment not
provided”
percentage of
agreement between
CARE & MDS 2.0

MDS 2.0
7-day
assessment
item

MDS 2.0
14-day
assessment
item

CARE: Major treatments: Total parenteral
nutrition (item III.D3a)
MDS 2.0: Nutritional approaches: Parenteral/IV
(item K5a)

92.9%

x

—

CARE: Major treatments: Blood transfusion(s)
(item D5a)
MDS 2.0: Special treatments and procedures:
Transfusions (item P1ak)

89.0%

—

x

CARE: Tracheostomy tube with suctioning (item
D11a)
MDS: Tracheostomy care (item P1aj)

99.7%

—

x

CARE: Tracheostomy tube with suctioning (item
D11a)
MDS 2.0: Suctioning (item P1ai)

99.8%

—

x

CARE: Ventilator weaning (item D14a)
MDS: Ventilator or respirator (item P1al)

99.2%

—

x

CARE: Ventilator non-weaning (item D15a)
MDS: Ventilator or respirator (item P1al)

99.3%

—

x

CARE: IV Chemotherapy (item D28a)
MDS: Chemotherapy (item P1aa)

99.4%

—

x

CARE: Peritoneal dialysis (item D17a)
MDS: Dialysis (item P1ab)

96.8%

—

x

CARE: Hemodialysis (item D16a)
MDS: Dialysis (item P1ab)

99.2%

—

x

CARE: High O2 concentration delivery system
with FiO2 > 40% (item D12a)
MDS 2.0: Oxygen therapy (item P1ag)

67.0%
Also (CARE=No;
MDS=Yes, 32.6%)

—

x

CARE: Specialty surface or bed (item D24a)
MDS: Pressure-relieving device for bed (item
M5b)

21.0%
Also (CARE=No;
MDS=Yes, 78.8%)

x

—

CARE: Complex wound management (item
D20a)
MDS: Surgical wound care (item M5f)

67.0%
Also (CARE=No;
MDS=Yes, 32.0%)

x

—
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ES.3.2.2

Skin Integrity Items

Differences in assessment windows, item definitions, and rating scales may explain
variation where the MDS 2.0 reports more pressure ulcers and wounds than the CARE Item Set
does.
Pressure Ulcers
Analyses comparing the two instruments’ items for Pressure Ulcers showed the
following: Among patients with zero, one, or two stage 2 pressure ulcers reported, there was a
high level of agreement between the CARE and MDS items. For example, among patients with
zero ulcers reported in CARE, 94 percent also had zero ulcers reported in the MDS. The data
representing the level of agreement for stage 3 and stage 4 pressure ulcers were based on less
than 2 percent of the sampled population and were not reported here.
Surgical Wounds and Other Major Wounds
Among patients with Delayed Surgical Wounds reported on the CARE Item Set,
89 percent had a Surgical Wound reported on the MDS 2.0. In contrast, among patients with no
delayed surgical wounds reported on the CARE Item Set, 39 percent had a surgical wound
reported on the MDS 2.0. This discrepancy is likely the result of differing item definitions; the
MDS 2.0 item is broader (all surgical wounds) than the CARE item (nonhealing surgical
wounds).
The comparison of CARE item Number of Other Wounds versus MDS 2.0 item Surgical
Wounds showed the following: Among patients with other major wounds reported on the CARE
Item Set, 81 percent had a surgical wound reported on the MDS 2.0. For patients with no other
major wounds reported on the CARE Item Set, only 33 percent had a surgical wound on the
MDS 2.0. Among patients with other major wounds reported on the CARE Item Set, 4 percent
had another lesion reported on the MDS 2.0. This discrepancy is predictable given the more
restrictive MDS item definition.
ES.3.2.3

Selected Cognitive Status and Mood Items

Short-Term Memory Items
In this section we compare the CARE items for recall of the words “sock,” “blue,” and
“bed” and the MDS 2.0 Short-Term Memory OK items. The CARE item rates the patient on
recall success for each of the three items and whether patients required a “cue” to prompt their
recall of each item during the 2-day assessment period. The MDS 2.0 (7-day assessment period)
uses a broader method to determine short-term memory problems (e.g., not able to recall
multiple items or not following through on a direction given 5 minutes earlier). The responses to
the individual CARE items may indicate short-term memory problems, whereas the MDS 2.0
item may not capture milder memory problems. The analysis results are consistent with this
hypothesis. The CARE item response “Yes after cueing” for these items rating patient ability to
recall each word showed 53, 54, 45 percent agreement when compared with the MDS 2.0 “Yes”
(memory problem). This may be explained because the CARE’s response scores the patient’s
ability to recall a word when a cue is given, whereas the same patient assessed by the MDS 2.0
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would not have been offered a cue word. Thus, on the MDS 2.0, the same patient would likely
not recall the word, resulting in the memory problem rating. Notably, for each of the three
CARE items, approximately 18 to 21 percent of patients who could recall “sock,” “blue,” or
“bed” were recorded as having short-term memory problems on the MDS 2.0.
Physical/Abusive Behavioral Symptoms Directed Toward Others
Among patients who were assessed on the CARE Item Set as not having physical
behavioral symptoms directed toward others, 98 percent were similarly assessed on the MDS 2.0.
Notably, among the patients who did have physical behavioral symptoms directed toward others
on the CARE Item Set, 61 percent did not have these behaviors reported on the MDS 2.0. This
result may have been due to the difference in the items’ “titles” or definitions.
Selected Mood Items
Among patients who were reported as not having Little Interest or Pleasure Doing Things
on the CARE Item Set, 98 percent also did not report Withdrawal from Activities on the MDS
and 98 percent did not report Reduced Social Interaction on the MDS 2.0. Among the patients
who did have some frequency of Little Interest or Pleasure Doing Things on the CARE Item Set,
the vast majority (ranging from 92 to 97 percent) did not report Withdrawal from Activities or
Reduced Social Interaction on the MDS. This discrepancy might be due to the more specific
MDS item definitions.
Among patients who were reported as not being Down, Depressed, or Hopeless on the
CARE Item Set, 99 percent also did not report Negative Statements, 99 percent did not report
Self-Deprecation, and 97 percent did not report Crying/Tearfulness on the MDS. Notably,
among the patients who did have some frequency of being Down, Depressed, or Hopeless on the
CARE Item Set, the vast majority (ranging from 87 to 100 percent) did not report Negative
Statements, Self-Deprecation, or Crying/Tearfulness on the MDS. This discrepancy might be
due to the more specific MDS item definitions or differences in how these behaviors are assessed
in SNFs.
ES.3.2.4

Impairments

Swallowing Items
In this section, we focus on CARE tube/parenteral feeding and MDS 2.0 feeding tube
items. Among patients whose CARE assessment reported usual ability with swallowing using
tube/parenteral feeding, 94 percent also had a feeding tube reported on the MDS 2.0. There are
differences in how each instrument categorizes these two items: MDS 2.0 allows multiple
selections among several choices for the clinician to indicate the facility’s nutritional approaches
taken with the patient; the CARE item’s more specific nature asks the clinician to choose only
one of three answers to represent the patient’s usual ability with swallowing. Choosing only one
answer results in the high frequency of “missing” data for the CARE item. The MDS 2.0 item
indicated Feeding Tube Not Used and highly agreed with the CARE item tube/parenteral feeding
coding “No,” resulting in the items showing a high agreement for the mapping of the findings
(99 percent).
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Select Communication Item
The CARE item Expression of Ideas and Wants and the MDS 2.0 item Making Self
Understood have similar definitions and scales. Both the CARE and MDS 2.0 report that
sampled patients who had no difficulty in self-expression (CARE) also indicated that they were
understood (MDS 2.0). Among those who were reported as being understood in MDS,
59 percent were reported as indicating some difficulty in self-expression, whereas 28 percent
were reported as indicating frequent difficulty in self-expression on CARE.
ES.3.2.5

Selected Functional Status Items

Functional Status Rating Scale
The MDS 2.0 uses two rating scales to capture functional status, whereas the CARE
rating scale captures both the self-performance and assistance provided in one rating scale. The
items for Physical Functioning (MDS 2.0 term) and Functional Status (CARE term) use different
rating scales to assess each instrument’s activities (e.g., eating). These rating scales are used in
the data analyses to compare the MDS 2.0’s two rating scales with the single CARE Item Set’s
rating scale and present a very complex set of challenges when presenting each instrument’s
activities (e.g., toileting, eating) for comparison.
The CARE rating scale is an independence scale, and the higher numbers indicate more
independence; the MDS 2.0 has two rating scales, a support rating scale and a self-performance
scale, that are dependence rating scales with the lower numbers indicating more independence.
Additionally, the definition differences may result in item categories between the CARE
and MDS 2.0 assessments not cleanly mapping. For example, a patient who is highly involved
with managing the equipment necessary for tube feeding but is not eating may score a higher
functional level on the MDS 2.0 because the MDS 2.0 item includes tube feeding, whereas the
CARE Item Set does not. The CARE Item Set includes tube feeding as a separate item. See
Table ES-2 for a mapping of the two types of MDS 2.0 item scales with the CARE function
scale.
Level of Performance and Data Analysis Challenges
Examples are provided to illustrate how each instrument assesses level of performance.
The CARE Item Set discriminates between a CARE level 3–Partial/Moderate Assistance and a
CARE level 2–Substantial/Maximal Assistance by assessing whether the helper did less than half
or more than half the effort.
On the MDS 2.0, the level of assistance between level 2–Limited Assistance and level
3–Extensive Assistance is determined by assessing (1) whether the helper provided non-weightbearing support or weight-bearing support, (2) if full staff support was needed, and (3) the
number of times assistance was needed during the assessment period.
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Table ES-2
CARE scale levels mapped to MDS 2.0 ADL self-performance scale levels, controlling for
MDS ADL support provided scale levels
MDS ADL support
provided level
0 – No setup or
physical help
1 – Setup help only
1 – Setup help only

Plus

CARE level

Equals

MDS ADL selfperformance level

+

6 – Independent

=

0 – Independent

+
+

5 – Setup or clean-up
5 – Setup or clean-up
4 – Supervision/touching
assistance
4 – Supervision/touching
assistance
4 – Supervision/touching
assistance
OR
3 – Partial/moderate assistance
3 – Partial/moderate assistance
OR
2 – Substantial/maximal
assistance
OR
1 – Dependent

=
=

0 – Independent
1 – Supervision

=

1 – Supervision

=

1 – Supervision

=

2 – Limited assistance

=

3 – Extensive
assistance

1 – Dependent

=

4 – Total dependence

1 – Setup help only

+

2 – One person
physical assist

+

2 – One person
physical assist

+

2 – One person
physical assist

+

2 – One person
physical assist

+

3 – Two+ person
physical assist

+

1 – Dependent

=

8 – Activity did not
occur

+

Letter code – Activity not
attempted

=

2 – Limited assistance
OR
3 – Extensive
assistance
OR
4 – Total dependence
8 – Activity did not
occur

A very complex set of data analyses challenges was met when presenting each of the two
instruments’ activities (e.g., toileting) and using the MDS 2.0’s two rating scales when
comparing the single CARE Item Set’s rating scale. To address this challenge, many crosstabulation tables compare data for specific MDS 2.0 and CARE activities (e.g., toileting,
eating) while controlling for (holding constant) the MDS 2.0’s rating scale ADL Support
Provided. Each of the tables that control for ADL Support Provided specify which of the four
levels (i.e., no setup or physical help, setup help only, one person physical assist, two+ person
physical assist) of the MDS 2.0 rating scale is being held constant for the data analysis. The
following are selected items from each of the two instruments describing the cross-tabulation
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data analysis tables. For most of the headings in the following sections, the activity name from
each instrument is stated followed by the ADL Support Provided that is held constant.
CARE Eating Item and MDS 2.0 Eating Item
The analyses show that approximately 50 to 99 percent of the paired CARE–MDS 2.0
assessments map as expected in terms of the functional item scale categories when the MDS 2.0
ADL Support item is considered. The highest percent agreement (approximately 99 percent)
occurs when the independent level is considered, mapping the independent and setup/clean-up
categories in CARE to the independent category in MDS 2.0. The lowest percent agreement
(approximately 51 percent of 187 paired assessments) is observed when the supervision category
is considered. Reviewing the analyses for this item suggests that consideration to mapping
functional item levels across tables (i.e., while controlling for MDS 2.0 ADL Support)
strengthens the already robust functional item category match between instruments.
CARE Toilet Hygiene Item and MDS 2.0 Toilet Use ADL Self-Performance Item when MDS 2.0
Support Level Is Controlled
Among the 873 patients who were evaluated as needing Partial Assistance on the CARE
Item Set and required a One Person Physical Assist on the MDS, the majority of responses were
seen in the expected MDS levels (36 percent in Limited Assistance and 53 percent in Extensive
Assistance). Similarly, CARE response level 2 (Substantial Assistance) maps well to MDS SelfPerformance level 3 (Extensive Assistance), showing 66 percent. The majority of responses in
the CARE Supervision or Setup categories fell into the expected MDS Self-Performance levels
when Setup Help Only is indicated in the MDS Support variable.
CARE Lying to Sitting Item and MDS 2.0 Bed Mobility ADL Self-Performance Item when MDS
2.0 Support Level Is Controlled
The majority of responses in the CARE Supervision or Setup categories fell into the
expected MDS Self-Performance levels when Setup Help only is indicated in the MDS Support
variable. Among the 779 patients who were evaluated as needing Partial Assistance on the
CARE Item Set and required a One Person Physical Assist on the MDS, the majority of
responses were seen in the expected MDS levels (42 percent in Limited Assistance and
52 percent in Extensive Assistance). Similarly, CARE response level 2 (Substantial Assistance)
maps well to MDS Self-Performance level 3 (Extensive Assistance), showing 66 percent
agreement.
CARE Chair/Bed-to-Chair Transfer Item and MDS 2.0 Transfer ADL Self-Performance Item
when MDS 2.0 Support Level Is Controlled
Among the nearly 800 patients who were evaluated as needing Partial Assistance on the
CARE Item Set and required a One Person Physical Assist on the MDS, 93 percent were
assessed in the predicted MDS Self-Performance categories of either Limited Assistance or
Extensive Assistance. There is also a bit of scatter outside the predicted response pairings,
indicating a more dependent response on the MDS 2.0. The discrepancy may be due to the
differing item definitions.
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When controlling for MDS 2.0 Transfer ADL Support Provided level 3 (Two+ Person
Physical Assist) and comparing the two items, the expected mapping agreement occurred
between CARE’s level Dependent and MDS 2.0 rating scores Extensive Assistance and Total
Dependence. There was greater than expected agreement between the MDS 2.0 rating Extensive
Assistance scores and the CARE rating scores Substantial/Maximal Assistance (88 percent),
Partial/Moderate Assistance (88 percent), and Supervision/Touching Assistance (86 percent).
CARE Roll Left and Right by MDS 2.0 Bed Mobility ADL Self-Performance when Controlling for
MDS 2.0 Bed Mobility ADL Support Provided
The data analysis showed a high amount of agreement (96 percent) for patients assessed
as Independent on the CARE Item Set and assessed as Independent in Self-Performance on the
MDS 2.0 who did not require Setup or Physical Help. There was good agreement between the
instruments for patients who were evaluated as needing Substantial Assistance on the CARE
Item Set and required a One Person Physical Assist on the MDS; 68 percent were assessed as
needing Extensive Assistance in Self-Performance on the MDS, which is the predicted response.
Similarly high levels of agreement are also shown within the CARE levels for Dependent, Partial
Assistance, and Supervision.
ES.3.3 Summary of the CARE Item Set and MDS 2.0 Analysis
This section profiles a set of descriptive analyses of the level of agreement between
selected CARE Item Set and MDS 2.0 Instrument items. A direct one-to-one item comparison
between the two instruments is not possible because of differences in assessment time frames,
item rating scales, and the sometimes unique definitions for similar items used to assess function.
This mapping of selected items and associated scales presents an important examination of how
selected CARE items are assessed and how they align with similar MDS 2.0 items. These
findings indicated a high to moderate level of agreement between the two assessment
instruments with respect to selected items. There was an absence of any large and/or unexpected
association(s) between the two instruments. Sometimes more modest agreement occurred
between functional item pairs (e.g., approximately 50 percent).
ES.4

CARE Item Set and OASIS-B Instruments: Overview, Background, and Methods

The purpose of this analysis is to assess the concurrent validity of the CARE Item Set
with the OASIS-B. Analyses are based on finalized CARE Item Set admission assessments
matched with OASIS-B “Start of Care” or “Resumption of Care” assessments. To begin, HHA
admission assessment data from the January 2010 CARE extract data (n = 4,996) were merged
with OASIS-B assessment data available through December 31, 2009, by HICN, gender, and
birth date. The final data set contained CARE admission assessments matched to either an
OASIS-B “Start of Care” or “Resumption of Care” assessment and contained 4,587 observations
(representing 92 percent of finalized CARE admission assessments from HHAs). As with the
IRF-PAI and MDS comparisons, items were selected for comparison if they captured concepts
included in the HHA PPS as case-mix adjustment variables.
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ES.4.1 Differences between CARE Item Set and OASIS-B
Although many CARE items share comparable concepts to OASIS-B items, there are
several key differences between the two assessment instruments that were anticipated to result in
differences in patient assessment and associated differences between assessment instrument item
responses.
Time Frame: The assessment time frame for the CARE Item Set is 2 calendar days (if
the patient is admitted before 12 noon) or 3 calendar days (for patients admitted after 12 noon).
The OASIS-B time frame for the majority of items evaluated in the following sections refers to
the patient’s status for most of the day of the assessment visit, or the patient’s usual status. The
CARE Item Set does instruct clinicians to report the usual (or typical) performance but with a
slightly longer time frame. A few of the OASIS-B items regarding prior service use and
conditions require a 14-day look-back period immediately preceding the assessment. The CARE
instrument has a 14-day look-back period only for the CARE Mood items.
Implication: In general, we expect that differences in assessment time period should play
little role in differences between OASIS-B and CARE Item Set responses. It is likely that the
data for both assessments were collected simultaneously the majority of the time.
Differences in Rating Scales: Differences between CARE and OASIS-B instruments
exist regarding alignment of scales. Further discussion about the CARE functional rating scale
versus the OASIS-B ADL/IADL rating scale is provided in the comparisons of these items and
the associated data analysis in the following sections.
Differences in Item Definitions: Although comparable concepts are used in the
comparison for this analysis, specific item definitions may not be identical.
Error: Some disagreement between the CARE and OASIS-B items may be attributable
to clinician reporting errors on one of the tools. As noted in the interrater reliability section in
Volume 2, and in prior evaluations of OASIS-B items, some items have lower reliability than
others.
ES.4.2 Selected Results for CARE and OASIS-B Instrument Items Analyzed
ES.4.2.1

Stage 2, 3, and 4 Pressure Ulcers Item

There is a high degree of agreement where expected between the CARE and OASIS-B
items for numbers of Stage 2, 3, and 4 pressure ulcers. For example, among those patients with
no Stage 2 pressure ulcers indicated in CARE, 99 percent also had no Stage 2 pressure ulcers
indicated in OASIS-B. Similarly, among those patients with one Stage 2 pressure ulcer recorded
in CARE, 80 percent also had one Stage 2 pressure ulcer recorded in OASIS-B. There was
85 percent agreement between the instruments for two Stage 2 pressure ulcers. However,
because of the small sample size, it is not possible to draw any conclusions about the agreement
between the instruments for any of the responses indicating more than one Stage 3 and 4 pressure
ulcer.
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ES.4.2.2

Surgical Wound Item

There was high agreement between the instruments among those CARE-assessed patients
with no Delayed Healing Surgical Wounds and OASIS-B–assessed patients who had either no
Problematic Surgical Wounds or Fully Granulated Surgical Wounds. Also, there was a high
degree of agreement (89 percent) between the instruments for patients with one Delayed Healing
Surgical Wound in CARE and either Partial Granulation or Not Healing in OASIS-B. The same
high level of agreement is evident when two Delayed Healing Surgical Wounds are indicated in
CARE.
ES.4.2.3

Pain Item

The results of the CARE item Pain Effect on Activities and OASIS-B item Frequency of
Pain Interfering with Patient’s Activity or Movement are of note. Because of the skip pattern in
the CARE Item Set, approximately 35 percent of patients in the sample had no response for this
item in CARE because they had no pain or hurting in the last 2 days. Only the patients who
responded “Yes” to an initial question about the presence of pain were assessed for pain’s effect
on activities. Therefore, it is possible to view the 70 percent of patients with a missing value in
CARE but with no pain in OASIS-B as a potential area of agreement.
Among patients who responded “Yes” to any pain present and reported that pain limits
their activities on CARE, 96 percent indicated that pain affects their movement or activities at
some frequency (ranging from less often than daily to all of the time) on OASIS-B.
Unexpectedly among patients who responded “Yes” to Any Pain Present but who reported that
Pain Does Not Limit Their Activities on CARE, the majority (59 percent) had daily (but not
constant) pain interfering with activity or movement reported on OASIS-B. One of the potential
reasons for this discrepancy is that CARE is set up as an interview item, and OASIS-B is not a
direct interview item.
ES.4.2.4

Bladder Incontinence Item and Bowel Incontinence Items

There was a high amount of agreement between the CARE item Frequency of Bladder
Incontinence and OASIS-B item Frequency of Incontinence or Urinary Catheter. For example,
among patients who were assessed as continent on the CARE Item Set, 92 percent reported no
urinary incontinence or catheter on OASIS-B.
There was a relatively high amount of agreement between the CARE item Frequency of
Bowel Incontinence and OASIS-B item Frequency of Bowel Incontinence. For example, among
patients who were reported to have bowel incontinence less than daily on the CARE Item Set,
97 percent were reported to have either no or very rare bowel incontinence, incontinence less
than weekly, incontinence one to three times weekly, or incontinence four to six times weekly on
OASIS-B, which follows the expected response pattern.
ES.4.2.5

Functional Status Section and Rating Scale Differences

The functional status section of the CARE Item Set is composed of three major sections:
Core Self-Care (Section A); Core Functional Mobility (Section B); and Supplemental Functional
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Ability (Section C). Alignment between the OASIS-B and CARE functional item scales is
variable for multiple reasons.
The CARE functional items were patterned after the IRF-PAI/FIM® functional items;
thus, the CARE Item Set align more closely with the IRF-PAI/FIM® definitions than the
OASIS-B definitions.
Functional Rating Scale Differences
•

The CARE scale for this item ascends to demonstrate independence, whereas the
OASIS-B scale for this item descends to demonstrate independence. For example, a
patient who is independent is scored as a six on the CARE Item Set, but the same
patient is scored as a zero on the OASIS-B Instrument.

•

The CARE scale is more subdivided, and each functional status item consistently uses
the same metric to demonstrate whether the patient requires helper assistance and the
amount of assistance the helper provides.

•

The CARE Item Set discriminates between a level 3–Partial/Moderate Assistance and
a level 2–Substantial/Maximal Assistance by assessing whether the helper did more
than half the effort. The OASIS-B does not distinguish between these two levels and
identifies only whether someone must help the patient to complete the activity.

•

The CARE functional item rating is a six-category scale, ranging from six through
one, whereas the OASIS-B ADL/IADL scale includes varied categories and can range
from zero to two, zero to three, zero to four, or zero to five per item. Each group of
rating scales included UK–unknown. The level descriptions that vary per item for the
OASIS-B are included in the analyses.

•

The CARE and OASIS-B instrument scales both assess patients’ usual performance.

•

Differences between the instruments (e.g., the assessment time frame window and the
rating scales) are important considerations in interpreting the mapping results.
Because the OASIS-B items vary, we have not included a mapping here as in the
prior comparisons with the MDS and IRF-PAI.

Upper Body Dressing Item
Because of the differences in the OASIS-B and CARE rating scales’ defining metrics, the
OASIS-B level Someone Must Help the Patient Put On Upper Body Clothing would be expected
to map to CARE levels Supervision or Touching Assistance, Partial/Moderate Assistance, and
Substantial/Maximal Assistance for the upper body dressing item. This result was indeed the
case because high levels of agreement were observed between these levels of the CARE scale
and their corresponding OASIS-B levels. In most cases, agreement exceeded 70 percent. There
was also high agreement (75 percent) for the comparable Independent rating for both
instruments.
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Lower Body Dressing and Putting On/Taking Off Footwear Items
The two CARE items’ (Lower Body Dressing and Putting On/Taking Off Footwear) data
were individually paired with the OASIS-B item Ability to Dress Lower Body to yield results for
the analyses. Overall, there was a high amount of agreement between the CARE lower body
dressing and OASIS-B lower body dressing items. The levels of agreement between the two
items range from 58 percent for agreement in setup responses to 81 percent agreement between
the CARE level Partial Assistance and OASIS-B level Someone Must Help Put On
Undergarments, Socks or Nylons, and Shoes.
Similarly, relatively high levels of agreement were observed between the CARE item
Putting On/Taking Off Footwear and the OASIS-B item Lower Body Dressing. Rating levels
ranged from 47 percent for agreement in setup responses to 75 percent agreement between the
CARE level Partial Assistance and OASIS-B level Someone Must Help Put On Undergarments,
Socks or Nylons, and Shoes.
More agreement was noted between the CARE lower body dressing item and the
OASIS-B item on identifying dependent patients than when looking at the CARE footwear item.
However, because the OASIS-B item includes lower body dressing and footwear management,
we expected that more patients were rated as dependent on the CARE footwear item than were
rated as not dependent on the OASIS-B item; 42 percent of patients dependent in the CARE
footwear item were only a level 2 (Someone Must Help Put On Undergarments, Slacks, Socks or
Nylons, and Shoes) on OASIS-B. This difference was expected because putting on footwear is a
more difficult activity than lower body dressing—hence the 43 percent agreement seen in the
cross-tabulation analysis.
CARE Chair/Bed to Chair Transfer Item and OASIS-B Transferring Item
The OASIS-B definition for the transferring item combines several concepts (i.e., the
ability to transfer on and off toilet or commode, the ability to transfer into and out of the tub or
shower, the ability to turn and position self in bed if patient is bedfast, and the ability to bear
weight). These activities are measured in separate items on CARE. Although there are
substantial differences in item definitions, the trends seen in the analyses indicate a high degree
of agreement between these items, suggesting that they are measuring similar concepts.
For example, by combining the percentage of patients assessed in each of the OASIS-B
rating scale items that matched the CARE item Dependent, 89 percent agreement was achieved
between the two instrument scales. The OASIS-B scale item and the percentage of agreement to
the CARE Dependent rating scale included Unable to Transfer Self but Able to Bear Weight
(30 percent), Unable to Transfer Self and Unable to Bear Weight (38 percent), Bedfast but Able
to Position Self (7 percent), and Bedfast and Unable to Position Self (14 percent). Patients who
were assessed as either Partial Assistance, Supervision, or Setup in CARE had approximately
73 to 87 percent of responses falling in the expected OASIS-B category of Transfers with
Minimal Human Assistance.
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Shower/Bathing Item
A key difference between the two instrument items is that the OASIS-B item Bathing
includes getting in and out of the shower or tub, whereas the CARE item Shower/Bathe Self does
not include these tasks. A range of high to moderate agreement was observed between the
CARE scale and corresponding OASIS-B levels: 87 percent for agreement between CARE
Independent and across the three OASIS-B levels (where agreement was anticipated between the
instruments) to 43 percent agreement between the CARE level Setup and OASIS-B level Able to
Bathe in Shower or Tub with Assistance of Another Person. The latter OASIS-B item includes
help getting in and out of the shower or tub. Again, shower/tub transfers are not included in the
CARE instrument, thus explaining the lesser agreement between instruments.
Mode of Mobility: Ambulation and Locomotion
The challenge in presenting the data for this section was great because OASIS-B has a
single ambulation/locomotion item, whereas the CARE Item Set asks the clinician to select
between four separate mobility distances or four separate wheeling distances to measure the
patient’s walking or wheeling ability. In addition, the OASIS-B combines stair climbing and
walking on uneven surfaces with the OASIS-B ambulation/locomotion item, whereas the CARE
separately measures the patient’s ability for these as two distinct items (“Ability to go up and
down steps” and “Walking on uneven surfaces”).
Only two of the four CARE distances for walking were used for the analyses, and two
CARE distance items were used for wheeling when comparing the single OASIS-B
ambulation/locomotion item. We generated individual frequency tables for the four chosen
CARE items (two for walking and two for wheeling), one frequency table for OASIS-B (shown
twice), and four separate cross-tabulation tables to compare the agreement between the four
CARE variables and one OASIS-B variable. Examples from each of the four cross-tabulation
analyses follow.
Comparison of CARE Walk 150 Feet versus OASIS-B ambulation/locomotion items.
Among patients who were assessed as Independent on the CARE Item Set Walk 150 Feet, 94
percent were assessed as either “Able to walk independently on even and uneven surfaces” or
“Requires use of a device to walk alone” on OASIS-B. Similarly high levels of agreement were
observed between the CARE Supervision category and the corresponding OASIS-B levels: 65
percent in the OASIS-B category of “Requires use of device or requires human supervision” and
33 percent in the OASIS-B category of “Able to walk only with the supervision or assistance of
another person at all times.”
Comparison of CARE Walk in Room Once Standing versus OASIS-B ambulation/
locomotion items. Among patients who were assessed as Independent on the CARE Item Set item
Walk in Room Once Standing, 88 percent were assessed as either “Able to walk independently on
even and uneven surfaces” or “Requires use of a device to walk alone” on OASIS-B. Similarly
high levels of agreement were observed between the CARE Supervision category for Walk in
Room Once Standing and the corresponding OASIS-B levels: 40 percent in the OASIS-B category
of “Requires use of device or requires human supervision” and 57 percent in the OASIS-B
category of “Able to walk only with the supervision or assistance of another person at all times.”
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Comparison of CARE Wheel 150 Feet versus OASIS-B ambulation/locomotion items
and comparison of CARE Wheel in Room Once Seated versus OASIS-B ambulation/locomotion
items. Among patients who were assessed as Independent in wheeling 150 feet and for those
patients separately assessed as Independent in wheeling once seated on the CARE Item Set, the
majority (45 and 46 percent, respectively) were categorized in OASIS-B as “Chairfast–unable to
ambulate but is able to wheel self independently.” This category is where the majority of coding
for each of these two instrument pairings was expected to fall. The analysis revealed 26 percent
agreement between the instruments for patients who were assessed on the CARE Item Set as
Independent in wheeling 150 feet and were assessed as “Requires use of device to walk alone” or
“Requires human supervision or assistance” on the OASIS-B. Recall that the OASIS-B codes
used for this item include ratings for walking for the most independent code (0) and chairfast or
bedfast for the most dependent codes.
Also, the analysis revealed 19 percent agreement between the instruments that assessed
patients who were Independent in wheeling once seated on the CARE Item Set and patients who
were assessed as “Requires use of device to walk alone” or “Requires human supervision or
assistance” on the OASIS-B. Sometimes the reason why the data take unexpected patterns such
as in this cross-tabulation is unclear. The multiple tasks included in the OASIS-B item may
account for these unexpected patterns.
ES.4.3 Summary of CARE Item Set and OASIS-B Instruments Analysis
Similar to the MDS 2.0 and IRF-PAI analyses summarized, the purpose of this analysis
was to measure the level of agreement between the CARE Item Set and the OASIS-B items.
Although a direct one-to-one item comparison between the two instruments is not possible due to
the instruments’ differences, the examination of each instrument’s items determined logical
pairings for comparison and use in the analysis. Although there are lesser differences between
the instruments that affect the results of the analysis (i.e., assessment time frame), there are
marked differences in the instruments’ rating scale categories that affect the comparison of the
instruments. For example, the variable inclusion or exclusion of activities, equipment used, or
levels of patient assistance required within each OASIS-B rating scale measurement may have
influenced the ability for precise agreement between activity item pairings. The complexity of
the multiple variables per OASIS-B item required specific pairings using a combination of
coding items per individual instrument activity in order to map the item to a similar CARE
item(s).
The mapping of items and associated scales resulted in this analysis and is presented to
increase the understanding of how CARE items were assessed vis-à-vis similar OASIS-B items
associated with payment policy at the time of data collection, where equivalent items were
available. Please note that some HHA PPS items were not possible to evaluate because of an
intentional lack of an equivalent CARE item, such as count of therapy visits or for patients with
multiple consecutive HHA episodes, an indicator of which episode the assessment corresponds
to in the sequence.
Considering the degree of differences in the item rating scales and the successful
matching of items according to most similar content, the item pairings from the CARE Item Set
and OASIS-B instruments demonstrated an overall moderate to high level of agreement where
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expected between the instruments. Again, the reliability of the items in these settings is reported
in Volume 2 of this set of reports, but these comparisons are helpful for understanding the impact
of improved item definitions and coding as they relate to expected scores.
ES.5

Conclusions

The findings in these reports are critical to understanding the applicability of using
standardized versions of items in place of historical items on the three mandated patient
assessment tools: IRF-PAI, MDS, and OASIS. The tools measure similar concepts of medical,
functional, and cognitive health status but use different items to measure these concepts. The
differences among these assessments make it impossible to compare patients across settings,
examine the adequacy of the access to care in different parts of the country, or monitor the
quality of care that similar patients may receive in different settings.
The standardized CARE items were based on an extensive stakeholder process that took
into account the existing items on the mandated assessment tools, the current scientific
approaches for determining patient complexity, and the methodological issues in using items in
different settings with differing staff mix. The items tested in the CARE assessment were based
on the current science in each of the fields of care. Consideration of the granularity of an item
and its ability to measure changes at both the high end and the low end of severity was important
if a standardized item would be able to measure care across the continuum. The selection
process also recognized the importance of clinical input from each of the five settings and the
variation in the types of clinicians involved in each setting.
The reliability tests reported in Volume 2 were important for determining the feasibility
of using standardized items across settings. The results showed that most items, with the
exception of several IADLs, such as laundry and shopping, were reliable. Comparisons with
earlier tests of the mandated assessment items showed that the standardized items were at least as
consistent as, and in some cases more reliable than, items in the existing assessment tools. The
goal of these tests was to at least match the reliability of items currently in use. The reliability
tests included in Volume 2 showed that moving to standardized items will not affect the
reliability of the information collected in the different settings.
The work in Volume 3 helps explain some of the differences between the standardized
items and each of the analogous current assessment items on each tool. Each of the three
mandated tools had different rules that they followed in measuring the concepts. The assessment
windows and look-back periods differed across tools. For some concepts, entirely different
items were used to measure a concept, whereas for other concepts, the item definitions varied
only slightly. However, these differences resulted in broader or narrower definitions of the
condition being measured. In most cases, the CARE item used the most granular or most
focused item.
The comparisons in Volume 3 are useful for understanding how patients were rated
differently using the standardized and setting-specific mandated assessment items. Differences
between items on the two different assessment items being compared were provided, comparing
assessment time frames, differences in rating scales, and, if applicable, differences in item
definitions and instructions in addition to other potential sources of variation between the two
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assessments. Paired ratings for cases in the CARE sample were shown as cross-tabulations of
the items being compared between the two assessments. Where items differed, the differences
were largely as expected.
The items tested in the PAC-PRD show that standardized items can be used across the
Medicare program to measure patient complexity. Although every item may not be relevant for
every patient, it is an important first step to have consistent ways of measuring items that are
relevant, independent of care site. Having reliable standardized items is necessary to allow
examination of the patients’ clinical changes at different points in their episode, regardless of
care site. This information is particularly important in today’s world as payers examine the value
of care provided in each setting and across a continuum of care.
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SECTION 12
INTRODUCTION
The Centers for Medicare & Medicaid Services (CMS) has undertaken a major initiative to
evaluate and realign the incentives for inpatient and post-acute services provided under the
Medicare program. Currently, about a fourth of all beneficiaries are admitted to a general acute
hospital each year; almost 35 percent of them are discharged to additional care in a long-term care
hospital (LTCH), inpatient rehabilitation facility (IRF), skilled nursing facility (SNF), or home
with additional services provided by a home health agency (HHA) (Gage et al., 2008). While
these services constitute a continuum of care for the patient, the current measurement systems do
not allow Medicare to examine the effects of these continuing services on the patient’s overall
health and functional status.
The Medicare program currently mandates that IRFs, SNFs, and HHAs each submit
assessment data on the beneficiary’s medical, functional, and cognitive status. This information is
used in both the payment and quality monitoring efforts at CMS. Medical status is also measured
to some extent in the Medicare Severity-Diagnosis Related Group (MS-DRG) based case-mix
system used to pay and monitor admissions in the acute hospital settings, both the short-term and
long-term care hospitals. Despite the inclusion of these factors in the existing systems, each
system was developed independently and uses different items to measure each set of concepts. For
example, only the post-acute care (PAC) settings (IRF, SNF, and HHA) measure functional status
and cognitive status independent of diagnosis codes. And each of the three PAC measurement
systems—Inpatient Rehabilitation Facility Patient Assessment Instrument (IRF-PAI), Minimum
Data Set (MDS), and Outcome and Assessment Information Set (OASIS), respectively—use
different items to measure function and cognition. As a result, the Medicare program has not been
able to measure changes in patients’ health status as they progress across their episode of care.
Further, this lack of standardized measurement makes it difficult to understand the extent to which
patients differ clinically in their use of different PAC settings. Past research has suggested that,
after controlling for differences in patient complexity, site of care decisions may be associated with
the availability of different service options (Gage et al., 2008). These analyses are based on the
standardized case-mix data available in claims. However, this limited information may mask
actual differences in patients using each PAC provider and their outcomes associated with service
use. Without standardized ways to measure the patients’ medical, functional, and cognitive status,
CMS is unable to adequately examine whether the costs and utilization patterns reflect differences
in patient case-mix complexity or other factors, not related to individual patient needs. Given the
differences in program costs associated with each type of Medicare provider, and the potential
impact on outcomes associated with different treatment approaches in the different types of
providers, it is important to understand the extent to which differences in program costs and
service utilization reflect patient needs, local practice patterns, or local supply options.
The Deficit Reduction Act of 2005 directed CMS to address this issue and develop
methods for measuring Medicare beneficiaries’ health status in a consistent way that would allow
CMS to examine whether Medicare’s various payment systems introduced inconsistent incentives
for treating clinically-similar patients. This contract addresses this issue by testing the use of a
standardized set of items for measuring medical, functional, cognitive, and social support factors in
the acute hospital, LTCH, IRF, SNF, and HHA. These items are based on the science behind the
currently mandated assessment items in the Medicare payment systems, including those in the
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mandated IRF-PAI, MDS, and OASIS instruments. Over the past few years, RTI has been
working with the Office of Clinical Standards and Quality and the research and clinical
communities associated with acute and PAC services, including case-mix measurement experts,
accreditation bodies (such as The Joint Commission and the Commission on the Accreditation of
Rehabilitation Facilities), provider associations, and others, to develop a select set of items based
on the science behind current assessment items that would be appropriate for measuring
beneficiary severity of illness, regardless of site of care. The objective was to capture the best
qualities of each of the mandated assessments while improving on them in important ways.
Input was collected through various stakeholder meetings, including several Open Door
Forums (ODFs) and Technical Expert Panels (TEPs). Two types of TEPs were conducted. The
first set of clinical experts were invited to identify the types of items that were important for
measuring case-mix differences that may explain patient complexity and the need for different
types of services. The second set of discussions focused on measurement issues. They included
experts from the acute hospital, LTCH, IRF, SNF, and HHA research communities. The results of
these panels were submitted for publication in the Federal Register and underwent two sets of
public comment periods. The results led to the development and pilot testing of the Continuity
Assessment Record and Evaluation (CARE) tool. The items were revised following the pilot test
and the resulting changes were implemented for use in the Post-Acute Care Payment Reform
Demonstration (PAC-PRD). Data were collected in the PAC-PRD from 2008 to 2010. Over
53,000 assessments were collected in acute hospitals, LTCHs, IRFs, SNFs, and HHAs.
Under the current project, two types of reliability tests were conducted and profiled in
Volume 2 of this set. The first is a traditional interrater reliability test which examines how well
the items measure the specific concepts when two clinicians are measuring the same patient at the
same time; and second, an approach which allowed examination of how discipline and setting
affected item scoring. Additional analyses of the internal consistency of the functional status
subscales in the standardized CARE items were also examined.
This volume profiles a set of additional analyses of the CARE items compared with items
measuring the same concepts in the mandated assessment instruments being collected at the time
of the PAC-PRD data collection. The purpose of this analysis is to understand item and coding
differences between the CARE items and the analogous items found in the mandated instruments
currently used by CMS. As described throughout the reporting of these results, we did not expect
a one-to-one match between CARE and the mandated assessment instruments. While the
standardized items were based on the science behind the current tools, the three existing tools
differed in the specific items used to measure a concept. The standardized CARE set applied one
item across each setting. The results are important for understanding how the standardized items
compare to those already used in the respective health communities to monitor the quality of care
and adjust payment policies for differences in patient severity or case-mix characteristics. This
report matches CARE data and mandated assessment items for each patient in the CARE sample to
examine these expected differences. The report is organized in three volumes:
•

Volume 1 is a report on the development of the CARE Item Set. Section 1 provides an
overview of the project, and Section 2 details the purpose and methods of the CARE
Item Set development.
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•

Volume 1, Section 3, describes in detail the justification for including each of the
CARE items in the assessment, including support from the literature.

•

Volume 1, Section 4, presents the process of obtaining stakeholder input for the
development of the CARE Item Set through Technical Expert Panel meetings.

•

Volume 1, Section 5, gives an overview of the two pilot tests of the CARE Item Set that
were conducted as part of the CARE Item Set development.

•

Volume 1, Section 6, presents the process and CARE Item Set changes resulting from
the Office of Management and Budget clearance review process.

•

Volume 1, Section 7, describes potential opportunities and challenges for the CARE
Item Set identified at the end of the initial item set development.

•

Volume 2 is a report on the reliability testing of the CARE Item Set. Section 8
provides an overview of the issues and our approach for testing the reliability and
validity of the standardized items developed to create consistent measurement
approaches across inpatient and PAC services.

•

Volume 2, Section 9, presents the methodology and results of the traditional interrater
reliability tests on paired assessments in each of the five settings (acute, LTCH, IRF,
SNF, HHA).

•

Volume 2, Section 10, reports the results of the cross-disciplinary, cross-setting
analysis of reliability using videos.

•

Volume 2, Section 11, contains additional analyses of internal consistency, focusing
specifically on development of the functional status subscales in the standardized items.

•

Volume 3 is a comparison of the CARE Item Set and current assessment items.
Section 12 introduces the analyses conducted to examine the comparability of the
CARE Item Set to items on assessment tools (IRF-PAI, MDS 2.0, and OASIS-B) being
used by Medicare certified providers at the time of data collection.

•

Volume 3, Section 13, examines the comparability of the standardized CARE items to
those currently in the IRF-PAI assessment tool. This section presents differences in the
actual items and crosswalks the two sets of items conceptually to help the reader
understand the differences and overlap in the standardized items relative to the current
IRF-PAI items.

•

Volume 3, Section 14, examines the concurrent validity of the CARE items relative to
the MDS 2.0 items for each patient in the SNF sample. While the MDS 3.0 went into
effect in 2010, the results are compared to the assessment data used at the time of data
collection. Due to the close collaboration of the CARE development team with the
MDS 3.0 development team, many of the CARE items are intentionally similar to those
in the MDS 3.0.

•

Volume 3, Section 15, reviews the CARE items relative to the OASIS-B items. Again,
while OASIS-C has since gone into effect, OASIS-B was being used during the time of
the reliability tests. Again, the CARE items were based on discussions with the
OASIS-C developers to create consistency in item modifications.
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•

Although many of the CARE items are consistent with those being put forth in the
MDS 3.0 and OASIS-C, the comparison analyses had to use data from the existing
mandated assessments at the time of each test for each of the patients in the respective
CARE samples. Hence, comparisons are made with MDS 2.0 and OASIS-B. In their
entirety, these analyses will be used to further refine the current CARE Item Set, as
outlined in Volume 3, Section 16, which considers conclusions and next steps.
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SECTION 13
IRF-PAI–CARE COMPARISONS
13.1

Overview

While Volume 2, Section 9, presented results of the reliability of each item, this section
allows the reader to understand differences between the Continuity Assessment Record and
Evaluation (CARE) items and those in the existing assessment tools. This section presents
comparisons of several items from the CARE Item Set and conceptually matching items from the
Inpatient Rehabilitation Facility Patient Assessment Instrument (IRF-PAI). The IRF-PAI, which
is the current assessment tool for the inpatient rehabilitation setting, includes items on medical,
functional, and cognitive health status. The focus of this analysis is on comparisons between the
existing function and cognitive IRF-PAI items that are used for payment and conceptually similar
CARE items. The IRF payment items are 12 of the motor items in the FIM® 3 Instrument; the
“Tub/Shower Transfer” FIM® item is not a payment item. The analysis included in this section
compares the scores for the CARE admission items to the IRF-PAI/FIM® items for each
beneficiary in our IRF sample.
To conduct these analyses, we merged the January 2010 extract of the CARE data with
IRF-PAI assessments available through December 31, 2010. 4 The merge was based on the
beneficiary identification number and a match on admission or discharge dates on each
assessment. We successfully matched 93 percent of the CARE assessments with IRF-PAI data
and have a total of 9,481 assessments: 4,890 admission assessments and 4,591 discharge
assessments. The analyses included in this chapter focus only on the admission assessment
items.
The analyses are organized based on the order of the CARE items in the Impairments and
Functional Status sections. Each section includes a brief overview of the items being compared,
IRF-PAI and CARE item definitions, frequencies of individual items, and lastly a crosstabulation of the paired items. We conducted correlations of the CARE and IRF-PAI items
individually with IRF length of stay (LOS) and report these results at the end of this chapter.
The purpose of these analyses is to examine the concurrent validity of the CARE Item
Set. As described throughout the reporting of these results, we did not expect a one-to-one
match between CARE and IRF-PAI item scores. This is because the CARE Item Set and the
IRF-PAI/FIM® Instrument differ in several fundamental ways. First, the instructions for
administration of the measure are not the same; second, the rating scales are structurally
different; and third, the item definitions are not the same. The background section provides
details on these differences, and we also include explanations of the logic underlying various
item-specific differences, as applicable.
3

FIM® is a trademark of Uniform Data System for Medical Rehabilitation, a division of UB Foundation
Activities, Inc.

4

CARE extract date 01/28/2010. Data shown in this chapter were generated with the req_lc008_v3, req_lc012,
req_lc013, and req_lc014 programs.
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13.2

Background

As previously noted, the CARE Item Set includes items in the Impairments and
Functional Status sections that are similar in concept to the IRF-PAI/FIM® items. The
comparable concepts in the Impairments section include the bladder and bowel management
items. The comparable concepts in the Functional Status section include items in Section A (the
Core Self-Care items), Section B (the Core Functional Mobility items), and Section C (the
Supplemental Functional Ability items). The results are organized by these sections. Some of
the CARE and IRF-PAI/FIM® items are similar, but for others, the comparable concepts are
more distal and may include more than one variable in the comparison. Finally, for other items
there are no equivalent items. As an example, the eating items in the CARE Item Set and IRFPAI/FIM® Instrument are similar, but not exactly the same. The CARE Item Set has separate
items for eating and administration of tube feedings. In the IRF-PAI/FIM® Instrument, these
activities are reported in a single item, eating. Walking is also measured very differently in the
two data sets, making it difficult to compare across the CARE Item Set and the IRF-PAI/FIM®
Instrument on those items.
13.2.1 Expected Differences in Item Response Codes
There are several reasons why FIM® scores on the IRF-PAI Instrument and CARE item
scores for similar items will not match, including the following:
•

•

Differences in data collection instructions:
–

Time frame: The assessment time frame for most of the FIM® items on the IRFPAI is 3 calendar days, whereas the CARE Item Set time frame is 2 calendar days
(if admitted before noon) or 3 calendar days (for patients admitted after noon).

–

Most dependent episode versus usual performance: If the patient’s functional
performance varies during the assessment time frame, the instructions for
completing the IRF-PAI/FIM® direct the clinician to report the patient’s most
dependent episode. For the CARE Item Set, we instruct clinicians to report the
patient’s usual performance during the CARE assessment time frame. 5

–

Implication: In general, these differences are likely to result in FIM® scores that
reflect a lower level of independence than the CARE Item Set’s assessment scores
for the same patient. Therefore, we would expect some FIM® scores to be lower
than CARE scores for some items.

Rating scale distinctions:
–

5

The CARE functional item rating scale has a range of 6 (Independent) to 1
(Dependent), and the FIM® scale on the IRF-PAI/FIM® Instrument has a range of 7
(Complete Independence) to 1 (Total Assistance). The definitions at each level
differ across each rating scale. The CARE scale was designed to provide better
specificity at the lowest level and to remove differences associated with use of a

Using the “usual” performance allowed patients to be rated on their typical ability level during the assessment
window as defined by status noted more than once, rather than on a potential outlier occurrence.
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device at the higher level, in keeping with the International Classification of
Function approach.
Below, the CARE rating scale definitions and the FIM® rating scale definitions are provided:
CARE Levels of Function
Activities may be completed with or without assistive devices. If helper assistance is
required because patient’s performance is unsafe or poor quality, score according to
amount of assistance provided.
6. Independent. Patient completes the activity by him/herself with no assistance from a
helper.
5. Setup or clean-up assistance. Helper SETS UP or CLEANS UP; patient completes
activity. Helper assists only prior to or following the activity.
4. Supervision or touching assistance. Helper provides VERBAL CUES or
TOUCHING/STEADYING assistance as patient completes activity. Assistance may
be provided throughout the activity or intermittently.
3. Partial/moderate assistance. Helper does LESS THAN HALF the effort. Helper lifts,
holds, or supports trunk or limbs, but provides less than half the effort.
2. Substantial/maximal assistance. Helper does MORE THAN HALF the effort. Helper
lifts or holds trunk or limbs and provides more than half the effort.
1. Dependent. Helper does ALL of the effort. Patient does none of the effort to
complete the task.
If activity was not attempted code:
M. Not attempted due to medical condition
S. Not attempted due to safety concerns
A. Task attempted but not completed
N. Not applicable
P. Patient refused
FIM® Levels of Function and Their Score
No Helper:
7. Complete independence. Patient safely performs all tasks of activity within a
reasonable amount of time without modification, assistive devices, or aids.
6. Modified independence. One or more of the following may be true: the activity
requires an assistive device or aid, takes more than a reasonable time, or activity
involves safety (risk) considerations.
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5. Supervision or setup. Patient requires no more help than standby, cueing, or coaxing
without physical contact; alternatively, the helper sets up need items or applies
orthoses or assistive/adaptive devices.
Helper:
4. Minimal contact assistance. The patient requires no more help than touching, and
expends 75 percent or more of the effort.
3. Moderate assistance. The patient requires more help than touching, or expends
between 50 and 74 percent of the effort.
2. Maximal assistance. The patient expends between 25 and 49 percent of the effort.
1. Total assistance. The patient expends less than 25 percent of the effort.
0. Activity does not occur. The patient does not perform the activity, and a helper does
not perform the activity during the entire assessment time frame.
Figure 13-1 shows how FIM® scores generally map to CARE Item Set scores. Note the
IRF-PAI/FIM® Instrument instructs the clinician to determine the assessment code based upon
what percentage of the task the patient can perform safely and independently. The CARE Item
Set instructs the clinician to determine what amount of assistance the helper provides for the
patient so that the patient can safely complete the activity.
We provide clinical examples below to assist with the interpretation of the data results.
Example of CARE score 6 and FIM® scores 6 & 7
•

The CARE Item Set and IRF-PAI/FIM® Instrument use distinct codes to reflect the
most independent patients. The CARE score 6–Independent is similar to merging the
FIM® scores of 7–Complete Independence and 6–Modified Independence. The
CARE score 6–Independent is reported for the patient who completes an activity with
or without an assistive device. The CARE Item Set includes separate items that
collect data about the patient’s use of mobility devices and aids. The IRF-PAI/FIM®
score 7–Complete Independence is used for the patient who completes the activity
with reasonable time, without a device, and without concern for the patient’s safety.
The PAI/FIM® score 6–Modified Independence is used for patients who need more
than a reasonable amount of time, who use a device, or for whom there is a safety
concern.
–

Example: A patient can safely feed him/herself without assistance and does not use
any devices; however, he requires more than a reasonable amount of time to
complete this activity. The clinician using the CARE Item Set codes 6–Independent
(the highest independence rating). The clinician using the IRF-PAI/FIM®
Instrument uses code 6–Modified Independence (the second highest independence
rating).
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Figure 13-1
General relationship between IRF-PAI/FIM® instrument levels and CARE Item Set levels

IRF-PAI FIM®
Instrument Level

CARE Item Set Level

7 - Complete Independence
(Without a device)

6 - Independent

(With or without a device)

6 - Modified Independence
(Device used)

5 - Set up or clean up assistance

(Helper sets up or cleans up only)

5 - Supervision or Set Up

(Pt. only needs cues, standby,
no physical contact)

4 - Supervision or Touching Assistance
(Helper provides verbal cues or
touching /steadying assist)

4 - Minimal Assistance

(Pt. performs 75% or more of tasks)

3 - Partial/Moderate Assistance

(Helper does less than half the effort)

3 - Moderate Assistance

(Pt. performs 50%-74% of tasks)

2 - Maximal Assistance

2 - Substantial/Maximal Assistance

(Pt. performs 25%-49% of tasks)

(Helper does more than half the effort)

1 - Total Assistance

1 - Dependent

(Pt. does less than 25% of tasks)

(Helper does all of the effort)
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Example of CARE score 5 & 4 and FIM® score 5
•

If the patient needs only setup or clean-up assistance and can be safely left to
complete the activity, the CARE item score is 5–Setup or Clean-up Assistance. The
IRF-PAI/FIM® Instrument scores this patient as 5–Supervision or Setup.
–

Example: The use of CARE score 5–Setup or Clean-up Assistance and IRFPAI/FIM® score 5–Supervision or Setup are reported if the patient needs a helper to
gather clothes for upper body dressing and the patient does not need any
supervision with the activity. If the helper provides setup assistance and then leaves
the room while the patient completes upper body dressing, then the scores for the
FIM® and the CARE data set may be the same—a score of 5. However, if a patient
needs supervision in addition to setup assistance, then the CARE score of 4–
Supervision or Touching Assistance is reported and indicates the need for the helper
to remain with the patient. The IRF-PAI/FIM® score for the patient who needs
supervision is scored 5–Supervision or Setup.

Example of CARE score 4 and FIM® score 5 & 4
•

The CARE score for a patient who needs only setup assistance differs from the
CARE score for a patient requiring supervision, verbal cueing, or touching/steadying
assistance to complete an activity. The CARE item is scored as 4–Supervision or
Touching Assistance for patients that need supervision, verbal cueing, or
touching/steadying. The IRF-PAI/FIM® Instrument rating scale uses one score for
these assistance levels.
–

•

Example: If a patient needs verbal cues to complete upper body or lower body
dressing, the clinician reports CARE score 4–Supervision or Touching Assistance.
When using the IRF-PAI/FIM® to assess the same patient, a score 5–Supervision or
Setup is reported (as long as no hands-on assistance is used for the patient during
any portion of the activity). However, if the patient requires steadying/touching
(e.g., steadying the patient while she pulls up her pants), the clinician will report the
IRF-PAI/FIM® Instrument score as 4–Minimal Assistance.

Clinician feedback favored the CARE Item Set’s ability to make clinically important
distinctions between the patient’s need for supervision (CARE score 4) and Setup or
Clean-up Assistance (CARE score 5). The need to provide supervision (CARE score
4) often means that the clinician is present intermittently or throughout the time that
the patient performs an activity (such as eating or walking). In contrast, Setup or
Clean-up (CARE score 5) often means that the clinician can leave (and attend to other
responsibilities) while the patient performs the remaining tasks. The clinician may
return to the patient at the end of the activity to provide any clean-up assistance.
Clinician feedback indicated that these distinctions have major implications regarding
the time needed to provide care for these higher-level patients.
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Example of CARE score 4 and FIM® score 4
•

An additional example shows some of the similarities in coding. A patient who needs
“touching/steadying assistance” would be coded on the CARE as 4–Supervision or
Touching Assistance because the patient is unsteady upon rising from sit to stand and
requires the clinician to place his/her hand onto the patient to steady him/her during
this activity. When assessing this same patient using the IRF-PAI/FIM®, score 4–
Minimal Assistance is also used because the patient performed 75 percent or more of
the task.

Example of CARE score 3 and FIM® scores 3 & 4
•

If the helper assists with less than half of the effort, the CARE item score is 3–
Partial/Moderate Assistance. This patient may be scored on the IRF-PAI/FIM®
Instrument as either a 4–Minimal Assistance (patient performs 75 percent or more of
the task) or 3–Moderate Assistance (patient performs 50–74 percent of the task),
depending on the patient’s need for assistance.
–

Example: A patient transfers to and from his bed with the helper providing lifting
assistance, but less than half the effort. The CARE coding for this patient is 3–
Partial/Moderate Assistance. The IRF-PAI/FIM® coding requires the clinician to
determine what percentage of the task the patient performs. If the patient performs
75 percent or more of the task, then the patient is scored a 4–Minimal Assistance,
but if the patient performs 50–74 percent of the task, then the FIM® score 3–
Moderate Assistance is reported.

Example of CARE scores 1 & 2 and FIM® scores 1 & 2
•

The CARE coding distinguishes between a patient who contributes a small amount of
effort (rated as level 2) and a patient who is totally dependent (rated as level 1). This
differs from the IRF-PAI/FIM® Instrument. If the helper assists the patient with more
than half of the effort, the CARE item score is 2–Substantial/Maximal Assistance.
This patient may be scored on the IRF-PAI/FIM® Instrument as either 2–Maximal
Assistance if the patient performs 25–49 percent of the task or 1–Total Assistance if
the patient performs less than 25 percent of the task.
–

Example: A patient is assessed using the CARE while transferring into and out of
bed. The helper does all of the effort to complete this activity upon admission to
the facility and scores the patient 1–Dependent. Upon discharge, the same patient
contributes a bit of effort while performing the activity and is scored 2–
Substantial/Maximal Assistance to documents the patient’s progress in performing
this activity. If the patient performed less than 25 percent of the task, then the IRFPAI/FIM® score would be 1–Total Assistance at both admission and discharge.
Clinician feedback during the CARE Item Set training indicated that it is important
to distinguish between patients who are unable to participate in an activity and
those patients who are beginning to participate in an activity. Clinicians also
emphasized that there are fundamental, relevant, and measurable distinctions among
lower functioning patients.
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Example of CARE scores 1 & 2 and FIM® score 1
•

The IRF-PAI/FIM® score 1–Total Assistance (patient performs less than 25 percent
of effort) includes a broader range of patient performance than the CARE score of 1.
The FIM® instrument’s lowest score includes patients who perform less than 25
percent of the activity, including patients who require total assistance. The CARE
rating scale differentiates between Level 1–Dependent and Level 2–
Substantial/Maximal Assistance (helper does more than half the effort).
The CARE approach is based on whether the patient can do more than half or less
than half the activity and, given that, how much assistance is needed. If the patient
can do more than half the activity, does the clinician need to stay and supervise or can
the clinician set up and safely walk away from the patient? If the patient does less
than half the activity, must the helper do all the effort or just more than half the
effort?

13.2.2 Item Definitions
When the functional assessment items in the CARE Item Set were developed, the
objective was to have definitions that would be relevant to assessing patients. Additionally,
CARE items were designed to focus on discrete activities; some FIM® items may capture
multiple concepts or activities. Thus, the definitions of items on the IRF-PAI/FIM® Instrument
and the CARE Item Set are often different. There are important distinctions between these two
instruments. For each activity on the CARE and IRF-PAI/FIM® instruments, there are unique
differences in task inclusion. Each instrument includes items that the other instrument does not.
13.2.3 Summary
The differences between the IRF-PAI/FIM® Instrument and the CARE Item Set,
including the administration and rating scales, are essential to recognize while interpreting the
results of the data comparison. It is not expected that a one-to-one comparison can be made
between IRF-PAI/FIM® and CARE items for these and other reasons that are highlighted below.
For each comparison below, it is noted where the expectation for the most overlap should occur.
When data appear inconsistent, we are unable to determine the patient’s true status.
13.3

Results of the IRF-PAI/FIM® Instrument & CARE Item Set Analysis

1. V. Impairments: A. Bladder and Bowel Management: A1, A2a, A3a, A4a, and A5a
Bladder (IRF-PAI/FIM®: G. Bladder and Function Modifiers)
The bladder management items in the Impairments section of the CARE Item Set
correspond to the FIM® bladder item on the IRF-PAI (item 39G) and two related function
modifiers, Bladder Level of Assistance (item 28) and Bladder Frequency of Accidents (item 29).
The items on the IRF-PAI/FIM® Instrument and the CARE Item Set document a similar
construct, but the definitions are quite different. Therefore, we expected that comparisons would
not match up in many cases. Differences between the items are provided below:
•

The assessment windows differ between the instruments:
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–

The admission assessment time frame for the item Bladder Level of Assistance is
assessed for the past 3 calendar days.

–

The admission assessment time frame for the Bladder Frequency of Accidents is
7 calendar days—4 days prior to the rehabilitation admission and the first 3 days in
the IRF. The IRF may not always have patient information about the frequency of
bladder accidents for the 4 days prior to the patient’s admission. The CARE Item
Set time frame is 2 calendar days (if admitted before noon) or 3 calendar days (for
patients admitted after noon), all days within the IRF stay.

–

The definitions of the IRF-PAI and CARE items differ, and the coding scales also
differ, so we did not expect scores to match for many records. The item definitions
for the CARE Item Set and the IRF-PAI items are provided below. The bladder
item on the CARE Item Set is an impairment as defined by the International
Classification of Function (ICF), because it relates to incontinence (i.e., dysfunction
at the organ level).

CARE Item Set Definitions:
A1. Does the patient have any impairments with bladder or bowel management (e.g., use
of a device or incontinence)? 0. No; 1. Yes
A2a. Does this patient use an external or indwelling device or require intermittent
catheterization? 0. No; 1. Yes
A3a. Indicate the frequency of incontinence:
0. Continent (no documented incontinence)
1. Stress incontinence only (bladder only)
2. Incontinent less than daily (only once during the 2-day assessment period)
3. Incontinent daily (at least once a day)
4. Always incontinent
5. No urine/bowel output (e.g., renal failure)
9. Not applicable (e.g., indwelling catheter)
A4a. Does the patient need assistance to manage equipment or devices related to
bladder care (e.g., urinal, bedpan, indwelling catheter, intermittent catheterization,
ostomy, incontinence pads/undergarments)? 0. No; 1. Yes
A5a. If the patient is incontinent or has an indwelling device, was the patient incontinent
(excluding stress incontinence) immediately prior to the current illness, exacerbation, or
injury? 0. No; 1. Yes; 9. Unknown
IRF-PAI/FIM® Instrument Definitions:
39G. Bladder Management: Includes the safe use of equipment or agents for bladder
management.
[Note: The lower score of IRF-PAI items 29. and 30. is entered as the 39.G score on the
FIM® instrument]
Function Modifiers: 29. Bladder Level of Assistance: Use FIM® levels 1-7 to score this
item, based upon the three day assessment period. Do not use code 0.
30. Bladder Frequency of Accidents: Use scale listed on IRF-PAI to score frequency of
accidents, based upon the 7 day calendar assessment period. Do not use code 0.
7. No accidents
6. No accidents, uses device such as a catheter
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5. One accident in the past 7 days
4. Two accidents in the past 7 days
3. Three accidents in the past 7 days
2. Four accidents in the past 7 days
1. Five or more accidents in the past 7 days
Other factors specific to these items that impact how the assessment data compare
include the following:
•

The CARE Item Set is designed with gateway questions in an effort to reduce
respondent burden. In the Impairment Section, if a patient does not use equipment
and does not have incontinence, then no impairment is indicated for item A1, and the
subsequent items in the section are skipped. There is no similar skip pattern on the
IRF-PAI/FIM® Instrument. In order to have a complete comparison for the analysis
CARE codes were populated when items were skipped because the patient did not
have any bladder impairments. For example patients who were coded as having no
impairments in item A1 were coded as not requiring external/indwelling devices and
not requiring intermittent catheterization in item A2a, as being continent in item A3a,
and as not needing assistance in item A4a.

•

For the FIM® items in the IRF-PAI, patients who do not void—for example, a patient
with renal failure—is coded 7–Complete Independence, whereas on the CARE Item
Set these patients would be coded as 5–No Urine/Bowel Output.

•

IRF-PAI/FIM® and CARE instruments both measure the “level of assistance” the
patient requires for managing the use of equipment/devices related to bladder care.
The IRF-PAI/FIM® Instrument function modifier (item 29) uses the FIM® scores 7–1
(Complete Independence through Total Assistance) to indicate the level of assistance
the patient requires. For the CARE item A4a, the clinician reports the patient’s need
for assistance in managing equipment or devices related to bladder care by answering
“Yes” or “No” to indicate the patient’s need. The CARE Item Set does not use a
rating scale to document assistance with bladder equipment.

•

The IRF-PAI/FIM® Instrument function modifier (item 30) reports the number of
“bladder accidents,” which are defined as the act of wetting linen or clothing with
urine, including urinal or bedpan spills. The CARE Item Set reports bladder
incontinence as the involuntary leakage of urine. Successful use of incontinence
pads/undergarments (diapers) results in the patients’ being incontinent without any
urine spilling onto linen or clothing. The FIM® item does not collect data on the
frequency of the patient’s “successful use” of incontinence pads/undergarments
(diapers); thus, the FIM® item reflects not the number of times a patient is incontinent
when using incontinence pads/undergarments (diapers) but the number of times the
patient has had a FIM® defined “bladder accident.”

•

To illustrate the differences between the two items the following example is
presented. In this example, the patient has urine leakage (i.e., incontinence) but is
usually successful in use of an incontinence undergarment (pad or diaper). On the
CARE Item Set, the patient is coded based on the number of times the patient was
incontinent (leaks urine) into his/her undergarment during the assessment period. The
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CARE item focuses on urine leakage only. In contrast, the IRF-PAI/FIM® would not
code this patient for frequency of incontinence contained within an incontinence
undergarment or pad. Instead the IRF-PAI/FIM® function modifier Frequency of
Accidents would assess the patient’s frequency for the act of wetting linen or clothing
with urine, including urinal or bedpan spills.
–

•

Example: During the assessment period the patient uses incontinence pads (4 times
each day), voids in the toilet the other times, and requires no assistance to use these
pads during the assessment period. One time during the assessment period the
patient did not wear an incontinence pad and leaked urine only once onto linen and
his clothing. This patient would be assessed by each instrument as follows: FIM®
Frequency of Accidents is coded as 5 for having one bladder accident in the past 7
days; CARE item A3a is coded 3–Incontinent Daily based on the patient’s
frequency of incontinence. For the CARE item, the patient is coded according to
his incontinence frequency, regardless of whether the urine is within the
incontinence pad or has spilled elsewhere (e.g., bed linen, clothing, could not
contain all urine into the urinal/bedpan in his/her haste to void). The CARE coding
indicates the frequency (always, at least once a day, less than daily, or stress
incontinence only). This patient would be coded as a 3–Incontinent Daily on the
CARE Item Set in this example (even if this patient had used his incontinence pads
successfully during the assessment period—this CARE code would remain the same
because CARE does not collect data on spilling urine onto other surfaces).

Stress incontinence is included on the CARE Item Set but is not addressed
specifically on the IRF-PAI/FIM® Instrument.

The overall frequencies for these items are shown in Tables 13-1a and 13-1b, followed by
the cross-tabulation of the items in Table 13-1c.
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Table 13-1a
CARE admission bladder impairment items
Item/Response Options
A1. Does the patient have any impairments with bladder or bowel management
(e.g., use of a device or incontinence)?
Missing
No
Yes
A2a. Does this patient use an external or indwelling device or require
intermittent catheterization?
Missing
No
Yes
A3a. Indicate the frequency of incontinence.
Missing
0 = Continent (no documented incontinence)
1 = Stress incontinence only (bladder only)
2 = Incontinent less than daily (only once during the 2-day assessment period)
3 = Incontinent daily (at least once a day)
4 = Always incontinent
5 = No urine output (e.g., renal failure)
9 = Not applicable (e.g., indwelling catheter)
SOURCE: RTI analysis of CARE Item Set data, 2008–2009.
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N

Percent

14
1,901
2,975

0.3
38.9
60.8

14
3,350
1,526

0.3
68.5
31.2

14
2,585
152
246
527
201
53
1,112

0.3
52.9
3.1
5.0
10.8
4.1
1.1
22.7

Table 13-1b
IRF-PAI/FIM® admission bladder items
Item/Response Options
IRF-PAI 29. Bladder Level of Assistance
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.
IRF-PAI 30. Bladder Frequency of Accidents
1 = Five or more accidents in the past 7 days
2 = Four accidents in the past 7 days
3 = Three accidents in the past 7 days

N

Percent

2,437
248
368
360
944
262
271

49.8
5.1
7.5
7.4
19.3
5.4
5.5

352

7.2

82
124

1.7
2.5

4 = Two accidents in the past 7 days

186

3.8

5 = One accident in the past 7 days

372

7.6

2,970
804

60.7
16.4

2,504

51.2

2 = Max. Assist.
3 = Mod. Assist.

220
345

4.5
7.1

4 = Min. Assist./Touching

370

7.6

5 = Supervision/Setup

938

19.2

6 = Mod. Independ.
7 = Complete Independ.

265
248

5.4
5.1

6 = No accidents, uses device such as a catheter
7 = No accidents
IRF-PAI/FIM® 39G. Bladder
(39G is the lower (more dependent) score from items 29 and 30 above)
1 = Total Assist.

NOTE: Missing = 0 (IRF-PAI/FIM® missing values).
®
SOURCE: RTI analysis of IRF-PAI/FIM instrument data, 2008–2009.
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Table 13-1c
CARE admission frequency of bladder incontinence by IRF-PAI/FIM® admission
frequency of accidents
IRF-PAI/
®

FIM
Instrument:
1. Five or
more
accidents in
the past 7
days

IRF-PAI/

IRF-PAI/

IRF-PAI/

FIM
Instrument:
2. Four
accidents in
the past 7
days

FIM
Instrument:
3. Three
accidents in
the past 7
days

FIM
Instrument:
4. Two
accidents in
the past 7
days

0 = Continent (n = 2,585)

2.7

0.9

1.7

2.9

6.8

59.2*

25.8*

1 = Stress incontinence only (n =
152)

8.6

0.7

0.7

3.3

9.9

65.1*

11.8*

2 = Incontinent less than daily (n =
246)

10.6*

3.3*

6.5*

8.5*

19.1*

38.6

13.4

3 = Incontinence Daily (n = 527)

22.8*

5.3*

9.3*

10.1

14.2

31.7

6.6

4 = Always incontinent (n = 201)

36.3*

6.5*

3.0*

8.0

7.0

36.3

3.0

5 = No urine output (n = 53)

1.9

0.0

1.9

1.9

3.8

52.8*

37.7*

9 = Not applicable i.e. indwelling
catheter (n = 1,112)

4.1

0.7

0.7

1.4

3.6

87.1*

2.2

CARE frequency of
incontinence (N = 4,876)

®

®

®

IRF-PAI/
®

®

IRF-PAI/ FIM
FIM
IRF-PAI/
Instrument:
Instrument:
®
FIM
6. No accidents,
5. One
uses device, Instrument:
accident in
7. No
e.g., catheter
the past 7
bedpan, diaper accidents
days

®

* These values indicate the area of anticipated overlap between the CARE and IRF-PAI/FIM Instrument responses.
NOTE: Missing = 14 (includes CARE Item Set missing values). Values refer to row percents.
®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/ FIM Instrument data, 2008–2009.

Summary Points
Because of the item and coding differences noted above, certain differences in coding
each patient were expected if the two item sets were operating similarly. In fact, they were, as
summarized below:
•

Sixty-one percent of all patients were scored on the CARE Item Set as having a
bladder or bowel impairment (e.g., uses device or had incontinence) at admission, and
31 percent used an external or indwelling devices or required intermittent
catheterization. Fifty-three percent of patients did not have bladder incontinence.

•

The IRF-PAI admission function modifier bladder items indicated that nearly 50
percent of all patients required total assistance, 61 percent had no accidents, and
overall, 51 percent had an overall FIM® score of 1–Total Assistance.

•

Table 13-1c compares the admission CARE bladder incontinence scores and IRF-PAI
frequency of bladder accidents scores for the same patients and expected areas of
highest overlap between the CARE and FIM® bladder items. As previously noted, we
did not expect scores to match at a high rate due to the many differences of these
items.
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•

On Table 13-1c, 87 percent of patients’ codes on the CARE’s Frequency of
Incontinence response 9–Not Applicable (e.g., indwelling catheter) were scored 6–No
Accidents (uses device, e.g., ostomy, bedpan, commode, diaper) on the IRF-PAI. The
high level of agreement for these items was expected, because when a patient was
assessed using the CARE and he/she had an indwelling catheter or other device the
clinician usually coded the item as “not applicable.” A patient with an indwelling
catheter would not be expected to have “accidents,” as defined by the IRF-PAI/FIM®
Instrument.

•

Among patients with stress incontinence on the IRF-PAI, 65 percent had an IRF-PAI
Bladder Accidents score of 6–No Accidents, Uses Device. Also, patients with a
CARE item score of 5–No Urine Output were most often coded 6–No Accidents,
Uses Device and 7–No Accidents.

•

Among patients with CARE Frequency of Continence response of 3–Incontinence
Daily, the IRF-PAI score of 6–No Accidents, Uses Device was the most common,
followed by 1–Five or More Accidents in the Past 7 Days. For patients with a CARE
score of 4–Always Incontinent, the most common IRF-PAI scores were 6–No
Accidents, Uses Device and 1–Five or More Accidents in the Past 7 Days. Patients
who are incontinent daily or always would have a greater probability of wetting linen
or clothing with urine, including urinal or bedpan spills, which is the IRFPAI/FIM®’s definition of bladder accidents. Patients coded as having incontinence
on the CARE, but not having accidents on the IRF-PAI may be due to the definition
differences; for example, urine being contained in the incontinence undergarment
without any leaking onto linen or clothing.

2. V. Impairments: A. Bladder and Bowel Management: A1, A2b, A3b, A4b, and A5b
Bowel ( IRF-PAI/FIM® Instrument: H. Bowel and Function Modifiers)
The bowel management items in the Impairments section of the CARE Item Set
correspond to the FIM® bowel item on the IRF-PAI (item 39H) and two related function
modifiers, Bowel Level of Assistance (item 31) and Bowel Frequency of Accidents (item 32);
however, these comparisons are not exact. The assessment time frames differ between the
instruments, and the rating scales also differ. The item definitions for the CARE Item Set and
the FIM® item on the IRF-PAI are provided below. Thus, the expected patterns of highest
overlap were similar to the bladder management items.
•

The assessment windows differ between the instruments:
–

The admission assessment time frame for the FIM® items on the IRF-PAI Bowel
Level of Assistance is assessed for the first 3 calendar days of the stay.

–

The admission assessment time frame for the FIM® items on the IRF-PAI Bowel
Frequency of Accidents is a 7-calendar-day assessment window that includes the 4
days prior to the rehabilitation admission and the first 3 days in the inpatient
rehabilitation facility. The facility may not have patient information about the
frequency of bowel accidents for the 4 days prior to the patient’s admission.

– The CARE Item Set time frame is 2 calendar days (if admitted before noon) or 3
calendar days (for patients admitted after noon).
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–

The definitions of items and coding differ, so we did not expect many of the records
to have the same codes. The item definitions for the CARE Item Set and the FIM®
items on the IRF-PAI are provided below. The bowel item on the CARE Item Set
is an impairment, as defined by the International Classification of Function (ICF),
because it relates to incontinence, i.e., dysfunction at the organ level.

CARE Item Set Definitions:
A1. Does the patient have any impairments with bladder or bowel management (e.g.,
use of a device or incontinence)? 0. No; 1. Yes
A2b. Does this patient use an external or indwelling device or require intermittent
catheterization? 0. No; 1. Yes
A3b. Indicate the frequency of incontinence.
0. Continent (no documented incontinence)
1. Stress incontinence only (bladder only)
2. Incontinent less than daily (only once during the 2-day assessment period)
3. Incontinent daily (at least once a day)
4. Always incontinent
5. No urine/bowel output (e.g., renal failure)
9. Not applicable (e.g., indwelling catheter)
A4b. Does the patient need assistance to manage equipment or devices related to bowel
care (e.g., urinal, bedpan, indwelling catheter, intermittent catheterization, ostomy,
incontinence pads/undergarments)? 0. No; 1. Yes
A5b. If the patient is incontinent or has an indwelling device, was the patient incontinent
(excluding stress incontinence) immediately prior to the current illness, exacerbation, or
injury? 0. No; 1. Yes; 9. Unknown
IRF-PAI/FIM® Instrument Definitions:
39H. Bowel Management: Includes the use of equipment or agents for bowel
management.
Function Modifiers:
31. Bowel Level of Assistance: Use IRF-PAI/FIM® Instrument levels 1-7 to score this
item, based upon the three day assessment period. Do not use code 0.
32. Bowel Frequency of Accidents: Use scale listed on IRF-PAI/FIM® Instrument to
score frequency of accidents, based upon the 7 calendar day assessment period. Do not
use code 0.
7. No accidents
6. No accidents, uses device such as an ostomy
5. One accident in the past 7 days
4. Two accidents in the past 7 days
3. Three accidents in the past 7 days
2. Four accidents in the past 7 days
1. Five or more accidents in the past 7 days
Other factors specific to these items that impact how the assessment data compare include
the following:
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•

The CARE Item Set is designed with gateway questions for this section, so that if no
impairment is indicated in item A1, the subsequent items in the section are skipped.
There is no similar skip pattern on the IRF-PAI/FIM® Instrument. The supplemental
items were populated on the CARE Item Set in order to have a complete comparison
of data. For patients who had no impairments in A1, as not requiring external or
indwelling devices in item A2b, as being continent in item A3b, and as not needing
assistance in item A4b.

•

The FIM® item on the IRF-PAI reports the number of “bowel accidents,” defined as
soiling linen or clothing with stool, which includes bedpan spills. The CARE Item
Set reports bowel incontinence, which is defined as involuntary leakage of stool.
This means that a person who is incontinent (leaks stool) according to the CARE Item
Set may be coded as not having accidents, that is, not soiling linen or clothing, if the
person has a device (adult diapers, bowel catheter, or colostomy) that can contain
the stool.

•

IRF-PAI/FIM® and CARE instruments both measure the level of assistance the
patient requires for managing the use of equipment/devices related to bowel care.
The IRF-PAI/FIM® Instrument function modifier 29 uses the FIM® scores 7–1
(Complete Independence through Total Assistance) to indicate the level of assistance
the patient requires. The clinician uses the CARE instrument item A4a to assess the
patient’s need for assistance in managing equipment or devices related to bowel care.
Clinicians use CARE codes “Yes” or “No” to indicate the patient’s need rather than
level of assistance required.

•

The overall frequencies for these items are shown in Tables 13-2a and 13-2b,
followed by the cross-tabulation of the items in Table 13-2c.
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Table 13-2a
CARE admission bowel impairment items
Item/Response Options
A1. Does the patient have any impairments with bladder or bowel management
(e.g., use of a device or incontinence)?
Missing
No
Yes
A2b. Does this patient use an external or indwelling device or require
intermittent catheterization?
Missing
No
Yes
A3b. Indicate the frequency of incontinence (bowel).
Missing
0 = Continent (no documented incontinence)
1 = Stress incontinence only (bladder only)
2 = Incontinent less than daily (only once during the 2-day assessment period)
3 = Incontinent daily (at least once a day)
4 = Always incontinent
5 = No urine/bowel output (e.g., renal failure)
9 = Not applicable (e.g., indwelling catheter)
A4b. Does the patient need assistance to manage equipment or devices related to
bowel care (e.g., urinal, bedpan, indwelling catheter, intermittent catheterization,
ostomy, incontinence pads/undergarments)?
Missing
No
Yes
A5b. If the patient is incontinent or has an indwelling device, was the patient
incontinent (excluding stress incontinence) immediately prior to the current
illness, exacerbation, or injury?
Missing
0 = No
1 = Yes
8 = Not Applicable (Patient does not have any impairments with bladder or
bowel management and for the analysis only we have inserted this code)
9 = Unknown

SOURCE: RTI analysis of CARE Item Set data, 2008–2009.
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N

Percent

14
1,901
2,975

0.3
38.9
60.8

14
4,704
172

0.3
96.2
3.5

14
3,857
N/A
399
296
178
71
75

0.3
78.9
N/A
8.2
6.1
3.6
1.5
1.5

14
2,695
2,181

0.3
55.1
44.6

14
493
189

0.3
10.1
3.9

3,857
337

78.9
6.9

Table 13-2b
IRF-PAI/FIM® admission bowel items
Item/Response Options
IRF-PAI/FIM® 29. Bowel Level of Assistance
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.
IRF-PAI/FIM® 30. Bowel Frequency of Accidents
1 = Five or more accidents in the past 7 days
2 = Four accidents in the past 7 days
3 = Three accidents in the past 7 days
4 = Two accidents in the past 7 days
5 = One accident in the past 7 days
6 = No accidents, uses device such as a catheter
7 = No accidents
IRF-PAI/FIM® 39G. Bowel
(39G is the lower (more dependent) score from items 29 and 30 above)
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.
SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
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N

Percent

1,551
297
339
363
693
1,470
177

31.7
6.1
6.9
7.4
14.2
30.1
3.6

314
67
87
171
377
2,808
1,066

6.4
1.4
1.8
3.5
7.7
57.4
21.8

1,597
273
336
378
710
1,441
155

32.7
5.6
6.9
7.7
14.5
29.5
3.2

Table 13-2c
CARE admission frequency of bowel incontinence by IRF-PAI/FIM® admission frequency
of accidents
IRF-PAI/
®

CARE frequency of
incontinence (N = 4,876)

0 = Continent (n = 3,857)
1 = Stress incontinence only (n =
0)
2 = Incontinent less than daily (n =
399)

FIM
Instrument:
1 = Five or
more
accidents in
the past 7
days

IRF-PAI/

IRF-PAI/

IRF-PAI/

FIM
Instrument:
2 = Four
accidents in
the past 7
days

FIM
Instrument:
3 = Three
accidents in
the past 7
days

FIM
Instrument:
4 = Two
accidents in
the past 7
days

3.6

0.6

1.0

2.1

5.8

61.6*

25.4*

N/A

N/A

N/A

N/A

N/A

N/A

N/A

9.0

8.8

®

®

®

IRF-PAI/
®

FIM
® IRF-PAI/
Instrument: IRF-PAI/ FIM
®
FIM
Instrument:
5 = One
Instrument:
6 = No
accident in
7 = No
the past 7 accidents, uses
accidents
device
days

+

4.5

10.0*

20.6*

44.6*

3 = Incontinence daily (n = 296)

22.6*

6.4

6.1

10.5

15.9

29.4

9.1

4 = Always incontinent (n = 178)

38.2*

7.3

6.7

8.4

9.6

25.3

+

5 = No bowel output (n = 71)

+

+

+

+

+

66.2*

9 = Not applicable (i.e., indwelling
catheter) (n = 75)

+

+

+

+

+

88.0*

15.5*

+

®

* These values indicate the area of anticipated overlap between the CARE Item Set and IRF-PAI/FIM Instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 14 (includes CARE Item Set missing values). Values refer to row percents.
®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.

Summary Points
Again, like the bladder incontinence sections, the differences in coding each patient with
the two sets of items were expected. The similarities and differences in coding are highlighted
below:
•

Sixty-one percent of all patients were scored on the CARE Item Set as having a
bladder or bowel impairment at admission. Almost 79 percent of patients did not
have bowel incontinence, and 55 percent of the patients did not require assistance to
manage equipment or devices related to bowel care.

•

The IRF-PAI admission bowel items Level of Assistance and Frequency of Accidents
indicated that nearly 32 percent of all patients required total assistance, 58 percent
had no accidents (soiling linen or clothing, etc.) and used a device, and 33 percent had
an overall FIM® score of 1–Total Assistance.

•

Table 13-2c presents the cross-tabulation of the CARE item scores for Frequency of
Incontinence and the scores for the IRF-PAI Bowel Frequency of Accidents items for
the same patients, and the expected areas of highest overlap between the CARE and
IRF-PAI bowel items. Among patients coded on the CARE as 9–Not Applicable,
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88 percent of patients on the IRF-PAI were scored 6–No Accidents (e.g., uses device:
ostomy, bedpan, commode, or diaper). The high level of agreement for these items
may have been because, when a patient was assessed using the CARE and he/she had
an indwelling catheter or other device, the clinician usually coded the item as “not
applicable.” The same patient assessed using the IRF-PAI Instrument was less likely
to have “accidents,” as defined by the FIM®. The relevance of this point is that,
because the CARE “incontinence” item and the IRF-PAI/FIM® term “accidents” do
not have the same meaning, the CARE’s Not Applicable and FIM®’s No Accidents
Uses Device usually had similar results of no soiling; thus the high level of agreement
for this item comparison is not unexpected.
•

Among patients with a CARE Frequency of Incontinence score of 0–Continent, 62
percent were scored 6–No Accidents (e.g., uses device: ostomy, bedpan, commode, or
diaper) on the IRF-PAI and 25 percent were scored 7–No Accidents.

3. VI. Functional Status: Core Self-Care: A1 Eating (IRF-PAI/FIM® Instrument:
A. Eating)
Eating
The CARE Eating item is similar to the FIM® Eating item on the IRF-PAI (39A);
however, there are some important differences to note. The assessment windows differ between
the instruments, as does the emphasis on usual performance versus most dependent functional
levels during the assessment time frame. The rating scales also differ. The item definitions for
the CARE Item Set and the IRF-PAI/FIM® Instrument item are included below.
CARE Item Set Definition:
A1. Eating: The ability to use suitable utensils to bring food to the mouth and swallow
food once the meal is presented on a table/tray. Includes modified food consistency.
IRF-PAI/FIM® Instrument Definition:
39A. Eating: includes the ability to use suitable utensils to bring food to mouth, as well
as the ability to chew and swallow the food once the meal is presented in the customary
manner on a table or tray. The patient performs this activity safely.
Other factors specific to these items that impact how the assessment data compare
include the following:
•

The FIM® Eating item on the IRF-PAI codes the patient’s ability to bring food to the
mouth, as well as the tasks required to administer tube feedings, when applicable.
The CARE eating item is limited to bringing food to the mouth and does not include
administering tube feedings. As a result, the data for the FIM® Eating item on the
IRF-PAI may reflect a score based on the degree of assistance a patient requires for
the activity of tube feeding administration. If the patient does not eat and gets all
nutrition through tube feedings, the CARE item for this patient would not have a
number score, but a letter code (e.g., M indicating the task was not completed due to
medical condition) instead.
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•

If the patient eats and received nutrition through a tube feeding, the IRF-PAI/FIM®
score may reflect the amount of assistance provided with tube feeding administration
and the CARE score would be based on the eating activity only. In this case, we
would expect the IRF-PAI/FIM® Instrument code to be at the lower levels at
admission relative to the CARE data.

The overall frequencies for these items are shown in Tables 13-3a and 13-3b, followed by
the cross-tabulation of the items in Table 13-3c. Figure 13-2 shows the individual distributions
of the IRF-PAI/FIM® Instrument to CARE Item Set responses.
Table 13-3a
CARE admission eating item
CARE Item Set: Core Self-Care: Eating (N = 4,890)
Missing

N

Percent

16

0.3

1 = Dependent (Helper does all of the effort)

161

3.3

2 = Substantial/max. assist. (Helper does more than half)

105

2.2

3 = Partial/mod. assist. (Helper does less than half)
4 = Supervision or touching assist.

247
725

5.1
14.8

5 = Setup or clean-up assist.

2,028

41.5

6 = Independent
A = Task attempted but not completed

1,408
+

28.8
0.1

39

0.8

N = Not applicable when coded

142

2.9

P = Patient refused
S = Not attempted due to safety concerns

+
13

0.1
0.3

M = Not attempted due to medical condition

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE Item Set data, 2008–2009.
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Table 13-3b
IRF-PAI/FIM® admission eating item
IRF-PAI/FIM® Instrument 39A. Eating

N

0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.

Percent

14

0.3

475

9.7

143

2.9

219

4.5

528

10.8

2,656

54.3

433

8.9

422

8.6

SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
Figure 13-2
Distributions of CARE and IRF-PAI/FIM® admission eating items
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rating scale (1=dependent; 6/7=independent)

7

NOTE: See above for the values for each rating scale. Please note that the CARE Item Set
rating scale ranges 1–6.
SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM® Instrument data, 2008–2009.
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Table 13-3c
CARE admission eating item by IRF-PAI/FIM® admission eating item

CARE Core Self-Care: Eating
(N = 4,874)

0=
5=
Activity
3=
4 = Min.
Superdoes not 1 = Total 2 = Max. Mod. Assist./Touch- vision/ 6 = Mod. 7 = Complete
occur
Assist. Assist. Assist.
ing
Setup Independ. Independ.

1 = Dependent (n = 161)

+

89.4*

+

+

+

+

+

+

2 = Substantial/max. assist. (n =
105)

+

36.2*

44.8*

+

+

11.4

+

+

3 = Partial/mod. assist. (n =
247)

+

14.6

10.9

25.1*

34.4*

13.8

+

+

4 = Supervision or touching
assist. (n = 725)

+

5.5

4.1

7.6

22.9*

56.0*

1.8

+

5 = Setup or clean-up assist. (n
= 2,028)

+

2.7

1.2

3.1

9.3

74.8*

4.6

4.1

6 = Independent (n = 1,408)

0.3

0.6

0.4

2.1

5.5

45.5

22.7*

22.9*

Letter codes (n = 200)

+

77.0

+

+

+

16.0

+

+
®

* These values indicate the area of anticipated overlap between the CARE Item Set and IRF-PAI/FIM Instrument
responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 16 (includes CARE Item Set missing values). Values refer to row percents.
®
SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.

Summary Points
•

The most frequent value for the CARE Eating item at admission is 5–Setup or Cleanup Assistance, with 42 percent of the patients.

•

The most frequent value for the FIM® Eating item on the IRF-PAI is 5–
Supervision/Setup, with 54 percent of patients.

•

In Table 13-3c, the cross-tabulations show that the CARE codes of 1, 2, 3, 4, and 5
tended to overlap with the IRF-PAI/FIM® codes, as expected. The highest agreement
was between a CARE value of 1–Dependent and a IRF-PAI/FIM® value of 1–Total
Assistance, followed by a CARE value of 2–Substantial/Maximal Assistance and
IRF-PAI/FIM® values of 1–Total Assistance and 2–Substantial/Maximal Assistance.
The score of 1 was expected, both because the rating scale definitions differ
(CARE = dependent and IRF-PAI/FIM® = 0–25 percent of the effort) and because the
IRF-PAI/FIM® codes represent the patient’s most dependent performance.

4. VI. Functional Status: Core Self-Care: A3 Oral Hygiene (IRF-PAI/FIM®
Instrument: B. Grooming)
The next CARE self-care item is oral hygiene. The CARE Item Set and IRF-PAI/FIM®
Instrument items do not have items that are directly comparable. We will compare the grooming
FIM® activity, which includes oral care and other grooming activities, to the CARE’s oral
hygiene item. The FIM® grooming item on the IRF-PAI includes four or five activities (oral
care, combing hair, washing hands, washing face, and either shaving or applying make-up). The
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CARE Item Set includes only 1 activity: oral hygiene. The CARE Item Set includes oral hygiene
because this activity would be completed in all acute and post-acute care settings. Focusing on a
single activity was expected to simplify the item. In addition to covering different activities,
these items also differ in the following areas: assessment period windows, CARE Item Set’s
emphasis on usual performance versus IRF-PAI/FIM® items’ emphasis on coding the patient’s
most dependent function, and the rating scales. The item definitions are below.
CARE Item Set Definition:
A3. Oral hygiene: The ability to use suitable items to clean teeth. Dentures: The ability
to remove and replace dentures from and to mouth, and manage equipment for soaking
and rinsing.
IRF-PAI/FIM® Instrument Definition:
39B Grooming: Grooming includes oral care, hair grooming (combing or brushing
hair), washing the hands, washing the face, and either shaving the face or applying
make-up. If the subject neither shaves nor applies make-up, Grooming includes only the
first four tasks. The patient performs this activity safely. This item includes obtaining
articles necessary for grooming.
The overall frequencies for these items are shown in Tables 13-4a and 13-4b, followed by
the cross-tabulation of the paired items in Table 13-4c. Figure 13-3 illustrates the individual
item distributions.
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Table 13-4a
CARE admission oral hygiene item
CARE Core Self-Care: Oral Hygiene (N = 4,890)
Missing
1 = Dependent (Helper does all of the effort)
2 = Substantial/max. assist. (Helper does more than half)
3 = Partial/mod. assist. (Helper does less than half)
4 = Supervision or touching assist.
5 = Setup or clean-up assist.
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical condition
N = Not applicable when coded
P = Patient refused
S = Not attempted due to safety concerns

N

Percent

16
220
195
555
1,118
2,274
369
14
11
53
40
25

0.3
4.5
4.0
11.4
22.9
46.5
7.6
0.3
0.2
1.1
0.8
0.5

N

Percent

34
523
426
705
1,131
1,960
66
45

0.7
10.7
8.7
14.4
23.1
40.1
1.4
0.9

SOURCE: RTI analysis of CARE Item Set data, 2008–2009.
Table 13-4b
IRF-PAI/FIM® admission grooming item
IRF-PAI/FIM® Instrument 39B. Grooming
0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.
SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
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Figure 13-3
Distributions of CARE admission oral hygiene item and IRF-PAI/FIM® admission
grooming item
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NOTE: See above for the values for each rating scale. Please note that the CARE Item Set
rating scale ranges 1–6.
SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM® Instrument data, 2008–2009.
Table 13-4c
CARE admission oral hygiene item by IRF-PAI/FIM® admission grooming item

CARE Core Self-Care: Oral
Hygiene (N = 4,874)

0=
Activity
does not
occur

4 = Min.
1 = Total 2 = Max. 3 = Mod. Assist./To
Assist.
Assist.
Assist.
uching

5 = Supervision/Setup

6 = Mod.
Independ.

7=
Complete
Independ.

1 = Dependent (n = 220)
2 = Substantial/max. assist. (n =
195)

+

86.4*

8.2

+

+

+

+

+

+

34.4*

44.1*

12.3

6.2

+

+

+

3 = Partial/mod. assist. (n = 555)
4 = Supervision or touching
assist. (n = 1,118)
5 = Setup or clean-up assist. (n =
2,274)

+

6.6

8.3

15.2*

31.8*

36.9

+

+

+

6.6

8.3

15.2

31.8*

36.9*

+

+

0.5
+

4.0
+

4.9

11.2

21.3

56.8*

0.9

+

3.0

8.4

21.7

44.4

16.1

30.8

11.1*
+

9.8*
+

6 = Independent (n = 369)
Letter codes (n = 143)

+

16.8

11.2

18.9

®

* These values indicate the area of anticipated overlap between the CARE Item Set and IRF-PAI/FIM Instrument
responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 16 (includes CARE Item Set missing values). Values refer to row percents.
®
SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.
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Summary Points
•

The most frequent value for the CARE Oral Hygiene item at admission is 5–Setup or
Clean-up Assistance, in which 47 percent of the responses are coded.

•

The most frequent value for the IRF-PAI/FIM® Instrument Grooming item is code 5–
Supervision/Setup, in which 40 percent of all responses are coded.

•

As shown in Table 13-4c, the CARE values of 1, 2, 3, 4, and 5 overlapped with the
IRF-PAI/FIM® values as expected. The most agreement was between a CARE value
of 1–Dependent and a IRF-PAI/FIM® value of 1–Total Assistance, followed by a
CARE value of 2–Substantial/Maximal Assistance and IRF-PAI/FIM® values of 1–
Total Assistance and 2–Maximal Assistance.

5. VI. Functional Status: Core Self-Care: A4 Toilet Hygiene (IRF-PAI/FIM®
Instrument: F. Toileting)
The next CARE self-care item is toilet hygiene. The Toileting FIM® item on the IRFPAI is most similar to this CARE item.
Factors to consider when comparing the data from these two instruments include the
differences in the time frames to complete the patient assessment, CARE Item Set’s emphasis on
usual performance versus IRF-PAI/FIM® items’ emphasis on coding the patient’s lowest
functional levels, and the differences in each instruments’ rating scales. The item definitions are
below.
CARE Item Set Definition:
A4. Toilet hygiene: The ability to maintain perineal hygiene, adjust clothes before and
after using toilet, commode, bedpan, urinal. If managing ostomy, include wiping opening
but not managing equipment.
IRF-PAI/FIM® Instrument Definition:
39F. Toileting: Toileting includes maintaining perineal hygiene and adjusting clothing
before and after using a toilet, commode, bedpan, or urinal. The patient performs this
activity safely.
The overall frequencies for these items are shown in Tables 13-5a and 13-5b, followed by
the cross-tabulation of these items in Table 13-5c. Figure 13-4 illustrates the individual item
distributions.
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Table 13-5a
CARE admission toilet hygiene item
CARE Core Self-Care: Toilet Hygiene (N = 4,890)
Missing
1 = Dependent (Helper does all of the effort)
2 = Substantial/max. assist. (Helper does more than half)
3 = Partial/mod. assist. (Helper does less than half)
4 = Supervision or touching assist.
5 = Setup or clean-up assist.
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical condition
N = Not applicable when coded
P = Patient refused
S = Not attempted due to safety concerns

N

Percent

16
1,173
891
1,097
1,152
318
108
12
20
69
19
15

0.3
24.0
18.2
22.4
23.6
6.5
2.2
0.3
0.4
1.4
0.4
0.3

N

Percent

48
1,938
854
805
928
264
41
12

1.0
39.6
17.5
16.5
19.0
5.4
0.8
0.3

SOURCE: RTI analysis of CARE Item Set data, 2008–2009.
Table 13-5b
IRF-PAI/FIM® admission toileting item
IRF-PAI/FIM® 39F. Toileting
0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.
SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
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Figure 13-4
Distributions of CARE admission toilet hygiene item by IRF-PAI/FIM® admission toileting
item
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NOTE: See above for the values for each rating scale. Please note that the CARE Item Set
rating scale ranges 1–6.
SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM® Instrument data, 2008–2009.
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Table 13-5c
CARE admission toilet hygiene item by IRF-PAI/FIM® admission toileting item

CARE Core Self-Care:
Toileting (N = 4,874)

5=
0=
3=
4 = Min.
SuperActivity
does not 1 = Total 2 = Max. Mod. Assist./Touch- vision/ 6 = Mod. 7 = Complete
ing
Setup Independ.
Assist. Assist. Assist.
Independ.
occur

1 = Dependent (n = 1,173)

1.1

90.1*

6.5

1.3

+

+

+

+

2 = Substantial/max. assist.
(n = 891)

+

43.2*

44.7*

7.9

2.4

+

+

+

3 = Partial/mod. assist. (n =
1,097)

+

22.4

18.3

37.1*

20.1*

+

+

+

4 = Supervision or touching
assist. (n = 1,152)

+

12.8

10.2

20.3

44.4*

10.1*

1.0

+

5 = Setup or clean-up assist.
(n = 318)

+

10.4

9.4

13.2

34.3

28.6*

+

+

6 = Independent (n = 108)

+

+

+

12.0

32.4

26.9

Letter codes (n = 135)

+

44.4

15.6

17.0

11.1

+

13.9*

+

+

+
®

* These values indicate the area of anticipated overlap between the CARE Item Set and IRF-PAI/FIM Instrument
responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 16 (includes CARE Item Set missing values). Values refer to row percents.
®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.

Summary Points
•

The most frequent values for the CARE toilet hygiene item at admission are 1–
Dependent (patient unable to perform any of the activity), in which 24 percent of the
responses are coded, and 4–Supervision or Touching Assistance, also with
approximately 24 percent of responses.

•

The most frequent value for the FIM® toileting item on the IRF-PAI is 1–Total
Assistance (patient performs less than 25 percent of the activity), in which 40 percent
of all responses are coded.

•

On Table 13-5c, the CARE values of 1, 2, 3, and 4 overlapped with the FIM® values
on the IRF-PAI as expected. The most agreement was between a CARE value of 1–
Dependent and the IRF-PAI/FIM® value of 1–Total Assistance, followed by a CARE
value of 2–Substantial/Maximal Assistance and IRF-PAI/FIM® values of 1–Total
Assistance and 2–Maximal Assistance.

6. VI. Functional Status: Core Self-Care: A5 Upper Body Dressing (IRF-PAI/FIM®
Instrument: D. Dressing Upper Body)
Next is the CARE self-care Upper Body Dressing item. The Dressing Upper Body FIM®
item on the IRF-PAI is similar and will be used for comparison. Factors to consider when
comparing the data from these two instruments include the differences in the time frames to
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complete the patient assessment, CARE Item Set’s emphasis on usual performance versus IRFPAI/FIM® items’ emphasis on coding the patient’s lowest functional levels, and the differences
in the instruments’ rating scales. The item definitions are below.
CARE Item Set Definition:
A5. Upper Body Dressing: The ability to put on and remove shirt or pajama top.
Includes buttoning, if applicable.
IRF-PAI/FIM® Instrument Definition:
39D. Dressing Upper Body includes dressing and undressing above the waist, as well as
applying and removing a prosthesis or orthosis when applicable. The patient performs
this activity safely.
The overall frequencies for these items are shown in Tables 13-6a and 13-6b, followed by
the cross-tabulation in Table 13-6c. Figure 13-5 illustrates the individual item distributions.
Table 13-6a
CARE admission upper body dressing item
CARE Core Self-Care: Upper Body Dressing (N = 4,890)
Missing
1 = Dependent (Helper does all of the effort)
2 = Substantial/max. assist. (Helper does more than half)
3 = Partial/mod. assist. (Helper does less than half)
4 = Supervision or touching assist.
5 = Setup or clean-up assist.
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical condition
N = Not applicable when coded
P = Patient refused
S = Not attempted due to safety concerns
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE Item Set data, 2008–2009.
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N

Percent

16
395
546
1,190
1,140
1,403
99
+
16
35
25
15

0.3
8.1
11.2
24.3
23.3
28.7
2.0
+
0.3
0.7
0.5
0.3

Table 13-6b
IRF-PAI/FIM admission dressing upper body item
®

IRF-PAI/FIM® 39D. Dressing Upper Body
0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.

N

Percent

128
722
717
869
1,129
1,284
24
17

2.6
14.8
14.7
17.8
23.1
26.3
0.5
0.4

SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
Figure 13-5
Distributions of CARE admission upper body dressing and IRF-PAI/FIM® admission
dressing upper body admission items
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NOTE: See above for the values for each rating scale. Please note that the CARE Item Set
rating scale ranges 1–6.
SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM® Instrument data, 2008–2009.
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Table 13-6c
CARE admission upper body dressing item by IRF-PAI/FIM® admission dressing upper
body item

CARE Core Self-Care: Upper
Body Dressing (N = 4,874)

5=
0=
3=
4 = Min.
SuperActivity
does not 1 = Total 2 = Max. Mod. Assist./Touch- vision/ 6 = Mod. 7 = Complete
ing
Setup Independ.
Assist. Assist. Assist.
Independ.
occur

1 = Dependent (n = 395)

8.1

83.3*

6.1

2 = Substantial/max. assist.
(n = 546)

3.1

25.6*

59.7*

7.5

3.3

3 = Partial/mod. assist.
(n = 1,190)

1.3

10.2

15.0

36.5*

4 = Supervision or touching
assist. (n = 1,140)

1.4

5.4

8.8

5 = Setup or clean-up assist.
(n = 1,403)

0.8

3.3

6 = Independent (n = 99)
Letter codes (n = 101)

+
34.7

+

+

+

+

+

+

+

+

33.4*

3.6

+

+

17.5

34.2*

32.4*

+

+

5.1

12.0

20.2

58.0*

+

+

+

+

+

20.2

34.3

16.2*

+

18.8

+

+

10.9

13.9

+

+
®

* These values indicate the area of anticipated overlap between the CARE Item Set and IRF-PAI/FIM Instrument
responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 16 (includes CARE Item Set missing values). Values refer to row percents.
®

SOURCE: RTI analysis of CARE and IRF-PAI/FIM Instrument data, 2008–2009.

Summary Points
•

The most frequent values for the CARE Upper Body Dressing item at admission are
5–Setup or Clean-up Assistance, in which 29 percent of the responses are coded; 3–
Partial/Moderate Assistance, with 24 percent; and 4–Supervision or Touching
Assistance, with 23 percent.

•

The most frequent values for the FIM® Dressing Upper Body item on the IRF-PAI are
5–Supervision/Setup, in which 26 percent of all responses are coded, and 4–Minimal
Assistance/Touching, with 23 percent.

•

All CARE values overlapped with the IRF-PAI/FIM® values as expected, with the
exception of 6, which overlapped most with an IRF-PAI/FIM® level of 5. The most
agreement was between a CARE value of 2–Substantial/Maximal Assistance and
IRF-PAI/FIM® values of 1–Total Assistance and 2–Maximal Assistance. There was
also high agreement among patients with CARE values of 1–Dependent and IRFPAI/FIM® values of 1–Total Assistance.

68

7. VI. Functional Status: Core Self-Care: A6 Lower Body Dressing (IRF-PAI/FIM®
Instrument: E. Dressing Lower Body)
The CARE self-care Lower Body Dressing item is similar to the Dressing Lower Body
FIM item on the IRF-PAI, with important exceptions noted below. Factors to consider when
comparing the data from these two instruments include the differences in the time frames to
complete the patient assessment, CARE Item Set’s emphasis on usual performance versus IRFPAI/FIM® items’ emphasis on coding the patient’s lowest functional levels, and the differences
in the instruments’ rating scales. The item definitions are below.
®

CARE Item Set Definition:
A6. Lower body dressing: The ability to dress and undress below the waist, including
fasteners. Does not include footwear.
IRF-PAI/FIM® Instrument Definition:
39E. Dressing Lower Body includes dressing and undressing from the waist down, as
well as applying and removing a prosthesis or orthosis when applicable. The patient
performs the activity safely.
Other factors specific to these items that impact how the assessment data compare
include the following:
•

The CARE item specifically excludes footwear. Putting on and taking off footwear is
measured in a separate CARE item. The FIM® item on the IRF-PAI for lower body
dressing includes dressing and undressing from the waist down and includes the
patient’s ability to put on and take off footwear and foot orthotics.

•

The lower body dressing items on the CARE and IRF-PAI/FIM® assessments each
include assessing the patient’s ability to put on and take off prostheses for above and
below the knee; however, the IRF-PAI/FIM® Instrument includes assessing the
patient’s ability to put on and take off ankle/foot orthoses or foot orthotics, whereas
the CARE Item Set has a separate measure for this skill, Putting on and Taking off
Footwear. Assistance with applying or removing a prosthesis or orthosis is scored as
a piece of clothing on the CARE Item Set, which is different than the scoring on the
IRF-PAI/FIM® Instrument.

The overall frequencies for these items are shown in Tables 13-7a and 13-7b, followed by
the cross-tabulation in Table 13-7c. Figure 13-6 illustrates the individual item distributions.
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Table 13-7a
CARE admission lower body dressing item
Core Self-Care: Lower Body Dressing (N = 4,890)
Missing
1 = Dependent (Helper does all of the effort)
2 = Substantial/max. assist. (Helper does more than half)
3 = Partial/mod. assist. (Helper does less than half)
4 = Supervision or touching assist.
5 = Setup or clean-up assist.
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical condition
N = Not applicable when coded
P = Patient refused
S = Not attempted due to safety concerns

N

Percent

16
1,284
1,428
1,172
670
196
32
11
17
31
26
+

0.3
26.3
29.2
24.0
13.7
4.0
0.7
0.2
0.4
0.6
0.5
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE Item Set data, 2008–2009.
Table 13-7b
IRF-PAI/FIM admission dressing lower body item
®

IRF-PAI/FIM® 39E. Dressing Lower Body
0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
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N

Percent

114
1,880
1,192
779
693
214
12
+

2.3
38.5
24.4
15.9
14.2
4.4
0.3
+

Figure 13-6
Distributions of CARE admission lower body dressing item and IRF-PAI/FIM® admission
dressing lower body item
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6
rating scale (1=dependent; 6/7=independent)

7

NOTE: See above for the values for each rating scale. Please note that the CARE Item Set
rating scale ranges 1–6.
SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM® Instrument data, 2008–2009.
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Table 13-7c
CARE admission lower body dressing item by IRF-PAI/FIM® admission dressing lower
body item

CARE Core Self-Care: Lower
Dressing (N = 4,874)

5=
0=
3=
4 = Min.
SuperActivity
does not 1 = Total 2 = Max. Mod. Assist./Touch- vision/ 6 = Mod. 7 = Complete
ing
Setup Independ.
Assist. Assist. Assist.
Independ.
occur

1 = Dependent (n = 1,284)

3.7

90.2*

4.8

1.0

+

+

+

+

2 = Substantial/max. assist. (n =
1,428)

1.0

32.6*

57.1*

7.6

1.5

+

+

+

3 = Partial/mod. assist. (n =
1,172)

1.1

13.6

20.1

41.4*

23.0*

+

+

+

4 = Supervision or touching
assist. (n = 670)

+

7.3

7.9

19.4

49.7*

14.9*

+

+

5 = Setup or clean-up assist. (n
= 196)

+

6.6

+

12.8

29.1

43.9*

+

+

6 = Independent (n = 32)
Letter codes (n = 92)

+

+

+

+

+

+

+

+

33.7

33.7

14.1

+

+

+

+

+
®

* These values indicate the area of anticipated overlap between the CARE Item Set and IRF-PAI/FIM Instrument
responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 16 (includes CARE Item Set missing values). Values refer to row percents.
®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.

Summary Points
•

The most frequent values for the CARE Lower Body Dressing item at admission are
2–Substantial/Maximal Assistance, in which 29 percent of the responses are coded,
and 1–Dependent, with 26 percent.

•

The most frequent value for the FIM® Dressing Lower Body item on the IRF-PAI is
1–Total Assistance, in which 39 percent of all responses are coded.

•

All CARE values overlapped with the IRF-PAI/FIM® values as expected. The most
agreement was among patients with a CARE value of 2–Substantial/Maximal
Assistance and IRF-PAI/FIM® values of 1–Total Assistance and 2–Maximal
Assistance.

8. VI. Functional Status: Core Functional Mobility: B3. Chair/Bed-to-Chair Transfer
(IRF-PAI/FIM® Instrument: I. Bed, Chair, Wheelchair Transfer)
The first comparison item in the functional mobility section is bed and chair transfers. It
appears in the CARE Item Set as the Chair/Bed-to-Chair Transfer item and is similar to the Bed,
Chair, Wheelchair Transfer item in the IRF-PAI/FIM® Instrument. Factors to consider when
comparing the data from these two instruments include the differences in the time frames to
complete the patient assessment, CARE Item Set’s emphasis on usual performance versus IRF72

PAI/FIM® items’ emphasis on coding the patient’s lowest functional levels, and the differences
in each instrument’s rating scales. The item definitions are below.
CARE Item Set Definition:
B3. Chair/Bed-to-Chair Transfer: The ability to safely transfer to and from a chair (or
wheelchair). The chairs are placed at right angles to each other.
IRF-PAI/FIM® Instrument Definition:
39I. Transfers: Bed, Chair, Wheelchair includes all aspects of transferring from a bed
to a chair and back, or from a bed to a wheelchair and back, or coming to a standing
position if walking is the typical mode of locomotion. The patient performs the activity
safely.
The overall frequencies for these items are shown in Tables 13-8a and 13-8b, followed by
the cross-tabulation in Table 13-8c. Figure 13-7 illustrates the individual item distributions.
Table 13-8a
CARE admission chair/bed-to-chair transfer item
CARE Core Self-Care: Chair/Bed-to-Chair (N = 4,890)
Missing
1 = Dependent (Helper does all of the effort)
2 = Substantial/max. assist. (Helper does more than half)
3 = Partial/mod. assist. (Helper does less than half)
4 = Supervision or touching assist.
5 = Setup or clean-up assist.
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical condition
N = Not applicable when coded
P = Patient refused
S = Not attempted due to safety concerns
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE Item Set data, 2008–2009.

73

N

Percent

15
537
789
1,721
1,613
68
65
+
33
17
12
12

0.3
11.0
16.1
35.2
33.0
1.4
1.3
+
0.7
0.4
0.3
0.3

Table 13-8b
IRF-PAI/FIM admission bed, chair, wheelchair transfer item
®

IRF-PAI/FIM® 39I. Bed, Chair, Wheelchair
0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.

N

Percent

24
1,183
908
1,425
1,196
127
15
12

0.5
24.2
18.6
29.1
24.5
2.6
0.3
0.3

SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
Figure 13-7
Distributions of CARE admission and IRF-PAI/FIM® admission chair/bed-to-chair transfer
admission items
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NOTE: See above for the values for each rating scale. Please note that the CARE Item Set
rating scale ranges 1–6.
SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM® Instrument data, 2008–2009.
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Table 13-8c
CARE admission chair/bed-to-chair transfer item by IRF-PAI/FIM® admission bed, chair,
wheelchair transfer item

CARE Core Self-Care:
Chair/Bed-to-Chair (N = 4,874)

5=
0=
3=
4 = Min.
SuperActivity
does not 1 = Total 2 = Max. Mod. Assist./Touch- vision/ 6 = Mod. 7 = Complete
ing
Setup Independ.
Assist. Assist. Assist.
Independ.
occur

1 = Dependent (n = 537)

+

92.9*

4.8

+

+

+

+

+

2 = Substantial/max. assist.
(n = 789)

+

39.9*

46.8*

11.4

+

+

+

+

3 = Partial/mod. assist.
(n = 1,721)

+

13.1

21.9

44.6*

19.8*

+

+

+

4 = Supervision or touching
assist. (n = 1,613)

+

5.0

7.7

33.4

48.8*

4.6*

+

+

5 = Setup or clean-up assist.
(n = 68)

+

+

+

+

44.1

30.9*

+

+

6 = Independent (n = 65)

+

+

+

+

30.8

35.4

+

+

Letter codes (n = 82)

+

63.4

+

+

+

+

+

+
®

* These values indicate the area of anticipated overlap between the CARE Item Set and IRF-PAI/FIM Instrument
responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 15 (includes CARE Item Set missing values). Values refer to row percents.
®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.

Summary Points
•

The most frequent values for the CARE Chair/Bed-to-Chair item at admission are 3–
Partial/Moderate Assistance, in which 35 percent of the responses are coded, and 4–
Supervision or Touching Assistance, with 33 percent.

•

The most frequent values for the FIM® Bed, Chair, Wheelchair item on the IRF-PAI
are 3–Moderate Assistance, in which 29 percent of all responses are coded; 4–Minimal
Assistance/Touching, with 25 percent; and 1–Total Assistance, with 24 percent.

•

Table 13-8c reported that the CARE values of 1, 2, 3, and 4 overlapped with the IRFPAI/FIM® values as expected. Similarly, CARE’s code 5–Setup or Clean-up
Assistance overlapped the most with IRF-PAI/FIM® levels 4–Minimal
Assistance/Touching and 5–Supervision/Setup. Patients coded as 6–Independent on
the CARE item were most often coded as needing supervision and minimal assistance
on the IRF-PAI/FIM® Instrument. The most agreement was among patients with a
CARE value of 1–Dependent and an IRF-PAI/FIM® value of 1–Total Assistance.
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9. VI. Functional Status: Core Functional Mobility: B4. Toilet Transfer (IRFPAI/FIM® Instrument: J. Toilet Transfer)
Next is the CARE toilet transfer item, which is being compared to the Toilet Transfer
item included in the IRF-PAI/FIM® Instrument. Factors to consider when comparing the data
from these two instruments include the differences in the time frames to complete the patient
assessment, CARE Item Set’s emphasis on usual performance versus IRF-PAI/FIM® items’
emphasis on coding the patient’s lowest functional levels, and the differences in the instruments’
rating scales. The item definitions are below.
CARE Item Set Definition:
B4. Toilet Transfer: The ability to safely get on and off a toilet or commode.
IRF-PAI/FIM® Instrument Definition:
39J. Toilet Transfer includes safely getting on and off a standard toilet.
Other factors specific to these items that impact how the assessment data compare
include the following:
•

Each instrument defines the activity differently. The CARE Item Set includes the
transfer on and off a toilet or commode, whereas the IRF-PAI/FIM® item defines the
toilet transfer as getting on and off a standard toilet.

The overall frequencies for these items are shown in Tables 13-9a and 13-9b, followed by
the cross-tabulation of the paired items in Table 13-9c. Figure 13-8 illustrates the individual
item distributions.
Table 13-9a
CARE admission toilet transfer item
CARE Item Set Core Functional Mobility: Toilet Transfer
(N = 4,890)
Missing
1 = Dependent (Helper does all of the effort)
2 = Substantial/max. assist. (Helper does more than half)
3 = Partial/mod. assist. (Helper does less than half)
4 = Supervision or touching assist.
5 = Setup or clean-up assist.
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical condition
N = Not applicable when coded
P = Patient refused
S = Not attempted due to safety concerns
SOURCE: RTI analysis of CARE Item Set data, 2008–2009.
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N
15
515
693
1,400
1,428
126
39
18
90
231
42
293

Percent
0.3
10.5
14.2
28.6
29.2
2.6
0.8
0.4
1.8
4.7
0.9
6.0

Table 13-9b
IRF-PAI/FIM admission toilet transfer item
®

IRF-PAI/FIM® 39J. Toilet Transfer
0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.

N

Percent

283
925
844
1,277
1,347
187
18
+

5.8
18.9
17.3
26.1
27.6
3.8
0.4
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
Figure 13-8
Distributions of CARE admission and IRF-PAI/FIM® admission toilet transfer admission
items
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NOTE: See above for the values for each rating scale. Please note that the CARE Item Set
rating scale ranges 1–6.
SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM® Instrument data, 2008–2009.
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Table 13-9c
CARE admission toilet transfer item by IRF-PAI/FIM® admission toilet transfer item

CARE Core Self-Care: Toilet
Transfer (N = 4,874)
1 = Dependent (n = 515)

0=
3=
4 = Min.
5 = SuperActivity
6 = Mod. 7 = Complete
does not 1 = Total 2 = Max. Mod. Assist./Touch- vision/
ing
Setup
Independ.
Independ.
Assist. Assist. Assist.
occur
12.4

75.7*

7.2

3.3

+

+

+

+

2 = Substantial/max. assist. (n =
693)

5.9

26.8*

49.4*

12.6

4.5

+

+

+

3 = Partial/mod. assist. (n =
1,400)

2.5

9.4

14.1

45.9*

27.0*

0.9

+

+

4 = Supervision or touching
assist. (n = 1,428)

1.2

3.1

5.3

24.4

58.3*

7.4*

+

+

5 = Setup or clean-up assist. (n
= 126)

+

+

+

18.3

31.7

31.7*

+

+

6 = Independent (n = 39)

+

+

+

+

33.3

+

18.0

24.5

27.0

22.3

6.5

+

Letter codes (n = 674)

20.5*
+

+
+

®

* These values indicate the area of anticipated overlap between the CARE Item Set and IRF-PAI/FIM Instrument
responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 15 (includes CARE Item Set missing values). Values refer to row percents.
®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.

Summary Points
•

The most frequent values for the CARE Toilet Transfer item at admission are values
of 3–Partial/Moderate Assistance and 4–Supervision or Touching Assistance, in each
of which 29 percent of the responses are coded.

•

The most frequent values for the FIM® Toilet Transfer item on the IRF-PAI are 3–
Moderate Assistance and 4–Minimal Assistance/Touching, in which 26 percent and
28 percent of all responses are coded, respectively.

•

All CARE values overlapped with the IRF-PAI/FIM® values as expected except for
6–Independent, which overlapped most with an IRF-PAI/FIM® level of 4–Minimal
Assistance/Touching. The most agreement was among patients with a CARE value
of 2–Maximal Assistance and IRF-PAI/FIM® values of 1–Total Assistance and 2–
Maximal Assistance. There was also substantial overlap between patients with
CARE values of 1–Dependent and IRF-PAI/FIM® values of 1–Total Assistance.

•

The CARE Item Set includes the transfer on and off a toilet or commode, whereas the
IRF-PAI/FIM® item defines the toilet transfer as taking place on and off a standard
toilet. This difference may have impacted a patient’s results in achieving a less
independent functional level in CARE than using IRF-PAI/FIM®. The rationale is
that a commode can be height adjusted to increase the ease of the transfer, impacting
the independence of a patient using a commode, whereas a standard toilet is not
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height adjustable and a taller or weaker patient may require more transfer assistance
from a helper.

10. VI. Functional Status: Core Functional Mobility: Mode of Mobility: B5-B5a-B5b
(IRF-PAI/FIM® Instrument: L. Walk/Wheelchair and Function Modifiers)
The next items to be discussed are the CARE Mode of Mobility items and the IRFPAI/FIM® Instrument 39L Locomotion item for Walk/Wheelchair, along with the associated
function modifiers (35, 36, 37, and 38). Factors to consider when examining the data from these
two instruments include the differences in the time frames to complete the patient assessment,
the differences in the instruments’ rating scales, differing administrative rules in how the
clinician should complete these items, and item definition differences. Given the very different
definitions, frequency data are presented for each item from each instrument. The item
definitions are below.
CARE Item Set Definitions:
Items B5, B5a, and B5b:
B5: Does this patient primarily use a wheelchair for mobility?
0. No (If No, code B5a for the longest distance completed.)
1. Yes (If Yes, code B5b for the longest distance completed.)
B5a. Select the longest distance the patient walks and code his/her level of
independence (Level 1-6) on that distance. Observe performance. (Select only one.)
1. Walk 150 ft (45 m): Once standing, can walk at least 150 feet (45 meters) in corridor
or similar space.
2. Walk 100 ft (30 m): Once standing, can walk at least 100 feet (30 meters) in corridor
or similar space.
3. Walk 50 ft (15 m): Once standing, can walk at least 50 feet (15 meters) in corridor or
similar space.
4. Walk in Room Once Standing: Once standing, can walk at least 10 feet (3 meters) in
room, corridor or similar space.
B5b. Select the longest distance the patient wheels and code his/her level of
independence (Level 1-6). Observe performance. (Select only one.)
1. Wheel 150 ft (45 m): Once sitting, can wheel at least 150 feet (45 meters) in corridor
or similar space.
2. Wheel 100 ft (30 m): Once sitting, can wheel at least 100 feet (30 meters) in corridor
or similar space.
3. Wheel 50 ft (15 m): Once sitting, can wheel at least 50 feet (15 meters) in corridor or
similar space.
4. Wheel in Room Once Seated: Once seated, can wheel at least 10 feet (3 meters) in
room, corridor, or similar space.
IRF-PAI/FIM® Instrument Definitions:
IRF-PAI Modifiers for Walking & Wheelchair:
Locomotion: Walk includes walking on a level surface once in a standing position. The
patient performs the activity safely. Wheelchair includes using a wheelchair on a level
surface once in a seated position. The patient performs the activity safely.
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39L. Locomotion Walk/Wheelchair
This item is scored at Admission based upon the expected mode of locomotion at
discharge. For example, if the patient walks at admission, and is expected to walk at
discharge, the score for item 37 is entered in 39L. If the patient uses a wheelchair at
admission, and is expected to use a wheelchair at discharge, item 38 is entered in 39L.
IRF-PAI Function Modifier for Walking:
35. Distance Walked: Code using: 3-150 feet; 2-50 to 149 feet; 1-Less than 50 feet; 0activity does not occur
37. Walk: Sccored on both level of assistance needed and distance of locomotion. Score
Levels 1-7; 0 if activity does not occur. Use information from Item 35 above to help
determine score.
IRF-PAI Function Modifier for Wheelchair:
36. Distance Traveled in Wheelchair: Code using: 3-150 feet; 2-50 to 149 feet; 1-Less
than 50 feet; 0-activity does not occur.
38. Wheelchair: Scored on both level of assistance needed and distance of locomotion.
Use IRF-PAI/FIM® Instrument levels 1-7 to score these items; use 0 if Activity does not
occur. Use information from Item 36 above to help determine score.
Other factors specific to these items that impact the reader’s review of each the item’s
frequency data include the following:
•

The CARE Item Set instructs the clinician to choose the patient’s primary mode of
mobility (walk or wheel). The clinician assesses the patient using only one of these
modes of mobility. Further, the patient is assessed on only one distance of the chosen
mode of mobility. This is shown on Table 13-10b below, which displays large
amounts of data as Coded on Other Item or Missing. On the CARE Item Set, all
walking items would have been left blank if the patient usually used the wheelchair.

•

On the IRF-PAI/FIM®, there are function modifier items that the clinician scores to
assess the patient’s distance walked or wheeled. There are also specific rules for the
clinician to follow when scoring IRF-PAI/FIM® item 39L. Item 39L requires the
clinician to enter only one mode of locomotion score from the appropriate function
modifiers walking (item 37) or wheelchair (item 38) score. Item 39L requires that the
patient’s reported mode of locomotion must match for admission and discharge.

The overall frequencies for these items are shown in Tables 13-10a through 13-10d.
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Table 13-10a
CARE admission mode of mobility items (B5)
CARE Core Functional Mobility: Mode of Mobility (B5)
(N = 4,890)

N

Does the patient primarily use a wheelchair for mobility?
Missing
0-No
1-Yes

16
2,771
2,103

Percent
0.3
56.7
43.0

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM® Instrument data, 2008–2009.
Table 13-10b
CARE admission mode of mobility items (B5a1-4)
CARE Core Functional
Mobility: Mode of Mobility
(B5a) (N = 4,890)

Walk
150 ft
N

Walk
150 ft
Percent

Walk
100 ft
N

Walk
100 ft
Percent

Walk
50 ft
N

Walk
50 ft
Percent

Walk in
Room Once
Standing
N

Walk in
Room Once
Standing
Percent

Coded on Other Item or
Missing

4,132

84.5

4,522

92.5

4,223

86.4

3,912

80.0

1 = Dependent

+

+

+

+

+

+

40

0.8

2 = Substantial/max. assist.

+

+

+

+

21

0.4

74

1.5

3 = Partial/mod. assist.

106

2.2

99

2.0

244

5.0

383

7.8

4 = Supervision or touching
assist.

537

11.0

246

5.0

363

7.4

271

5.5

5 = Setup or clean-up assist.

29

0.6

+

+

+

+

+

+

6 = Independent

24

0.5

+

+

+

+

+

+

149

3.1

25

0.5

A = Attempted not completed

+

+

+

+

31

0.6

M = Medical condition

+

+

+

+

+

+

N = Not applicable

40

0.8

+

+

+

+

+

+

+

+

P = Patient refused

+

+

+

+

+

+

S = Safety concerns

+

+

+

+

+

+

15

0.3

+ Cells based on a sample size of n < 11 are not shown.
NOTE: On the CARE Item Set, all walking items would have been left uncoded if the patient usually used the
wheelchair, resulting in the high n and percentages reported here as Coded on Other Item or Missing.
®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.
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Table 13-10c
IRF-PAI/FIM admission distance walked and distance traveled in wheelchair
®

35. Distance
Walked
N

Response Options
0 = Activity does not
occur
1 = Less than 50 feet
2 = 50 to 149 feet
3 = 150 feet

35. Distance
Walked
Percent

891
2,078
1,168
753

18.2
42.5
23.9
15.4

36. Distance
Traveled in
Wheelchair
N

36. Distance
Traveled in
Wheelchair
Percent

1,924
1,286
926
754

39.4
26.3
18.9
15.4

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM® Instrument data, 2008–2009.
Table 13-10d
IRF-PAI/FIM® admission function modifiers and walk/wheelchair item
®

®

37. Walk
percent

38.
Wheelchair
N*

38.
Wheelchair
percent*

IRF-PAI/FIM
Instrument 39L.
Walk/Wheelchair**
N

872

17.8

1,747

35.7

501

10.3

1 = Total Assist.

2,087

42.7

1,602

32.8

2,155

44.1

2 = Max. Assist.

1,164

23.8

888

18.2

1,320

27.0

3 = Mod. Assist.

45

0.9

30

0.6

48

1.0

4 = Min. Assist./Touching

589

12.0

144

2.9

602

12.3

5 = Supervision/Setup

124

2.5

407

8.3

218

4.5

6 = Mod. Independ.

+

+

71

1.5

40

0.8

7 = Complete Independ.

+

+

+

+

+

Response options
0 = Activity does not occur

37.
Walk
N

+

IRF-PAI/FIM
Instrument 39L.
Walk/Wheelchair**
percent

+ Cells based on a sample size of n < 11 are not shown.
®

*The IRF-PAI/FIM function modifiers scores for Walk/Wheelchair (items 37 and 38) consider both the level of
assistance and the distance of the locomotion.
®

**The FIM item 39L admission score is based upon the expected mode of locomotion at discharge. For example:
If the patient uses a wheelchair at admission but is expected to walk at discharge the score entered into 39L is from
item 37 Walk. If the patient is expected to use a wheelchair at discharge then 39L is scored using item 38.
®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.

Summary Points
•

Less than half (43 percent) of the patients in our sample assessed with the CARE Item
Set primarily used a wheelchair for mobility upon admission.
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•

The CARE code reflects the patient’s admission performance using his or her usual
mobility device during the admission assessment period. The clinician chooses to
code the patient’s performance using walking or wheeling. The IRF-PAI/FIM®
Instrument instructs the clinicians to select the mode of locomotion by anticipating
what mode of locomotion the patient will usually be using at discharge or, if the
clinician is uncertain of the anticipated mode of locomotion at discharge, the clinician
is to complete at admission both scores for wheelchair mobility and walking in the
function modifier items (35, 36, 37, and 38). The result of this rule is that for the
IRF-PAI/FIM® there will be both a walking and wheelchair score reported for each
patient, whereas the clinician using the CARE Item Set codes one score for the
patient’s performance using the most frequently used mode of mobility (walking or
wheeling) during the admission assessment period in the rehabilitation program.

•

Review of the function modifiers on the IRF-PAI showed that, upon admission, the
most frequent distance walked was code 1–Less than 50 Feet and the most frequent
distance wheeled was code 0–Activity Does Not Occur. The walk function modifier
most often coded was 1–Total Assistance, and the most frequent codes for the
wheelchair modifier were 0–Activity Does Not Occur and 1–Total Assistance.

11. VI. Functional Status: C. Supplemental Functional Ability: C1. Wash Upper Body
(IRF-PAI/FIM® Instrument: B. Grooming and C. Bathing)
The first supplemental functional ability item is Wash Upper Body. There is not an
equivalent item on the IRF-PAI/FIM® Instrument, so we will compare these items using the
Grooming and Bathing IRF-PAI/FIM® Instrument items as approximate items. The definitions
below provide additional detail on the differences in these concepts. Factors to consider when
comparing the data from these two instruments include the differences in the definitions and the
time frames to complete the patient assessment, CARE Item Set’s emphasis on usual
performance versus IRF-PAI/FIM® items’ emphasis on coding the patient’s lowest functional
levels, and the differences in the instruments’ rating scales. The item definitions are below.
CARE Item Set Definition:
C1. Wash Upper Body: The ability to wash, rinse, and dry the face, hands, chest, and
arms while sitting in a chair or bed.
IRF-PAI/FIM® Instrument Definitions:
39B. Grooming includes oral care, hair grooming (combing or brushing hair), washing
the hands, washing the face, and either shaving the face or applying make-up. If the
subject neither shaves nor applies make-up, Grooming includes only the first four tasks.
The patient performs this activity safely. This item includes obtaining articles necessary
for grooming.
39C. Bathing includes washing, rinsing, and drying the body from the neck down
(excluding the neck and back) in either a tub, shower or sponge/bed bath. The patient
performs the activity safely.
Other factors specific to these items that impact how the assessment data compare
include the following:
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•

The CARE Wash Upper Body item overlaps with the IRF-PAI/FIM® Grooming item
for the tasks of washing hands and face. The IRF-PAI/FIM® Grooming item includes
other tasks that do not appear on the CARE Wash Upper Body item (i.e., oral care
and hair grooming). The IRF-PAI/FIM® Bathing item includes upper and lower body
bathing, whereas the CARE Wash Upper Body item does not include lower body
bathing. These differences will impact the comparison of the two instruments.

The overall frequencies for these items are shown in Tables 13-11a and 13-11b, followed
by a cross-tabulation of these items in Table 13-11c. Figure 13-9 illustrates the individual item
distributions between the CARE Wash Upper Body item and the IRF-PAI/FIM® Instrument
Bathing item.
Table 13-11a
CARE admission wash upper body item
CARE Supplemental Functional Ability: Wash Upper Body
(N = 4,890)
Missing
1 = Dependent (helper does all of the effort)
2 = Substantial/max. assist. (Helper does more than half)
3 = Partial/mod. assist. (Helper does less than half)
4 = Supervision or touching assist.
5 = Setup or clean-up assist.
6 = Independent
A = Task attempted but not completed
E = Not completed due to environmental constraints
M = Not attempted due to medical condition
N = Not applicable when coded
P = Patient refused
S = Not attempted due to safety concerns
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE Item Set, 2008–2009.
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N
20
322
430
948
1,357
1,413
147
+
14
34
56
65
77

Percent
0.4
6.6
8.8
19.4
27.8
28.9
3.0
+
0.3
0.7
1.2
1.3
1.6

Table 13-11b
IRF-PAI/FIM admission grooming & bathing items
®

Response Options

N

Percent

34
523
426
705
1,131
1,960
66
45

0.7
10.7
8.7
14.4
23.1
40.1
1.4
0.9

161
805
1,058
1,437
1,071
323
23
12

3.3
16.5
21.6
29.4
21.9
6.6
0.5
0.3

®

IRF-PAI/FIM 39B. Grooming
0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.
IRF-PAI/FIM® 39C. Bathing
0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.
SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
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Figure 13-9
Distributions of CARE admission wash upper body and IRF-PAI/FIM® bathing admission
items

35
30

percent

25
20

CARE pct
FIM pct

15
10
5
0
1

2

3

4

5

6

7

rating scale (1=dependent; 6/7=independent)

NOTE: See above for the values for each rating scale. Please note that the CARE Item Set
rating scale ranges 1–6.
SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM® Instrument data, 2008–2009.
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Table 13-11c
CARE admission wash upper body item by IRF-PAI/FIM® admission bathing item
CARE Core Functional
Mobility: Wash Upper Body (N
= 4,870)

0=
Activity
3=
4 = Min.
5 = Super6 = Mod. 7 = Complete
does not 1 = Total 2 = Max. Mod. Assist./Touch- vision/
occur
ing
Setup
Independ.
Independ.
Assist. Assist. Assist.

1 = Dependent (n = 322)

+

82.3*

9.9

+

+

+

+

+

2 = Substantial/max. assist.
(n = 430)

+

40.2*

44.7*

10.7

+

+

+

+

3 = Partial/mod. assist.
(n = 948)

3.1

14.7

33.7*

34.9*

12.2*

1.5

+

+

4 = Supervision or touching
assist. (n = 1,357)

2.3

8.1

20.9

34.6*

25.7*

8.3*

+

+

5 = Setup or clean-up assist.
(n = 1,413)

3.2

4.7

11.6

33.6

35.3*

11.0*

+

+

+

7.5

25.9

32.0

17.7*

8.2*

+

17.8

22.5

24.9

15.0

5.1

+

+

6 = Independent (n = 147)
Letter codes (n = 253)

+
12.7

®

* These values indicate the area of anticipated overlap between the CARE Item Set and IRF-PAI/FIM Instrument
responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 20 (includes CARE Item Set missing values). Values refer to row percents.
®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.

Summary Points
•

The most frequent values for the CARE Wash Upper Body item at admission are 5–
Setup or Clean-up Assistance and 4–Supervision or Touching Assistance.
Approximately 29 percent and 28 percent of the patients are assessed with these
codes, respectively.

•

The most frequent value for the FIM® Grooming item on the IRF-PAI is 5–
Supervision/Setup, in which 40 percent of the responses are coded. The most
frequent value for the IRF-PAI/FIM® Instrument bathing item is 3–Moderate
Assistance, in which 29 percent of all responses are coded.

•

As seen on Table 13-11c, all CARE Upper Body Bathing item values overlapped with
the IRF-PAI/FIM® Bathing item values as expected. For CARE levels 3–6, FIM®
scores tended to be lower; these more dependent scores make sense, because the
FIM® requires washing the entire body, a harder activity than washing the upper
body. The greatest agreement was between patients assessed for CARE’s code 1–
Dependent and a IRF-PAI/FIM® code 1–Total Assistance. There was also significant
agreement among patients with CARE code 2–Substantial/Maximal Assistance and
IRF-PAI/FIM® codes 1–Total Assistance and 2–Maximal Assistance.
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12. VI. Functional Status: C. Supplemental Functional Ability: C2. Shower/Bathe Self
(IRF-PAI/FIM® Instrument: C. Bathing)
The next CARE supplemental functional ability item is the Shower/Bathe Self item,
which is most similar to the Bathing item on the IRF-PAI/FIM® Instrument. Factors to consider
when comparing the data from these two instruments include the differences in the time frames
to complete the patient assessment, CARE Item Set’s emphasis on usual performance versus
IRF-PAI/FIM® items’ emphasis on coding the patient’s lowest functional levels, and the
differences in the instruments’ rating scales. The item definitions are below.
CARE Item Set Definition:
C2. Shower/bathe self: The ability to bathe self in shower or tub, including washing,
rinsing, and drying, self. Does not include transferring in/out of tub/shower.
IRF-PAI/FIM® Instrument Definition:
39C. Bathing includes washing, rinsing, and drying the body from the neck down
(excluding the neck and back) in either a tub, shower or sponge/bed bath. The patient
performs the activity safely.
The overall frequencies for these items are shown in Tables 13-12a and 13-12b, followed
by the cross-tabulation in Table 13-12c. Figure 13-10 illustrates the individual item
distributions.
Table 13-12a
CARE admission shower/bathe self item
CARE Supplemental Functional Ability: Shower/bathe self
(N = 4,890)
Missing
1 = Dependent (helper does all of the effort)
2 = Substantial/max. assist. (Helper does more than half)
3 = Partial/mod. assist. (Helper does less than half)
4 = Supervision or touching assist.
5 = Setup or clean-up assist.
6 = Independent
A = Task attempted but not completed
E = Not completed due to environmental constraints
M = Not attempted due to medical condition
N = Not applicable when coded
P = Patient refused
S = Not attempted due to safety concerns
SOURCE: RTI analysis of CARE Item Set data, 2008–2009.
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N

Percent

20
461
804
1,210
697
244
36
20
76
347
464
121
390

0.4
9.4
16.4
24.7
14.3
5.0
0.7
0.4
1.6
7.1
9.5
2.5
8.0

Table 13-12b
IRF-PAI/FIM® admission bathing item
IRF-PAI/FIM® 39C. Bathing
0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.

N

Percent

161
805
1,058
1,437
1,071
323
23
12

3.3
16.5
21.6
29.4
21.9
6.6
0.5
0.3

SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
Figure 13-10
Distributions of CARE admission shower/bathe self and IRF-PAI/FIM® bathing admission
items
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rating scale (1=dependent; 6/7=independent)

NOTE: See above for the values for each rating scale. Please note that the CARE Item Set
rating scale ranges 1–6.
SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM® Instrument data, 2008–2009.
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Table 13-12c
CARE admission shower/bathe self item by IRF-PAI/FIM® admission bathing item
CARE Supplemental
Functional Ability:
Shower/Bathe Self (N = 4,870)

0=
Activity
3=
4 = Min.
5 = Super6 = Mod. 7 = Complete
does not 1 = Total 2 = Max. Mod. Assist./Touch- vision/
occur
ing
Setup
Independ.
Independ.
Assist. Assist. Assist.

1 = Dependent (n = 461)

2.4

70.5*

18.7

2 = Substantial/max. assist. (n =
804)

6.5

+

+

+

+

3.1

14.8*

55.1*

22.6

3.7

+

+

+

3 = Partial/mod. assist. (n =
1,210)

2.6

6.4

11.6

51.7*

25.5*

2.0

+

+

4 = Supervision or touching
assist. (n = 697)

3.0

3.6

6.9

20.1

50.8*

15.1*

+

+

5 = Setup or clean-up assist. (n
= 244)

+

5.3

9.8

18.4

26.2

34.8*

+

+

6 = Independent (n = 36)

+

+

+

+

+

+

+

+

Letter codes (n = 1,418)

4.6

17.1

22.2

28.4

20.2

6.8

+

+
®

* These values indicate the area of anticipated overlap between the CARE Item Set and IRF-PAI/FIM Instrument
responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 20 (includes CARE Item Set missing values). Values refer to row percents.
®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.

Summary Points
•

At admission, the most frequent value for the CARE item Shower/Bathe Self is 3–
Partial/Moderate Assistance, in which 25 percent of the responses are coded.

•

The most frequent value for the FIM® bathing item on the IRF-PAI is 3–Moderate
Assistance, in which 29 percent of all responses are coded.

•

All CARE values overlapped with the IRF-PAI/FIM® values as expected. The most
agreement was among patients with a CARE value of 3–Partial/Moderate Assistance
and IRF-PAI/FIM® values of 3–Moderate Assistance and 4–Minimal Assistance.

13. VI. Functional Status: C. Supplemental Functional Ability: C6. Putting On/Taking
Off Footwear (IRF-PAI/FIM® Instrument: E. Dressing-Lower Body)
The next CARE supplemental functional ability is the Putting on/Taking off Footwear
item, which is most similar to the Dressing–Lower Body item on the IRF-PAI/FIM® Instrument.
On the CARE Item Set, the footwear item is separate and is not combined with lower extremity
dressing. The tasks required for Putting on/Taking off Footwear are intrinsically different from
the tasks required for lower extremity dressing.
Factors to consider when comparing the data from these two instruments include the
differences in the time frames to complete the patient assessment, CARE Item Set’s emphasis on
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usual performance versus IRF-PAI/FIM® items’ emphasis on coding the patient’s lowest
functional levels, and the differences in the instruments’ rating scales. The item definitions are
below.
CARE Item Set Definition:
C6. Putting on/taking off footwear: The ability to put on and take off socks and shoes or
other footwear that are appropriate for safe mobility.
IRF-PAI Definition:
39E. Dressing Lower Body includes dressing and undressing from the waist down, as
well as applying and removing a prosthesis or orthosis when applicable. The patient
performs the activity safely.
The overall frequencies for these items are shown in Tables 13-13a and 13-13b, followed
by the cross-tabulation in Table 13-13c.
Table 13-13a
CARE admission putting on/taking off footwear item
CARE Supplemental Functional Ability: Putting on/Taking off
Footwear (N = 4,890)
Missing
1 = Dependent (helper does all of the effort)
2 = Substantial/max. assist. (Helper does more than half)
3 = Partial/mod. assist. (Helper does less than half)
4 = Supervision or touching assist.
5 = Setup or clean-up assist.
6 = Independent
A = Task attempted but not completed
E = Not completed due to environmental constraints
M = Not attempted due to medical condition
N = Not applicable when coded
P = Patient refused
S = Not attempted due to safety concerns
+ Cells with a value of n < 11 are not shown.
SOURCE: RTI analysis of CARE Item Set data, 2008–2009.
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N

Percent

20
1,782
1,005
760
557
270
63
27
+
96
141
20
141

0.4
36.4
20.6
15.5
11.4
5.5
1.3
0.6
+
2.0
2.9
0.4
2.9

Table 13-13b
IRF-PAI/FIM admission dressing lower body item
®

IRF-PAI/FIM® 39E. Dressing–Lower Body
0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.

N

Percent

114
1,880
1,192
779
693
214
12
+

2.3
38.5
24.4
15.9
14.2
4.4
0.3
+

+ Cells with a value of n < 11 are not shown.
SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
Table 13-13c
CARE admission putting on/taking off footwear item by IRF-PAI/FIM® admission dressing
lower body item
CARE Supplemental
Functional Ability: Putting
on/Taking off footwear (N =
4,870)

0=
3=
4 = Min.
5 = SuperActivity
6 = Mod. 7 = Complete
does not 1 = Total 2 = Max. Mod. Assist./Touch- vision/
ing
Setup
Independ.
Independ.
occur
Assist. Assist. Assist.

1 = Dependent (n = 1,782)

2.6

70.2*

20.0

5.9

1.1

+

+

+

2 = Substantial/max. assist. (n =
1,005)

1.3

26.8*

47.6*

19.5

4.6

+

+

+

3 = Partial/mod. assist. (n =
760)

1.8

12.6

23.0

34.2*

26.3*

1.8

+

+

4 = Supervision or touching
assist. (n = 557)

+

7.5

9.5

20.8

45.2*

15.3*

+

+

5 = Setup or clean-up assist. (n
= 270)

+

7.0

7.8

13.3

40.7*

27.4*

+

+

6 = Independent (n = 63)
Letter codes (n = 433)

+

+

+

17.5

19.1

27.0*

+

+

5.5

45.5

22.6

11.1

11.3

3.7

+

+
®

* These values indicate the area of anticipated overlap between the CARE Item Set and IRF-PAI/FIM Instrument
responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Values refer to row percents.
®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.
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Summary Points
•

The most frequent value for the CARE supplemental functional ability item Putting
on/Taking off Footwear at admission is 1–Dependent, in which 36 percent of the
responses are coded.

•

The most frequent value for the FIM® Dressing Lower Body item on the IRF-PAI is
1–Total Assistance, in which 39 percent of all responses are coded.

•

As seen on Table 13-13c, footwear CARE item values tend to overlap with the IRFPAI/FIM® values as expected. The most agreement was the combination of patients
with a CARE value of 2–Substantial/Maximal Assistance and IRF-PAI/FIM® values
of 1–Total Assistance and 2–Maximal Assistance. There was also substantially high
agreement among patients with a CARE value of 1–Dependent and an IRF-PAI/FIM®
value of 1–Total Assistance.

14. VI. Functional Status: C. Supplemental Functional Ability: Mode of Mobility: C7,
C7c, and C7d. (IRF-PAI/FIM® Instrument: M. Stairs)
The final CARE supplemental functional ability is the mode of mobility items for stairs,
which is most similar to the stairs item on the IRF-PAI/FIM® Instrument. Factors to consider
when comparing the data from these two instruments include the differences in the time frames
to complete the patient assessment, CARE Item Set’s emphasis on usual performance versus
IRF-PAI/FIM® items’ emphasis on coding the patient’s lowest functional levels, and the
differences in the instruments’ rating scales.
The item definitions are below.
CARE Item Set Definitions:
C7. Does this patient primarily use a wheelchair for mobility? 0. No; 1. Yes
C7c. 12 steps: The ability to go up and down 12 steps with or without a rail.
C7d. 4 steps: The ability to go up and down 4 steps with or without a rail.
IRF-PAI/FIM® Instrument Definition:
39M. Stairs includes going up and down 12 to 14 stairs (one flight) indoors in a safe
manner.
Other factors specific to these items that impact the reader’s review of each item’s
frequency data include the following:
•

The CARE Item Set has two distinct items for assessing a patient’s level of assistance
needed to go up and down 12 or 4 steps. The IRF-PAI/FIM® Instrument uses one
item to assess the patient’s ability to go up and down 12–14 stairs. The clinician
codes the patient’s performance based upon the above item definition; however, the
IRF-PAI/FIM® Instrument has an Exception Code of 5 that is used if the patient can
perform “household ambulation,” defined as going up and down 4–6 stairs
independently, with or without a device. The activity takes more than a reasonable
amount of time, or there are safety considerations. Note that IRF-PAI/FIM® code 5
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can also be used to code the patient who requires supervision for going up and down
12–14 stairs.
The overall frequencies for these items are shown in Tables 13-14a and 13-14b, followed
by the cross-tabulation of the 12 steps item on the CARE Item Set with the FIM® stairs item on
the IRF-PAI/FIM® Instrument in Table 13-14c.
Table 13-14a
CARE admission supplemental functional mode of mobility item (C7c and C7d)
CARE Supplemental Functional Mode of Mobility
(C7c and C7d) (N = 4,890)
Coded on Other Item or Missing
1 = Dependent (helper does all of the effort)
2 = Substantial/max. assist. (Helper does more
than half)
3 = Partial/mod. assist. (Helper does less than half)
4 = Supervision or touching assist.
5 = Setup or clean-up assist.
6 = Independent
A = Task attempted but not completed
E = Not completed due to environmental
constraints
M = Not attempted due to medical condition
N = Not applicable when coded
P = Patient refused
S = Not attempted due to safety concerns

12
Steps
N

12 Steps
Percent

4 Steps
N

4 Steps
Percent

2,094
+

42.8
+

2,094
+

42.8
+

+
32
121
59
12
283

+
0.7
2.5
1.2
0.3
5.8

+
98
257
52
16
23

+
2.0
5.3
1.1
0.3
0.5

61
384
896
23
914

1.3
7.9
18.3
0.5
18.7

408
294
779
18
843

8.3
6.0
15.9
0.4
17.2

+ Cells with a value of n < 11 are not shown.
SOURCE: RTI analysis of CARE Item Set data, 2008–2009.
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Table 13-14b
IRF-PAI/FIM® admission stairs item
IRF-PAI/FIM® 39M. Stairs
0 = Activity does not occur
1 = Total Assist.
2 = Max. Assist.
3 = Mod. Assist.
4 = Min. Assist./Touching
5 = Supervision/Setup
6 = Mod. Independ.
7 = Complete Independ.

N

Percent

3,622
432
681
+
108
35
+
+

74.1
8.8
13.9
+
2.2
0.7
+
+

+ Cells with a value of n < 11 are not shown.
SOURCE: RTI analysis of IRF-PAI/FIM® Instrument data, 2008–2009.
Summary Points
•

Since managing stairs is a challenging activity for many patients on admission, letter
codes on the CARE and the 0–Activity Does Not Occur are common on both the
CARE Item Set and the IRF-PAI/FIM® Instrument. For the CARE Item Set, there is
a skip pattern that skips over the stair items if the patient primarily uses a wheelchair.
This results in the item appearing on Table 13-14a as Coded on Other Item or
Missing.

•

Nearly 43 percent of all patients were coded as Coded on Other Item or Missing for
the CARE item, and 74 percent were coded as 0–Activity Does Not Occur on the
IRF-PAI/FIM® Instrument. This result may suggest that providing shorter and longer
distances allowed more patients to be coded.

15. Correlations with IRF Length of Stay
The final results that we will report are the correlations between the CARE Item Set and
IRF-PAI/FIM® Instrument functional items with length of stay, which addresses predictive
validity. Table 13-15 displays the correlations between a subset of the CARE Item Set’s
function items individually with IRF length of stay (LOS) side by side with the correlations
between the IRF-PAI/FIM® Instrument items and IRF LOS.
While LOS is not equivalent with resource intensity, it provides general information on
the expected direction and relationship between functional items and a measureable outcome that
represents length of treatment. LOS was originally used as a predictor with IRF payment models
and we use it here as a proxy to look at the relative effects of CARE Item Set and IRF-PAI/FIM®
Instrument items and their association with the amount of rehabilitation treatment received. As is
shown in Table 13-15, the correlation coefficients are similar between all of the CARE
functional items and the IRF-PAI/FIM® Instrument items measuring the same concept.
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Table 13-15
Relative correlations of CARE admission and IRF-PAI/FIM® admission functional items
with IRF length of stay

CARE Item Set Item

Correlation
Coefficient
with IRF LOS

VI.A.1 Core Self-Care: Eating

−0.226

®

IRF-PAI/FIM Instrument
Item
Self-Care: Eating

Correlation
Coefficient with
IRF LOS
—

VI.A.2 Core Self-Care: Tube Feeding

−0.197

Self-Care: Eating

−0.271

VI.A.3 Core Self-Care: Oral Hygiene

−0.260

Self-Care: Grooming

−0.279

VI.A.4 Core Self-Care: Toilet Hygiene

−0.377

Self-Care: Toileting

−0.364

VI.A.5 Core Self-Care: Upper Body Dressing

−0.323

Self-Care: Dressing - Upper

−0.320

VI.A.6 Core Self-Care: Lower Body Dressing

−0.350

Self-Care: Dressing - Lower

—

VI.C.6 Supplemental Function: Put On/Take
Off Footwear

−0.306

Self-Care: Dressing - Lower

−0.345

VI.B.3 Core Mobility: Chair/Bed to Chair
Transfer

−0.395

Transfers: Bed, Chair,
Wheelchair

−0.389

VI.B.4 Core Mobility: Toilet Transfer Code

−0.367

Transfers: Toilet

−0.368

VI.C.1 Supplemental Function: Wash Upper
Body

−0.293

Self-Care: Grooming

−0.279

VI.C.2 Supplemental Function: Shower/Bathe
Self

−0.323

Self-Care: Bathing

−0.357

®

SOURCE: RTI analysis of CARE Item Set and IRF-PAI/FIM Instrument data, 2008–2009.

Summary Points

13.4

•

To perform these initial correlations, we converted the values into numbers, which
means that the letter codes and missing data are not included.

•

The negative correlation coefficients refer to there being a negative relationship
between function and LOS; higher or more independent function was associated with
shorter LOS.

•

The correlations with the IRF LOS with the CARE items and IRF-PAI/FIM®
Instrument items are generally similar. There are some instances where the absolute
value of the correlation is slightly higher on the CARE items. For example, the
CARE toilet hygiene item correlation with IRF LOS is −0.377, whereas the IRFPAI/FIM® Instrument toileting correlation is −0.364. For other items, the correlation
with IRF LOS was higher for the IRF-PAI/FIM® Instrument item than for the CARE
item. Overall it appears the CARE Item Set’s capacity to explain LOS is comparable
to that of the IRF-PAI/FIM® Instrument.

Concluding Summary for Section

There was generally good agreement between CARE Item Set and IRF-PAI/FIM®
Instrument scoring levels where agreement was expected, that is, for areas where the item
definition was similar. Specifically, because of similarities between task performance definitions
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across the self-care items of the CARE and IRF-PAI items, agreement was excellent and
predictable based on the altered structure of the measure response levels. This pattern was
remarkably consistent across the self-care items as well as those supplemental items with similar
activity definitions.
The IRF-PAI/FIM® Instrument and CARE Item Set levels mapped as we expected (see
Figure 13-1 showing how FIM® scores on the IRF-PAI/FIM® Instrument map to CARE Item Set
scores):
•

IRF-PAI/FIM® levels 7–Complete Independence and 6–Modified Independence
mapped to CARE level 6–Independent.

•

IRF-PAI/FIM® level 5–Supervision/Setup mapped to CARE level
5–Setup or Clean-up and CARE level 4–Supervision or Touching Assistance.

•

IRF-PAI/FIM® level 4 mapped to CARE level 4–Supervision or Touching Assistance
and CARE level 3–Partial/Moderate Assistance.

•

IRF-PAI/FIM® level 3–Moderate Assistance mapped to CARE level 3–
Partial/Moderate Assistance.

•

IRF-PAI/FIM® level 2–Maximal Assistance mapped to CARE level 2–
Substantial/Maximal Assistance and CARE level 1–Dependent.

•

IRF-PAI/FIM® level 1–Total Assistance mapped to CARE level 2–
Substantial/Maximal Assistance and CARE level 1–Dependent.

Agreement between some items on the IRF-PAI/FIM® Instrument and the CARE tool for
items that were conceptually similar was not expected, because the item definitions were very
different. For example, definition differences for bowel and bladder items and for walking items
challenged comparisons.
This report begins to address the issue of how the CARE items are associated with IRF
LOS. To be a successful measure across the full continuum of post-acute care, the measure will
need to have comparable explanatory power for resource use when compared to measures
currently being applied in those settings. Our preliminary analyses showed that the relationship
between LOS and individual CARE items were comparable to correlations between individual
IRF-PAI items and LOS, even though the latter measure was tailored specifically to fit the IRF
setting.
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SECTION 14
MDS 2.0–CARE COMPARISONS
14.1

Overview

The analyses in this section compare the Continuity Assessment Record and Evaluation
(CARE) Item Set items to the Minimum Data Set (MDS) 2.0 prospective payment items
(resource utilization group (RUG)-III V5.20) for the same patient. The analyses are similar to
the comparisons of the CARE Item Set and the Inpatient Rehabilitation Facility Patient
Assessment Instrument (IRF-PAI)/ FIM® instrument discussed in Section 13. Analyses profiled
in this section compare the scores for CARE admission assessments matched with MDS 2.0
assessments for the Post-Acute Care Payment Reform Demonstration (PAC-PRD) sample.
To conduct these analyses, we merged the January 2010 extract of the CARE data with
MDS 2.0 assessments available through December 31, 2010. An initial merge was done based
on Medicare beneficiary identification number, gender, and birth date. Additional matches were
identified using social security number. The match was refined using the admission date on the
CARE matched to the assessment reference date on the MDS 2.0 and the sample restricted to
only CARE admission assessments and MDS 2.0 admission or 5-day prospective payment
system (PPS) assessments. We restricted the time frame between matched assessments to less
than 7 days to reduce discrepancies in observations on the two assessments that could be
attributable to differences in timing and to match the look-back period for the MDS 2.0. We
successfully matched 93.3 percent of the CARE assessments with MDS 2.0 data and have a total
of 3,977 assessments. The analyses included in this chapter focus only on the admission
assessment items. 6
14.2

Expected Differences in Response Item Codes between CARE and the MDS 2.0

While many CARE items address activities that are also included on the MDS 2.0, there
are several key differences between the two assessment instruments that may result in variations
in data reported on the two assessments. Differences related to an instrument’s item definition
and assessment scales are addressed individually below, under item-by-item comparisons. Key
differences between the two assessment instruments, affecting all item-by-item comparisons
include:
•

Differences between CARE and MDS 2.0 regarding assessment instructions
–

6

Time Frame: The assessment time frame for the CARE Item Set is 2 calendar
days (if admitted before 12 noon) or 3 calendar days (for residents admitted after
12 noon). Selected items from both the MDS 2.0 instrument and CARE Item Set
were compared for this analysis. The MDS 2.0 5-day PPS assessment was used
for these patients who are covered by Medicare A.

CARE extract date 01/28/2010. All data shown in this memo were generated with programs CAREREL017 and
CAREREL018.
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▪

The items on the MDS 2.0 are usually assessed during a 7-day look-back
period. The assessment allows up to 3 additional grace period days (for the 5day PPS instrument) during which the resident is assessed by “looking back
over the last 7-day assessment period.”

▪

Some of the patients assessed with the MDS 2.0 have a 7-day look-back
period that may include his/her status as a patient during his/her prior inpatient
hospital stay.
○ For example, if the assessment is being completed on the 5th or 6th day
after the resident’s admission to the skilled nursing facility (SNF), then the
7-day look-back period would include pre-SNF admission day(s) from the
acute facility.

▪

–

Other items on the MDS 2.0 and CARE Item Set require a 14-day look-back
period. The MDS 2.0 includes a small number of items that require a 30-day
look-back period that would also include the patient’s SNF preadmission
period.

Implication: Patients may be assessed at different points in their episode and
therefore have different acuity levels on the MDS 2.0 and the CARE Item Set.
When preadmission days are included in the 7-day look-back period and when
only one instrument uses the 14-day look-back period, the resident’s prior acuity
level can impact the data comparison of the two instruments. These status
differences may occur at preadmission or post-admission to the SNF. For
example, issues that may be present prior to the SNF admission and included in
the MDS window may be resolved prior to the CARE assessment time frame.
▪

For these analyses, recognizing that large differences between CARE and
MDS 2.0 assessment time frames would increase variation between paired
CARE–MDS 2.0 assessment items, this report restricts the time frame
between matched assessments to 8 days or less.

–

Item Rating Scales: Differences between CARE and MDS 2.0 exist and a
comparison and alignment of the rating scales will be noted with each item
comparison.

–

Functional Status Rating Scale: Differences between CARE and MDS 2.0
functional status rating scales exist, and will also be noted with each item
comparison. The CARE rating scale is an independence scale and higher
numbers indicate more independence; the MDS 2.0 has two rating scales, a
support rating scale and a self-performance scale, that are dependence rating
scales with lower numbers indicating more independence. A comparison of the
CARE Item Set functional item levels and the MDS 2.0 activities of daily living
(ADL) Self-Performance item levels are mapped and provided in Table 14-28c.
The CARE functional item rating scale has a range of 6-1 and the MDS 2.0 uses
two scales to assess function (e.g., ADL Self-Performance and ADL Support
100

Provided). These two MDS 2.0 functional components are captured within each
CARE functional item.
▪

Example of how each instrument determines the patient’s level of
performance:
○ The CARE Item Set discriminates between a CARE level 3–
Partial/Moderate Assistance and a CARE level 2–Substantial/Maximal
Assistance by assessing whether the helper did less than half or more than
half the effort.
○ On the MDS 2.0, the level of assistance between level 2–Limited
Assistance and level 3–Extensive Assistance is determined by assessing
(1) whether the helper provided non-weight-bearing support or weightbearing support, (2) if full staff support was needed, and (3) the number of
times assistance was needed during the assessment period.

–

Item Definitions: Although similar concepts are compared in this analysis,
specific item definitions may not be identical. Specific item definitions for the
two instruments will precede each comparison table.

–

Administration Differences: Another source of potential variation between the
CARE Item Set and MDS 2.0 items may be due to different types of clinicians
conducting the CARE assessment and the MDS 2.0 assessment.

–

Error: Some disagreement between the CARE and MDS 2.0 items may be
attributable to clinician reporting errors on one of the tools. As noted in the
interrater reliability section in Volume 2, and in prior evaluations of MDS 2.0
items, there are some items that have lower reliability than others.

These important differences between instrument items, administration, and rating scales
will be considered while interpreting the results of comparisons. For each item the CARE
definitions of the item and the MDS 2.0 definitions are reported, followed by item frequencies.
The tables that follow report the percent of patients with a given CARE item and response across
available MDS 2.0 responses. Expected areas of agreement are marked with an asterisk.
14.3

Results: CARE Item Set—MDS 2.0 Comparisons

A. Current Medical Information: Major Treatments
CARE Item: Major Treatments: Total Parenteral Nutrition (item III.D3a) vs. MDS 2.0 Item:
Nutritional Approaches: Parenteral/IV (item K5a)
The Current Medical Information-Major Treatments section of the CARE Item Set
assesses whether the patient received total parenteral nutrition (TPN) (item III.D3a) during the 2day admission assessment period and allows for up to 30 treatment items to be checked. The
MDS 2.0 assesses whether a patient received Parenteral/IV (item K5a) in the last 7 days and
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allows for up to eight nutritional approaches items to be checked. The definitions from the
CARE and MDS 2.0 are:
CARE Definition:
D3a. Total Parenteral Nutrition: Which of the following treatments did the patient receive during
the 2-day assessment period? For treatments such as blood transfusions, dialysis, or IV
chemotherapy, is the patient currently receiving them as part of their treatment plan?
MDS 2.0 Definition:
K5a. Parenteral/IV: A 7-day look-back period that includes only fluids administered for nutrition
or hydration, such as: IV fluids or hyperalimentation, including TPN, administered continuously
or intermittently; IV fluids running at keep vein open (KVO); IV fluids administered via heparin
locks; IV fluids contained in IV piggybacks; and IV fluids used to reconstitute medications for IV
administration. Do not include: IV medications; IV fluids administered as a routine part of an
operative or diagnostic procedure or recovery room stay; IV fluids administered solely as flushes;
or parenteral/IV fluids administered during chemotherapy or dialysis.
Item frequencies for CARE and MDS 2.0 are shown in Tables 14-1a and 14-1b,
respectively. A cross-tabulation of the items by instrument is presented in Table 14-1c.
Table 14-1a
CARE admission total parenteral nutrition at assessment
CARE: TPN
Missing
0 = No
1 = Yes

Frequency (n)
14
3,954
+

Percent
0.4
99.4
+

+ Cells based on a sample size of n < 11 are not shown.
NOTE: TPN = Total parenteral nutrition.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-1b
MDS 2.0 admission total parenteral nutrition during 7-day assessment period
MDS: TPN
Missing
0 = No
1 = Yes

Frequency (n)
+
3,694
277

Percent
+
92.9
7.0

+ Cells based on a sample size of n < 11 are not shown.
NOTE: TPN = Total parenteral nutrition
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-1c
CARE admission TPN item by MDS 2.0 admission TPN
CARE: TPN
Missing
0 = No
1 = Yes
Total

MDS
Missing

MDS
0 = No

MDS
1 = Yes

MDS
Total

—
+
+
+

100.0
93.0*
+
3,694

—
6.9
+
277

14
3,954
+
3,977

* Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: TPN = Total parenteral nutrition.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
•

There is a high degree of agreement between the two instruments. Table 14-1c
illustrates that 93 percent of the time, the CARE Item Set assessment was in
agreement with the MDS 2.0 assessment in reporting that the patient was not
receiving TPN.

•

Approximately 67 percent of the time, the CARE Item Set assessment was in
agreement with the MDS 2.0 assessment in reporting that the patient was receiving
TPN. While this latter agreement rate may be lower than expected, one must also
consider that the total number of matched assessments for patients receiving TPN
(using CARE) is only nine. That is, of nine paired assessments, six CARE–MDS 2.0
paired assessments were in agreement in terms of assessing whether the patient
received TPN treatment. On the other three cases, CARE assessments coded the
patient as receiving TPN, while the three paired MDS 2.0 assessments coded the
same patient as not receiving TPN. These differences could be due to coding errors
(e.g., MDS 2.0 IV medications being coded under Section O–Medications or Section
P–Special Care, the information source used to populate the instrument, or
differences in the look-back period).

CARE Item: Major Treatments: Blood Transfusion(s) (item D5a) vs. MDS 2.0 Item: Special
Treatments and Procedures: Transfusions (item P1ak)
The Major Treatments section of the CARE Item Set reports whether the patient received
Blood Transfusion(s) (item D5a) during the 2-day admission assessment period and allows for
up to 30 treatment items to be checked. The MDS 2.0 assesses whether a patient received any
one of twelve treatments—one being a transfusion (item P1ak)—either at the facility or at a
hospital as an outpatient or inpatient during the last 14 days. The definitions from the CARE and
MDS 2.0 are included below.
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CARE Definition:
D5a. Major Treatments: Blood Transfusion(s): Which of the following treatments did the patient
receive during the 2-day assessment period? For treatments such as blood transfusions, dialysis,
or IV chemotherapy, is the patient currently receiving them as part of their treatment plan?
MDS 2.0 Definition:
P1ak. Special Treatments and Procedures: Transfusions
Special Treatments, Procedures, and Programs. Special Care. Fourteen-day look-back to
identify any special treatments, therapies, or programs that the patient received in the specified
time period. Do not code services that were provided solely in conjunction with a surgical or
diagnostic procedure and the immediate post-operative or post-procedure recovery period.
Treatments. The following treatments may be received by a nursing facility patient either at the
facility, at a hospital as an outpatient, or as an inpatient, etc. Transfusions. Includes transfusions
of blood or any blood products (e.g., platelets), which are administered directly into the
bloodstream. Do not include transfusions that were administered during dialysis or chemotherapy.
Item frequencies for CARE and MDS 2.0 are shown in Tables 14-2a and 14-2b,
respectively. A cross-tabulation of the items by instrument is presented in Table 14-2c.
Table 14-2a
CARE admission blood transfusions at assessment
CARE: Blood transfusions

Frequency

Missing
0 = No
1 = Yes

14
3,954
+

Percent
0.4
99.4
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-2b
MDS 2.0 admission transfusions during 14-day assessment period
MDS 2.0: Transfusions

Frequency

0 = No
1 = Yes

3,540
437

Percent
89.0
11.0

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-2c
CARE admission blood transfusion by MDS 2.0 admission transfusion item
CARE: Blood
transfusions
Missing
0 = No
1 = Yes
Total

0 = No
85.7
89.1*
+
3,540

1 = Yes
+
10.9
+
437

Total
14
3,954
+
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
•

There is a high degree of agreement between the two instruments as evidenced by
Table 14-2c. This table illustrates that almost 90 percent of the time, the CARE Item
Set assessment was in agreement with the MDS 2.0 assessment in reporting that the
patient did not receive a blood transfusion.

•

Eleven percent of patients who did not have a blood transfusion according to the
CARE Item Set did have a transfusion according to the MDS 2.0.

•

As in the TPN discussion above, this difference could be due to different assessment
periods; the MDS includes time before admission, whereas the CARE assessment
window is within the SNF stay. Also, the MDS 2.0 item excludes blood transfusions
during dialysis; the CARE item does not have any exclusions.

•

While further investigation is necessary to determine the reason for the disagreement
in findings (e.g., coding error), one possibility is the date difference between the
matched assessments may account for this variation. That is, the MDS 2.0
assessment paired with the CARE Item Set may account for as much as an 8-day
difference between the patient’s assessment dates. It is possible that the CARE Item
Set would accurately assess a patient who has received a blood transfusion in the last
2 days, while the MDS 2.0 assessment from 8 days earlier would accurately assess the
patient as not having received a blood transfusion.
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CARE Item: Tracheostomy Tube with Suctioning (item D11a) vs. MDS 2.0 Item: Suctioning
(item P1ai)
The Major Treatments section of the CARE Item Set assesses whether the patient has a
tracheostomy tube with suctioning (item D11a) during the 2-day admission assessment period.
The MDS 2.0 assesses whether a patient received any one of twelve treatments—one being
tracheostomy care (item P1aj)—either at the facility or at a hospital as an outpatient or inpatient
during the last 14 days. The definitions from the CARE and MDS 2.0 are included below.
CARE Definition:
D11a. Major Treatments: Tracheostomy Tube with Suctioning: Which of the following
treatments did the patient receive during the 2-day assessment period? For treatments such as
blood transfusions, dialysis, or IV chemotherapy, is the patient currently receiving them as part of
their treatment plan?
MDS 2.0 Definition:
P1ai. Special Treatments and Procedures: Suctioning.
Special Treatments, Procedures, and Programs. Special Care. Fourteen-day look-back to
identify any special treatments, therapies, or programs that the patient received in the specified
time period. Do not code services that were provided solely in conjunction with a surgical or
diagnostic procedure and the immediate post-operative or post-procedure recovery period.
Treatments. The following treatments may be received by a nursing facility patient either at the
facility, at a hospital as an outpatient, or as an inpatient, etc. Suctioning. Includes
nasopharyngeal or tracheal aspiration only. Oral suctioning should not be coded here.
Item frequencies for CARE and MDS 2.0 are shown in Tables 14-3a and 14-3b,
respectively. A cross-tabulation of the items by instrument is presented in Table 14-3c.
Table 14-3a
CARE admission tracheostomy tube with suctioning at assessment
CARE: Trach with suctioning
Missing
0 = No
1 = Yes

Frequency
14
3,925
38

Percent
0.4
98.7
1.0

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-3b
MDS 2.0 admission suctioning during 14-day assessment period
MDS: Suctioning
0 = No
1 = Yes

Frequency
3,929
48

Percent
98.8
1.2

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-3c
CARE admission tracheostomy tube with suctioning by MDS 2.0 admission suctioning item
CARE: Trach with
suctioning
Missing
0 = No
1 = Yes
Total

0 = No
92.9
99.7*
+
3,929

1 = Yes
+
0.3
94.7*
48

Total
14
3,925
38
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
Table 14-3c illustrates that between 95 and 99 percent of the paired assessments are in
agreement; of a total of 3,977 assessments, fewer than 11 assessment pairs are in disagreement.
That is, 48 cases in the MDS 2.0 assessments reported that the patient received suction, whereas
only 38 cases in the CARE Item Set reported that the patient had a tracheostomy tube with
suctioning. While further investigation is necessary to determine the reason for the disagreement
in findings (e.g., coding error), one possible cause for the reported difference may be the date
difference between the matched assessments. That is, the MDS 2.0 assessment paired with the
CARE Item Set may account for as much as an 8-day difference between the patient’s
assessment dates. It is possible that the CARE Item Set could accurately assess a patient who
has received a treatment/procedure in the last 2 days, while the MDS 2.0 assessment from 8 days
earlier could accurately assess the patient as also having received a treatment/procedure.
CARE Item: Tracheostomy Tube with Suctioning (item D11a) vs. MDS 2.0 Item:
Tracheostomy Care (item P1aj)
The Major Treatments section of the CARE Item Set assesses whether the patient
received a tracheostomy tube with suctioning (item D11a) during the 2-day admission
assessment period. The MDS 2.0 assesses whether a patient received any one of twelve
treatments—one being tracheostomy care (item P1aj)—either at the facility or at a hospital as an
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outpatient or inpatient during the last 14 days. The definitions from the CARE and MDS 2.0 are
included below.
CARE Definition:
D11a. Major Treatments: Tracheostomy Tube with Suctioning: Which of the following
treatments did the patient receive during the 2-day assessment period? For treatments such as
blood transfusions, dialysis, or IV chemotherapy, is the patient currently receiving them as part of
their treatment plan?
MDS 2.0 Definition:
P1aj. Special Treatments and Procedures: Tracheostomy Care.
Special Treatments, Procedures, and Programs. Special Care. Fourteen-day look-back to
identify any special treatments, therapies, or programs that the patient received in the specified
time period. Do not code services that were provided solely in conjunction with a surgical or
diagnostic procedure and the immediate post-operative or post-procedure recovery period.
Treatments. The following treatments may be received by a nursing facility patient either at the
facility, at a hospital as an outpatient, or as an inpatient, etc. Tracheostomy. Includes cleansing
of tracheostomy and cannula.
Item frequencies for CARE and MDS 2.0 are shown in Tables 14-4a and 14-4b,
respectively. A cross-tabulation of the items by instrument is presented in Table 14-4c.
Table 14-4a
CARE admission trach tube with suctioning at assessment
CARE Trach tube with suctioning

Frequency

Missing
0 = No
1 = Yes

14
3,925
38

Percent
0.4
98.7
1.0

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-4b
MDS 2.0 admission tracheostomy care during 14-day assessment period
MDS: Trach care
0 = No
1 = Yes

Frequency
3,933
44

Percent
98.9
1.1

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-4c
CARE admission tracheostomy tube with suctioning by MDS 2.0 admission tracheostomy
care items
CARE: Trach with
suction

0 = No

1 = Yes

Total

Missing
0 = No
1 = Yes
Total

92.9
99.8*
+
3,933

+
+
94.7*
44

14
3,925
38
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
These results are similar to the item comparison results regarding CARE tracheostomy
tube with suction to MDS 2.0 suctioning. Here again, we expect a high degree of agreement
between the two instruments. Table 14-4c illustrates that 99 percent of the paired assessments
are in agreement regarding the presence of a tracheostomy tube with suctioning (CARE Item Set)
and tracheostomy care (MDS 2.0). Of the total 3,977 paired assessments, fewer than 11
assessment pairs are in disagreement. That is, few MDS 2.0 assessments reported that the patient
did not receive tracheostomy care while the CARE Item Set reported that the patient had a
tracheostomy tube with suctioning. Again, we point out that a possible cause for the reported
difference may be the differences in the look-back period between the matched assessments.
That is, the MDS 2.0 assessment paired with the CARE Item Set may account for as much as an
8-day difference between the patient’s assessment dates. It is possible that the CARE Item Set
could accurately assess a patient who has received a treatment/procedure in the last 2 days, while
the MDS 2.0 assessment from 8 days earlier could accurately assess the patient as not having
received a treatment/procedure.
CARE Item: High O2 Concentration Delivery System with FiO2 > 40% (item D12a) vs. MDS
2.0 Item: Oxygen Therapy (item P1ag)
The Major Treatments section of the CARE Item Set assesses whether the patient
received high O2 concentration delivery system with FiO2 > 40 percent (item D12a) during the 2day admission assessment period and allows for up to 30 treatment items to be checked. The
MDS 2.0 assesses whether a patient received any one of twelve treatments—one being Oxygen
therapy (item P1ag)—either at the facility or at a hospital as an outpatient or inpatient during the
last 14 days. The definitions from the CARE and MDS 2.0 are included below.
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CARE Definition:
D12a. Major Treatments: High O2 Concentration Delivery System with FiO2 > 40 percent:
Which of the following treatments did the patient receive during the 2-day assessment period? For
treatments such as blood transfusions, dialysis, or IV chemotherapy, is the patient currently
receiving them as part of their treatment plan?
MDS 2.0 Definition:
P1ag. Special Treatments and Procedures: Oxygen Therapy.
Special Treatments, Procedures, and Programs. Special Care. Fourteen-day look-back to
identify any special treatments, therapies, or programs that the patient received in the specified
time period. Do not code services that were provided solely in conjunction with a surgical or
diagnostic procedure and the immediate post-operative or post-procedure recovery period.
Treatments. The following treatments may be received by a nursing facility patient either at the
facility, at a hospital as an outpatient, or as an inpatient, etc. Oxygen Therapy. Includes
continuous or intermittent oxygen via mask, cannula, etc. (does not include hyperbaric oxygen for
wound therapy).
Item frequencies for CARE and MDS 2.0 are shown in Tables 14-5a and 14-5b,
respectively. A cross-tabulation of the items by instrument is presented in Table 14-5c.
Table 14-5a
CARE admission high O2 concentration delivery system with FiO2 > 40% at assessment
CARE: High O2 delivery

Frequency

Missing
0 = No
1 = Yes

14
3,930
33

Percent
0.4
98.8
0.8

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-5b
MDS 2.0 admission oxygen therapy during 14-day assessment period
MDS: Oxygen therapy

Frequency

Percent

2,652
1,325

66.7
33.3

0 = No
1 = Yes

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-5c
CARE admission high O2 concentration delivery system by FiO2 > 40% and MDS 2.0
oxygen therapy items
CARE: High O2
delivery

0 = No

1 = Yes

Total

Missing
0 = No
1 = Yes
Total

+
67.4*
+
2,652

+
32.6
100*
1,325

14
3,930
33
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
Comparison between the two instruments regarding the oxygen therapy item shows a
more modest agreement when the percent yes/no responses for oxygen item are aligned between
the two assessments (Table 14-5c) than seen in previously compared items above. That is,
approximately 33 percent of CARE Item Set assessments report that the patient did not receive a
major treatment regarding high O2 concentration delivery system with FiO2 > 40 percent, while
the paired MDS 2.0 assessment reported that the patient received oxygen therapy. These results
are within expectations given the definition differences between the MDS 2.0 and the CARE
Item Set. The MDS 2.0 captures a much broader range of patients receiving oxygen with its
definition of this item as “continuous or intermittent oxygen.” The CARE Item Set is more
restrictive in terms of including patients with a definition of “High O2 concentration delivery
system with FiO2 > 40 percent.” The MDS 2.0 also has a longer look-back window for this
service. Despite this definitional difference, the item illustrates some agreement between the two
assessment instruments.
CARE Item: Ventilator Weaning (D14a) vs. MDS 2.0 Item: Ventilator or Respirator (P1al)
The Major Treatments section of the CARE Item Set assesses whether the patient
received ventilator weaning (item D14a) during the 2-day admission assessment period. The
MDS 2.0 assesses whether a patient received any one of twelve treatments—one being ventilator
or respiratory care (item P1al)—either at the facility or at a hospital as an outpatient or inpatient
during the last 14 days. The definitions from the CARE and MDS 2.0 are included below.
CARE Definition:
D14a. Major Treatments: Ventilator Weaning: Which of the following treatments did the patient
receive during the 2-day assessment period? For treatments such as blood transfusions, dialysis,
or IV chemotherapy, is the patient currently receiving them as part of their treatment plan?
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MDS 2.0 Definition:
P1al. Special Treatments and Procedures: Ventilator/Respirator.
Special Treatments, Procedures, and Programs. Special Care. Fourteen-day look-back to
identify any special treatments, therapies, or programs that the patient received in the specified
time period. Do not code services that were provided solely in conjunction with a surgical or
diagnostic procedure and the immediate post-operative or post-procedure recovery period.
Treatments. The following treatments may be received by a nursing facility patient either at the
facility, at a hospital as an outpatient, or as an inpatient, etc. Ventilator or Respirator. Assures
adequate ventilation in patients who are or who may become unable to support their own
respiration. Includes any type of electrically or pneumatically powered closed system mechanical
ventilator support devices. Any patient who was in the process of being weaned off of the
ventilator or respirator in the last 14 days should be coded under this definition. Does not include
Continuous Positive Airway Pressure (CPAP) or Bi-level Positive Airway Pressure (BIPAP)
devices.
Item frequencies for CARE and MDS 2.0 are shown in Tables 14-6a and 14-6b,
respectively. A cross-tabulation of the items by instrument is presented in Table 14-6c.
Table 14-6a
CARE admission ventilator weaning (D14a) at assessment
CARE: Vent weaning
Missing
0 = No
1 = Yes

Frequency

Percent

14
3,954
+

0.4
99.4
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-6b
MDS 2.0 admission ventilator or respirator care during 14-day assessment period
MDS: Ventilator/respirator

Frequency

0 = No
1 = Yes

3,938
39

Percent
99.0
1.0

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-6c
CARE admission ventilator weaning by MDS 2.0 admission ventilator or respirator care
items
CARE: Vent weaning
Missing
0 = No
1 = Yes
Total

0 = No
100
99.2*
+
3,938

1 = Yes

Total

—
0.8
+
39

14
3,954
+
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
There is a high degree of agreement between the two instruments as evidenced by the
findings in Table 14-6c. Table 14-6c illustrates that over 99 percent of the time, the CARE Item
Set assessment was in agreement with the MDS 2.0 assessment in terms of reporting that the
patient was being weaned from a ventilator (CARE) or was on a ventilator/respirator (MDS 2.0).
Of the total 3,977 paired assessments, fewer than 11 CARE Item Sets reported the patient as
receiving ventilator weaning where the MDS 2.0 reported the patient was not receiving ventilator
or respirator treatment. One major reason for the paired assessment difference may be due to
definitional differences; the MDS 2.0 definition is more inclusive than the CARE Item Set
definition. That is, the CARE Item Set will code a patient as a yes only if they are on a ventilator
AND being weaned from the ventilator. A separate item on the CARE Item Set reports on nonweaning ventilators. The MDS 2.0 will code a patient as a yes if the patient is on a ventilator or
respirator, regardless of whether the patient is actively being weaned or not. Despite this
definitional difference, there is still a high level of item agreement between the two types of
assessments.
CARE Item: Ventilator Non-Weaning (D15a) vs. MDS 2.0 Item: Ventilator or Respirator
(P1al)
The Major Treatments section of the CARE Item Set assesses whether the patient
received ventilator non-weaning (item D15a) during the 2-day admission assessment period.
The MDS 2.0 assesses whether a patient received any one of 12 treatments—one being ventilator
or respiratory care (item P1al)—either at the facility or at a hospital as an outpatient or inpatient
during the last 14 days. The definitions from the CARE and MDS 2.0 are included below.
CARE Definition:
D15a. Major Treatments: Ventilator non-weaning: Which of the following treatments did the
patient receive during the 2-day assessment period? For treatments such as blood transfusions,
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dialysis, or IV chemotherapy, is the patient currently receiving them as part of their treatment
plan?
MDS 2.0 Definition:
P1al. Special Treatments and Procedures: Ventilator/Respirator.
Special Treatments, Procedures, and Programs. Special Care. Fourteen-day look-back to
identify any special treatments, therapies, or programs that the patient received in the specified
time period. Do not code services that were provided solely in conjunction with a surgical or
diagnostic procedure and the immediate post-operative or post-procedure recovery period.
Treatments. The following treatments may be received by a nursing facility patient either at the
facility, at a hospital as an outpatient, or as an inpatient, etc. Ventilator or Respirator. Assures
adequate ventilation in patients who are or who may become unable to support their own
respiration. Includes any type of electrically or pneumatically powered closed system mechanical
ventilator support devices. Any patient who was in the process of being weaned off of the
ventilator or respirator in the last 14 days should be coded under this definition. Does not include
CPAP or BIPAP devices.
Item frequencies for CARE and MDS 2.0 are shown in Tables 14-7a and 14-7b,
respectively. A cross-tabulation of the items by instrument is presented in Table 14-7c.
Table 14-7a
CARE admission ventilator non-weaning (D15a) at assessment
CARE: Vent non-weaning
Missing
0 = No
1 = Yes

Frequency

Percent

14
3,953
+

0.4
99.4
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-7b
MDS 2.0 admission ventilator or respirator care during 14-day assessment period
MDS: Ventilator

Frequency

0 = No
1 = Yes

3,938
39

Percent
99.0
1.0

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-7c
CARE admission ventilator non-weaning and MDS 2.0 admission ventilator or respirator
care items
CARE: Vent nonweaning
Missing
0 = No
1 = Yes
Total

0 = No

1 = Yes

Total

100
99.3*
+
3,938

—
0.7
+
39

14
3,953
+
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
Again, we see a high degree of agreement between the two instruments as evidenced by
Table 14-7c, which illustrates that over 99 percent of the time, the CARE Item Set assessment
was in agreement with the MDS 2.0 assessment in terms of reporting that the patient was not on
a ventilator.
CARE Item: Hemodialysis (D16a) vs. MDS 2.0 Item: Dialysis (P1ab)
The Major Treatments section of the CARE Item Set assesses whether the patient
received hemodialysis (item D16a) during the 2-day admission assessment period and allows for
up to 30 treatment items to be checked. The MDS 2.0 assesses whether a patient received any
one of twelve treatments—one dialysis (item P1ab)—either at the facility or at a hospital as an
outpatient or inpatient during the last 14 days. The definitions from the CARE and MDS 2.0 are
included below.
CARE Definition:
D16a. Major Treatments: Hemodialysis: Which of the following treatments did the patient
receive during the 2-day assessment period? For treatments such as blood transfusions, dialysis,
or IV chemotherapy, is the patient currently receiving them as part of their treatment plan?
MDS 2.0 Definition:
P1ab. Special Treatments and Procedures: Dialysis.
Special Treatments, Procedures, and Programs. Special Care. Fourteen-day look-back to
identify any special treatments, therapies, or programs that the patient received in the specified
time period. Do not code services that were provided solely in conjunction with a surgical or
diagnostic procedure and the immediate post-operative or post-procedure recovery period.
115

Treatments. The following treatments may be received by a nursing facility patient either at the
facility, at a hospital as an outpatient, or as an inpatient, etc. Dialysis. Includes peritoneal or
renal dialysis that occurs at the nursing facility or at another facility. Record treatments of
hemofiltration, Slow Continuous Ultrafiltration (SCUF), Continuous Arteriovenous Hemofiltration
(CAVH), and Continuous Ambulatory Peritoneal Dialysis (CAPD) in this item. IVs, IV
medications, and blood transfusions administered during dialysis are not coded under the
respective items K5a (parenteral/IV), P1ac (IV medications), and P1ak (transfusions).
Item frequencies for CARE and MDS 2.0 are shown in Tables 14-8a and 14-8b,
respectively. A cross-tabulation of the items by instrument is presented in Table 14-8c.
Table 14-8a
CARE admission hemodialysis (D16a) at assessment
CARE: Hemodialysis
Missing
0 = No
1 = Yes

Frequency

Percent

14
3,858
105

0.4
97.0
2.6

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-8b
MDS 2.0 admission dialysis during 14-day assessment period
MDS: Dialysis

Frequency

Percent

3,846
131

96.7
3.3

0 = No
1 = Yes

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-8c
CARE admission hemodialysis by MDS 2.0 admission dialysis items
CARE: Hemodialysis
Missing
0 = No
1 = Yes
Total

0 = No

1 = Yes

Total

92.9
99.2*
+
3,846

+
0.8
96.2*
131

14
3,858
105
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Summary Results
There is a high degree of congruency between the two instruments as evidenced by
percent agreement (Table 14-8c). Table 14-8c illustrates that over 99 percent of the time, the
CARE Item Set assessment was in agreement with the MDS 2.0 assessment in terms of reporting
that the patient was receiving dialysis. A small percentage (0.8 percent; fewer than 11 paired
assessments) are not in agreement; the CARE Item Set reports that the patient is on dialysis,
while the MDS 2.0 reports that the patient is not receiving dialysis. Here again, the reason for
the difference in this small number of assessments may be attributed to the different assessment
look-back periods between the matched assessments. That is, the MDS 2.0 assessment paired
with the CARE Item Set may account for as much as an 8-day difference between the patient’s
assessment dates. It is possible that the CARE Item Set could accurately assess a patient who
has received a treatment/procedure in the last 2 days, while the MDS 2.0 assessment from 8 days
earlier could accurately assess the patient as not having received a treatment/procedure.
CARE Item: Peritoneal Dialysis (D17a) vs. MDS 2.0 Item: Dialysis (P1ab)
The Major Treatments section of the CARE Item Set assesses whether the patient
received peritoneal dialysis (item D17a) during the 2-day admission assessment period and
allows for up to 30 treatment items to be checked. The MDS 2.0 assesses whether a patient
received any one of twelve treatments—one being dialysis (item P1ab)—either at the facility or
at a hospital as an outpatient or inpatient during the last 14 days. The definitions from the CARE
and MDS 2.0 are included below.
CARE Definition:
D17a. Major Treatments: Peritoneal Dialysis: Which of the following treatments did the patient
receive during the 2-day assessment period? For treatments such as blood transfusions, dialysis,
or IV chemotherapy, is the patient currently receiving them as part of their treatment plan?
MDS 2.0 Definition:
P1ab. Special Treatments and Procedures: Dialysis.
Special Treatments, Procedures, and Programs. Special Care. Fourteen-day look-back to
identify any special treatments, therapies, or programs that the patient received in the specified
time period. Do not code services that were provided solely in conjunction with a surgical or
diagnostic procedure and the immediate post-operative or post-procedure recovery period.
Treatments. The following treatments may be received by a nursing facility patient either at the
facility, at a hospital as an outpatient, or as an inpatient, etc. Dialysis. Includes peritoneal or
renal dialysis that occurs at the nursing facility or at another facility. Record treatments of
hemofiltration, SCUF, CAVH, and CAPD in this item. IVs, IV medications, and blood transfusions
administered during dialysis are not coded under the respective items K5a (parenteral/IV), P1ac
(IV medications), and P1ak (transfusions).
Item frequencies for CARE and MDS 2.0 are shown in Tables 14-9a and 14-9b,
respectively. A cross-tabulation of the items by instrument is presented in Table 14-9c.
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Table 14-9a
CARE admission peritoneal dialysis (D17a) at assessment
CARE: Peritoneal dialysis
Missing
0 = No
1 = Yes

Frequency

Percent

14
3,957
+

0.4
99.5
+

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-9b
MDS 2.0 admission dialysis during 14-day assessment period
MDS: Dialysis

Frequency

0 = No
1 = Yes

3,846
131

Percent
96.7
3.3

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-9c
CARE admission peritoneal dialysis by MDS 2.0 admission dialysis items
CARE: Peritoneal
dialysis
Missing
0 = No
1 = Yes
Total

0 = No

1 = Yes

Total

92.9
96.8*
+
3,846

+
3.2
+
131

14
3,957
+
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
The level of agreement between the CARE Item Set and the MDS 2.0 item regarding
dialysis is relatively high. Table 14-9c shows approximately 97 percent agreement between the
paired assessments in terms of reporting that the patient was not receiving dialysis. The level of
agreement decreases (83 percent) when the two assessment types are compared in reporting that
the patient is receiving dialysis. However, that 83 percent represents only one assessment. The
difference between the two assessment types may be illustrative of the MDS 2.0 definition that
captures more than peritoneal dialysis under this item (e.g., CAVH is also included in the MDS
2.0 dialysis item).
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CARE Item: Complex Wound Management (D20a) vs. MDS 2.0 Item: Surgical Wound Care
(M5f)
The Major Treatments section of the CARE Item Set assesses whether the patient
received complex wound management (item D20a) during the 2-day admission assessment
period. The MDS 2.0 assesses whether a patient received any of nine skin treatments in the last
7 days—one being surgical wound care (item M5f). The definitions from the CARE and MDS
2.0 are included below.
CARE Definition:
D20a. Major Treatments: Complex Wound Management: Which of the following treatments
did the patient receive during the 2-day assessment period? For treatments such as blood
transfusions, dialysis, or IV chemotherapy, is the patient currently receiving them as part of their
treatment plan?
MDS 2.0 Definition:
M5f. Skin Condition: Skin Treatments. Document any specific or generic skin treatments the
resident has received in the past 7 days. Skin does not include eyes or oral mucosa. Include any
intervention for treating or protecting any type of surgical wound. Examples of care include
topical cleansing, wound irrigation, application of antimicrobial ointments, application of
dressings of any type, suture removal, and warm soaks or heat application.
Item frequencies for CARE and MDS 2.0 are shown in Tables 14-10a and 14-10b,
respectively. A cross-tabulation of the items by instrument is presented in Table 14-10c.
Table 14-10a
CARE admission complex wound management (D20a) at assessment
CARE: Complex wound
management

Frequency

Missing
0 = No
1 = Yes

14
3,934
29

Percent
0.4
98.9
0.7

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-10b
MDS 2.0 admission surgical wound care (M5f) during 7-day assessment period
MDS: Surgical wound care
Missing
0 = No
1 = Yes

Frequency

Percent

+
2,681
1,287

+
67.4
32.4

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-10c
CARE complex wound management by MDS 2.0 surgical wound care
CARE: Complex
wound management
Missing
0 = No
1 = Yes
Total

Missing

0 = No

1 = Yes

Total

+
+
+
+

78.6
67.4*
62.1
2,681

+
32.4
+
1,287

14
3,934
29
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
Item congruency for surgical wound care/complex wound management is lower
compared to the level of agreement illustrated when the CARE Item Set item was compared to
Special Treatment MDS 2.0 items (findings above). The paired assessments are in agreement
about 67 percent of the time in terms of coding that the patient did not receive wound
care/management; about 38 percent of the time, the paired assessments were in agreement in
terms of coding that the patient received wound care/management. The likely reason for the
coding discrepancy between the two assessment types is due to the CARE Item Set’s more
restrictive definition regarding complex wound management as opposed to the broad MDS 2.0
item definition regarding surgical wound care. That is, the MDS 2.0 definition includes any
intervention for treating or protecting any type of surgical wound, such as topical cleansing,
wound irrigation, application of antimicrobial ointments, application of dressings of any type,
suture removal, and warm soaks or heat application. The CARE Item Set definition of complex
wound management would not include all of these MDS 2.0 procedures. Second, the MDS
assessment includes care in the prior 7 days, which may precede admission to the SNF, while the
CARE item reflects only treatments received in the SNF.
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CARE Item: Specialty Surface or Bed (D24a) vs. MDS 2.0 Item: Pressure Relieving Device for
Bed (M5b)
The Current Medical Information-Major Treatments section of the CARE Item Set
assesses whether the patient used a specialty surface or bed (item III.D24a) during the 2-day
admission assessment period and allows for up to 30 treatment items to be checked. The MDS
2.0 assesses whether a patient received a Pressure Relieving Device for a Bed (item M5b) in the
last 7 days and allows for up to 10 skin treatments to be checked. The definitions from the
CARE and MDS 2.0 are:
CARE Definition:
D24a. Specialty Surface or Bed: Which of the following treatments did the resident receive
during the 2-day assessment period? For treatments such as blood transfusions, dialysis, or IV
chemotherapy, is the resident currently receiving them as part of their treatment plan? Specialty
Surface or Bed (i.e., air fluidized, bariatric, low air loss, or rotation bed).
MDS 2.0 Definition:
M5b. Pressure Relieving Device(s) for a Bed: Check treatments or programs received during
the last 7 days. Pressure Relieving Device for a Bed—Includes air fluidized, low air loss therapy
beds, flotation, water, or bubble mattress or pad placed on the bed. Do not include egg crate
mattresses in this category.
The overall frequencies for these items are shown in Tables 14-11a and 14-11b below,
followed by the cross-tabulation of the items in Table 14-11c.
Table 14-11a
CARE—Frequency of specialty surface or bed (D24a) during 2-day assessment period
CARE: Specialty surface or bed

Frequency

Missing
0 = No
1 = Yes

14
3,747
216

Percent
0.4
94.2
5.4

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-11b
MDS 2.0 admission pressure-relieving devices for bed (M5b) at assessment
MDS: Specialty bed

Frequency

Missing
0 = No
1 = Yes

Percent

+
794
3,174

+
20.0
79.8

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-11c
CARE admission specialty surface or bed by MDS 2.0 admission pressure relieving devices
for bed
CARE: Specialty
surface or bed

Missing

0 = No

1 = Yes

Total

Missing
0 = No
1 = Yes
Total

+
+
+
+

+
21*
+
794

100
78.8
95.8*
3,174

14
3,747
216
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
•

Among patients who were reported as using a Specialty Surface or Bed on the CARE
Item Set, 95.8 percent were similarly reported as using a Pressure Relieving Device
for Bed on the MDS 2.0.

•

Notably, for patients who were not reported as using a Specialty Surface or Bed on
the CARE Item Set, 78.8 percent were reported as using a Pressure Relieving Device
for Bed on the MDS 2.0. This discrepancy may be due to the different assessment
windows between the two tools; alternatively, this may be because the MDS 2.0 item
definition is broader, and references “water, or bubble mattress or pad,” while the
CARE item definition does not.

CARE Item: IV Chemotherapy (D28a) vs. MDS 2.0 Item: Chemotherapy (P1aa)
The Current Medical Information-Major Treatments section of the CARE Item Set
assesses whether the patient received IV Chemotherapy (item III.D28a) during the 2-day
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admission assessment period and allows for up to 30 treatment items to be checked. The MDS
2.0 assesses whether a patient received Chemotherapy (item P1aa) in the last 7 days and allows
for up to 18 special treatments, procedures, and programs to be checked. The definitions from
the CARE and MDS 2.0 are:
CARE Definition:
D28a. IV Chemotherapy: Which of the following treatments did the patient receive during the
2-day assessment period? For treatments such as blood transfusions, dialysis, or IV
chemotherapy, is the patient currently receiving them as part of their treatment plan?
MDS 2.0 Definition:
P1aa. Chemotherapy: Check treatments or programs received in during the last 14 days.
Chemotherapy—Include any type of chemotherapy (anticancer drug) given by any route.
The overall frequencies for these items are shown in Tables 14-12a and 14-12b below,
followed by the cross-tabulation of the items in Table 14-12c.
Table 14-12a
CARE admission IV chemotherapy (D28a) at assessment
CARE: IV chemo
Missing
0 = No
1 = Yes

Frequency
14
3,960
+

Percent
0.4
99.6
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-12b
MDS 2.0 admission chemotherapy during 14-day assessment period
MDS: Chemotherapy
0 = No
1 = Yes

Frequency
3,951
26

Percent
99.4
0.7

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-12c
CARE admission IV chemotherapy by MDS 2.0 admission chemotherapy items
CARE: IV
Chemotherapy
Missing
0 = No
1 = Yes
Total

0 = No
100
99.4*
+
3,951

1 = Yes
—
0.6
—
26

Total
14
3,960
+
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
•

Among patients who were reported as not receiving IV Chemotherapy on the CARE
Item Set, 99.4 percent were similarly reported as not receiving Chemotherapy on the
MDS 2.0.

Skin Integrity
CARE Item: Number of Stage 2 Pressure Ulcers (G2a) vs. MDS 2.0 Item: Number of Stage 2
Ulcers (M1b)
The Skin Integrity section of the CARE Item Set asks how many Stage 2 pressure ulcers
(G2a) were present during the 2-day admission assessment window, while the MDS 2.0 asks
how many Stage 2 ulcers were present (M1b) in the last 7 days. The definitions from the CARE
and MDS 2.0 are included below.
CARE Definition:
G2a. Stage 2: Partial thickness loss of dermis presenting as a shallow open ulcer with red pink
wound bed, without slough. May also present as an intact or open/ruptured serum-filled blister
(excludes those resulting from skin tears, tape stripping, or incontinence-associated dermatitis).
MDS 2.0 Definition:
M1b. Stage 2: A partial thickness loss of skin layers that presents clinically as an abrasion,
blister, or shallow crater.
Key CARE and MDS 2.0 Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.
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•

Item Definitions: While the CARE and MDS 2.0 definitions for Stage 2 Pressure
Ulcers are similar in many respects, the MDS 2.0 ulcer item also includes venous or
vascular ulcers.

•

Number of Ulcers: While the CARE allows up to 8 ulcers (8 = 8 or more ulcers), the
MDS 2.0 item allows up to 9 (9 = 9 or more ulcers).

Implications
•

The MDS 2.0 and CARE assessments may indicate that a patient has a different
number of Stage 2 pressure ulcers due to the difference in assessment time frame.

•

The MDS 2.0 assessment may also indicate a greater number of Stage 2 ulcers
because the item definition includes vascular ulcers, while the CARE item does not.

•

Additionally, category 8 on the CARE Item Set (8 or more ulcers) will incorporate
both MDS 2.0 categories 8 (8 ulcers) and 9 (9 or more ulcers).

The overall frequencies for these items are shown in Tables 14-13a and 14-13b below,
followed by the cross-tabulation of the items in Table 14-13c.
Table 14-13a
CARE admission frequency of stage 2 pressure ulcers (G02a) during 2-day assessment
period
CARE: Stage 2 pressure
ulcer
Missing
0 = 0 ulcers
1 = 1 ulcers
2 = 2 ulcers
3 = 3 ulcers
4 = 4 ulcers
5 = 5 ulcers
7 = 7 ulcers

Frequency
+
3,665
222
63
14
+
+
+

Percent
+
92.2
5.6
1.6
0.4
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-13b
MDS 2.0 admission frequency of stage 2 ulcers during 7-day assessment period
MDS: Stage 2 pressure ulcer
Missing
0 = 0 ulcers
1 = 1 ulcers
2 = 2 ulcers
3 = 3 ulcers
4 = 4 ulcers
5 = 5 ulcers
6 = 6 ulcers
7 = 7 ulcers
8 = 8 ulcers
9 = 9 or more

Frequency
11
3,522
291
98
28
12
+
+
+
+
+

Percent
0.3
88.6
7.3
2.5
0.7
0.3
+
+
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-13c
CARE admission number of stage 2 pressure ulcers by MDS 2.0 admission number of
stage 2 ulcers
CARE: Stage 2
pressure ulcer
Missing
0 = 0 ulcers
1 = 1 ulcers
2 = 2 ulcers
3 = 3 ulcers
4 = 4 ulcers
5 = 5 ulcers
7 = 7 ulcers
Total

Missing
+
+
+
+
+
+
+
+
11

0=0 1=1 2=2 3=3 4=4 5=5 6=6 7=7 8=8 9=9
ulcers ulcer ulcers ulcers ulcers ulcers ulcers ulcers ulcers ulcers Total
+
+
+
+
+
+
+
+
+
+
+
94.5* 3.4
1
0.4
+
+
+
+
+
+
3,665
19.4
68.9* 8.1
+
+
+
+
+
+
+
222
17.5
+
55.6* +
+
+
+
+
+
+
63
+
+
+
+
+
+
+
+
+
+
14
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
3,522
291
98
28
12
+
+
+
+
+
+

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Summary Results
•

Among patients with zero, one, or two Stage 2 pressure ulcers reported, there is a
high level of agreement between the CARE and MDS 2.0 items. For example, among
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patients with zero ulcers reported in CARE, 94.5 percent also had zero ulcers reported
in the MDS 2.0.
•

As the number of pressure ulcers observed per patient increases, there is a decrease in
the amount of agreement between the CARE and MDS 2.0 items, likely attributable
to the lower number of patients with more than one pressure ulcer. Differences in
assessment windows and item definitions may explain variation where the MDS 2.0
reports more Stage 2 ulcers than the CARE Item Set.

CARE Item: Number of Stage 3 Pressure Ulcers (G2b) vs. MDS 2.0 Item: Number of Stage 2
Ulcers (M1c)
The Skin Integrity section of the CARE Item Set asks how many Stage 3 pressure ulcers
(G2b) were present during the 2-day admission assessment window, while the MDS 2.0 asks
how many Stage 3 ulcers were present (M1c) in the last 7 days. The definitions from the CARE
and MDS 2.0 are included below.
CARE Definition:
G2b. Stage 3: Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon, or
muscles are not exposed. Slough may be present but does not obscure the depth of tissue loss.
May include undermining and tunneling.
MDS 2.0 Definition:
M1c. Stage 3: A full thickness of skin is lost, exposing the subcutaneous tissues—presents as a
deep crater with or without undermining adjacent tissue.
Key Care and MDS 2.0 Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: While the CARE and MDS 2.0 definitions for Stage 3 Pressure
Ulcers are similar in many respects, the MDS 2.0 ulcer item also includes venous or
vascular ulcers.

•

Number of Ulcers: While the CARE item allows up to 8 ulcers (8 = 8 or more ulcers),
the MDS 2.0 item allows up to 9 ulcers (9 = 9 or more ulcers).

Implications
•

The MDS 2.0 and CARE assessments may indicate that a patient has different
numbers of Stage 3 pressure ulcers due to the difference in assessment time frame.

•

The MDS 2.0 assessment may also indicate a greater number of Stage 3 ulcers
because the item definition includes vascular ulcers, while the CARE item does not.
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•

Additionally, category 8 on the CARE Item Set (8 or more ulcers) will incorporate
both MDS 2.0 categories 8 (8 ulcers) and 9 (9 or more ulcers).

The overall frequencies for these items are shown in Tables 14-14a and 14-14b below,
followed by the cross-tabulation of the items in Table 14-14c.
Table 14-14a
CARE admission frequency of stage 3 pressure ulcers (G02b) at assessment
CARE: Stage 3 pressure ulcers
Missing
0 = 0 ulcers
1 = 1 ulcers
2 = 2 ulcers
4 = 4 ulcers

Frequency

Percent

+
3,942
23
+
+

+
99.1
0.6
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-14b
MDS 2.0 admission frequency of stage 3 ulcers during 7-day assessment period
MDS: Stage 3 pressure ulcers

Frequency

Missing
0 = 0 ulcers
1 = 1 ulcer
2 = 2 ulcers
3 = 3 ulcers
4 = 4 ulcers
7 = 7 ulcers

11
3,917
34
12
+
+
+

Percent
0.3
98.5
0.9
0.3
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-14c
CARE admission number of stage 3 pressure ulcers by MDS 2.0 admission number of
stage 3 ulcers
CARE: Stage 3
pressure ulcers

Missing

0=0
ulcers

1=1
ulcer

2=2
ulcers

3=3
ulcers

4=4
ulcers

7=7
ulcers

Total

+

+

+

+

+

+

+

+

99.1*

0.5

+

+

+

+

3,942

Missing
0 = 0 ulcers

0.3

1 = 1 ulcers

+

+

65.2*

+

+

+

+

23

2 = 2 ulcers

+

+

+

+

+

+

+

+

4 = 4 ulcers

+

+

+

+

+

+

+

+

11

3,917

34

12

+

+

+

3,977

Total

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Summary Results
•

Among patients with zero or one Stage 3 pressure ulcers reported, there is a high level
of agreement between the CARE and MDS 2.0 items. For example, among patients
with zero ulcers reported in CARE, 99.1 percent also had zero ulcers reported in the
MDS 2.0.

CARE Item: Number of Stage 4 Pressure Ulcers (G2c)
MDS 2.0 Item: Number of Stage 4 Ulcers (M1d)
The Skin Integrity section of the CARE Item Set asks how many Stage 4 pressure ulcers
(G2c) were present during the 2-day admission assessment window, while the MDS 2.0 asks
how many Stage 4 ulcers were present (M1d) in the last 7 days. The definitions from the CARE
and MDS 2.0 are included below.
CARE Definition:
G2c. Stage 4: Full thickness tissue loss with visible bone, tendon, or muscle. Slough or eschar
may be present on some parts of the wound bed. Often includes undermining and tunneling.
MDS 2.0 Definition:
M1d. Stage 4: A full thickness of skin and subcutaneous tissue is lost, exposing muscle or bone.
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Key CARE and MDS 2.0 Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: While the CARE and MDS 2.0 definitions for Stage 4 Pressure
Ulcers are similar in many respects, the MDS 2.0 ulcer item also includes venous or
vascular ulcers.

•

Number of Ulcers: While the CARE item allows up to 8 ulcers (8 = 8 or more ulcers),
the MDS 2.0 item allows up to 9 ulcers (9 = 9 or more ulcers)

Implications
•

The MDS 2.0 and CARE assessments may indicate that a patient has different
numbers of Stage 4 pressure ulcers due to the difference in assessment time frame.

•

The MDS 2.0 assessment may also indicate a greater number of Stage 4 ulcers
because the item definition includes vascular ulcers, while the CARE item does not.

•

Additionally, category 8 on the CARE Item Set (8 or more ulcers) will incorporate
both MDS 2.0 categories 8 (8 ulcers) and 9 (9 or more ulcers).

The overall frequencies for these items are shown in Tables 14-15a and 14-15b below
followed by the cross-tabulation of the items in Table 14-15c.
Table 14-15a
CARE admission frequency of stage 4 pressure ulcers (G02c) during 2-day assessment
period
CARE: Stage 4 pressure ulcers

Frequency

Missing
0 = 0 ulcers
1 = 1 ulcers
2 = 2 ulcers
3 = 3 ulcers
4 = 4 ulcers
5 = 5 ulcers

+
3,932
28
+
+
+
+

Percent
+
98.9
0.7
+
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-15b
MDS 2.0 admission frequency of stage 4 ulcers during 7-day assessment period
MDS: Stage 4 pressure ulcers

Frequency

Missing
0 = 0 ulcers
1 = 1 ulcer
2 = 2 ulcers
3 = 3 ulcers
4 = 4 ulcers
5 = 5 ulcers
6 = 6 ulcers
7 = 7 ulcers
8 = 8 ulcers
9 = 9 ulcers

Percent

11
3,802
100
34
+
+
+
+
+
+
+

0.3
95.6
2.5
0.9
+
+
+
+
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-15c
CARE admission number of stage 4 pressure ulcers by MDS 2.0 admission number of
stage 4 ulcers
CARE: Stage 4
pressure ulcers

0=0 1=1 2=2 3=3 4=4 5=5 6=6 7=7 8=8 9=9
Missing ulcers ulcer ulcers ulcers ulcers ulcers ulcers ulcers ulcers ulcers Total

Missing

+

+

+

+

+

+

+

+

+

+

+

+

0 = 0 ulcers

0.3

96.5*

1.9

0.8

+

+

+

+

+

+

+

3,932

1 = 1 ulcers

+

+

82.1*

+

+

+

+

+

+

+

+

+

2 = 2 ulcers

+

+

+

+

+

+

+

+

+

+

+

+

3 = 3 ulcers

+

+

+

+

+

+

+

+

+

+

+

+

4 = 4 ulcers

+

+

+

+

+

+

+

+

+

+

+

+

5 = 5 ulcers

+

+

+

+

+

+

+

+

+

+

+

+

Total

11

3,802

100

34

+

+

+

+

+

+

+

3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Summary Results
•

Among patients with zero or one Stage 4 pressure ulcers reported, there is a high level
of agreement between the CARE and MDS 2.0 items. For example, among patients
with zero ulcers reported in CARE, 96.5 percent also had zero ulcers reported in the
MDS 2.0.

CARE Item: Number of Surgical Wounds with Delayed Healing (G05a)
MDS 2.0 Item: Any Surgical Wounds Present (M4g)
The Skin Integrity section of the CARE Item Set asks how many Surgical Wounds with
Delayed Healing (G5a) were present during the 2-day admission assessment window, while the
MDS 2.0 asks if any Surgical Wounds were present (M4g) in the last 7 days. For comparison
purposes, the CARE item was recoded into a binary categorical variable. The definitions from
the CARE and MDS 2.0 are included below.
CARE Definition:
G5a. Delayed Healing of Surgical Wound: A major wound that requires ongoing care from
delayed healing.
MDS 2.0 Definition:
M4g. Surgical Wounds: Includes healing and non-healing, open or closed surgical incisions,
skin grafts, or drainage sites on any part of the body. This category does not include healed
surgical sites or stomas.
Key CARE and MDS 2.0 Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: Although both items focus on healing of surgical wounds, the MDS
2.0 definition is more comprehensive, and is not limited to surgical wounds with
delayed healing.

•

Number of Wounds: The CARE Item Set asks for the number of surgical wounds
present, while the MDS 2.0 asks whether any surgical wounds are present. For the
purpose of this comparison, the CARE item was collapsed into a binary variable
indicating whether any wounds are present.

Implications
•

The MDS 2.0 and CARE assessments might differ in the number of surgical wounds
reported due to the difference in assessment time frame.

132

•

In addition, due to the more comprehensive MDS 2.0 item definition, it is possible
that patients with no Delayed Healing of Surgical Wounds recorded in CARE would
have Surgical Wounds reported in the MDS 2.0.

The overall frequencies for these items are shown in Tables 14-16a and 14-16b below
followed by the cross-tabulation of the items in Table 14-16c.
Table 14-16a
CARE admission surgical wounds with delayed healing (G05a)
CARE: Surgical wounds

Frequency

Percent

Missing
0 = No delayed surgical wounds present

+
3,842

+
96.6

132

3.3

1 = Delayed surgical wounds present
+ Cells based on a sample size of n < 11 are not shown.

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-16b
MDS 2.0 admission surgical wounds during 7-day assessment period
MDS: Surgical wounds

Frequency

Percent

Missing

+

+

0 = No
1 = Yes

2,341
1,626

58.9
40.9

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-16c
CARE presence of surgical wounds with delayed healing by MDS 2.0 surgical wounds
CARE: Surgical wounds

Missing

0 = No

1 = Yes

Total

Missing

+

+

+

+

0 = No delayed surgical wounds present

0.3

39.3

3,842

1 = Delayed surgical wounds present
Total

+
+

88.6*
1,626

132
3,977

60.5*
11.4
2,341

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Summary Results
•

Among patients with Delayed Surgical Wounds reported on the CARE Item Set, 88.6
percent had a Surgical Wound reported on the MDS 2.0.

•

In contrast, among patients with no Delayed Surgical Wounds reported on the CARE
Item Set, 39.3 percent did have a Surgical Wound reported on the MDS 2.0. This
discrepancy is likely the result of differing item definitions; the MDS 2.0 item is
broader (all surgical wounds) than the CARE item (non-healing surgical wounds).

CARE Item: Number of Trauma-Related Wounds (e.g., Burns) Present (G5b) vs. MDS 2.0
Item: Any Burns Present (M4b)
The Skin Integrity section of the CARE Item Set asks how many Trauma-Related
Wounds (e.g., Burns) (G5b) were present during the 2-day admission assessment window, while
the MDS 2.0 asks if any Burns were present (M4b) in the last 7 days. For comparison purposes,
the CARE item was recoded into a binary categorical variable. The definitions from the CARE
and MDS 2.0 are included below.
CARE Definition:
G5b. Trauma-Related Wound (e.g., Burns): A major trauma-related wound (e.g., burn) that
requires ongoing care because of draining, infection, or delayed healing.
MDS 2.0 Definition:
M4b. Burns (Second or Third Degree): Includes burns from any cause (e.g., heat, chemicals) in
any stage of healing. This category does not include first-degree burns (changes in skin color
only).
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: Although both include burns, the focus of the items is different.
The CARE item emphasizes trauma-related wounds, including burns, while the MDS
2.0 focuses exclusively on second- or third-degree burns.

•

Number of Wounds: The CARE Item Set asks for the number of trauma-related
wounds present, while the MDS 2.0 asks whether any burns are present. For the
purpose of this comparison, the CARE item was collapsed into a binary variable
indicating whether any wounds are present.

Implications
•

The MDS 2.0 and CARE assessments might indicate that a patient has different
numbers of burns due to the difference in assessment time frame.
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•

In addition, the more restrictive MDS 2.0 item definition may result in patients who
are categorized with a trauma-related wound on the CARE Item Set, but do not meet
the definition of a second- or third-degree burn for the MDS 2.0.

The overall frequencies for these items are shown in Tables 14-17a and 14-17b below,
followed by the cross-tabulation of the items in Table 14-17c.
Table 14-17a
CARE admission trauma related wounds (e.g., burns) (G05b) during 2-day assessment
period
MDS: Trauma-related wounds

Frequency

Missing
0 = No trauma-related wounds present
1 = Trauma-related wounds present

Percent

+
3,930
44

+
98.8
1.1

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-17b
MDS 2.0 admission burns during 7-day assessment period
MDS: Burns
Missing
0 = No
1 = Yes

Frequency
+
3,954
14

Percent
+
99.4
0.4

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-17c
CARE admission presence of trauma-related wounds (e.g., burns) by MDS 2.0 admission
burns second/third degree
CARE: Trauma-related wounds

Missing

Missing
0 = No trauma-related wounds present
1 = Trauma-related wounds present
Total

+
0.2
+
+

0 = No

1 = Yes

Total

+
0.3
+
14

+
3,930
44
3,977

+
99.5*
95.5
3,954

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Summary Results
•

Among patients with no Trauma-Related Wounds reported on the CARE Item Set,
99.5 percent did not have a second- or third-degree burn reported on the MDS 2.0.

CARE Item: Number of Other Wounds (e.g., Incontinence Associated Dermatitis, Normal
Surgical Wound Healing) Present (G5e)
MDS 2.0 Item: Surgical Wounds (M4g)
The Skin Integrity section of the CARE Item Set asks how many Other Wounds (e.g.,
Incontinence Associated Dermatitis, Normal Surgical Wound Healing) (G5e) were present
during the 2-day admission assessment window, while the MDS 2.0 asks if any Surgical Wounds
were present (M4g) in the last 7 days. For comparison purposes, the CARE item was recoded
into a binary categorical variable. The definitions from the CARE and MDS 2.0 are included
below.
CARE Definition:
G5e. Number of Other Wounds (e.g., Incontinence Associated Dermatitis, Normal Surgical
Wound Healing): A major wound that requires ongoing care from delayed healing.
MDS 2.0 Definition:
M4g. Surgical Wounds: Includes healing and non-healing, open or closed surgical incisions,
and skin grafts or drainage sites on any part of the body. This category does not include healed
surgical sites or stomas.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: Although both include surgical wounds, the focus of the items is
different. The CARE item includes a broad category of “other” wounds, including
normally healing surgical wounds, while the MDS 2.0 focuses on exclusively surgical
wounds.

•

Number of Wounds: The CARE Item Set asks for the number of wounds present,
while the MDS 2.0 asks whether any surgical wounds are present. For the purpose of
this comparison, the CARE item was collapsed into a binary variable indicating
whether any wounds are present.

Implications
•

The MDS 2.0 and CARE assessments might indicate that a patient has different
numbers of surgical wounds due to the difference in assessment time frame.
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•

In addition, due to the more restrictive MDS 2.0 item definition, it is possible that
patients with Other Major Wounds recorded in CARE would not have Surgical
Wounds indicated in the MDS 2.0.

•

Finally, surgical wounds included in the MDS 2.0 item may be more appropriately
categorized in the CARE item G5a, Delayed Healing of Surgical Wounds.

The overall frequencies for these items are shown in Tables 14-18a and 14-18b below,
followed by the cross-tabulation of the items in Table 14-18c.
Table 14-18a
CARE admission other wounds (e.g., incontinence associated dermatitis, normal surgical
wound healing) (G05e)
CARE: Other wounds
Missing
0 = No other major wounds present
1 = Other major wounds present

Frequency
+
3,359
615

Percent
+
84.5
15.5

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-18b
MDS 2.0 admission surgical wounds during 7-day assessment period
MDS: Surgical wounds
Missing
0 = No
1 = Yes

Frequency
+
2,341
1,626

Percent
+
58.9
40.9

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-18c
CARE admission presence of other wounds (e.g., incontinence associated dermatitis,
normal surgical wound healing) by MDS 2.0 admission surgical wounds
CARE: Other wounds
Missing
0 = No other major wounds present
1 = Other major wounds present
Total

Missing
+
+
—
10

0 = No
+
66.2*
18.5
2,341

1 = Yes
+
33.5
81.5*
1,626

Total
+
3,359
615
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
•

Among patients with Other Major Wounds reported on the CARE Item Set,
81.5 percent had a surgical wound reported on the MDS 2.0.

•

For patients with no Other Major Wounds reported on the CARE Item Set,
66.2 percent did not have wounds on the MDS 2.0 and the remaining 33.5 percent did
have a surgical wound. This discrepancy is not unexpected given the potential for
surgical wounds to also be captured in CARE item G5a, Delayed Healing of Surgical
Wounds.

CARE Item: Number of Other Wounds (e.g., Incontinence Associated Dermatitis, Normal
Surgical Wound Healing) Present (G5e)
MDS 2.0 Item: Open Lesions Other than Ulcers, Rashes, Cuts (e.g., Cancer Lesions) (M4c)
The Skin Integrity section of the CARE Item Set asks how many Other Wounds (e.g.,
Incontinence Associated Dermatitis, Normal Surgical Wound Healing) (G05e) were present
during the 2-day admission assessment window, while the MDS 2.0 asks if any Open Lesions
Other than Ulcers, Rashes, or Cuts were present (M4c) in the last 7 days. For comparison
purposes, the CARE item was recoded into a binary categorical variable. The definitions from
the CARE and MDS 2.0 are included below.
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CARE Definition:
G5e. Number of Other Wounds (e.g., Incontinence Associated Dermatitis, Normal Surgical
Wound Healing): A major wound that requires ongoing care from delayed healing.
MDS 2.0 Definition:
M4c. Open Lesions Other than Ulcers, Rashes, Cuts (e.g., cancer lesions)
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The focus of the items is different. The CARE item includes a
broad category of “other” wounds, including normally healing surgical wounds, while
the MDS 2.0 focuses more on lesions (e.g., cancer lesions) that are not ulcers, rashes,
or cuts.

•

Number of Wounds: The CARE Item Set asks for the number of wounds present,
while the MDS 2.0 asks whether any other lesions are present. For the purpose of this
comparison, the CARE item was collapsed into a binary variable indicating whether
any wounds are present.

Implications
•

The MDS 2.0 and CARE assessments might indicate that a patient has different
numbers of wounds due to the difference in the assessment time frame.

•

In addition, due to the more restrictive MDS 2.0 item definition, it is possible that
patients with Other Major Wounds recorded in CARE would not have Other Lesions
indicated in the MDS 2.0.

The overall frequencies for these items are shown in Tables 14-19a and 14-19b below,
followed by the cross-tabulation of the items in Table 14-19c.
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Table 14-19a
CARE admission other wounds (e.g., incontinence associated dermatitis, normal surgical
wound healing) (G05e)
CARE: Other wounds

Frequency

Percent

+
3,359
615

+
84.5
15.5

Missing
0 = No other major wounds present
1 = Other major wounds present

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-19b
MDS 2.0 admission open lesions other than ulcers, rashes, or cuts during 7-day assessment
period
MDS: Open lesions

Frequency

Percent

+
3,838
130

+
96.5
3.3

Missing
0 = No
1 = Yes

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-19c
CARE admission presence of other wounds (e.g., incontinence associated dermatitis,
normal surgical wound healing) by MDS 2.0 admission open lesions other than ulcers,
rashes, or cuts
CARE: Other wounds

Missing

Missing
0 = No other major wounds present
1 = Other major wounds present
Total

+
+
+
+

0 = No

1 = Yes

Total

+
96.5*
96.3
3,838

+
3.2
3.7*
130

+
3,359
615
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Summary Results
•

Among patients with Other Major Wounds reported on the CARE Item Set, 3.7
percent had another lesion reported on the MDS 2.0. This discrepancy is not
unexpected given the more restrictive MDS 2.0 item definition.

B. Cognitive Status, Mood, & Pain
Cognitive Status
CARE Item: Comatose (A1) vs. MDS 2.0 Item: Comatose (B1)
The Cognitive Status section of the CARE Item Set asks whether a patient is in a
Persistent Vegetative State or has No Discernable Consciousness during the 2-day admission
assessment window; the MDS 2.0 assesses this same item, but over the last 7 days. The
definitions from the CARE and MDS 2.0 are included below.
CARE Definition:
A1. Persistent Vegetative State/No Discernible Consciousness at Time of Admission
MDS 2.0 Definition:
B1. Persistent Vegetative State/No Discernible Consciousness: Indicates whether a patient’s
clinical record includes a documented neurological diagnosis of coma or persistent vegetative
state.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The item definitions are very similar.

Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment windows. While a patient may be comatose closer to admission (on the
CARE assessment), they may no longer be so later in their stay, during the MDS 2.0
assessment period.

The overall frequencies for these items are shown in Tables 14-20a and 14-20b below,
followed by the cross-tabulation of the items in Table 14-20c.
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Table 14-20a
CARE admission persistent vegetative state
CARE: Comatose
Missing
0 = No
1 = Yes

Frequency

Percent

+
3,964
11

+
99.7
0.3

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-20b
MDS 2.0 admission persistent vegetative state during 7-day assessment period
MDS: Comatose

Frequency

Missing
0 = No
1 = Yes

+
3,976
+

Percent
+
100.0
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
•

All (100 percent) of patients reported as not comatose on the CARE assessment were
also reported as not comatose on the MDS 2.0.

CARE Items: Recall of “Sock,” “Blue,” and “Bed” (B3c1–B3c3) vs. MDS 2.0 Item: ShortTerm Memory OK (B2a)
The Cognitive Status section of the CARE Item Set assesses a patient’s short-term
memory by telling them to remember three words (“sock,” “blue,” and “bed”) in item B3a, and
then asking them to repeat these words after the words have been stated by the clinician. After
this first attempt (immediate recall) the clinician states the three words again with a “cue”
category (e.g., blue, a color) and allows the clinician to repeat the words up to two more times
before a short interval of time (a few minutes) passes and the patient is then asked to recall the
items B3c1 through B3c3 during the 2-day admission assessment window. The MDS 2.0 asks a
clinician to assess whether the patient’s “short-term memory is OK” using a similar approach—
patients are asked to repeat a recent experience or asked to remember three items. The clinician
repeats the three words immediately to verify the items were correctly heard and understood by
the patient and then talks about another subject. After 5 minutes the patient is asked to repeat the
three items. The definitions from the compared CARE and MDS 2.0 items are included below.
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CARE Definitions:
B3a. Repetition of Three Words: Ask patient: “I am going to say three words for you to
remember. Please repeat the words after I have said all three. The words are sock, blue, and
bed. Now tell me the three words.”
(Patient responds.)
After the patient’s first attempt say: “I will repeat each of the three words with a cue and ask you
about them later: sock, something to wear; blue, a color; bed, a piece of furniture.”
(Three other, unrelated questions are asked in the interim.)
B3c. Recall: Ask patient: “Let’s go back to the first question. What were those three words that
I asked you to repeat?” If unable to remember a word, give a cue (i.e., something to wear, a
color, a piece of furniture) for that word.
B3c1. Recalls “sock?”
B3c2. Recalls “blue?”
B3c3. Recalls “bed?”
MDS 2.0 Definition:
B2a. Short-Term memory OK: Seems/appears to recall after 5 minutes.
RAI Suggested Process: Ask the resident to describe a recent event that both of you had the
opportunity to remember. Or, you could use a more structured short-term memory test. For
example, ask the resident to remember three items (book, watch, table) for a few minutes. After
you have stated all three items, ask the resident to repeat them (to verify that you were heard and
understood). Then proceed to talk about something else—do not be silent, do not leave the
room. In 5 minutes, ask the resident to repeat the name of each item. If the resident is unable to
recall all three items, code “1.”
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.
On the MDS 2.0 short-term memory item, the clinician is instructed to identify the
most representative level of function, not the highest. Even if the clinician believes
the patient’s memory status is impacted by medication or other influences, the
clinician still captures the patient’s status during the assessment period to demonstrate
the level of acuity during the admission assessment period. The patient’s status may
change over the MDS 2.0’s 7-day look-back period and a higher level of functioning
may be the most representative of the patient’s level of functioning.
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•

Item Definitions: During the 7-day look-back period, the clinician asks the patient to
describe a recent event or the clinician can use a more structured short-term memory
test (i.e., ask the patient to remember three items and have patient recall after a 5minute period). Although the items use similar methods to assess short-term
memory, the MDS 2.0 calls for the clinician to indicate a problem with short-term
memory if the patient is unable to recall all three items. The CARE recall rates the
patient on recall success for each of the three items and if the patient required a “cue”
to prompt the patient’s recall of each item of the 2-day assessment period.

•

Scales: While the MDS 2.0 item is binary, the CARE includes an intermediary
response indicating that the patient could recall an item after cueing. The clinician
records the immediate response and then repeats the three words to the patient and
adds the category of the word to each. The clinician uses the category later to
facilitate recall of the word if the patient does not recall the word spontaneously.
Attaching a category to the word may enhance the patient’s later recall of the word.

Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment windows. A patient may exhibit more memory closer to admission. This
would lead to expected lower cognitive status scores for patients assessed in the 2-day
assessment period, whereas the patient assessed using the MDS 2.0 may be assessed
at a higher level of cognitive status.

•

Since the MDS 2.0 uses a different method to determine short-term memory problems
(not recalling multiple items or following through on a direction given 5 minutes
earlier), the responses to the individual CARE items may indicate short-term memory
problems when the MDS 2.0 item does not.

•

On the CARE Item Instrument, the patient’s ability to recall a word when a cue was
given by the clinician was likely marked on the MDS 2.0 as the patient having a
memory problem equal to the patient having had no recall of the item (no cue given
on MDS 2.0) that could lead to lower cognitive status scores.

Each of the three CARE items is compared individually to the MDS 2.0 titled “Item for
Short-Term Memory OK.” The overall frequencies for each item are shown in Tables 14-21a(13) and 14-21b, followed by the cross-tabulation of the items in Table 14-21c(1-3).
Table 14-21a(1)
CARE admission recalls “sock”
CARE: Recalls “sock”
Missing
0 = No, could not recall
1 = Yes, after cueing
2 = Yes, no cue required

Frequency
168
746
645
2,418

Percent
4.2
18.8
16.2
60.8

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-21a(2)
CARE admission recalls “blue”
CARE: Recalls “blue”
Missing
0 = No, could not recall
1 = Yes, after cueing
2 = Yes, no cue required

Frequency
168
657
671
2,481

Percent
4.2
16.5
16.9
62.4

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-21a(3)
CARE admission recalls “bed”
CARE: Recalls “bed”
Missing
0 = No, could not recall
1 = Yes, after cueing
2 = Yes, no cue required

Frequency
168
849
816
2,144

Percent
4.2
21.4
20.5
53.9

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-21b
MDS 2.0 admission short-term memory OK during 7-day assessment period
MDS: Short-term memory
Missing
0 = No
1 = Yes (memory
problem)

Frequency
22
2,397
1,558

Percent
0.6
60.3
39.2

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-21c(1)
CARE recalls “sock” by MDS 2.0 “short-term memory OK” items

CARE: Recalls “sock”
Missing
0 = No, could not recall
1 = Yes, after cueing
2 = Yes, no cue required
Total

Missing

0 = No
19.6
17.7
46.7
79.9*
2,397

+
+
+
0.6
22

1 = Yes
(memory
problem)

Total

78.6
82*
53
19.5
1,558

168
746
645
2,418
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-21c(2)
CARE admission recalls “blue” by MDS 2.0 admission short-term memory OK items

CARE: Recalls “blue”

Missing

0 = No

1 = Yes
(memory
problem)

Missing
0 = No, could not recall
1 = Yes, after cueing
2 = Yes, no cue required
Total

+
+
+
0.6
22

19.6
16.4
45.2
78.7*
2,397

78.6
83.3*
54.4
20.7
1,558

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Total
168
657
671
2,481
3,977

Table 14-21c(3)
CARE admission recalls “bed” by MDS 2.0 admission short-term memory OK items

CARE: Recalls “bed”

Missing

Missing
0 = No, could not recall
1 = Yes, after cueing
2 = Yes, no cue required
Total

+
+
+
0.6
22

0 = No
19.6
21.3
54.3
81.2*
2,397

1 = Yes
(memory
problem)
78.6
78.4*
45.1
18.3
1,558

Total
168
849
816
2,144
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
•

See Tables 14-2c(1-3). Among patients who could not recall “sock” on the CARE
assessment, 82.0 percent were judged to have short-term memory problems on the
MDS 2.0. Similarly, 83.3 percent who could not recall “blue” and 78.4 percent who
could not recall “bed” were judged to have short-term memory problems on the MDS
2.0. Discrepancies here may be due to the MDS 2.0 using a different method to
determine short-term memory problems (not recalling multiple items or following
through on a direction given 5 minutes earlier), the responses to the individual CARE
items may indicate short-term memory problems while the MDS 2.0 item may not
capture milder memory problems.

•

A possible reason for the results of the CARE “Yes after cueing” item’s percentage of
agreement (53 percent, 54.4 percent, 45.1 percent) to the MDS 2.0 “Yes” (memory
problem) may be the following:
–

•

The CARE’s response scores the patient’s ability to recall a word when a cue is
given while the same patient assessed by the MDS 2.0 would not have been
offered a cue word and thus would likely not recall the word resulting in the MDS
2.0 score of 1 = Yes (memory problem).

Notably, for each of the three CARE items, approximately 18.3 to 20.7 percent of
patients who could recall “sock,” “blue,” or “bed” were recorded as having short-term
memory problems on the MDS 2.0. This may be related to the 7-day MDS 2.0
assessment period (compared to the CARE 2- or 3-day assessment period).
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Behavioral Signs & Symptoms
CARE Item: Physical Behavioral Symptoms Directed Toward Others (E1) vs. MDS 2.0 Item:
Physically Abusive Behavioral Symptoms (E4Ac)
The Behavioral Signs & Symptoms section of the CARE Item Set asks whether a patient
has demonstrated Physical Behavioral Symptoms Directed Toward Others during the 2-day
admission assessment window, while the MDS 2.0 assesses the frequency of Physically Abusive
Behavioral Symptoms over the last 7 days. For purposes of comparison, the MDS 2.0 categories
were collapsed into a binary variable indicating whether or not the behavior was present. The
definitions from the CARE and MDS 2.0 are included below.
CARE Definition:
E1. Physical Symptoms: Physical behavioral symptoms directed toward others (e.g., hitting,
kicking, pushing).
MDS 2.0 Definition:
E4Ac. Physically Abusive Behaviors: Others were hit, shoved, scratched, or sexually abused.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The item definitions are very similar.

•

Scales: While the CARE item is binary, the MDS 2.0 assesses the frequency of
behavior over the last 7 days. For purposes of comparison, the MDS 2.0 responses
were collapsed into binary categories.

Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment windows.

The overall frequencies for these items are shown in Tables 14-22a and 14-22b, followed
by the cross-tabulation of the items in Table 14-22c.
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Table 14-22a
CARE admission physical behavioral symptoms directed toward others
CARE: Physical behavioral symptoms

Frequency

Percent

13
3,907
57

0.3
98.2
1.4

Missing
0 = No
1 = Yes

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-22b
MDS 2.0 admission physically abusive behavioral symptoms directed toward others during
7-day assessment period
MDS: Physically abusive
behavioral symptoms

Frequency

Percent

Missing
0 = No
1 = Yes

17
3,897
63

0.4
98.0
1.6

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-22c
CARE admission by MDS 2.0 physical behavioral symptoms directed toward others items
CARE: Physical
behavioral
symptom
Missing
0 = No
1 = Yes
Total

Missing
+
0.4
—
17

0 = No
+
98.5*
61.4
3,897

1 = Yes

Total

+

13
3,907
57
3,977

1
38.6*
63

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
•

Among patients who were assessed on the CARE Item Set as not having Physical
Behavioral Symptoms Directed Toward Others, 98.5 percent were similarly assessed
on the MDS 2.0.
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Notably, among the patients who did have Physical Behavioral Symptoms Directed
Toward Others on the CARE Item Set, 61.4 percent did not have these behaviors reported on the
MDS 2.0. This discrepancy might be due to the difference in assessment time frames.
CARE Item: Verbal Behavioral Symptoms Directed Toward Others (E2) vs. MDS 2.0 Item:
Verbally Abusive Behavioral Symptoms (E4Ab)
The Behavioral Signs & Symptoms section of the CARE Item Set asks whether a patient
has demonstrated Verbal Behavioral Symptoms Directed Toward Others during the 2-day
admission assessment window, while the MDS 2.0 assesses the frequency of Verbally Abusive
Behavioral Symptoms over the last 7 days. For purposes of comparison, the MDS 2.0 categories
were collapsed into a binary variable indicating whether or not the behavior was present. The
definitions from the CARE and MDS 2.0 are included below.
CARE Definition:
E2. Verbal Symptoms: Verbal behavioral symptoms directed toward others (e.g., threatening,
screaming at others).
MDS 2.0 Definition:
E4Ab. Verbally Abusive Behaviors: Others were threatened, screamed at, or cursed at.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The item definitions are very similar.

•

Scales: While the CARE item is binary, the MDS 2.0 assesses the frequency of
behavior over the last 7 days. For purposes of comparison, the MDS 2.0 responses
were collapsed into binary categories.

Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment windows.

The overall frequencies for these items are shown in Tables 14-23a and 14-23b, followed
by the cross-tabulation of the items in Table 14-23c.

150

Table 14-23a
CARE admission verbal behavioral symptoms directed toward others
CARE: Verbal behavioral symptoms
Missing
0 = No
1 = Yes

Frequency

Percent

13
3,862
102

0.3
97.1
2.6

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-23b
MDS 2.0 admission verbally abusive behavioral symptoms directed toward others during 7day assessment period
MDS: Verbal behavioral symptoms

Frequency

Percent

Missing
0 = No verbal abuse during past 7 days
1 = Verbal abuse present during past 7 days

17
3,861
99

0.4
97.1
2.5

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-23c
CARE by MDS 2.0 verbally abusive behavioral symptoms directed toward others items
CARE: Verbal
behavioral symptoms
Missing
0 = No
1 = Yes
Total

Missing

0 = No

1 = Yes

Total

+
0.4
—
17

92.3
98*
64.7
3,861

+
1.6
35.3*
99

13
3,862
102
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Summary Results
•

Among patients who were reported as not having Verbal Behavioral Symptoms
Directed Toward Others on the CARE Item Set, 98.0 percent were also assessed this
way on the MDS 2.0.
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•

Notably, among the patients who did have Verbal Behavioral Symptoms Directed
Toward Others on the CARE Item Set, 64.7 percent did not have these behaviors
reported on the MDS 2.0.

Mood
CARE Item: Little Interest or Pleasure in Doing Things (F2b) vs. MDS 2.0 Items: Withdrawal
from Activities of Interest (E1o) and Reduced Social Interaction (E1p)
The Mood section of the CARE Item Set asks the patient how often during the past 2
weeks they have been bothered by Little Interest or Pleasure in Doing Things during the 2-day
admission assessment window. The MDS 2.0 assesses the frequency of two analogous items in
the last 30 days: Withdrawal from Activities of Interest and Reduced Social Interaction. The
definitions from the CARE and MDS 2.0 are included below.
CARE Definition:
F2b. Little Interest or Pleasure in Doing Things? If Yes, how many days in the last 2 weeks?
MDS 2.0 Definitions:
E1o. Withdrawal from Activities of Interest: e.g., no interest in long-standing activities or
being with family/friends
E1p. Reduced Social Interaction: e.g., less talkative, more isolated
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is for the last 30
days.

•

Item Definitions: The MDS 2.0 items are more specific than the CARE item, although
they assess the same type of behavior. In addition, the CARE item is an interview
question, while the MDS 2.0 items are assessed by clinician observation.

•

Scales: While both items assess the frequency of this behavior, the MDS 2.0 has a
three-level scale that asks whether the behavior was not present at all, present up to 5
days a week, or present almost daily. The CARE Item Set has a screener question
asking whether the behavior was present at all during the past 2 weeks, and if the
answer is yes, there is a subsequent four-level scale question assessing the frequency
during the past 2 weeks.

Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment windows.
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•

Due to the more specific nature of the MDS 2.0 items, the CARE item may indicate
that a patient has little interest or pleasure in doing things when the corresponding
MDS 2.0 items are not selected.

•

If the patient is able to reflect upon and disclose the answers for this item, the CARE
Item Set’s self-report questions may be more accurate than the MDS 2.0’s clinician
observations of the patient (i.e., for the CARE items the patient may be able to reflect
upon their usual mood in the last 2 weeks, whereas the MDS 2.0 limits the span of
time that the patient’s mood is observed by the clinician for the last 30 days).

The overall frequencies for these items are shown in Tables 14-24a and 14-24b, followed
by the cross-tabulation of the items in Table 14-24c.
Table 14-24a
CARE admission little interest or pleasure in doing things
CARE: Little interest or pleasure
Missing
0 = Never little interest doing things

Frequency

Percent

553
2,690

13.9
67.6

1 = Yes generally, and 0-1 days in last 2 wks

38

1.0

2 = Yes generally, and 2-6 days in last 2 wks

398

10.0

3 = Yes generally, and 7-11 days in last 2 wks

145

3.7

4 = Yes generally, and 12-14 days in last 2 wks

153

3.9

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-24b(1)
MDS 2.0 admission withdrawal from activities of interest during 7-day assessment period
MDS: Withdrawn
Missing
0 = Not indicated in last 30 days
1 = Indicator exhibited up to 5 days/week
2 = Indicator exhibited daily or almost daily

Frequency

Percent

17
3,898
52

0.4
98.0
1.3

+

+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-24b(2)
MDS 2.0 admission reduced social interaction during 7-day assessment period
MDS: Reduced interaction

Frequency

Missing
0 = Not indicated in last 30 days
1 = Indicator exhibited up to 5 days/week

Percent

17
3,853
91

0.4
96.9
2.3

16

0.4

2 = Indicator exhibited daily or almost daily

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-24c(1)
CARE admission little interest or pleasure in doing things by MDS 2.0 admission
withdrawal from activities items
Missing

Not
present

1 = Up to
5 days

2 = Daily

Missing

0.4

97.5

1.6

+

553

0 = Never little interest doing things

0.5

98.4*

1

+

2,690

1 = Yes generally, and 0-1 days in last 2 wks

+

97.4

+

+

38

2 = Yes generally, and 2-6 days in last 2 wks

+

97.7

+

+

398

3 = Yes generally, and 7-11 days in last 2 wks

+

94.5

+

+

145

4 = Yes generally, and 12-14 days in last 2 wks

+

96.7

+

+

153

Total

17

3,898

52

+

3,977

CARE: little interest or pleasure

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Total

Table 14-24c(2)
CARE admission little interest or pleasure in doing things by MDS 2.0 admission reduced
social interaction items
Missing

Not
present

1 = Up to
5 days

2 = Daily

Missing

0.4

94.8

3.8

1.1

553

0 = Never little interest doing things

0.5

97.6*

1.7

+

2,690

1 = Yes generally, and 0-1 days in last 2 wks

+

97.4

+

+

38

2 = Yes generally, and 2-6 days in last 2 wks

+

97.2

+

+

398

3 = Yes generally, and 7-11 days in last 2 wks

+

94.5

+

+

145

4 = Yes generally, and 12-14 days in last 2 wks

+

92.8

+

+

153

Total

17

3,853

91

16

3,977

CARE: Little interest or pleasure

Total

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Summary Results
•

Among patients who were reported as not having Little Interest or Pleasure Doing
Things on the CARE Item Set, 98.4 percent also did not report Withdrawal from
Activities on the MDS 2.0 and 97.6 percent did not report Reduced Social Interaction
on the MDS 2.0.

Notably, among the patients who did have some frequency of Little Interest or Pleasure
Doing Things on the CARE Item Set, the vast majority (ranging from 92 percent to 97 percent)
did not report Withdrawal from Activities or Reduced Social Interaction on the MDS 2.0. This
discrepancy might be due to the more specific MDS 2.0 item definitions.
CARE Item: Down, Depressed, or Hopeless (F2d) vs. MDS 2.0 Items: Patient Made Negative
Statements (E1a), Self-Deprecation (E1e) and Crying or Tearfulness (E1m)
The Mood section of the CARE Item Set asks the patient how often during the past 2
weeks they have been bothered by Feeling Down, Depressed, or Hopeless during the 2-day
admission assessment window. The MDS 2.0 assesses the frequency of three analogous items in
the last 30 days: Patient Made Negative Statements, Self-Deprecation, and Crying or
Tearfulness. The definitions from the CARE and MDS 2.0 are included below.
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CARE Definition:
F2d. Feeling Down, Depressed, or Hopeless? If Yes, how many days in the last 2 weeks?
MDS 2.0 Definitions:
E1a. Resident Made Negative Statements: e.g., “Nothing matters; would rather be dead;
what’s the use; regrets having lived so long; let me die.”
E1e. Self-Deprecation: e.g., “I am nothing; I am of no use to anyone.”
E1m. Crying or Tearfulness
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The MDS 2.0 items are more specific than the CARE item, although
they assess the same type of behavior. In addition, the CARE item is an interview
question, while the MDS 2.0 items are assessed by clinician observation.

•

Scales: While both items assess the frequency of this behavior, the MDS 2.0 has a
three-level scale that asks whether the behavior was not present at all, present up to 5
days a week, or present almost daily. The CARE Item Set has a screener question
asking whether the behavior was present at all during the past 2 weeks, and if the
answer is yes, there is a subsequent four-level scale question assessing the frequency
during the past 2 weeks.

Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment windows.

•

Due to the more specific nature of the MDS 2.0 items, the CARE item may indicate
that a patient is down, depressed, or hopeless when the corresponding MDS 2.0 item
does not indicate a positive response.

The overall frequencies for these items are shown in Tables 14-25a and 14-25b, followed
by the cross-tabulation of the items in Table 14-25c.
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Table 14-25a
CARE admission down, depressed, or hopeless
CARE: Down, depressed, or hopeless
Missing
0 = Never down, depressed, or hopeless
1 = Yes generally, and 0-1 days in last 2 wks
2 = Yes generally, and 2-6 days in last 2 wks
3 = Yes generally, and 7-11 days in last 2 wks
4 = Yes generally, and 12-14 days in last 2 wks

Frequency

Percent

549
2,402
57
667
157
145

13.8
60.4
1.4
16.8
4.0
3.7

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-25b(1)
MDS 2.0 admission patient made negative statements during 7-day assessment period
MDS: Negative statements
Missing
0 = Not indicated in last 30 days
1 = Indicator exhibited up to 5 days/week
2 = Indicator exhibited daily or almost daily

Frequency
17
3,897
62
+

Percent
0.4
98.0
1.6
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-25b(2)
MDS 2.0 admission self-deprecation during 7-day assessment period
MDS: Self-deprecation
Missing
0 = Not indicated in last 30 days
1 = Indicator exhibited up to 5 days/week
2 = Indicator exhibited daily or almost daily

Frequency

Percent

17
3,942
17
+

0.4
99.1
0.4
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-25b(3)
MDS 2.0 admission crying or tearfulness during 7-day assessment period
MDS: Crying
Missing
0 = Not indicated in last 30 days
1 = Indicator exhibited up to 5 days/week
2 = Indicator exhibited daily or almost daily

Frequency

Percent

17
3,811
145
+

0.4
95.8
3.7
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-25c(1)
CARE admission down, depressed, or hopeless by MDS 2.0 admission patient made
negative statements items

Missing

Not
indicated

Up to 5
days/wk

Daily/
almost
daily

Total

Missing

+

97.6

+

+

549

0 = Never down, depressed, or hopeless

0.5

98.7*

0.9

+

2,402

1 = Yes generally, and 0-1 days in last 2 wks

+

94.7

+

+

57

2 = Yes generally, and 2-6 days in last 2 wks

+

97.5

2.2*

+

667

3 = Yes generally, and 7-11 days in last 2 wks

+

98.1

+

+

157

4 = Yes generally, and 12-14 days in last 2 wks

+

91.7

+

+

145

Total

17

3,897

62

+

3,977

CARE: Depressed

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-25c(2)
CARE admission down, depressed, or hopeless by MDS 2.0 admission self-deprecation item

Missing

Not
indicated

Missing

0.4

98.9

0 = Never down, depressed, or hopeless

0.5

99.3*

1 = Yes generally, and 0-1 days in last 2 wks

+

2 = Yes generally, and 2-6 days in last 2 wks

CARE: Depressed

Up to 5
days/wk
0.5

Daily/
almost
daily

Total

+

549

+

+

2,402

98.2

+

+

57

+

99

+

+

667

3 = Yes generally, and 7-11 days in last 2 wks

+

100

+

+

157

4 = Yes generally, and 12-14 days in last 2 wks

+

96.6

+

+

145

Total

17

+

3,977

3,942

17

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-25c(3)
CARE admission down, depressed, or hopeless by MDS 2.0 admission crying or tearfulness
items

Missing

Not
indicated

Up to 5
days/wk

Daily/
almost
daily

+

95.1

4.2

+

549

0.5

97.0*

2.5

+

2,402

1 = Yes generally, and 0-1 days in last 2 wks

+

98.2

+

+

57

2 = Yes generally, and 2-6 days in last 2 wks

+

94.0

5.5*

+

667

3 = Yes generally, and 7-11 days in last 2 wks

+

94.9

+

+

157

4 = Yes generally, and 12-14 days in last 2
wks

+

86.9

11.7*

+

145

Total

17

3,811

145

+

3,977

CARE: Depressed
Missing
0 = Never down, depressed, or hopeless

Total

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Summary Results
•

Among patients who were reported as not being Down, Depressed, or Hopeless on
the CARE Item Set, 98.7 percent also did not report Negative Statements,
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99.3 percent did not report Self-Deprecation, and 97.0 percent did not report Crying
or Tearfulness on the MDS 2.0.
•

Notably, among the patients who did have some frequency of being Down,
Depressed, or Hopeless on the CARE Item Set, the vast majority (ranging from
87 percent to 100 percent) did not report Negative Statements, Self-Deprecation, or
Crying or Tearfulness on the MDS 2.0. This discrepancy might be due to the more
specific MDS 2.0 item definitions or differences in how these behaviors are assessed.

C. Impairments
Hearing, Vision, and Communication
CARE Item: Expression of Ideas and Wants (C1b) vs. MDS 2.0 Item: Making Self Understood
(C4)
The Hearing, Vision, and Communication section of the CARE Item Set assesses the
patient’s usual ability with Expression of Ideas and Wants, during the 2-day admission
assessment window. The MDS 2.0 similarly indicates a patient’s ability to make them
understood during the last 7 days. The definitions from the CARE and MDS 2.0 are included
below.
CARE Definition:
C1b. Expression of Ideas and Wants: The ability to express complex messages, needs, and
ideas in clear speech.
MDS 2.0 Definition:
C4. Making Self Understood: To document the resident’s ability to express or communicate
requests, needs, opinions, urgent problems, and social conversation, whether in speech, writing,
sign language, or combinations of these.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The CARE and MDS 2.0 items are very similar, although the MDS
2.0 item includes writing and sign language as means of communicating, whereas the
CARE Item Set does not.

•

Scales: The CARE item scale has four levels, ranging from expresses self without
difficulty (4) to rarely/never able to express (1). The MDS 2.0 scale also has four
levels, but higher scores indicate more dependence, and ranges from understood (0) to
rarely/never understood (3).
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Implications
•

The CARE and MDS 2.0 assessment data may be different due to differences in the
assessment windows.

The overall frequencies for these items are shown in Tables 14-26a and 14-26b, followed
by the cross-tabulation of the items in Table 14-26c.
Table 14-26a
CARE admission expression of ideas and wants
CARE: Expression of ideas and wants

Frequency

Percent

+
77
265
583
3,015
29
+

+
1.9
6.7
14.7
75.8
0.7
+

Missing
1 = Rarely/never expresses self
2 = Frequent difficulty in self-expression
3 = Some difficulty in self-expression
4 = No difficulty in self-expression
8 = Unable to assess
9 = Unknown
+ Cells based on a sample size of n < 11 are not shown.

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-26b
MDS 2.0 admission making self understood during 7-day assessment period
MDS: Makes self understood
Missing
0 = Understood
1 = Usually understood
2 = Sometimes understood
3 = Rarely/never understood

Frequency

Percent

13
3,262
397
236
69

0.3
82.0
10.0
5.9
1.7

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-26c
CARE by MDS 2.0 self-expression/making self understood items

Missing

0=
Understood

1=
Usually

2=
Sometimes

3=
Rarely/
never

Total

Missing

+

+

+

+

+

+

1 = Rarely/never expresses self

+

+

+

41.6

2 = Frequent difficulty in self expression

+

27.9

32.8

3 = Some difficulty in self expression

+

58.7

0.4

94*

4.5

+

+

CARE: Expression of ideas and wants

4 = No difficulty in self expression
8 = Unable to assess

+

28*

40.3*

77

4.9

265

12.2

+

583

1

+

3,015

34*

41.4

48.3
+

9 = Unknown

+

+

+

+

Total

13

3,262

397

236

69

29
+
3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Summary Results
•

As indicated by cells marked with an asterisk in Table 14-26c, there is a high degree
of agreement between the CARE and MDS 2.0 items at the level of No Difficulty of
Self-Expression and Making Self Understood.

•

Among those with no difficulty in self-expression reported in CARE, 94.0 percent
also indicated in MDS 2.0 that they were understood.

•

Among those who were reported as having some difficulty in self-expression on the
CARE Item Set, 58.7 percent were coded as being understood on MDS 2.0. Among
those who were reported as rarely/never expressing on the CARE Item Set,
approximately 42 percent were rarely/never understood on the MDS 2.0 and another
40 percent were sometimes understood on the MDS 2.0. These discrepancies may be
due to the longer MDS 2.0 assessment period. The CARE Item would have assessed
the patient at a higher acuity level, right after admission.

D. Functional Status: Usual Performance
1. The functional status section of the CARE Item Set is comprised of three major
sections: Core Self Care (Section A); Core Functional Mobility (Section B); and
Supplemental Functional Ability (Section C). The results below are organized by
these three CARE sections. While, in general, the functional items on the CARE
Item Set and the MDS 2.0 have some similarities, there are several key ways that the
functional items differ. There are differences in the CARE and MDS 2.0 functional
assessment time frames: CARE uses 2 calendar days (if admitted before 12 noon) or 3
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calendar days (for patients admitted after 12 noon). The MDS 2.0 uses a 7-day lookback period.
2. The functional rating scales differ between the two assessment instruments:
a) The direction of the rating scale is different (e.g., MDS 2.0 rates independent as
zero and higher scores indicate more dependence; CARE rates independent as six,
and lower scores indicate more dependence).
i. the number of levels within each rating scale; and
ii. MDS 2.0 has two rating scales (ADL Support Provided and ADL SelfPerformance) and the CARE Item Set has one rating scale.
b) The CARE rating scale assesses the patient’s usual performance while MDS 2.0
ADL Support Provided rating scale assesses the patient’s worst performance and
the ADL Self-Performance assesses the patient’s usual performance. Similarities
and differences between the CARE Item Set functional rating scale and the MDS
2.0 functional rating scales are discussed in detail below.
Functional Status Rating Scales
•

One CARE functional rating scale versus two MDS 2.0 functional rating scales:
–

The CARE Functional Status rating scale (six-item rating scale)


The MDS 2.0 uses two rating scales to assess functional status:
o
o

ADL Self-Performance (five-level rating scale) PLUS
ADL Support Provided (four-level rating scale)

–

In order to map functional item scores between these two assessments, the data
are moderated by the MDS 2.0 ADL Support Provided rating scale’s level, prior
to comparing individual assessment item data. This is shown in more detail in
Table 14-27 below.

–

CARE functional status rating scale vs. MDS 2.0 ADL Self-Performance
scale: The CARE functional rating scale has six levels, ranging from one through
six, while the MDS 2.0 ADL Self-Performance scale includes five levels, ranging
from zero to four.


The CARE rating scale is an independence scale and the MDS 2.0 rating
scales are dependence scales. Therefore, the scoring scales are reversed, and a
patient who is independent is scored as a six on the CARE rating scale;
whereas the same patient is scored as a zero on the MDS 2.0 instrument.



Both the CARE and the MDS 2.0 ADL Self-Performance scales assess for
usual performance. However, the MDS 2.0 captures frequency of
performance within the functional rating scale category. For example, the
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MDS 2.0 supervision level definition includes that the supervision occurred
three or more times during the last 7 days, whereas CARE Item Set assesses
based on whether the supervision required was the patient’s usual
performance.
o Scale-level definitions differ between the two instruments. Specifically,
the CARE rating scale discriminates between a level 3–Partial/Moderate
Assistance) and a level 2–Substantial/Maximal Assistance) by assessing
whether the helper did more than half the effort. On the MDS 2.0, the
level of assistance between level 2–Limited Assistance and level 3–
Extensive Assistance is determined by assessing (1) whether the helper
provided non-weight-bearing support or weight-bearing support, (2) if full
staff support was needed, and (3) the number of times assistance was
needed during the assessment period.
CARE Functional Status Rating Scale vs. MDS 2.0 ADL Support Provided Scale
•

As previously stated, the CARE Functional Status rating scale contains a 6-level
rating scale ranging from six through zero and includes assistance provided to
perform the activity.

•

The MDS 2.0 uses two rating scales to assess functional status: ADL SelfPerformance (five-level rating scale) plus ADL Support Provided (four-level rating
scale).
–

The MDS 2.0 ADL Support Provided rating scale is a four-level scale ranging
from zero (no support) to three (two+ person physical assist).

–

0 – No Setup or Physical Help

–

1 – Setup Help Only

–

2 – One Person Physical Assist

–

3 – Two+ Person Physical Assist

–

8 – Activity did not occur

•

Here again, the scale order between the CARE rating scale and the MDS 2.0 is
reversed. For example, the CARE rating scale assesses a patient who is independent
in his/her performance on a task as patient code six; the MDS 2.0 ADL Support
Provided scale assesses this same patient using the code zero.

•

The CARE item scores reflect the patient’s usual performance, whereas the MDS 2.0
ADL Support Provided scale assesses the highest level of support provided or, stated
differently, the patient’s worst performance over the last 7 days.
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•

Mapping items between the CARE rating scale and MDS 2.0 is best accomplished
through noting differences between the instruments, while accounting for differences
as each activity and rating scale data are presented.
For example, the CARE functional item scale level 5 (i.e., setup or clean-up
assistance) maps relatively closely to the MDS 2.0 ADL Support Provided item scale
level 1 (i.e., setup help only). However, clear mapping of the remaining item scale
levels are more ambiguous: level 2 (indicating one person is needed for physical
assistance) or level 3 (indicating two or more persons provide physical assistance).

Differences between the instruments (e.g., the assessment time frame window and the
rating scales) are important considerations in interpreting the mapping results. A close mapping
is possible if differences between the instruments are accounted for as each item rating scale
level is mapped. Toward this end, the expected overlap between the two instruments’ functional
item categories is marked with an asterisk in the table results presented below.
Mapping or Comparing the Instruments’ Rating Scales
As previously noted, the Physical Functioning (MDS 2.0) and Functional Status (CARE)
use different rating scales to assess each instrument’s ADLs (e.g., toileting). These rating scales
are used in the data analyses to compare the MDS 2.0’s two rating scales with the single CARE
Item Set’s rating scale and present a very complex set of challenges when presenting each
instruments “activities” (e.g., toileting, eating) for comparison. To address this challenge, the
reader will note that many cross-tabulation tables compare data for specific MDS 2.0 and CARE
activities (e.g., toileting) while “controlling for” (holding constant) the MDS 2.0’s rating scale
called “ADL Support Provided.” Each of tables that control for ADL Support Provided will
specify which of the four levels from this MDS 2.0 rating scale is being held constant for the
data analysis. Within the table titles, the “activity” is followed by the ADL Support Provided
level of the group of assessments that will be mapped using the CARE rating scale vs. the MDS
2.0 Self-Performance rating scale.
For example, Table 14-28d(2) is titled “Controlling for MDS 2.0 eating ADL support
provided = 1 (setup only): CARE eating by MDS 2.0 eating ADL self-performance.” This table
compares the activity of eating and looks only at patients who were reported as needing 1–Setup
Only according to the MDS 2.0 rating scale definition for ADL Support Provided. Next, these
patients’ assessments were compared to the single CARE rating scale and the MDS 2.0 rating
scale of ADL Self-Performance. When these two scales were compared, a percentage of
agreement is marked on the table. This method of analysis (mapping or cross-tabulation)
allowed the MDS 2.0’s rating scale ADL Self-Performance to be compared with the CARE’s
single rating scale while still accounting for the MDS 2.0’s second rating scale called “ADL
Support Provided.” The CARE rating scale addresses the patient’s self-performance and support
provided within its single rating scale.
Table 14-27 is the first-level mapping between the CARE Item Set functional status
rating scale levels and the MDS 2.0 ADL Self-Performance rating scale levels, controlling for
MDS 2.0 ADL Support Provided rating scale levels. This table provides a visual of how the
functional status rating scales are aligned between the two instruments. Cross-tabulation
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functional rating scale results between the CARE rating scale and the MDS 2.0 are presented in
the table row series 14-27-E(1) through 14-27-E(5). Here, the MDS 2.0 ADL support level is the
“control” item used to maximize alignment between the two instruments. Expected areas of
agreement in the tables are marked with an asterisk.
Table 14-27
CARE scale levels mapped to MDS 2.0 ADL self-performance scale levels, controlling for
MDS 2.0 ADL support provided scale levels
Table
series

MDS 2.0 ADL
support provided
level

Plus

CARE level

Equals

MDS 2.0 ADL selfperformance level

#E(1)

0 – No setup or
physical help

+

6 – Independent

=

0 – Independent

#E(2)

1 – Setup help only

+

5 – Setup or clean-up

=

0 – Independent

#E(2)

1 – Setup help only

+

5 – Setup or clean-up

=

1 – Supervision

#E(2)

1 – Setup help only

+

4 – Supervision/touching
assistance

=

1 – Supervision

#E(3)

2 – One person
physical assist

+

4 – Supervision/touching
assistance

=

1 – Supervision

+

4 – Supervision/touching
assistance
OR
3 – Partial/moderate
assistance

=

2 – Limited assistance

=

3 – Extensive assistance

=

4 – Total dependence

#E(3)

2 – One person
physical assist

#E(3)

2 – One person
physical assist

+

3 – Partial/moderate
assistance
OR
2 – Substantial/maximal
assistance
OR
1 – Dependent

#E(3)

2 – One person
physical assist

+

1 – Dependent

#E(4)

#E(5)

3 – Two+ person
physical assist

+

1 – Dependent

=

2 – Limited assistance
OR
3 – Extensive assistance
OR
4 – Total dependence

8 – Activity did not
occur

+

Letter code – activity not
attempted

=

8 – Activity did not occur
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Below we recap the differences between the functional status rating scale definitions for
each assessment instrument:
CARE Scale
Activities may be completed with or without assistive devices.
6.

Independent. Patient completes the activity by him/herself with no assistance from
a helper.

5.

Setup or clean-up assistance. Helper SETS UP or CLEANS UP; patient completes
activity. Helper assists only prior to or following the activity.

4.

Supervision or touching assistance. Helper provides VERBAL CUES or
TOUCHING/STEADYING assistance as patient completes activity. Assistance may
be provided throughout the activity or intermittently.

3.

Partial/moderate assistance. Helper does LESS THAN HALF the effort. Helper
lifts, holds, or supports trunk or limbs, but provides less than half the effort.

2.

Substantial/maximal assistance. Helper does MORE THAN HALF the effort.
Helper lifts or holds trunk or limbs and provides more than half the effort.

1.

Dependent. Helper does ALL of the effort. Patient does none of the effort to
complete the task.

If activity was not attempted code:
M. Not attempted due to medical condition
S.

Not attempted due to safety concerns

A. Tasks attempted but not completed
N. Not applicable
P.

Patient refused

MDS 2.0 ADL self-performance functional scale
0.

Independent. No help or oversight—OR—Help/oversight provided only one or two
times during last 7 days.

1.

Supervision. Oversight, encouragement, or cueing provided three or more times
during last 7 days—OR—Supervision (three or more times) plus physical assistance
provided only one or two times during last 7 days.
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2.

Limited assistance. Resident highly involved in activity; received physical help in
guided maneuvering of limbs or other nonweight bearing assistance three or more
times—OR—More help provided only one or two times during last 7 days.

3.

Extensive assistance. While resident performed part of activity, over last 7-day
period, help of following type(s) provided three or more times:
− Weight-bearing support
− Full staff performance during part (but not all) of last 7 days

4.

Total dependence. Full staff performance of activity during entire 7 days.

8.

Activity did not occur—during entire 7 days.

MDS 2.0 ADL support provided functional scale
Rating is reported at the resident’s most dependent level, even if the amount of assistance
occurs only once during the last 7 days.
0.

No setup or physical help from staff.

1.

Setup help only.

2.

One person physical assist.

3.

Two+ person physical assist.

8.

Activity did not occur—during entire 7 days.

Core Self Care – Usual Performance
CARE Item: Eating (A1) vs. MDS 2.0 ADL Self-Performance Item: Eating (G1Ah)
The Functional Status section of the CARE Item Set assesses a patient’s usual
performance regarding Eating during the 2-day admission assessment period. The MDS 2.0 also
assesses Eating, but codes for the patient’s self-performance over all shifts during the last 7 days.
We compare this item between the two instruments by first reporting frequency statistics by
CARE Item Set and MDS 2.0 ADL Self-Performance (Tables 14-28a and 14-28b), followed by a
cross-tabulation of the two items, with respect to the MDS 2.0 ADL Support item
(Table 14-28c). The definitions from the CARE and MDS 2.0 are also included below for easy
reference.
CARE Definition:
A1. Eating: The ability to use suitable utensils to bring food to the mouth and swallow food
once the meal is presented on a table/tray. Includes modified food consistency.
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MDS 2.0 Definition:
G1(A)h. Eating: How the resident eats and drinks, regardless of skill. Do not include
eating/drinking during medication pass. Includes intake of nourishment by other means (e.g.,
tube feeding, total parenteral nutrition). Measures what the resident actually did (not what he or
she might be capable of doing) within each ADL category over the last 7 days according to a
performance-based scale. The intent is to record the resident’s self-care performance in ADLs
(i.e., what the resident actually did for himself or herself and/or how much verbal or physical
help was required by staff members) during the last 7 days.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The MDS 2.0 eating item includes intake of nourishment by tube
feeding and total parenteral nutrition, whereas the CARE item does not. Tube
feeding is assessed separately from eating in the CARE Item Set.

•

Scales: As described previously, there are differences between the CARE and MDS
2.0 ADL Self-Performance rating scales in terms of (1) direction, (2) number of
categories, and (3) MDS 2.0 using two rating scales to capture functional status while
the CARE rating scale captures both the self-performance and assistance provided in
one rating scale.

Implications
•

The CARE and MDS 2.0 item scores may differ slightly due to differences in the
assessment time frame. For example, the function level on the MDS 2.0 may be
higher than that reported on the CARE, because the MDS 2.0 assessment captures
activity within the last 7 days, allowing for improvement beyond the 2-day
assessment period in the CARE Item Set.

•

Additionally, the definition differences may result in item categories between the
CARE and MDS 2.0 assessments not cleanly mapping. For example, a patient who is
independent on tube feeding management but is eating with setup assistance may be
coded as more dependent on the MDS 2.0 because the MDS 2.0 item includes tube
feeding while the CARE Item Set does not.

Item frequencies by instrument are shown in Tables 14-28a and 14-28b, followed by the
cross-tabulation of the CARE and MDS 2.0 ADL Self-Performance items in Table 14-28c.
Tables 14-28d(1) through 14-28d(5) show the cross-tabulation of the CARE and MDS 2.0 ADL
Self-Performance items, controlling for different levels of MDS 2.0 ADL Support Provided.
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Table 14-28a
CARE admission eating
CARE: Eating

Frequency

Percent

+
122
136
223
336
1,732
1,325
+
20
63
+
11

+
3.1
3.4
5.6
8.5
43.6
33.3
+
0.5
1.6
+
0.3

Missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns
+ Cells based on a sample size of n < 11 are not shown.

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-28b
MDS 2.0 admission eating ADL self-performance 7-day assessment period
MDS: Eating self-performance

Frequency

Percent

0 = Independent

2,361

59.4

1 = Supervision

809

20.3

2 = Limited assistance

331

8.3

3 = Extensive assistance

280

7.0

4 = Total dependence

191

4.8

8 = Activity did not occur

+

+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-28c
CARE admission eating by MDS 2.0 admission eating self-performance

CARE: Eating

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

8 = Activity
did not
occur

Total

+

+

+

Missing

+

+

+

+

1 = Dependent

+

+

+

28.7

52.5*

+

122

2 = Substantial assist.

10.3

12.5

11

46.3*

19.9

+

136

3 = Partial assist.

22.9

22

23.3*

26

5.8

+

223

4 = Supervision

33.3

36*

14.3

11.6

4.8

+

336

5 = Setup assist.

67.4*

21.6

7.8

2.8

+

+

1,732

6 = Independent

74.7*

17.8

5.3

1.7

+

+

1,325

+

+

14

57

+

100

809

331

280

191

+

3,977

L = Letter code
Total

14
2,361

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-28d(1)
Controlling for MDS 2.0 eating ADL support provided = 0 (no setup or physical help):
CARE eating by MDS 2.0 eating ADL self-performance

CARE: Eating

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

8 = Activity
did not
occur

Total

Missing

+

+

+

+

+

+

+

1 = Dependent

+

+

+

+

+

+

+

2 = Substantial assist.

+

+

+

+

+

+

+

3 = Partial assist.

+

+

+

+

+

+

+

4 = Supervision

+

+

+

+

+

+

13

5 = Setup assist.

85.9

+

+

+

+

+

64

6 = Independent

89.8*

10.2

—

—

—

—

127

27

—

—

—

—

214

Total

187

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009
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Table 14-28d(2)
Controlling for MDS 2.0 eating ADL support provided = 1 (setup only): CARE eating by
MDS 2.0 eating ADL self-performance

Eating

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

8=
Activity
did not
occur

Total

Missing

+

+

+

+

+

+

+

1 = Dependent

+

+

+

+

+

+

12

2 = Substantial assist.

+

58.3

+

+

+

+

24

3 = Partial assist.

54.7

45.3

—

—

—

—

86

4 = Supervision

48.7

50.8*

+

+

+

+

187

5 = Setup assist.

76.8*

22.8*

+

+

+

+

1,408

6 = Independent

79.9

19.4

+

+

+

+

1,059

L = Letter code

76.5

+

+

+

+

+

17

2,098

683

11

+

+

+

2,795

Total

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-28d(3)
Controlling for MDS 2.0 eating ADL support provided = 2 (one person physical assist):
CARE eating by MDS 2.0 eating ADL self-performance

CARE: Eating

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

Total

+

105

1 = Dependent

+

+

+

33.3*

2 = Substantial assist.

+

+

13.9

56.5*

24.1

+

108

3 = Partial assist.

+

+

38.6*

43.2*

+

+

132

4 = Supervision

+

17.2*

35.8*

28.4

11.2

+

134

5 = Setup assist.

11.5

16.9

50.4

18.1

+

+

260

6 = Independent

21.7

13

45.7

15.2

+

+

138

L = Letter code

+

+

+

17.9

73.1

+

78

Total

75

99

319

273

189

—

955

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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61*

8=
Activity
did not
occur

The cross-tabulation results above indicate a relatively good agreement between the items
when the two assessment instruments are compared. More than half of the assessment pairs are
in alignment when the CARE Item Set Setup and Assist category or Independent is included with
the MDS 2.0 Independent category (as there is no other logical mapping).
The following tables illustrate the closest mapping of the functional item scale between
CARE and MDS 2.0. The mapping incorporates the two MDS 2.0 functional items (i.e., SelfPerformance and Support) matching them to the one CARE functional scale (i.e., controlling for
the MDS 2.0 Support scale in a cross-tabular presentation). The cells marked with an asterisk
indicate expected areas of functional item/scale agreement between the matched CARE–MDS
2.0 assessments.
Summary Results
•

Cell sizes for ADL Support Provided = 3 (two+ person physical assist) and ADL
Support Provided = 8 (activity did not occur) were all smaller than 11, so results are
not reported here.

•

An examination of Tables 14-28d(1-5) illustrates that approximately 50 percent to
99 percent of the paired CARE–MDS 2.0 assessments map as expected in terms of
the functional item scale categories when the MDS 2.0 ADL Support item is
considered. The highest percent agreement (approximately 99 percent) occurs when
the independent level is considered, mapping the independent and setup/clean-up
categories in CARE to the independent category in MDS 2.0 (see Table 14-28d(2)).

•

As we move through the tables, lower agreement percentages are observed. For
example, the lowest percent agreement (approximately 51 percent of 187 paired
assessments) is observed when the supervision category is considered (see
Table 14-28d(2)). However, the best mapping is understood if the CARE functional
item category is observed over multiple tables. For example, the best mapping of the
“supervision” functional category between the two instruments not only accounts for
the 51 percent in Table 14-28d(2) (controlling for MDS 2.0 Setup help support) but
also includes the supervision matches controlling for MDS 2.0 one person assistance
support (Table 14-28d(3); 17 percent of 134 paired assessments). This consideration
to mapping functional item levels across tables (i.e., while controlling for MDS 2.0
ADL Support) strengthens the already robust functional item category match between
instruments.

•

While there are a number of paired assessments where the functional item scale does
not align (e.g., CARE reports 1, dependent; MDS 2.0 reports 0, independent; see
Table 14-28d(2)) it is usually the case that the number of paired assessments in these
instances is small (e.g., 66 percent of 12 paired assessments; Table 14-28d(2)).

•

Further investigation is warranted regarding investigating those paired assessments
demonstrating agreement in unexpected cells (e.g., CARE functional items coded as
partial assistance, substantial assistance and dependence matched to MDS 2.0 ADL
independent with ADL setup support; see Table 14-28d(2)). However, again it is
173

noted that the number of cases is small (less than 70 out of 2,795 paired assessments
in this example).
CARE Item: Tube Feeding (A2) vs. MDS 2.0 ADL Self-Performance Item: Eating (G1Ah)
The Functional Status section of the CARE Item Set assesses a patient’s most usual
performance with Tube Feeding during the 2-day admission assessment window. The MDS 2.0
also assesses Tube Feeding as part of the Eating item, but codes for the patient’s selfperformance over all shifts during the last 7 days. This comparison first reports basic statistics
on the CARE and MDS 2.0 ADL Self-Performance items, followed by a cross-tabulation of
these two variables, modified by the MDS 2.0 ADL Support item. The definitions from the
CARE and MDS 2.0 are included below.
CARE Definition:
A2. Tube Feeding: The ability to manage all equipment/supplies related to obtaining nutrition.
MDS 2.0 Definition:
G1(A)h. Eating: How resident eats and drinks (regardless of skill). Includes intake of
nourishment by other means (e.g., tube feeding, total parenteral nutrition).
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The MDS 2.0 item includes both tube feeding and regular eating
function, whereas the CARE item focuses strictly on tube feeding. In the CARE Item
Set, tube feeding is assessed separately from eating.

•

Scales: As discussed previously, there are significant differences between the single
CARE and the two MDS 2.0 rating scales.

Implications
•

The CARE and MDS 2.0 assessment data may be different due to differences in the
assessment time frame windows. The function level on the MDS 2.0 may be higher
than that reported on the CARE because the MDS 2.0 assessment may be occurring
up to 7 days later than the CARE assessment.

•

Additionally, the differing definitions may also generate score differences. For
example, a patient who manages tube feeding, but cannot eat may be scored as more
dependent on the MDS 2.0 because that item includes eating while the CARE does
not.

The overall frequencies for these items are shown in Tables 14-29a and 14-29b, followed
by the cross-tabulation of the CARE and MDS 2.0 ADL Self-Performance items in
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Table 14-29c. Tables 14-29d(1) through 14-29d(5) show the cross-tabulation of the CARE and
MDS 2.0 ADL Self-Performance items, controlling for different levels of MDS 2.0 ADL Support
Provided.
The cross-tabulation results above indicate a high degree of agreement between the two
CARE and MDS 2.0 items for patients coded as dependent on the CARE Item Set. Among the
CARE Dependent responses, 68.8 percent map to Total Dependence in the MDS 2.0. Due to the
relatively small cell sizes at the other levels, it is not possible to truly judge agreement of
responses.
Table 14-29a
CARE admission tube feeding
CARE: Tube feeding
Missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency

Percent

+
125
+
+
+
+
+
15
+
3,800
+
+

+
3.1
+
+
+
+
+
0.4
+
95.6
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-29b
MDS 2.0 admission eating ADL self-performance 7-day assessment period
MDS: Eating

Frequency

Percent

0 = Independent

2,361

59.4

1 = Supervision

809

20.3

2 = Limited assistance

331

8.3

3 = Extensive assistance

280

7.0

4 = Total dependence

191

4.8

+

+

8 = Activity did not occur

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009
Table 14-29c
CARE tube feeding by MDS 2.0 eating ADL self-performance

CARE: Eating

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

8 = Activity
did not
occur

Total

+

+

+

+

68.8*

+

125

Missing

+

+

+

1 = Dependent

+

+

+

2 = Substantial assist.

+

+

+

+

+

+

+

3 = Partial assist.

+

+

+

+

+

+

+

4 = Supervision

+

+

+

+

+

+

+

5 = Setup assist.

+

+

+

+

+

+

+

6 = Independent

+

+

+

+

+

+

+

L = Letter code
Total

16

61

21

8.5

6.6

2.7

+

3,826

2,361

809

331

280

191

+

3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Tables 14-29d(1-3) illustrate the closest mapping of the functional item scale between
CARE and MDS 2.0. The mapping incorporates the two MDS 2.0 functional items (i.e., SelfPerformance and Support) matching them to the one CARE functional item (i.e., controlling for
the MDS 2.0 Support item in a cross-tabular presentation). The cells marked with an asterisk
indicate expected areas of functional item/scale agreement between the matched CARE–MDS
2.0 assessments.
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Table 14-29d(1)
Controlling for MDS 2.0 eating ADL support provided = 0 (no setup or physical help):
CARE tube feeding by MDS 2.0 eating ADL self-performance

CARE: Eating

0=
1=
2 = Limited
Independent Supervision assistance

Missing

+

3=
Extensive
assistance

4 = Total
dependence

8 = Activity
did not
occur

Total

+

+

+

+

+

+

L = Letter code

87.3

12.7

—

—

—

—

213

Total

187

27

—

—

—

—

214

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-29d(2)
Controlling for MDS 2.0 eating ADL support provided = 1 (setup help only): CARE tube
feeding by MDS 2.0 eating ADL self-performance

CARE: Eating

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

8 = Activity
did not
occur

Total
+

Missing

+

+

+

+

+

+

1 = Dependent

+

+

+

+

+

+

2 = Substantial assist.

+

+

+

+

+

+

+

3 = Partial assist.

+

+

+

+

+

+

+

5 = Setup assist.

+

+

+

+

+

+

+

6 = Independent

+

+

+

+

+

+

+

L = Letter code

75

24.5

0.4

+

+

—

2,764

2,098

683

11

+

+

—

2,795

Total

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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13

Table 14-29d(3)
Controlling for MDS 2.0 eating ADL support provided = 2 (one person physical assist):
CARE tube feeding by MDS 2.0 eating ADL self-performance

CARE: Eating

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

8 = Activity
did not
occur

Total

1 = Dependent

+

+

+

18*

76.6*

+

111

2 = Substantial assist.

+

+

+

+

+

+

+

3 = Partial assist.

+

+

+

+

+

+

+

4 = Supervision
touching assist.

+

+

+

+

+

+

+

5 = Setup assist.

+

+

+

+

+

+

+

L = Letter code

8.7

11.8

37.5

29.6

12.3

—

837

Total

75

99

319

273

189

—

955

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Summary Results
•

Cell sizes for ADL Support Provided = 3 (two+ person physical assist) and ADL
Support Provided = 8 (activity did not occur) were all smaller than 11, so results are
not reported here.

•

Table 14-29d(3) demonstrates a relatively high amount of agreement between the
CARE and MDS 2.0 items. Among the 111 patients who were evaluated as
Dependent on the CARE Item Set and required a One Person Physical Assist on the
MDS 2.0, the majority of responses were seen in the expected MDS 2.0 levels
(76.6 percent in Total Dependence).

CARE Item: Toilet Hygiene (A4) vs. MDS 2.0 ADL Self-Performance Item: Toilet Use (G1Ai)
The Functional Status section of the CARE Item Set assesses a patient’s most usual
performance with Toilet Hygiene during the 2-day admission assessment window. The MDS 2.0
also assesses Toilet Hygiene as part of the Toilet Use item, but codes for the patient’s selfperformance over all shifts during the last 7 days. This comparison first reports basic statistics
on the CARE and MDS 2.0 ADL Self-Performance items, followed by a cross-tabulation of
these two variables, modified by the MDS 2.0 ADL Support item. The definitions from the
CARE and MDS 2.0 are included below.
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CARE Definition:
A4. Toilet Hygiene: The ability to maintain perineal hygiene, adjust clothes before and after
using toilet, commode, bedpan, or urinal. If managing ostomy, include wiping opening, but not
managing equipment.
MDS 2.0 Definition:
G1(A)i. Toilet Use: How patient uses the toilet room (or commode, bedpan, urinal); transfer
on/off toilet, cleanses, changes pad, manages ostomy or catheter, and adjusts clothes.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The MDS 2.0 item includes both toilet hygiene and toilet transfer
function, whereas the CARE item focuses strictly on toilet hygiene. In the CARE
Item Set, toilet transfer is assessed separately from toilet hygiene.

•

Scales: As discussed previously, there are significant differences between the single
CARE and the two MDS 2.0 rating scales.

Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment windows. The function level on the MDS 2.0 may be higher than that
reported on the CARE because the MDS 2.0 assessment may be occurring up to 7
days later than the CARE assessment.

•

Additionally, the differing definitions may also generate item differences. For
example, a patient who is able to manage toilet hygiene but not transferring may
score lower on the MDS 2.0 because that item includes transfer abilities while the
CARE does not.

The overall frequencies for these items are shown in Tables 14-30a and 14-30b, followed
by the cross-tabulation of the CARE and MDS 2.0 ADL Self-Performance items in
Table 14-30c. Tables 14-30d(1-5) show the cross-tabulation of the CARE and MDS 2.0 ADL
Self-Performance items, controlling for different levels of MDS 2.0 ADL Support Provided.
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Table 14-30a
CARE admission toilet hygiene
CARE: Toilet hygiene

Missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency

Percent

+
472
864
1,185
833
364
224
+
13
+
+
+

+
11.9
21.7
29.8
21.0
9.2
5.6
+
0.3
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-30b
MDS 2.0 admission toilet use ADL self-performance 7-day assessment period
MDS: Toilet use

0 = Independent
1 = Supervision
2 = Limited assistance
3 = Extensive assistance
4 = Total dependence
8 = Activity did not occur

Frequency

Percent

153
261
1,044
2,137
380
+

3.9
6.6
26.3
53.7
9.6
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-30c
CARE toilet hygiene by MDS 2.0 toilet use ADL self-performance
0=
1=
2 = Limited
CARE: Toilet hygiene Independent Supervision assistance
Missing

+

+

1 = Dependent

+

+

2 = Substantial assist.

+

3 = Partial assist.

+

3=
Extensive
assistance

4 = Total
dependence

8 = Activity
did not
occur

Total

+

+

+

+

3

51.5

44.9*

+

472

1.3

12

74.3*

11.8

+

864

2.4

6.2

27.1*

60.4

3.9

+

1,185

4 = Supervision

4.6

10.6*

41.1

43.1

+

+

833

5 = Setup assist.

9.1

12.1

48.4

29.1

+

+

364

6 = Independent

21*

19.2

37.5

21.4

+

+

224

+

65.6

+

+

32

1,044

2,137

380

+

3,977

L = Letter code

+

+

Total

153

261

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

The cross-tabulation results above indicate a high degree of agreement between the two
CARE and MDS 2.0 items. With respect to simple CARE–MDS 2.0 ADL Self-Performance
cross-tabulation results, Table 14-30c shows strong agreement between CARE level 2
(Substantial Assistance) and MDS 2.0 level 3 (Extensive Assistance). Among the CARE
Substantial Assistance responses, 74.3 percent map to Extensive Assistance in the MDS 2.0 and
12.0 percent map to Limited Assistance. Similarly, among the CARE Dependent responses in
this table, 44.9 percent map to the Total Dependence level in the MDS 2.0. Agreement among
the remaining levels does not exceed 30 percent, but this may be the result of differing item
definitions or the MDS 2.0 Support Provided variable, which is not considered in Table 14-30c.
The following tables illustrate the closest mapping of the functional item scale between
CARE and MDS 2.0. The mapping incorporates the two MDS 2.0 functional items (i.e., SelfPerformance and Support), matching them to the one CARE functional item (i.e., controlling for
the MDS 2.0 Support item in a cross-tabular presentation). The cells marked with an asterisk
indicate expected areas of functional item/scale agreement between the matched CARE–MDS
2.0 assessments.
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Table 14-30d(1)
Controlling for MDS 2.0 toilet hygiene ADL support provided = 0 (no setup or physical
help): CARE toilet hygiene by MDS 2.0 toilet use ADL self-performance
CARE: Toilet
hygiene

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

8 = Activity
did not
Total
occur

1 = Dependent

+

+

+

+

+

+

+

2 = Substantial assist.

+

+

+

+

+

+

+

3 = Partial assist.

81.3

+

+

+

+

+

16

4 = Supervision touching
assist.

68.2

+

+

+

+

+

22

5 = Setup assist.

78.3

+

+

+

+

+

23

6 = Independent

89.7*

+

+

+

+

+

29

75

18

—

—

—

—

93

Total

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-30d(2)
Controlling for MDS 2.0 toilet hygiene ADL support provided = 1 (setup help only): CARE
toilet hygiene by MDS 2.0 toilet use ADL self-performance

CARE: Toilet
hygiene
Missing
2 = Substantial assist.
3 = Partial assist.
4 = Supervision touching
assist.
5 = Setup assist.
6 = Independent
Total

0=
1=
2 = Limited
Independent Supervision assistance
+
+
+
25.8
28.2*
43.8
51

+
+
77.1

3=
Extensive
assistance

8=
Activity
4 = Total did not
dependence occur

Total

+
+
+

+
+
+

+
+
+

+
+
+

+
+
35

71*

+

+

+

+

62

71.8*
56.3
122

+
+
+

+
+
+

+
+
+

+
+
+

39
32
176

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-30d(3)
Controlling for MDS 2.0 toilet hygiene ADL support provided = 2 (one person physical
assist): CARE toilet hygiene by MDS 2.0 toilet use ADL self-performance

CARE: Toilet
hygiene
Missing
1 = Dependent
2 = Substantial assist.
3 = Partial assist.
4 = Supervision touching
assist.
5 = Setup assist.
6 = Independent
L = Letter code
Total

0=
1=
2 = Limited
Independent Supervision assistance
+
+
+
—
—
5.6
+
+
18.3
+
5
35.9*
+

5.5*

+
+
+
27

3.9
14.1
+
121

3=
Extensive
assistance
+
38.4*
65.6*
53.2*

49.1*

43.8

61.7
53.8
+
1,014

31.6
26.3
62.5
1,344

8=
Activity
4 = Total did not
dependence occur
+
+
56*
+
14.8
+
5
+

Total
+
250
520
873

+

+

676

+
+
+
277

+
+
+
+

282
156
24
2,783

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-30d(4)
Controlling for MDS 2.0 toilet use ADL support provided = 3 (two+ person physical assist):
CARE toilet hygiene by MDS 2.0 toilet use ADL self-performance
CARE: Toilet
hygiene
1 = Dependent
2 = Substantial assist.
3 = Partial assist.
4 = Supervision
touching assist.
5 = Setup assist.
6 = Independent
L = Letter code
Total

0=
1=
2 = Limited
Independent Supervision assistance
+
+
+
+
+
+
+
+
+

3=
Extensive
assistance
67.1*
89.9
96.6

8=
4 = Total Activity did
dependence not occur
32.9*
+
7.5
+
+
+

Total
219
335
261

+

+

+

84.9

+

+

73

+
+
+
+

+
+
+
+

+
+
+
28

85
+
+
792

+
+
+
103

+
+
+
+

20
+
+
923

*Expected areas of agreement are marked with an asterisk.
+ Cells with a value of n < 11 or an equivalent percentage are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Summary Results
•

Cell sizes for ADL Support Provided = 3 (two+ person physical assist) and ADL
Support Provided = 8 (activity did not occur) were all smaller than 11 so results are
not reported here.
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•

Tables 14-30d(1-4) generally show a high amount of agreement between the CARE
Toilet Hygiene item and MDS 2.0 Toilet Use ADL Self-Performance item when
MDS 2.0 Support Level is controlled.

•

In Table 14-30d(2), the majority of responses in the CARE Supervision or Setup
categories fell into the expected MDS 2.0 Self-Performance levels when Setup Help
Only is indicated in the MDS 2.0 Support level variable.

•

For example, Table 14-30d(3) demonstrates a relatively high degree of agreement
between the CARE and MDS 2.0 items. Among the 873 patients who were evaluated
as needing Partial Assistance on the CARE Item Set and required a One Person
Physical Assist on the MDS 2.0, the majority of responses were seen in the expected
MDS 2.0 levels (35.9 percent in Limited Assistance and 53.2 percent in Extensive
Assistance). Similarly, CARE response level 2 (Substantial Assistance) maps well to
MDS 2.0 Self-Performance level 3 (Extensive Assistance), showing 65.6 percent
agreement.

•

Although clinicians were instructed that any patient who required a Two+ Person
Physical Assist in the MDS 2.0 should be scored as Dependent in CARE regardless of
MDS 2.0 Self-Performance level, Table 14-30d(4) indicates that this may not have
occurred. Also, discrepancies showing more dependence on the MDS 2.0 might also
be the result of differing assessment time frames and item definitions.
–

For example, an unexpectedly high number of patients received CARE rating
scales: 3–Partial/Moderate Assistance and 2–Substantial/Maximal Assistance
when receiving a MDS 2.0 Extensive Assistance rating. This may have been due
to the MDS 2.0 rule for Self-Performance rating of Extensive Assistance and
Limited Assistance. In this case, the patient may have required weight-bearing
assistance more than three times during the task of toilet transfer within the MDS
2.0 item of “toilet use.” Patients requiring weight-bearing support three times or
more during the any of the tasks within the MDS 2.0 Toilet Use item would have
received the Extensive Assistance rating; and any patient requiring guided
maneuvering of limbs or other non-weight-bearing assistance three or more times
or one or two times of weight-bearing assistance, would have been rated as
requiring Limited Assistance. The CARE Toilet Hygiene item does not include
assessing the patient’s toilet transfer ability, while the MDS 2.0 item Toilet Use
includes this task. Also, the MDS 2.0’s 7-day assessment period would have
increased the likelihood of the patient requiring weight-bearing assistance three or
more times during the more dependent nighttime hours as compared to the less
frequent need for assistance during the CARE assessment period. CARE assesses
the usual performance of the patient and in this item toilet transfer would have
been separate.

184

CARE Item: Lying to Sitting on Side of Bed (B1) vs. MDS 2.0 ADL Self-Performance Item:
Bed Mobility (G1Aa)
The Functional Status section of the CARE Item Set assesses a patient’s most usual
performance with Lying to Sitting on Side of Bed during the 2-day admission assessment
window. The MDS 2.0 also assesses how a patient moves to and from a lying position as part of
the Bed Mobility item, but codes for the patient’s self-performance over all shifts during the last
7 days. This comparison first reports basic statistics on the CARE and MDS 2.0 ADL SelfPerformance items, followed by a cross-tabulation of these two variables, modified by the MDS
2.0 ADL Support item. The definitions from the CARE and MDS 2.0 are included below.
CARE Definition:
B1. Lying to Sitting on Side of Bed: The ability to safely move from lying on the back to sitting
on the side of the bed with feet flat on the floor, no back support.
MDS 2.0 Definition:
G1(A)a. Bed Mobility: How patient moves to and from lying position, turns side to side, and
positions body while in bed.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The MDS 2.0 item Bed Mobility includes three different activities
(lying to sitting on the side of the bed, roll left to right, and sit to lying) that the
CARE Item Set assesses individually.

•

Scales: As discussed previously, there are significant differences between the CARE
and MDS 2.0 ADL Self-Performance scales.

Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment look-back periods. The function level on the MDS 2.0 may be higher
than that reported on the CARE because the MDS 2.0 assessment may be occurring
up to 7 days later than the first day of the CARE assessment.

•

Additionally, the differing definitions may also generate item level of difficulty
differences. For example, a patient who is able to manage lying to sitting at the side
of the bed without assistance, but requires hands-on assistance for the task of rolling
from side to side (e.g., due to a lateral hip wound) may achieve a more dependent
score on MDS 2.0 Bed Mobility. The MDS 2.0 would include all three activities
(lying to sitting on the side of the bed, roll left to right, and sit to lying) when scoring
the patient. This would result in a lower score on the MDS 2.0 Bed Mobility than on
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the CARE single task of lying to sitting. Each of the three tasks that made up the
MDS 2.0 activity are assessed and scored separately on the CARE Item Set. This
example of item definition differences may also explain in general the crosstabulation results for Table 14-31c. This would result in the patient being rated more
dependent on the MDS 2.0 Bed Mobility item when compared to the CARE lying to
sitting item that would be scored at a higher rating of independence. The overall
frequencies for these items are shown in Tables 14-31a and 14-31b, followed by the
cross-tabulation of the CARE and MDS 2.0 ADL Self-Performance items in
Table 14-31c. Tables 14-31d(1-4) show the cross-tabulation of the CARE and
MDS 2.0 ADL Self-Performance ratings, controlling for different levels of MDS 2.0
ADL Support Provided.
Table 14-31a
CARE admission lying to sitting on side of bed 2-day admission assessment period
CARE: Lie to sit
Missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency
+
224
736
1,355
981
213
404
+
38
+
+
+

Percent
+
5.6
18.5
34.1
24.7
5.4
10.2
+
1.0
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-31b
MDS 2.0 admission bed mobility ADL self-performance 7-day assessment period
MDS: Bed mobility

Frequency

Percent

+

+

0 = Independent

335

8.4

1 = Supervision

254

6.4

2 = Limited assistance

966

24.3

2,230

56.1

191

4.8

Missing

3 = Extensive assistance
4 = Total dependence

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-31c
CARE lying to sitting by MDS 2.0 bed mobility ADL self-performance

CARE: Lie to sit

Missing

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

Total

Missing

+

+

+

+

+

+

1 = Dependent

+

+

+

+

50.4

44.2*

224

2 = Substantial assist.

+

+

+

12.1

79.8*

6.4

736

3 = Partial assist.

+

5.1

3.8

25.8*

64.1

1.3

1,355

4 = Supervision
touching assist.

+

11.2

11.0*

32.2

45.1

+

981

5 = Setup assist.

+

15

15

25.8

43.7

+

213

6 = Independent

+

28.2*

13.1

35.9

22.5

+

404

L = Letter code

+

+

+

+

55.7

32.8

61

Total

+

335

254

966

2,230

191

3,977

+

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

The cross-tabulation results above indicate a fair degree of agreement between the two
CARE and MDS 2.0 items with a somewhat wide range (11.0 percent to 79.8 percent). With
respect to simple CARE–MDS 2.0 ADL Self-Performance cross-tabulation results, Table 14-31c
shows strong agreement between CARE level 2 (Substantial Assistance) and MDS 2.0 level 3
(Extensive Assistance). Among the CARE Substantial Assistance responses, 79.8 percent map
to Extensive Assistance in the MDS 2.0 and 12.1 percent map to Limited Assistance. Similarly,
among the CARE Dependent responses in this table, 44.2 percent map to the Total Dependence
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level in the MDS 2.0. Agreement among the remaining levels does not exceed 30 percent. This
is likely due to only one task (CARE item lying to sitting) of the three tasks within the MDS 2.0
Bed Mobility activity are being compared. The MDS 2.0 Bed Mobility activity is comprised of
three different activities (lying to sitting on the side of the bed, roll left to right, and sit to lying).
The difference may also be due to the use of the MDS 2.0 Support Provided scale that would
require the clinician to assess the patient’s greatest amount of support required during the 7-day
look-back period that is not considered (controlled for) in Table 14-31c.
Following is a rationale of how a more dependent ADL Support Provided rating may
have impacted the results seen in Table 14-31c.
•

CARE rating of 1–Independent was mapped to MDS 2.0, Self-Performance rating of
2–Limited Assistance 39.9 percent of the time. This may have occurred if the same
patient assessed on the CARE rating scale during the first 2- to 3-day assessment
period did not usually require supervision, setup, or any hands-on assistance. That
same patient would have been rated on the MDS 2.0 Self-Performance scale as 2–
Limited Assistance AND was either rated on the MDS 2.0 Support Provided rating
scales as 2–One Person Physical Assist, or 3–Two+ Person Physical Assist. Because
the MDS 2.0 rating scales are used over a 7-day look-back period, there may have
been more times that the patient needed intermittent assistance at the one- or twoperson level whereas the CARE’s 2- to 3-day assessment look-back period may not
have resulted in the same number (or “usual” need) of physical assistance noted for
the MDS 2.0 assessment period.

The following tables illustrate the closest mapping of the functional item scale between
CARE and MDS 2.0. The mapping incorporates the two MDS 2.0 functional items (i.e., SelfPerformance and Support), matching them to the one CARE functional item (i.e., controlling for
the MDS 2.0 Support item in a cross-tabular presentation). The cells marked with an asterisk
indicate expected areas of functional item/scale agreement between the matched CARE–MDS
2.0 assessments.
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Table 14-31d(1)
Controlling for MDS 2.0 bed mobility ADL support provided = 0 (no setup or physical
help): CARE lying to sitting by MDS 2.0 bed mobility ADL self-performance

CARE: Lie to sit

Missing

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

Total

Missing

+

+

+

+

+

+

+

1 = Dependent

+

+

+

+

+

+

+

2 = Substantial assist.

+

+

+

+

+

+

+

3 = Partial assist.

+

97.8

+

+

+

+

45

4 = Supervision
touching assist.

+

98.7

+

+

+

+

76

5 = Setup assist.

+

86.4

+

+

+

+

22

6 = Independent

+

95.4*

+

+

+

+

87

Total

+

226

+

+

+

+

235

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-31d(2)
Controlling for MDS 2.0 bed mobility ADL support provided = 1 (setup help only): CARE
lying to sitting by MDS 2.0 bed mobility ADL self-performance

CARE: Lie to sit

Missing

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

Total

1 = Dependent

+

+

+

+

+

+

+

2 = Substantial assist.

+

+

+

+

+

+

+

3 = Partial assist.

+

35.1

64.9

+

+

+

37

4 = Supervision
touching assist.

+

30.3

69.7*

+

+

+

99

5 = Setup assist.

+

35.5*

64.5*

+

+

+

31

6 = Independent

+

39.5

60.5

+

+

+

43

L = Letter code

+

+

+

+

+

+

+

Total

+

74

146

+

+

+

220

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-31d(3)
Controlling for MDS 2.0 bed mobility ADL support provided = 2 (one person physical
assist): CARE lying to sitting by MDS 2.0 bed mobility ADL self-performance

CARE: Lie to sit
Missing
1 = Dependent
2 = Substantial assist.
3 = Partial assist.
4 = Supervision
touching assist.
5 = Setup assist.
6 = Independent
L = Letter code
Total

Missing

0=
1=
2 = Limited
Independent Supervision assistance

+
+
+
+

+
+
+
1.5

+

+

+
+
+
+

+
6.4
+
35

+
+
+
3.2
6*
+
10
+
96

3=
Extensive
assistance

4 = Total
dependence

Total

+
+
26
42.5*

+
35*
66.4*
51.7*

+
55*
6.4
+

+

48.5*

44.1

+

614

43.9
59.4
+
907

46.3
24.2
+
1,028

+
+
+
71

60
327
779

123
219
14
2,137

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-31d(4)
Controlling for MDS 2.0 bed mobility ADL support provided = 3 (two+ person physical
assist): CARE lying to sitting by MDS 2.0 bed mobility ADL self-performance

CARE: Lie to sit
Missing
1 = Dependent
2 = Substantial assist.
3 = Partial assist.
4 = Supervision
touching assist.
5 = Setup assist.
6 = Independent
L = Letter code
Total

Missing

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence
+
41*
6.5
+

+
161
400
494

Total

+
+
+
+

+
+
+
+

+
+
+
+

+
1.2*
+
3.6

+
57.1*
92.5
94.1

+

+

+

9.4

89.1

+
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+
+
+
+

+
+
+
+

+
+
+
+

+
25.5
+
58

97.3
69.1
64.4
1,202

+
+
33.3
120

37
55
45
1,385

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Summary Results
•

Tables 14-31d(1-4) generally show a fair amount of agreement between the CARE
Lying to Sitting item and MDS 2.0 Bed Mobility ADL Self-Performance item when
MDS 2.0 Support Level is controlled.

•

For example, the data in Table 14-31d(3) demonstrate a relatively high amount of
agreement between the CARE and MDS 2.0 items. Among the 779 patients who
were evaluated as needing Partial Assistance on the CARE Item Set and required a
One Person Physical Assist on the MDS 2.0, the majority of responses were seen in
the expected MDS 2.0 levels (42.5 percent in Limited Assistance and 51.7 percent in
Extensive Assistance). Similarly, CARE response level 2 (Substantial Assistance)
maps well to MDS 2.0 Self-Performance level 3 (Extensive Assistance), showing
66.4 percent agreement.

•

As shown in Table 14-31d(2), the majority of responses in the CARE Supervision or
Setup categories also fall into the expected MDS 2.0 Self-Performance levels when
Setup Help only is indicated in the MDS 2.0 Support variable.

•

Although clinicians were instructed that any patient who required a Two+ Person
Physical Assist in the MDS 2.0 should be scored as Dependent in CARE regardless of
MDS 2.0 Self-Performance level, Table 14-31d(4) indicates that this may not have
occurred. However, discrepancies showing more dependence on the MDS 2.0 might
also be the result of differing item definitions and the effects of the different
assessment time frames. The item definitions in this case are the CARE item lying to
sitting being compared to the three tasks within the MDS 2.0 Bed Mobility activity
(lying to sitting on the side of the bed, roll left to right, and sit to lying). The
difference may also be due to the use of the MDS 2.0 Support Provided scale that
would require the clinician to assess the patient’s greatest amount of support required
during the 7-day look-back period.

CARE Item: Sit to Stand (B2) vs. MDS 2.0 ADL Self-Performance Item: Transfer (G1Ab)
The Functional Status section of the CARE Item Set assesses a patient’s most usual
performance with Sit to Stand during the 2-day admission assessment window. The MDS 2.0
also assesses how a patient moves to a standing position as part of the Transfer item, but codes
for the patient’s self-performance over all shifts during the last 7 days. This comparison first
reports basic statistics on the CARE and MDS 2.0 ADL Self-Performance rating scales, followed
by a cross-tabulation of these two variables, modified by the MDS 2.0 ADL 2.0 Support rating
scale. The definitions from the CARE and MDS 2.0 are included below.
CARE Definition:
B2. Sit to Stand: The ability to safely come to a standing position from sitting in a chair or on
the side of the bed.
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MDS 2.0 Definition:
G1(A)b. Transfer: How patient moves between surfaces—to/from bed, chair, wheelchair, or to
a standing position (EXCLUDE to/from bath/toilet).
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The MDS 2.0 item includes both sit to stand and to/from bed, chair
and wheelchair transfers, whereas the CARE item focuses strictly on standing from a
sitting position. In the CARE Item Set, other types of transfers are assessed
separately.

•

Scales: As discussed previously, there are significant differences between the CARE
and MDS 2.0 ADL Self-Performance scales.

Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment windows. The function level on the MDS 2.0 may be higher than that
reported on the CARE because the MDS 2.0 assessment may be occurring up to 7
days later than the CARE assessment.

•

Additionally, each instrument’s unique definitions may also generate rating scale
differences for each of the instrument’s functional activities. For example, a patient
who is able to manage sitting to standing but not other types of transfers may score
lower on the MDS 2.0 because that item includes other transfer abilities while the
CARE item focuses exclusively on the task of sitting to standing.

The overall frequencies for these items are shown in Tables 14-32a and 14-32b, followed
by the cross-tabulation of the CARE and MDS 2.0 ADL Self-Performance rating scales in
Table 14-32c. Tables 14-32d(1-5) show the cross-tabulation of the CARE and MDS 2.0 ADL
Self-Performance rating scale, controlling for different levels of the MDS 2.0 ADL Support
Provided rating scale.
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Table 14-32a
CARE admission sit to stand 2-day admission assessment period
CARE: Sit to stand

Frequency

Missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

+
211
721
1,249
1,205
184
215
12
92
52
+
29

Percent
+
5.31
18.13
31.41
30.3
4.63
5.41
0.3
2.31
1.31
+
0.73

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-32b
MDS 2.0 admission transfer ADL self-performance 7-day assessment period
MDS: Transfer

Frequency

Percent

Missing

+

+

0 = Independent

146

3.67

1 = Supervision

243

6.11

2 = Limited assistance

1,144

28.77

3 = Extensive assistance

2,162

54.36

232

5.83

49

1.23

4 = Total dependence
8 = Activity did not occur

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-32c
CARE sit to stand by MDS 2.0 transfer ADL self-performance

CARE: Sit to
stand

2=
3=
Limited Extensive 4 = Total
0=
1=
Missing Independent Supervision assistance assistance dependence
+

+

8=
Activity
did not
occur

Total

+

+

8.1

211

Missing

+

+

+

+

1 = Dependent

+

+

+

+

46.4*

41.2*

2 = Substantial
assist.

+

+

+

12.1

79.1*

6.5

+

721

3 = Partial assist.

+

1

4.2

30.3*

62.4*

1.6

+

1,249

4 = Supervision
touching assist.

+

4.1

10*

40.7

44.7

+

+

1,205

5 = Setup assist.

+

8.7

17.4

44

29.3

+

+
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6 = Independent

+

27.4*

14.9

40

17.2

+

+

215

L = Letter code

+

+

+

7.9

43.4

37

11.1
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Total

+

146

243

1,144

2,162

232

49

3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

The cross-tabulation results above (Tables 14-32a through 14-32c) indicate a relatively
high degree of agreement between the two CARE and MDS 2.0 items. With respect to simple
CARE–MDS 2.0 ADL Self-Performance cross-tabulation results, Table 14-32c shows a high
degree of agreement overall, and particularly at the more dependent ends of the functional scale.
For example, among the CARE Dependent responses, 41.2 percent map to Total Dependence in
the MDS 2.0 and 46.4 percent map to Extensive Assistance. Similarly, among the CARE
Substantial Assistance responses in this table, 79.1 percent map to the Extensive Assistance level
in the MDS 2.0. However, it is noteworthy that the CARE Supervision level responses mapped
mostly to either the MDS 2.0 Limited Assistance (40.7 percent) or Extensive Assistance
(44.7 percent) responses. This may be a result of differing item definitions or the MDS 2.0
Support Provided variable, which is not considered in Table 14-32c.
The following tables illustrate the closest mapping of the functional item scale between
CARE and MDS 2.0. The mapping incorporates the two MDS 2.0 functional status rating scales
(i.e., Self-Performance and Support), matching them to the one CARE functional status rating
scale (i.e., controlling for the MDS 2.0 Support item in a cross-tabular presentation). The cells
marked with an asterisk indicate expected areas of functional status rating scale agreement
between the matched CARE–MDS 2.0 assessments.
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Table 14-32d(1)
Controlling for MDS 2.0 transfer ADL support provided = 0 (no setup or physical help):
CARE sit to stand by MDS 2.0 transfer ADL self-performance

CARE: Sit to
stand
2 = Substantial assist.
3 = Partial assist.
4 = Supervision
touching assist.
5 = Setup assist.
6 = Independent
Total

3=
0=
1=
2 = Limited Extensive 4 = Total
Missing Independent Supervision assistance assistance dependence

8=
Activity
did not
occur

Total

+
+

+
+

+
+

+
+

+
+

+
+

+
+

+
+

+

71.4

+

+

+

+

+

35

+
+
+

+
91.8*
80

+
+

+
+
+

+
+
+

+
+
+

+
+
+

12
49
100

20

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-32d(2)
Controlling for MDS 2.0 transfer ADL support provided = 1 (setup help only): CARE sit to
stand by MDS 2.0 transfer ADL self-performance

CARE: Sit to
stand
Missing
1 = Dependent
2 = Substantial assist.
3 = Partial assist.
4 = Supervision
touching assist.
5 = Setup assist.
6 = Independent
Total

8=
Activity
3=
0=
1=
2 = Limited Extensive 4 = Total did not
Missing Independent Supervision assistance assistance dependence occur

Total

+
+
+
+

+
+
+
+

+
+
+
85.7

+
+
+
+

+
+
+
+

+
+
+
+

+
+
+
+

+
+
+
21

+

25.3

73.4*

+

+

+

+

79

+
+
+

+
+
38

81.5*
65
113

+
+
+

+
+
+

+
+
+

+
+
+

27
20
152

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-32d(3)
Controlling for MDS 2.0 transfer ADL support provided = 2 (one person physical assist):
CARE sit to stand by MDS 2.0 transfer ADL self-performance

CARE: Sit to
stand

8=
3=
Activity
0=
1=
2 = Limited Extensive 4 = Total did not
Missing Independent Supervision assistance assistance dependence occur

Total

Missing

+

+

+

+

+

+

+

1 = Dependent

+

+

+

+

44.1*

41.2*

+

34

2 = Substantial assist.

+

+

+

29.2

64.8*

+

+

253

3 = Partial assist.

+

+

4.3

43.4*

50.9*

+

+

786

4 = Supervision
touching assist.

+

+

5.7*

53.9*

39.5

+

+

866

5 = Setup assist.

+

+

+

62

30.6

+

+

121

6 = Independent

+

+

12.5

65

16.7

+

+

120

L = Letter code

+

+

+

41.4

41.4

+

Total

+

23

106

1,052

992

38

+

+

29

+

2,211

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-32d(4)
Controlling for MDS 2.0 transfer ADL support provided = 3 (two+ person physical assist):
CARE sit to stand by MDS 2.0 transfer self-performance

CARE: Sit to
stand

8=
Activity
3=
0=
1=
2 = Limited Extensive 4 = Total did not
Missing Independent Supervision assistance assistance dependence occur

1 = Dependent

+

+

+

+

52.2*

2 = Substantial assist.

+

+

+

2.8

3 = Partial assist.

+

+

+

8.8

4 = Supervision
touching assist.

+

+

+

5 = Setup assist.

+

+

6 = Independent

+

L = Letter code
Total

Total

45.9*

+

159

88.6

7.9

+

458

87.6

3.5

+

434

+

87.6

+

+

225

+

+

70.8

+

+

24

+

+

+

65.4

+

+

26

+

+

+

+

50.4

47.5

+

139

+

+

+

91

1,170

194

+

1,465

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Summary Results
•

Except for “activity did not occur” and “letter code,” which had perfect agreement,
cell sizes for ADL Support Provided = 8 (activity did not occur) were all smaller than
11, so results are not reported in a table here.

•

Tables 14-32d(1-4) generally show a fair amount of agreement between the CARE Sit
to Stand item and MDS 2.0 Transfer ADL Self-Performance item when MDS 2.0
Support Level is controlled.

•

For example, Table 14-32d(2) indicates that of the 79 patients who were evaluated as
needing Supervision on the CARE Item Set and required Setup Help Only on the
MDS 2.0, 73.4 percent were assessed as needing Supervision in Self-Performance on
the MDS 2.0.

•

Additionally, Table 14-32d(3) also demonstrates a relatively high amount of
agreement between these two items. For example, among the 1,652 patients who
were evaluated as needing either Partial Assistance or Supervision on the CARE Item
Set and required a One Person Physical Assist on the MDS 2.0, the majority of
responses were seen in the expected MDS 2.0 rating levels. Unsurprisingly, there is
also a bit of scatter outside the “predicted” area of Table 14-32d(3). Most of this
occurs below and to the right of the area marked with asterisks, indicating a more
dependent response on the MDS 2.0. This may be due to the differing item
definitions.

•

In Table 14-32d(4), the expected mapping agreement occurred between CARE 1–
Dependent and MDS 2.0 rating scores 4–Total Dependence and 3–Extensive
Assistance; however, there was greater than expected agreement between the MDS
2.0 3–Extensive Assistance scores and the CARE rating scores 6–Independent
through 2–Substantial/Maximal Assistance. This may be attributable to the MDS 2.0
rule requiring physical assistance provided three or more times to reduce the patient’s
performance value to Extensive Assistance. The difference in the assessment lookback periods could have contributed to this outcome or the multiple types of transfers
required by the MDS 2.0 Transfer item versus the CARE single item of sit to stand.
Finally, sometimes these unexpected results were produced and it is unknown if these
were due to clinician coding errors.

•

Although clinicians were instructed that any patient who required a Two+ Person
Physical Assist in the MDS 2.0 should be scored as Dependent in CARE regardless of
MDS 2.0 Self-Performance level, Table 14-32d(4) indicates that this may not have
occurred. However, discrepancies showing more dependence on the MDS 2.0 might
also be the result of differing assessment time frames and item definitions as stated
above.
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CARE Item: Chair/Bed-to-Chair Transfer (B3) vs. MDS 2.0 ADL Self-Performance Item:
Transfer (G1Ab)
The Functional Status section of the CARE Item Set assesses a patient’s most usual
performance with Chair/Bed-to-Chair Transfer during the 2-day admission assessment window.
The MDS 2.0 also assesses how a patient transfers to/from bed to chair as part of the Transfer,
but codes for the patient’s self-performance are observed over all shifts during the last part of the
7-day assessment period. This comparison first reports basic statistics on the CARE and MDS
2.0 ADL Self-Performance rating scales, followed by a cross-tabulation of these two variables,
modified by the MDS 2.0 ADL Support rating scale. The definitions from the CARE and MDS
2.0 are included below.
CARE Definition:
B3. Chair/Bed-to-Chair Transfer: The ability to safely transfer to and from a chair (or a
wheelchair). The chairs are placed at right angles to each other.
MDS 2.0 Definition:
G1(A)b. Transfer: How patient moves between surfaces—to/from bed, chair, wheelchair,
standing position (EXCLUDE to/from bath/toilet).
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The MDS 2.0 item includes both chair-to-bed transfer and other
types of transfers, whereas the CARE item focuses strictly transferring to/from bed to
chair. In the CARE Item Set, other types of transfers are assessed separately.

•

Scales: As discussed previously, there are significant differences between the CARE
and MDS 2.0 ADL Self-Performance scales.

Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment windows. The function level on the MDS 2.0 may be higher than that
reported on the CARE because the MDS 2.0 assessment may be occurring up to 7
days later than the CARE assessment (if completed on day 1).

•

Additionally, the differing definitions may also generate item differences. For
example, a patient who is able to manage chair-to-bed transfers but not other types of
transfers may score lower on the MDS 2.0 because that item includes the ability to
transfer to/from bed, chair, wheelchair, and a standing position while the CARE item
focuses exclusively on chair-to-bed transfer.
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The overall frequencies for these items are shown in Tables 14-33a and 14-33b below,
followed by the cross-tabulation of the CARE and MDS 2.0 ADL Self-Performance rating scales
in Table 14-33c. Tables 14-33d(1-5) show the cross-tabulation of the CARE and MDS 2.0 ADL
Self-Performance rating scales, controlling for different levels of MDS 2.0 ADL Support
Provided.
The cross-tabulation results above indicate a relatively high degree of agreement between
the items in the two assessment instruments. With respect to simple CARE–MDS 2.0 ADL SelfPerformance cross-tabulation results, Table 14-33c shows a high degree of agreement overall,
and particularly at the more dependent ends of the scale. For example, among the CARE
Dependent responses, 45.1 percent map to Total Dependence in the MDS 2.0. Similarly, among
the CARE Substantial Assistance responses, 79.2 percent map to the Extensive Assistance level
in the MDS 2.0, and in the CARE Partial Assistance responses, 30.6 percent map to Limited
Assistance and 62.0 percent map to Extensive Assistance in the MDS 2.0.
The following tables illustrate the closest mapping of the functional item scale between
CARE and MDS 2.0. The mapping incorporates the two MDS 2.0 functional items (i.e., SelfPerformance and Support), matching them to the one CARE functional item (i.e., controlling for
the MDS 2.0 Support item in a cross-tabular presentation). The cells marked with an asterisk
indicate expected areas of functional item/scale agreement between the matched CARE–MDS
2.0 assessments.
Table 14-33a
CARE admission chair/bed-to-chair transfer 2-day admission assessment period
CARE: Chair/bed-to-chair transfer
Missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency

Percent

+
266
739
1,265
1,221
176
171
11
66
21
12
25

+
6.69
18.58
31.81
30.7
4.43
4.3
0.28
1.66
0.53
0.3
0.63

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-33b
MDS 2.0 admission transfer ADL self-performance 7-day assessment period
MDS: Transfer self-performance

Frequency

Percent

Missing
0 = Independent

+
146

+
3.67

1 = Supervision

243

6.11

2 = Limited assistance

1,144

28.77

3 = Extensive assistance

2,162

54.36

232

5.83

49

1.23

4 = Total dependence
8 = Activity did not occur
+ Cells based on a sample size of n < 11 are not shown.

SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-33c
CARE chair/bed-to-chair transfer by MDS 2.0 transfer ADL self-performance
2=
Limited
CARE: Chair/bed-to0=
1=
Missing Independent Supervision assistance
chair transfer
Missing

+

+

+

1 = Dependent

+

+

2 = Substantial assist.

+

+

3 = Partial assist.

+

1

4 = Supervision
touching assist.

+

5 = Setup assist.

8=
Activity
3=
Extensive 4 = Total did not
assistance dependence occur

+

+

+

+

42.5

+

12.6

4.4

30.6*

4.1

10.3*

41.5*

+

9.7

17.6

6 = Independent

+

32.7*

15.8

L = Letter code

+

+

+

Total

+

146

243

+

+

45.1*

8.6

266

79.2*

6.2

+

739

62*

1.6

+

1,265

43.7

+

+

1,221

45.5

27.3

+

+

176

37.4

12.3

+

+

171

+

56.3

28.1

10.4

135

1,144

2,162

232

49

3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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+

Total

Table 14-33d(1)
Controlling for MDS 2.0 transfer ADL support provided = 0 (no setup or physical help):
CARE chair/bed-to-chair transfer by MDS 2.0 transfer ADL self-performance
8=
3=
Activity
CARE: Chair/bed-to0=
1=
2 = Limited Extensive 4 = Total
did not
chair transfer
Missing Independent Supervision assistance assistance dependence occur
3 = Partial assist.
4 = Supervision
touching assist.
5 = Setup assist.
6 = Independent
Total

Total

+

+

+

+

+

+

+

+

—

66.7

33.3

—

—

—

—

33

+
+
—

+
91.8*
80

+
+

+
+
—

+
+
—

+
+
—

+
+
—

13
49
100

20

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-33d(2)
Controlling for MDS 2.0 transfer ADL support provided = 1 (setup help only): CARE
chair/bed-to-chair transfer by MDS 2.0 transfer ADL self-performance
8=
3=
Activity
CARE: Chair/bed-to0=
1=
2 = Limited Extensive 4 = Total did not
chair transfer
Missing Independent Supervision assistance assistance dependence occur
Missing
1 = Dependent
2 = Substantial assist.
3 = Partial assist.
4 = Supervision
touching assist.
5 = Setup assist.
6 = Independent
Total

Total

+
+
+
+

+
+
+
+

+
+
+
85.7

+
+
+
+

+
+
+
+

+
+
+
+

+
+
+
+

+
+
+
21

+

+

72.6*

+

+

+

+

84

+
+
—

+
+
38

84.6*
64.7
113

+
+
+

+
+
—

+
+
—

+
+
—

26
17
152

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-33d(3)
Controlling for MDS 2.0 transfer ADL support provided = 2 (one person physical assist):
CARE chair/bed-to-chair transfer by MDS 2.0 transfer ADL self-performance

CARE: Chair/bed-to0=
1=
2 = Limited
chair transfer
Missing Independent Supervision assistance
Missing
1 = Dependent
2 = Substantial assist.
3 = Partial assist.
4 = Supervision
touching assist.
5 = Setup assist.
6 = Independent
L = Letter code
Total

3=
Extensive
assistance

8=
Activity
4 = Total did not
dependence occur

Total

+
+
+
+

+
+
+
+

+
+
+
+

+
+
+
+

+
37.8*
66.5*
49.9*

+
48.6*
+
+

+
+
+
+

+
37
266
793

+

+

+

+

38.8

+

+

884

+
+
+
—

+
+
+
23

+
+
+
106

+
+
+
1,052

25
14.8
67.9
992

+
+
+
38

+
+
+
+

112
88
28
2,211

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-33d(4)
Controlling for MDS 2.0 transfer ADL support provided = 3 (two+ person physical assist):
CARE chair/bed-to-chair transfer by MDS 2.0 transfer ADL self-performance

CARE: Chair/bed-to0=
1=
2 = Limited
Missing Independent Supervision assistance
chair transfer
1 = Dependent
+
+
+
0.5*
2 = Substantial assist.
+
+
+
3.5
3 = Partial assist.
+
+
+
8.6
4 = Supervision
+
+
+
11.4
touching assist.
5 = Setup assist.
+
+
+
+
6 = Independent
+
+
+
+
L = Letter code
+
+
+
+
Total
+
+
+
91

3=
Extensive
assistance
48.3*
88.1
87.8
86.4
80
+
61.3
1,170

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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8=
Activity
did not
4 = Total
dependence occur
49.8*
+
8
+
3.2
+

Total
205
463
442

+

+

220

+
+
38.7
194

+
+
+
+

25
17
93
1,465

Table 14-33d(5)
Controlling for MDS 2.0 transfer ADL support provided = 8 (did not occur): CARE
chair/bed-to-chair transfer by MDS 2.0 transfer ADL self-performance
8=
3=
Activity
CARE: Chair/bed-to0=
1=
2 = Limited Extensive 4 = Total did not
chair transfer
Missing Independent Supervision assistance assistance dependence occur
1 = Dependent
2 = Substantial assist.
3 = Partial assist.
L = Letter code
Total

—
+
+
—
—

—
+
+
—
—

—
+
+
—
—

—
+
+
—
—

—
+
+
—
—

—
+
+
—
—

100
+
+
100*
49

Total
23
+
+
14
49

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Summary Results
•

Tables 14-33d(1-5) show a fair amount of agreement between the CARE Chair/Bedto-Chair Transfer item and MDS 2.0 Transfer ADL Self-Performance item when
MDS 2.0 Support Level is controlled.

•

For example, Table 14-33d(2) indicates that of the 84 patients who were evaluated as
needing Supervision on the CARE Item Set and required Setup Help Only on the
MDS 2.0, 72.6 percent were assessed as needing Supervision in Self-Performance on
the MDS 2.0.

•

Additionally, Table 14-33d(3) demonstrates a relatively high amount of agreement
between these two items. For example, among the 793 patients who were evaluated
as needing Partial Assistance on the CARE Item Set and required a One Person
Physical Assist on the MDS 2.0, 93.4 percent were assessed in the predicted MDS 2.0
Self-Performance categories of either Limited Assistance or Extensive Assistance.
Unsurprisingly, there is also a bit of scatter outside the “predicted” area of
Table 14-33d(3). Most of this occurs below and to the right of the “predicted” area,
indicating a more dependent response on the MDS 2.0. This may be due to the
differing item definitions, but further analyses will be undertaken to explore such
discrepancies.

•

Although clinicians were instructed that any patient who required a Two+ Person
Physical Assist in the MDS 2.0 should be scored as Dependent in CARE regardless of
MDS 2.0 Self-Performance level, Table 14-33d(4) indicates that this may not have
occurred. However, discrepancies showing more dependence on the MDS 2.0 might
also be the result of differing assessment time frames and item definitions.
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•

Following is a rationale of how using assessments that were coded as 3–Two+ Person
Physical Assist for the ADL Support Provided rating may have impacted the results
seen in Table 14-33d(4):
–

The expected mapping agreement occurred between CARE 1–Dependent and
MDS 2.0 rating scores 3–Extensive Assistance and 4–Total Dependence;
however, there was greater than expected agreement between the MDS 2.0, 3–
Extensive Assistance scores and the CARE rating scores 2–Substantial/Maximal
Assistance (88.1 percent), 3–Partial/Moderate Assistance (87.8 percent), and 4–
Supervision/Touching Assistance (86.4 percent). This may be attributable to the
MDS 2.0 rule of physical assistance provided three or more times resulting in
lowering the level of the independence, performance value to 3–Extensive
Assistance. Finally, sometimes these unexpected results were produced and it is
unknown if these were due to clinician coding errors.

CARE Item: Toilet Transfer (B4) vs. MDS 2.0 ADL Self-Performance Item: Toilet Use (G1Ai)
The Functional Status section of the CARE Item Set assesses a patient’s most usual
performance with Toilet Transfer during the 2-day admission assessment window. The MDS 2.0
also assesses toilet transfer abilities as part of the Toilet Use item, but codes for the patient’s selfperformance over all shifts during the last 7 days. This comparison first reports basic statistics
on the CARE and MDS 2.0 ADL Self-Performance items, followed by a cross-tabulation of
these two variables, modified by the MDS 2.0 ADL Support item. The definitions from the
CARE and MDS 2.0 are included below.
CARE Definition:
B4. Toilet Transfer: The ability to safely get on and off a toilet or commode.
MDS 2.0 Definition:
G1(A)i. Toilet Use: How patient uses the toilet room (or commode, bedpan, urinal); transfer
on/off toilet, cleanses, changes pad, manages ostomy or catheter, or adjusts clothes.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The MDS 2.0 item includes both toilet transfer and toilet hygiene,
whereas the CARE item focuses strictly transferring to/from the toilet/commode. In
the CARE Item Set, toilet hygiene is assessed separately.

•

Scales: As discussed previously, there are significant differences between the CARE
and MDS 2.0 ADL Self-Performance scales.
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Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment windows. The function level on the MDS 2.0 may be higher than that
reported on the CARE because the MDS 2.0 assessment may be occurring up to 7
days later than the CARE assessment.

•

Additionally, the differing definitions may also generate item differences. For
example, a patient who is able to manage toilet transfers but not toilet hygiene may
score lower on the MDS 2.0 because that item includes hygiene activities while the
CARE item focuses exclusively on transfer.

The overall frequencies for these items are shown in Tables 14-34a and 14-34b, followed
by the cross-tabulation of the CARE and MDS 2.0 ADL Self-Performance items in
Table 14-34c. Tables 14-34d(1-5) show the cross-tabulation of the CARE and MDS 2.0 ADL
Self-Performance items, controlling for different levels of MDS 2.0 ADL Support Provided.
Table 14-34a
CARE admission toilet transfer 2-day admission assessment period
CARE: Toilet transfer
Missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency

Percent

+
255
734
1,238
1,111
186
166
11
100
76
20
77

+
6.41
18.46
31.13
27.94
4.68
4.17
0.28
2.51
1.91
0.5
1.94

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-34b
MDS 2.0 admission toilet use ADL self-performance 7-day assessment period
MDS: Toilet use self-performance

Frequency

Percent

0 = Independent

153

3.85

1 = Supervision

261

6.56

2 = Limited assistance

1,044

26.25

3 = Extensive assistance

2,137

53.73

4 = Total dependence

380

9.55

8 = Activity did not occur

+

+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-34c
CARE toilet transfer by MDS 2.0 toilet ADL self-performance
CARE: Toilet
transfer

8 = Activity
did not
occur

Total

+

+

47.1*

+

255

0=
1=
2 = Limited 3 = Extensive 4 = Total
assistance dependence
Independent Supervision assistance

Missing

+

+

1 = Dependent

+

+

4.3

2 = Substantial assist.

+

+

10.5

76*

12.4

+

734

3 = Partial assist.

1.2

4.8

26.8*

63.7*

3.6

+

1,238

4 = Supervision
touching assist.

4.9

11.6*

41.1*

41

1.4

+

1,111

5 = Setup assist.

13.4

17.2

44.1

24.2

+

+

186

6 = Independent

31.3*

17.5

35.5

13.3

+

+

166

9.2

51.8

36.3

+

284

1,044

2,137

380

+

3,977

L = Letter code

+

+

Total

153

261

+

+
47.1

+

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

The cross-tabulation results above indicate a high degree of agreement between the items
when the two assessment instruments are compared. With respect to simple CARE–MDS 2.0
ADL Self-Performance cross-tabulation results, there is a high degree of agreement overall, and
particularly at the more dependent ends of the scale. For example, among the CARE Dependent
responses, 47.1 percent map to Total Dependence in the MDS 2.0. Similarly, among the CARE
Substantial Assistance responses, 76.0 percent map to the Extensive Assistance level in the MDS
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2.0; in the CARE Partial Assistance responses, 26.8 percent map to Limited Assistance and
63.7 percent map to Extensive Assistance in the MDS 2.0.
The following tables illustrate the closest mapping of the functional item scale between
CARE and MDS 2.0. The mapping incorporates the two MDS 2.0 functional items (i.e., SelfPerformance and Support), matching them to the one CARE functional item (i.e., controlling for
the MDS 2.0 Support item in a cross-tabular presentation). The cells marked with an asterisk
indicate expected areas of functional item/scale agreement between the matched CARE–MDS
2.0 assessments.
Table 14-34d(1)
Controlling for MDS 2.0 toilet ADL support = 0 (no setup or physical assistance): CARE
toilet transfer by MDS 2.0 toilet use ADL self-performance

CARE: Toilet
transfer

0=
1=
2 = Limited 3 = Extensive
Independent Supervision assistance
assistance

4 = Total
dependence

8=
Activity
did not
occur

Total

1 = Dependent

+

+

+

+

+

+

+

3 = Partial assist.

+

+

+

+

+

+

+

4 = Supervision
touching assist.

83.9

+

+

+

+

+

31

5 = Setup assist.

+

+

+

+

+

+

14

+

+

+

+

+

41

6 = Independent

85.4*

L = Letter code

+

+

+

+

+

+

+

Total

75

18

+

+

+

+

93

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-34d(2)
Controlling for MDS 2.0 toilet support provided = 1 (setup help only): CARE toilet transfer
by MDS 2.0 toilet use ADL self-performance

CARE: Toilet
transfer

0=
1=
2 = Limited 3 = Extensive
Independent Supervision assistance
assistance

4 = Total
dependence

8=
Activity
did not
occur

Total

Missing

+

+

+

+

+

+

+

2 = Substantial assist.

+

+

+

+

+

+

+

3 = Partial assist.

+

65.2

+

+

+

+

23

4 = Supervision
touching assist.

23.6

76.4*

+

+

+

+

89

5 = Setup assist.

30.6*

69.4*

+

+

+

+

36

6 = Independent

+

61.9

+

+

+

+

21

L = Letter code

+

+

+

+

+

+

+

Total

51

122

+

+

+

+

176

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-34d(3)
Controlling for MDS 2.0 toilet use support provided = 2 (one person physical assist): CARE
toilet transfer by MDS 2.0 toilet ADL self-performance

CARE: Toilet
transfer

0=
1=
2 = Limited 3 = Extensive
Independent Supervision assistance
assistance

4 = Total
dependence

8=
Activity
did not
occur

Total

+

+

+

Missing

+

+

+

+

1 = Dependent

+

+

7.9

34.3*

57.1*

+

140

2 = Substantial assist.

+

+

18

65.3*

15.5

+

400

3 = Partial assist.

+

4.5

34.4*

56.1*

4.3

+

931

4 = Supervision
touching assist.

+

6.2*

49.6*

41.9

1.5

+

904

5 = Setup assist.

+

+

62.3

30.8

+

+

130

6 = Independent

+

+

62.4

16.1

+

+

93

L = Letter code

+

+

13.1

42.1

42.6

+

183

Total

27

121

1,014

1,344

277

+

2,783

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-34d(4)
Controlling for MDS 2.0 toilet use ADL support provided = 3 (two+ person physical assist):
CARE toilet transfer by MDS 2.0 toilet use ADL self-performance

CARE: Toilet
transfer

0=
1=
2 = Limited 3 = Extensive
Independent Supervision assistance
assistance

8=
Activity
did not
occur

Total

35.7*

+

112

8.8

+

330

4 = Total
dependence

1 = Dependent

+

+

—

64.3*

2 = Substantial assist.

+

+

+

89.7

3 = Partial assist.

+

+

+

95

+

+

280

4 = Supervision
touching assist.

+

+

+

87.4

+

+

87

5 = Setup assist.

+

+

+

+

+

+

+

6 = Independent

+

+

+

+

+

+

11

L = Letter code

+

+

72.2

25.8

+

97

Total

+

+

+
28

792

103

+

923

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-34d(5)
Controlling for MDS 2.0 toilet use ADL support provided = 8 (did not occur): CARE toilet
transfer by MDS 2.0 toilet ADL self-performance

CARE: Toilet
transfer

0=
1=
2 = Limited 3 = Extensive
Independent Supervision assistance
assistance

4 = Total
dependence

8=
Activity
did not
occur

Total

1 = Dependent

+

+

+

+

+

+

+

Total

+

+

+

+

+

+

+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Summary Results
•

Tables 14-34d(1-4) demonstrate a fair amount of agreement between the CARE
Toilet Transfer item and MDS 2.0 Toilet Use ADL Self-Performance item when
MDS 2.0 Support Level is controlled.

•

For example, Table 14-34d(2) indicates that of the 89 patients who were evaluated as
needing Supervision on the CARE Item Set and required Setup Help Only on the
MDS 2.0, 76.4 percent were assessed as needing Supervision in Self-Performance on
the MDS 2.0.
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•

Additionally, Table 14-34d(3) demonstrates a relatively high amount of agreement
between these two items. For example, among the 931 patients who were evaluated
as needing Partial Assistance on the CARE Item Set and required a One Person
Physical Assist on the MDS 2.0, 90.5 percent were assessed in the predicted MDS 2.0
Self-Performance categories of either Limited Assistance or Extensive Assistance.
Unsurprisingly, there is also a bit of scatter outside the “predicted” area of
Table 14-34d(3). Most of this occurs below and to the right of the “predicted” area,
indicating a more dependent response on the MDS 2.0. This may be due to the
differing item definitions. Sometimes these unexpected results were produced and it
is unknown if these were due to clinician coding errors.

•

Although clinicians were instructed that any patient who required a Two+ Person
Physical Assist in the MDS 2.0 should be scored as Dependent in CARE regardless of
MDS 2.0 Self-Performance level, Table 14-34d(4) indicates that this may not have
occurred. However, discrepancies showing more dependence on the MDS 2.0 might
also be the result of differing assessment time frames and item definitions.

•

Following is a rationale of how using assessments that were coded as 3–Two+ Person
Physical Assist for the ADL Support Provided rating may have impacted the results
seen in Table 14-34d(4).
–

The expected mapping agreement occurred between CARE 1–Dependent and
MDS 2.0 rating scores 3–Extensive Assistance and 4–Total Dependence;
however there was greater than expected agreement between the MDS 2.0, 3–
Extensive Assistance scores and the CARE rating scores 2–Substantial/Maximal
Assistance (89.7 percent), 3–Partial/Moderate Assistance (95 percent), and 4–
Supervision/Touching Assistance (87.4 percent). This may be attributable to the
MDS 2.0 rule of physical assistance provided three or more times results in
lowering the level of the independence, performance value to 3–Extensive
Assistance. Finally, sometimes these unexpected results were produced and it is
unknown if these were due to clinician coding errors.

CARE Item: Roll Left and Right (C3) vs. MDS 2.0 ADL Self-Performance Item: Bed Mobility
(G1Aa)
The Functional Status section of the CARE Item Set assesses a patient’s most usual
performance with Roll Left and Right during the 2-day admission assessment window. The
MDS 2.0 also assesses roll left and right abilities as part of the Bed Mobility item, but codes for
the patient’s self-performance over all shifts during the last 7 days. This comparison first reports
basic statistics on the CARE and MDS 2.0 ADL Self-Performance items, followed by a crosstabulation of these two variables, modified by the MDS 2.0 ADL Support item. The definitions
from the CARE and MDS 2.0 are included below.
CARE Definition:
C3. Roll Left and Right: The ability to roll from lying on back to left and right, and roll back to
back.
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MDS 2.0 Definition:
G1(A)a. Bed Mobility: How patient moves to and from lying position, turns side to side, and
positions body while in bed.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). In contrast, the MDS 2.0 assessment time frame is 7 calendar days.

•

Item Definitions: The MDS 2.0 Bed Mobility item includes rolling left and right as
well as other bed mobility activities, whereas the CARE item focuses strictly on
rolling left to right. In the CARE Item Set, other bed mobility functions are assessed
separately.

•

Scales: As discussed previously, there are significant differences between the CARE
and MDS 2.0 ADL Self-Performance scales.

Implications
•

The CARE and MDS 2.0 assessments may be different due to differences in the
assessment windows. The function level on the MDS 2.0 may be higher than that
reported on the CARE because the MDS 2.0 assessment may be occurring up to 7
days later than the CARE assessment.

•

Additionally, the differing definitions may also generate item differences. For
example, a patient who is able to manage rolling left to right but not manage other
bed mobility activities may score lower on the MDS 2.0 because that item includes
multiple mobility activities while the CARE item focuses exclusively on rolling left
and right.

The overall frequencies for these items are shown in Tables 14-35a and 14-35b, followed
by the cross-tabulation of the CARE and MDS 2.0, ADL Self-Performance items in
Table 14-35c. Tables 14-35d(1-4) show the cross-tabulation of the CARE and MDS 2.0 ADL
Self-Performance items, controlling for different levels of MDS 2.0 ADL Support Provided.
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Table 14-35a
CARE admission roll left and right 2-day admission assessment period
CARE: Roll left and right

Frequency

Percent

Missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
E = Not attempted due to environmental constraints
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

90
178
542
1,108
951
246
717
+
+
104
18
+
+

2.26
4.48
13.63
27.86
23.91
6.19
18.03
+
+
2.62
0.45
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
Table 14-35b
MDS 2.0 admission bed mobility ADL self-performance 7-day assessment period
MDS: Bed mobility

Frequency

Percent

Missing

+

+

0 = Independent

335

8.42

1 = Supervision

254

6.39

2 = Limited assistance

966

24.29

2,230

56.07

3 = Extensive assistance
4 = Total dependence

191

4.8

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-35c
CARE roll left and right by MDS 2.0 bed mobility ADL self-performance
CARE: Roll left and
right

Missing

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

Total

Missing

+

15.6

+

20

45.6

+

90

1 = Dependent

+

+

+

+

44.9

50*

178

2 = Substantial assist.

+

+

+

8.1

79.3*

10

542

3 = Partial assist.

+

4

4

22.8*

67.2

2

1,108

4 = Supervision
touching assist.

+

7

8.8*

27.8

55.2

1.2

951

5 = Setup assist.

+

14.6

7.3

31.7

45.9

+

246

6 = Independent

+

23.3*

11.4

36

29.1

+

717

L = Letter code

+

+

+

32.4

60

+

145

Total

+

335

254

966

2,230

191

3,977

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

The cross-tabulation results above indicate a relatively high degree of agreement between
the items when the two assessment instruments are compared. With respect to simple CARE–
MDS 2.0, ADL Self-Performance cross-tabulation results, there is a high degree of agreement at
the more dependent levels. Among the CARE Dependent responses, 50 percent map to Total
Dependence in the MDS 2.0. Similarly, among the CARE Substantial Assistance responses,
79.3 percent map to the Extensive Assistance level in the MDS 2.0.
The following tables illustrate the closest mapping of the functional item scale between
CARE and MDS 2.0. The mapping incorporates the two MDS 2.0 functional items (i.e., SelfPerformance and Support) matching them to the one CARE functional item (i.e., controlling for
the MDS 2.0 Support item in a cross-tabular presentation). The cells marked with an asterisk
indicate expected areas of functional item/scale agreement between the matched CARE–MDS
2.0 assessments.
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Table 14-35d(1)
Controlling for MDS 2.0 bed mobility ADL support provided = 0 (no setup or physical
help): CARE roll left and right by MDS 2.0 bed mobility ADL self-performance

CARE: Roll left and right

Missing

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

Total

Missing

+

92.3

+

+

+

+

13

1 = Dependent

+

+

+

+

+

+

+

2 = Substantial assist.

+

+

+

+

+

+

+

3 = Partial assist.

+

96.7

+

+

+

+

30

4 = Supervision touching
assist.

+

95.2

+

+

+

+

42

5 = Setup assist.

+

96.8

+

+

+

+

31

6 = Independent

+

96.5*

+

+

+

+

115

Total

+

226

+

+

+

+

235

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-35d(2)
Controlling for MDS 2.0 bed mobility ADL support provided = 1 (setup help only): CARE
roll left and right by MDS 2.0 bed mobility ADL self-performance

CARE: Roll left and right

Missing

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

Total

Missing

+

+

+

+

+

+

+

1 = Dependent

+

+

+

+

+

+

+

2 = Substantial assist.

+

+

+

+

+

+

+

3 = Partial assist.

+

+

75.8

+

+

+

33

4 = Supervision touching
assist.

+

30.5

69.5*

+

+

+

59

5 = Setup assist.

+

+

75*

+

+

+

16

6 = Independent

+

46.5

53.5

+

+

+

86

L = Letter code

+

+

+

+

+

+

+

Total

+

74

146

+

+

+

220

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Table 14-35d(3)
Controlling for MDS 2.0 bed mobility ADL support provided = 2 (one person physical
assist): CARE roll left and right by MDS 2.0 bed mobility ADL self-performance

CARE: Roll left and right

Missing

0=
1=
2 = Limited
Independent Supervision assistance

Missing

+

+

+

1 = Dependent

+

+

2 = Substantial assist.

+

+

3 = Partial assist.

+

+

2.8

4 = Supervision touching
assist.

+

+

6.9*

5 = Setup assist.

+

+

+

6 = Independent

+

4

7.7

L = Letter code

+

+

+

Total

+

35

3=
Extensive
assistance

4 = Total
dependence Total

47.2

44.4

+

+

32.5*

+

18.6

67.9*

12.7

221

54.6*

+

608

42.5*

48.2

+

577

48.4

46.4

+

153

59

29.4

+

405

46.4

50.5

+

97

907

1,028

71

2,137

40*

96

+

36

60*

40

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.

Table 14-35d(4)
Controlling for MDS 2.0 bed mobility ADL support provided = 3 (two+ person physical
assist): CARE roll left and right by MDS 2.0 bed mobility ADL self-performance

CARE: Roll left and right Missing

0=
1=
2 = Limited
Independent Supervision assistance

3=
Extensive
assistance

4 = Total
dependence

Total

Missing

+

+

+

+

80.6

+

31

1 = Dependent

+

+

+

+

50.4

48.9

133

2 = Substantial assist.

+

+

+

+

90.3

8.4

310

3 = Partial assist.

+

+

+

2.3

94.5

3

437

4 = Supervision touching
assist.

+

+

+

+

90.5

+

273

5 = Setup assist.

+

+

+

+

91.3

+

46

6 = Independent

+

+

+

+

81.1

+

111

L = Letter code

+

+

+

+

86.4

+

44

Total

+

+

+

58

1202

120

1,385

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and MDS 2.0 assessment data, 2008-2009.
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Summary Results
•

Tables 14-35d(1-4) generally show a fair amount of agreement between the CARE
Roll Left and Right item and MDS 2.0 Bed Mobility ADL Self-Performance item
when MDS 2.0 Support Level is controlled.

•

For example, Table 14-35d(1) indicates that of the 115 patients who were evaluated
as Independent on the CARE Item Set and did not require Setup or Physical Help on
the MDS 2.0, 96.5 percent were assessed as Independent in Self-Performance on the
MDS 2.0. One would expect patients to be more dependent on the CARE Item Set as
a result of being assessed within a 2-day window as opposed to the 7-day MDS 2.0
window.

•

Table 14-35d(3) also demonstrates a relatively high amount of agreement between
these two items. For example, among patients who were evaluated as needing
Substantial Assistance on the CARE Item Set and required a One Person Physical
Assist on the MDS 2.0, 67.9 percent were assessed as needing Extensive Assistance
in Self-Performance on the MDS 2.0, which is the predicted response. Similarly high
levels of agreement are also shown within the CARE levels for Dependent, Partial
Assistance, and Supervision in this table. Unsurprisingly, there is also a bit of scatter
outside the “predicted” area of Table 14-35d(3). Most of this occurs below and to the
right of the “predicted” area, indicating a more dependent response on the MDS 2.0.
This may be due to the differing item definitions, but further analyses will be
undertaken to explore such discrepancies further.

•

Although clinicians were instructed that any patient who required a Two+ Person
Physical Assist in the MDS 2.0 should be scored as Dependent in CARE regardless of
MDS 2.0 Self-Performance level, Table 14-35d(4) indicates that this may not have
occurred. However, discrepancies showing more dependence on the MDS 2.0 might
also be the result of differing assessment time frames and item definitions.

•

Following is a rationale of how using assessments that were coded as 3–Two+ Person
Physical Assist for the ADL Support Provided rating may have impacted the results
seen in Table 14-35d(4).
–

The expected mapping agreement occurred between CARE 1–Dependent and
MDS 2.0 rating scores 3–Extensive Assistance and 4–Total Dependence;
however, there was greater than expected agreement between the MDS 2.0, 3–
Extensive Assistance scores and the CARE rating scores 2–Substantial/Maximal
Assistance (90.3 percent), 3–Partial/Moderate Assistance (94.5 percent), and 4–
Supervision/Touching Assistance (90.5 percent). This may be attributable to the
MDS 2.0 rule of physical assistance provided 3 or more times results in lowering
the level of the independence, performance value to 3–Extensive Assistance.
Finally, sometimes these unexpected results were produced and it is unknown if
these were due to clinician coding errors.
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14.4

CARE–MDS 2.0 Comparison Next Steps

These analyses present an initial step in measuring the level of agreement between
selected CARE Item Sets and the MDS 2.0 instrument items. While direct one-to-one item
comparisons between the two instruments is not possible due to differences in, for example,
assessment time frames, item ratings scales, and the sometimes unique definitions for similar
items used to assess function, this mapping of selected items and associated scales presents an
important first look at how selected CARE items are assessed and aligned vis-à-vis similar MDS
2.0 items. These findings indicated a high to moderate level of agreement between the two
assessment instruments with respect to selected items. Furthermore, and perhaps most
instructive, is the absence of any large and/or unexpected association(s) between the two
instruments. That is, while the functional item scale percent agreement between paired
instruments was sometimes modest (e.g., approximately 50 percent), an off-setting or higher
percent agreement between opposite ends of the functional scale alignment was not observed
(e.g., a negative correlation after accounting for reversed scales was not observed). The highest
percent agreement between instruments was observed when CARE functional item level 2 (e.g.,
substantial/maximal assistance) was mapped to MDS 2.0 ADL Self-Performance item level 3
(e.g., Extensive assistance), regardless of ADL Support Provided.
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SECTION 15
OASIS-B–CARE COMPARISONS
15.1

Overview

In parallel with the efforts to compare Continuity Assessment Record and Evaluation
(CARE) items with their analogs on the Inpatient Rehabilitation Facility Patient Assessment
Instrument (IRF-PAI)/ FIM® and Minimum Data Set (MDS) 2.0, additional analyses were
undertaken to address the CARE item performance relative to the Outcome and Assessment
Information Set (OASIS)-B prospective payment items.
Analyses are based on finalized CARE Item Set admission assessments matched with
OASIS-B “start of care” or “resumption of care” assessments. To begin, we merged home health
agency (HHA) admission assessment data from the January 2010 CARE extract data (n = 4,996)
with OASIS-B assessment data available through December 31, 2009, 7 by beneficiary Medicare
identification number (HICN), gender, and birth date. This resulted in 95.8 percent of CARE
admission assessments being matched with an OASIS-B assessment, not taking into account
assessment date. For the remaining HHA CARE assessments without an OASIS-B match, two
additional matches were undertaken. For the first, we generated a CARE proxy social security
number (SSN) using the first nine digits of the HICNs on CARE and looked for matches using
this variable and the OASIS-B SSN, gender, and birth date variables. Second, following advice
of HHA researchers who had observed agencies erroneously recording HICN in the OASIS-B
Medicaid ID field, another match was performed between the CARE HICN and OASIS-B
Medicaid ID number, in addition to gender and birth date. However, only one additional match
was identified using this strategy. After these additional matches, which do not take into account
assessment date, 96.3 percent of CARE assessments were matched to OASIS-B assessments (n =
4,810 pairs of assessments).
The final refinement to the CARE Item Set–OASIS-B merge was to take into account
assessment dates. Large differences between CARE and OASIS-B assessment time frames
would increase variation between paired CARE Item Set–OASIS-B assessment items; therefore,
we restricted our final sample of matched assessments to those with a gap between the OASIS-B
start of care (or resumption of care) date and CARE Item Set admission date of no more than 4
days. The final data set containing CARE admission assessments matched to either an OASIS-B
“Start of Care” or “Resumption of Care” assessment yielded 4,587 observations (representing
91.8 percent of finalized CARE admission assessments from HHAs). The vast majority of
assessment pairs in the final sample had the same OASIS-B start of care and CARE admission
date (96 percent) or only 1-day difference (an additional 3 percent).
Similar to the comparisons with the IRF-PAI and MDS above, the purpose of this
analysis is to assess the concurrent validity of the CARE Item Set.

7

CARE extract date 01/28/2010. Data shown in this chapter were generated with programs CAREREL041,
CAREREL040, CAREREL037, and CAREREL036.
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15.2

Differences between CARE Item Set and OASIS-B

While many CARE items have close analogs to OASIS-B items, there are several key
differences between the two assessment instruments that may result in variation in patient
assessment and associated variation between assessment instrument items. Differences related to
an instrument’s item definition and assessment scales are addressed individually below, under
item-by-item comparisons. Major differences between the two assessment instruments, affecting
all item-by-item comparisons include:
•

15.3

Differences between CARE and OASIS-B regarding assessment instructions:
–

Time Frame: The assessment time frame for the CARE Item Set is 2 calendar
days (if admitted before 12 noon) or 3 calendar days (for patients admitted after
12 noon). The time frame for most items in the OASIS-B (evaluated below)
refers to the patient’s status the day of the assessment visit, or the patient’s usual
status. The CARE Item Set does instruct clinicians to report the usual (or typical)
performance but with a slightly longer time frame. A few of the OASIS-B items
regarding prior service use and conditions require a 14-day look-back period
immediately preceding the assessment. The CARE Item Set uses a 14-day lookback period for a few items as well.

–

Implication: In general, we expect that differences in assessment time period
should play little role in differences between OASIS-B and CARE Item Set
responses. It is likely that the data for both assessments were collected
simultaneously the majority of the time.

•

Differences between CARE and OASIS-B Instruments exist regarding alignment of
scales.

•

Although comparable concepts are used in the comparison for this analysis, specific
item definitions may not be identical.

•

Error: As noted in prior sections, some disagreement between the CARE and
OASIS-B items may be attributable to clinician reporting errors on one of the tools.
As noted in the interrater reliability section in Volume 2, and in prior evaluations of
OASIS-B items, there are some items that have lower reliability than others.

Results: CARE–OASIS-B Comparisons

A. Current Medical Information: Major Treatments
CARE Item: Major Treatments: Total Parenteral Nutrition (item III.D3a)
OASIS-B Item: Therapies that the Patient Receives at Home (item M0250)
The Current Medical Information-Major Treatments section of the CARE Item Set
assesses whether the patient received Total Parenteral Nutrition (TPN) (item III.D3a) during the
2-day admission assessment period. The OASIS-B assesses whether a patient received therapy
at the home (item M0250) and allows for up to three nutritional approaches items to be checked.
The definitions from the CARE and OASIS-B are:
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CARE Definition:
D3a. Total Parenteral Nutrition: Which of the following treatments did the patient receive
during the 2-day assessment period? For treatments such as blood transfusions, dialysis, or
IV chemotherapy, is the patient currently receiving them as part of their treatment plan?
Check all that apply: Total Parenteral Nutrition.
OASIS-B Definition:
M0250. Therapies the Patient Receives at Home: Identifies whether the patient is
receiving intravenous, parenteral nutrition, or enteral nutrition therapy at home, whether or
not the HHA is administering the therapy. Therapies the patient receives at home: (Mark all
that apply.) [2] Parenteral nutrition (TPN or lipids).
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set item is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment identifies if the patient receives the therapy
in the home. The general instructions imply that the response on the OASIS-B should
be for the day of the assessment, though it can include patient history and referral
orders.

•

Item Definitions: The CARE and OASIS-B definitions for this therapy, parenteral
nutrition, are similar. Note, though, that the OASIS-B definition specifically includes
lipids and explicitly includes services received in the home whether or not the HHA is
administering the therapy.

•

Scales: Neither the CARE nor OASIS-B assessment use a scale for this item, yet both
assess whether the patient receives/received it in his/her current setting.

Implications
•

We would expect close agreement between OASIS-B and CARE on this item.

Given the very low frequency of TPN administration in the Post-Acute Care Payment
Reform Demonstration (PAC-PRD) HHA sample, it is not feasible to present results from item
frequencies for CARE and OASIS-B and cross-tabulation of the items by instrument.
Agreement
CARE Items: Multiple Types of IV Antibiotic Administration (item III.D25a)
IV Vasoactive Medications (item III. D26a)
IV Anti-Coagulants (item III. D27a)
IV Chemotherapy (item III. D28a)
OASIS-B Item: Therapies that the Patient Receives at Home (item M0250)
To obtain a single measure comparable to OASIS-B intravenous or infusion therapy
indicator, we combined multiple items from the Current Medical Information-Major Treatments
section of the CARE assessment which indicate whether the patient received the following types
of IV therapy during the 2-day admission assessment period:
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•

Multiple Types of IV Antibiotic Administration (item III.D25a)

•

IV Vasoactive Medications (e.g., pressors, dilators, medications for pulmonary
edema) (item III. D26a)

•

IV Anti-Coagulants (item III. D27a)

•

IV Chemotherapy (item III. D28a)

The OASIS-B assesses whether a patient received therapy at the home (item M0250) and
allows for up to three nutritional approach items to be checked, one of which is 1–Intravenous or
infusion therapy (excludes TPN).
In order to compare these items, a new CARE variable was created to indicate whether
any of the items for Multiple Types of IV Antibiotic Administration, IV Vasoactive Medications,
IV Anti-Coagulants, or IV Chemotherapy were checked. This CARE variable indicating Any IV
Therapy Use was compared to the OASIS-B M0250 Therapies item responses.
The definitions from the CARE and OASIS-B are:
CARE Definitions:
Which of the following treatments did the patient receive during the 2-day assessment
period? For treatments such as blood transfusions, dialysis, or IV chemotherapy, is the
patient currently receiving them as part of their treatment plan?
D25a. Multiple Types of IV Antibiotic Administration
D26a. IV Vasoactive Medications (e.g., pressors, dilators, medications for pulmonary
edema)
D27a. IV Anti-Coagulants
D28a. IV Chemotherapy
OASIS-B Definition:
M0250. Therapies that the Patient Receives at Home: Identifies whether the patient is
receiving intravenous, parenteral nutrition, or enteral nutrition therapy at home, whether or
not the HHA is administering the therapy. Therapies the patient receives at home: (Mark all
that apply.) [1] Intravenous or infusion therapy (excludes TPN).
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). As discussed for TPN above, the OASIS-B assessment identifies if
the patient receives the therapy in the home. The general instructions imply that the
response on the OASIS-B should be for the day of the assessment, though it can
include patient history and referral orders.

•

Item Definitions: The CARE and OASIS-B definitions for this therapy are similar,
but the OASIS-B definition for the item is broader because it includes infusion
therapy, too.
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•

Scales: Neither the CARE nor OASIS-B assessments use a scale for this iteminstead, a binary response of whether patient receives/received the therapy or not in
his/her current setting.

Implications
•

The time frame for data collection on the OASIS-B and CARE assessments would
appear to have little impact on agreement across the tools.

•

Because the OASIS-B item is more inclusive, with the more general category of IV
therapy in addition to infusion therapy, we anticipate more patients with IV or
infusion therapy indicated on the OASIS-B tool than the CARE Item Set. Though it
has been suggested that the counts will be higher based on the CARE Item Set
because clinicians may be more likely to recognize that one of the more specific items
applies to the patient they are evaluating than the single, more general OASIS-B item.

•

Additionally, the CARE assesses whether a patient receives multiple antibiotics
intravenously, which might only detect a smaller set of patients who have greater
patient acuity while OASIS-B only assesses whether or not a patient receives any
type of intravenous or infusion therapy.

The overall frequencies for these items are shown in Tables 15-1a and 15-1b below,
followed by the cross-tabulation of the items in Table 15-1c.
Table 15-1a
CARE admission major treatments: IV therapy (any listed)
CARE: Major treatments: IV therapy*
0 = No
1 = Yes

Frequency

Percent

4,546
41

99.1
0.9

* Takes into account responses from the following CARE items: III.D25a
through D28a.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-1b
OASIS-B start of care therapies the patient receives at home: IV therapy
(M0250) intravenous or infusion therapy
OASIS-B: IV therapy
0 = No
1 = Yes

Frequency

Percent

4,507
80

98.3
1.7

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-1c
CARE admission IV therapy item by OASIS-B start of care IV therapy
CARE: IV therapy

0 = No

1= Yes

Total

0 = No
1= Yes
Total

98.6*
63.4
4,507

1.4
36.6*
80

4,546
41
4,587

*Expected areas of agreement are marked with an asterisk.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Summary Results
•

Of the patients with no IV therapy reported on CARE, 98.6 percent also had no
intravenous or infusion therapy indicated on OASIS-B, indicating a high level of
agreement in item responses.

•

More patients were reported with IV therapy on OASIS-B (n = 80) than were reported
on CARE (n = 41).

•

Among patients who did report IV therapy on CARE, 63.4 percent did not indicate
intravenous or infusion therapy on OASIS-B. It may be that the more explicit list of
IV therapies on the CARE Item Set resulted in more patients being detected receiving
these therapies than OASIS-B.

B. Current Medical Information: Skin Integrity
CARE Item: Number of Stage 2 Pressure Ulcers (item III.G2a)
OASIS-B Item: Number of Stage 2 Ulcers (item M0450b)
The Skin Integrity section of the CARE Item Set asks how many Stage 2 pressure ulcers
(item III.G2a) were present during the 2-day admission assessment window, while the OASIS-B
asks how many Stage 2 ulcers were present (M0450b) in the last 24-hour period and the time
during the visit. The definitions from the CARE and OASIS-B are included below.
CARE Definition:
G2a. Stage 2: Partial thickness loss of dermis presenting as a shallow open ulcer with red
pink wound bed, without slough. May also present as an intact or open/ruptured serum-filled
blister (excludes those resulting from skin tears, tape stripping, or incontinence associated
dermatitis).
OASIS-B Definition:
M0450b. Stage 2: Partial thickness skin loss involving epidermis and/or dermis. The ulcer
is superficial and presents clinically as an abrasion, blister, or shallow crater.
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Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The CARE and OASIS-B definitions for Stage 2 pressure ulcers are
similar. However, it should be noted that OASIS-B includes an additional item
requesting a count of Stage 1 pressure ulcers.

•

Scales: While the CARE item scale plateaus at 8 (8 = eight or more ulcers), the
OASIS-B item scale plateaus at 4 (4 = four or more ulcers).

Implications
•

It is not likely that any differences in OASIS-B and CARE assessments would be due
to the difference in assessment time frame.

•

Additionally, category 4 on the OASIS-B tool (four or more ulcers) will incorporate
CARE categories 4 (four ulcers), 5 (five or more ulcers), 6 (six or more ulcers), 7
(seven or more ulcers), and 8 (eight or more ulcers).

•

Because the CARE does not include an item for counts of Stage 1 ulcers, while the
OASIS-B does, we hypothesized it might be possible that there will be more ulcers
reported in the CARE counts because some ulcers reported as Stage 1 on OASIS-B
are being reported as Stage 2 on CARE.

The overall frequencies for these items are shown in Tables 15-2a and 15-2b below,
followed by the cross-tabulation of the items in Table 15-2c.
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Table 15-2a
CARE admission frequency of stage 2 pressure ulcers (G02a) at assessment
CARE: Frequency of stage 2 pressure ulcers
Missing
0 = 0 ulcers*
1 = 1 ulcers
2 = 2 ulcers
3 = 3 ulcers
4 = 4 ulcers
5 = 5 ulcers
6 = 6 ulcers
7 = 7 ulcers
Unknown

Frequency
+
4,390
138
40
+
+
+
+
+
+

Percent
+
95.7
3.0
0.9
+
+
+
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
*Assessments with no unhealed pressure ulcers at Stage 2 or higher or unstageable (III.G2)
were coded as having zero pressure ulcers on this item.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-2b
OASIS-B start of care frequency of stage 2 ulcers
OASIS-B: Frequency of stage 2 ulcers
0 = 0 ulcers
1 = 1 ulcers
2 = 2 ulcers
3 = 3 ulcers
4 = 4 or more

Frequency

Percent

4,388
142
40
+
+

95.7
3.1
0.9
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-2c
CARE admission stage 2 pressure ulcer item by OASIS-B start of care stage 2 pressure
ulcer item
OASISB: 0 = 0
ulcers

OASISB: 1 = 1
ulcers

OASISB: 2 = 2
ulcers

OASISB: 3 = 3
ulcers

OASISB: 4 = 4
or more
ulcers

OASISB: Total

0 = 0 ulcers

99.3*

0.6

+

+

+

4,390

1 = 1 ulcers
2 = 2 ulcers

16.7
+

79.7*
+

+
85.0*

+
+

+
+

138
40

3 = 3 ulcers

+

+

+

+

+

+

4 = 4 ulcers

+

+

+

+

+

+

6 = 6 ulcers
7 = 7 ulcers

+
+

+
+

+
+

+
+

+
+

+
+

9 = Unknown

+

+

+

+

+

+

4,388

142

40

+

+

4,587

CARE: Frequency of stage 2
pressure ulcers

Total

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 3. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
•

As indicated by the areas marked with an asterisk in Table 15-2c, there is a high
degree of agreement where expected between the CARE and OASIS-B items for
numbers of Stage 2 pressure ulcers.

•

Among those patients with “no” Stage 2 pressure ulcers indicated in CARE,
99.3 percent also had “no” Stage 2 pressure ulcers indicated in OASIS-B.

•

Similarly, among those patients with one Stage 2 pressure ulcer recorded in CARE,
79.7 percent also had one Stage 2 pressure ulcer recorded in OASIS-B.

•

It does look like there were more ulcers being reported on CARE than on OASIS-B,
but the count of assessments where this occurs is quite small.

CARE Item: Number of Stage 3 Pressure Ulcers (item III.G2b)
OASIS-B Item: Number of Stage 3 Ulcers (item M0450c)
The Skin Integrity section of the CARE Item Set asks how many Stage 3 pressure ulcers
(item III.G2b) were present during the 2-day admission assessment window, while the OASIS-B
asks how many Stage 3 ulcers were present (M0450c) on the day of the assessment visit. The
definitions from the CARE and OASIS-B are included below.
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CARE Definition:
G2b. Stage 3: Full-thickness tissue loss. Subcutaneous fat may be visible but bone, tendon,
or muscles are not exposed. Slough may be present but does not obscure the depth of tissue
loss. May include undermining and tunneling.
OASIS-B Definition:
M0450c. Stage 3: Full-thickness skin loss involving damage or necrosis of subcutaneous
tissue which may extend down to, but not through, underlying fascia. The ulcer presents
clinically as a deep crater with or without undermining of adjacent tissue.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The CARE and OASIS-B definitions for Stage 3 pressure ulcers are
similar.

•

Scales: While the CARE item scale plateaus at 8 (8 = eight or more ulcers), the
OASIS-B item scale plateaus at 4 (4 = four or more ulcers).

Implications
•

It is not likely that any differences in OASIS-B and CARE assessments on this item
would be due to the difference in assessment time frame.

•

The presence of a Stage 1 item on OASIS-B that is not on CARE should probably not
impact the agreement observed on the Stage 3 items.

The overall frequencies for these items are shown in Tables 15-3a and 15-3b below,
followed by the cross-tabulation of the items in Table 15-3c.
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Table 15-3a
CARE admission frequency of stage 3 pressure ulcers (G02b) at assessment
CARE: Frequency of stage 3 pressure ulcers
Missing
0 = 0 ulcers*
1 = 1 ulcers
2 = 2 ulcers
3 = 3 ulcers
4 = 4 ulcers
Unknown

Frequency

Percent

+
4,526
39
11
+
+
+

+
98.7
0.9
0.2
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
*Assessments with no unhealed pressure ulcers at Stage 2 or higher or unstageable (III.G2)
were coded as having zero pressure ulcers on this item.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-3b
OASIS-B start of care frequency of stage 3 ulcers
OASIS-B: Frequency of stage 3 ulcers
0 = 0 ulcers
1 = 1 ulcers
2 = 2 ulcers
3 = 3 ulcers
4 = 4 or more

Frequency

Percent

4,527
41
15

98.7
0.1
0.3

+

+

+

+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-3c
CARE admission number of stage 3 pressure ulcers and OASIS-B start of care number of
stage 3 ulcers
OASISB: 0 = 0
ulcers

OASISB: 1 = 1
ulcers

OASISB: 2 = 2
ulcers

OASISB: 3 = 3
ulcers

OASISB: 4 = 4
or more
ulcers

OASISB: Total

0 = 0 ulcers

99.7*

0.2

+

+

+

4,526

1 = 1 ulcers

+

84.6*

+

+

+

39

2 = 2 ulcers

+

+

+

+

+

11

3 = 3 ulcers

+

+

+

+

+

+

4 = 4 ulcers
9 = Unknown

+
+

+
+

+
+

+
+

+
+

+
+

41

15

+

+

4,587

CARE: Frequency of stage 3
pressure ulcers

Total

4,527

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 4. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
•

As indicated by the areas marked with an asterisk in Table 15-3c, there is a high
degree of agreement between the CARE and OASIS-B items where predicted for
numbers of Stage 3 pressure ulcers.

•

Among those patients with no Stage 3 pressure ulcers indicated in CARE,
99.7 percent also had no Stage 3 pressure ulcers indicated in OASIS-B.

•

Similarly, among those with one Stage 3 pressure ulcer recorded in CARE,
84.6 percent also had one Stage 3 pressure ulcer recorded in OASIS-B.

•

The very small cell sizes for three or four Stage 3 pressure ulcers (n = 3 and n = 1,
respectively) recorded on either tool mitigate any concern over the low agreement
between CARE and OASIS-B on these items.

CARE Item: Number of Stage 4 Pressure Ulcers (item III.G2c)
OASIS-B Item: Number of Stage 4 Ulcers (item M0450d)
The Skin Integrity section of the CARE Item Set asks how many Stage 4 pressure ulcers
(G2c) were present during the 2-day admission assessment window, while the OASIS-B asks
how many Stage 4 ulcers were present (M0450d) on the day of the home visit and time during
the home visit. The definitions from the CARE and OASIS-B are included below.
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CARE Definition:
G2c. Stage 4: Full-thickness tissue loss with visible bone, tendon, or muscle. Slough or
eschar may be present on some parts of the wound bed. Often includes undermining and
tunneling.
OASIS-B Definition:
M0450d. Stage 4: Full-thickness skin loss with extensive destruction, tissue necrosis, or
damage to muscle, bone, or supporting structures (e.g., tendon, joint capsule, etc.).
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is day of the assessment visit.

•

Item Definitions: The CARE and OASIS-B definitions for Stage 4 pressure ulcers are
similar.

•

Scales: While the CARE item scale plateaus at 8 (8 = eight or more ulcers), the
OASIS-B item scale plateaus at 4 (4 = four or more ulcers).

Implications
•

It is not likely that any differences in OASIS-B and CARE assessments on this item
would be due to the difference in assessment time frame.

•

Additionally, category 4 on the OASIS-B tool (four or more ulcers) will incorporate
CARE categories 4 (four ulcers), 5 (five or more ulcers), 6 (six or more ulcers), 7
(seven or more ulcers), and 8 (eight or more ulcers).

The overall frequencies for these items are shown in Tables 15-4a and 15-4b below,
followed by the cross-tabulation of the items in Table 15-4c.
Table 15-4a
CARE admission frequency of stage 4 pressure ulcers (G02b) at assessment
CARE: Frequency of stage 4 pressure ulcers
Missing
0 = 0 ulcers*
1 = 1 ulcers
2 = 2 ulcers
Unknown

Frequency
+
4,563
17
+
+

Percent
+
99.5
0.4
+
+

+ Cells based on a sample size of n < 11 are not shown.
* Assessments with no unhealed pressure ulcers at Stage 2 or higher or unstageable (III.G2) were
coded as having zero pressure ulcers on this item.
NOTE: Missing = 4.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-4b
OASIS-B start of care frequency of stage 4 ulcers
OASIS-B: Frequency of stage 4 ulcers
Frequency
0 = 0 ulcers
1 = 1 ulcers
2 = 2 ulcers
3 = 3 ulcers
4 = 4 or more

45.7
17
+
+
+

Percent
99.6
0.4
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
•

There is a high degree of agreement between the CARE and OASIS-B items for
numbers of Stage 4 pressure ulcers. There were very few Stage 4 ulcers at admission
in this sample. These results are not shown in a table.

•

Among those with no Stage 4 pressure ulcers indicated in CARE, 100 percent also
had no Stage 4 pressure ulcers indicated in OASIS-B.

•

Similarly, among those with one Stage 4 pressure ulcer recorded in CARE,
88.2 percent also had one Stage 4 pressure ulcer recorded in OASIS-B.

•

It is not possible to draw any conclusions about the agreement between the CARE
and OASIS-B item for any of the responses indicating more than one Stage 4 pressure
ulcer.

CARE Item: Number of Unstageable Pressure Ulcers (item III.G2d)
OASIS-B Item: Number of Unobservable Pressure Ulcers (item M0450e)
The Skin Integrity section of the CARE Item Set asks how many unstageable pressure
ulcers (item III.G2d) were present during the 2-day admission assessment window, while the
OASIS-B asks if the patient has at least one pressure ulcer that cannot be observed (M0450e) on
the day of the home visit and time during the home visit. The definitions from the CARE and
OASIS-B are included below.
CARE Definition:
G2d. Unstageable: Full-thickness tissue loss in which the base of the ulcer is covered by
slough (yellow, gray, green, or brown) or eschar (tan, brown, or black) in the wound bed.
Include ulcers that are known or likely, but are not stageable due to non-removable dressing,
device, cast, or suspected deep tissue injury in evolution.
OASIS-B Definition:
M0450e. Unobservable Pressure Ulcers: In addition to the above, is there at least one
pressure ulcer that cannot be observed due to the presence of eschar or a non-removable
dressing, including casts?
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Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the visit.

•

Item Definitions: The CARE definition includes unstageable ulcers but also includes
ulcers that are known or likely but not stageable due to a non-removable dressing,
device, cast, or suspected deep tissue injury in evolution, while OASIS-B only
indicates the presence or absence of any pressure ulcers that cannot be observed due
to the presence of an eschar or a non-removable dressing, including casts, rather than
a count.

•

Scales: While the CARE item scale plateaus at 8 (8 = eight or more ulcers), the
OASIS-B item identifies whether at least one pressure ulcer in this category is present
or not.

Implications
•

It is not likely that any differences in OASIS-B and CARE assessments on this item
would be due to the difference in assessment time frame.

The overall frequencies for these items are shown in Tables 15-5a and 15-5b below,
followed by the cross-tabulation of the items in Table 15-5c.
Table 15-5a
CARE admission frequency of unstageable unhealed pressure ulcers (G02d) at assessment
CARE: Unstageable unhealed pressure ulcer at
assessment count
0 = 0 ulcers*
1 = 1 ulcers
2 = 2 ulcers
3 = 3 ulcers
9 = Unknown

Frequency
4,557
18
+
+
+

Percent
99.4
0.4
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
*Assessments with no unhealed pressure ulcers at Stage 2 or higher or unstageable (III.G2) were
coded as having zero pressure ulcers on this item.
NOTE: Missing = 4.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-5b
OASIS-B start of care presence of at least one unobservable ulcer
OASIS-B: Unobservable pressure ulcer
0 = No
1 = Yes

Frequency
4,563
24

Percent
99.5
0.5

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Table 15-5c
CARE admission unstageable ulcer item by OASIS-B start of care presence of at least one
unobservable pressure ulcer item
CARE: Admission unstageable ulcer

0 = No

1 = Yes

Total

99.9*
44.4
+
+
+
4,563

0.1
55.6*
+
+
+
24

4,557
18
+
+
+
4,587

0 = 0 ulcers
1 = 1 ulcers
2 = 2 ulcers
3 = 3 ulcers
9 = Unknown
Total

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 4. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
•

As indicated by the areas marked with an asterisk in Table 15-5c, there is a fair
degree of agreement where it was predicted between the CARE item for number of
unstageable/unobservable pressure ulcers and the OASIS-B items for any
unobservable pressure ulcers.

•

Among those patients with “no” unstageable/unobservable pressure ulcers indicated
in CARE, 99.9 percent also had no unobservable pressure ulcers indicated in
OASIS-B.

•

The low prevalence of any unstageable/unobservable pressure ulcers in the sample
make it difficult to interpret the few cases where CARE reports an ulcer but OASIS-B
does not.
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CARE Item: Number of Surgical Wounds with Delayed Healing (item III.G5a)
OASIS-B Item: Status of Most Problematic (Observable) Surgical Wound (item M0488)
The Skin Integrity section of the CARE Item Set asks how many surgical wounds with
delayed healing (item III.G5a) were present during the 2-day admission assessment window,
while the OASIS-B identifies the degree of healing visible in the most problematic surgical
wound (M0488) on the day of the visit. The definitions from the CARE and OASIS-B are
included below.
In order to compare these items, a new binary CARE variable was created to indicate
whether any surgical wounds were recorded in item III G5a. This CARE variable indicating Any
Surgical Wounds Present was compared to the OASIS-B M0488 Status of Most Problematic
Surgical Wound item responses.
CARE Definition:
G5a. Delayed Healing of Surgical Wound: A major wound that requires ongoing care
from delayed healing.
OASIS-B Definition:
M0488. Status of Most Problematic (Observable) Surgical Wound: Identifies the degree
of healing visible in the most problematic surgical wound. The “most problematic” wound is
the one that may be complicated by the presence of infection, location of wound, large size,
difficult management of drainage, or slow healing. [1] Fully granulating; [2] Early/partial
granulation; [3] Not-healing; [NA] No observable surgical wound.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The CARE definition asks for the number of major surgical wounds
with delayed healing while OASIS-B identifies the degree of healing visible in the
most problematic surgical wound.

•

Scales: While the CARE item scale for this item is based on the number of wounds,
the OASIS-B item assesses the status of the most problematic wound and moves from
fully granulating (1) to not healing (3).

Implications
•

The differences in item definitions, in particular the classification of a wound as
“unhealed” for CARE versus “fully granulating” for OASIS-B is likely to result in
some inconsistencies between the two tools for less severe surgical wounds. Fully
granulating wounds on OASIS-B may or may not get counted on CARE.

The overall frequencies for these items are shown in Tables 15-6a, 15-6b, and 15-6c
below, followed by the cross-tabulation of the items in Tables 15-6d and 15-6e.
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Table 15-6a
CARE admission count of delayed healing surgical wounds
CARE: Major wound count: Delayed healing surgical
wound
0*
1
2
3
4
5
6
7

Frequency

Percent

4,315
219
26
+
+
+
+
+

94.1
4.8
0.6
+
+
+
+
+

*Responses for patients with no major wounds that require ongoing care because of draining,
infection, or delayed healing (III.G5) were coded as zeros on this item.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 13.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Table 15-6b
CARE admission indicator of delayed healing surgical wounds
CARE: Surgical wound > 0

Frequency

0*
1

4,315
259

Percent
94.07
5.65

*Responses for patients with no major wounds that require ongoing care because of draining,
infection, or delayed healing (III.G5) were coded as zeros on this item.
NOTE: Missing = 13.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-6c
OASIS-B start of care status of most problematic (observable) surgical wound
OASIS-B: Surgical wound indicator

Frequency

No observable surgical wound
1 = Fully granulating
2 = Early/partial granulation
3 = Not healing

3,303
305
799
180

Percent
72.0
6.7
17.4
3.9

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Table 15-6d
CARE admission count of unhealed surgical wounds at admission item by OASIS-B start of
care status of most problematic (observable) surgical wound
CARE: Count of
unhealed surgical
wounds

No
observable
surgical
wound

0

75.9*

1
2

1 = Fully
granulating

2=
Early/partial
granulation

3 = Not
healing

Total

6.8*

14.9

2.4

7.8
+

+
+

58.9*
61.5*

29.7*
+

3

+

+

+

+

+

4

+

+

+

+

+

5
6

+
+

+
+

+
+

+
+

+
+

7

+

+

+

+

+

3,303

305

799

180

Total

4,315
219
26

4,587

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 13. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-6e
CARE indicator of unhealed surgical wounds at admission item by OASIS-B start of care
status of most problematic (observable) surgical wound

CARE: Unhealed
surgical wound
0
1

No
observable
surgical
wound
75.9*
7.3

Total

3,303

1 = Fully
granulating
6.8*
+
305

2=
Early/partial
granulation

3 = Not
healing

Total

2.4
29.7*

4,315
259

180

4,587

14.9
59.5*
799

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 13. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
Comparison of number of surgical wounds in CARE with most problematic surgical wound
in OASIS-B:
•

As indicated by the areas marked with an asterisk in Table 15-6d, there is substantial
agreement between the CARE item for number of surgical wounds with delayed
healing and the OASIS-B items for most problematic surgical wound.

•

Among those patients with no delayed healing surgical wounds indicated in CARE,
82.7 percent had either no problematic surgical wounds or fully granulated surgical
wounds indicated in OASIS-B.

•

Similarly the agreement for those with one delayed healing surgical wound in CARE
is relatively high at 88.6 percent (either partial granulation or not healing in
OASIS-B). The same level of agreement is evident when two delayed healing
surgical wounds are indicated in CARE.

Comparison of any surgical wounds in CARE with most problematic surgical wound in
OASIS-B:
•

As indicated by the areas marked with an asterisk in Table 15-6e, there is substantial
agreement between the CARE indicator for any surgical wounds with delayed healing
and the OASIS-B items for most problematic surgical wound.

•

Similar to the pattern observed in the previous comparison, there is a high degree of
agreement between patients with no delayed healing of a surgical wound in CARE
with those who had no surgical wounds (75.9 percent) or fully granulated surgical
wounds (6.8 percent) in OASIS-B.
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•

Among those with at least one delayed healing surgical wounds indicated in CARE,
89.2 percent had either partially granulated or not healing surgical wounds in
OASIS-B.

CARE Item: Number of Diabetic Foot Ulcer(s) (item III.G05c) and Number of Vascular
Ulcer(s) (Arterial or Venous Including Diabetic Ulcers not Located on the Foot) (item
III.G05d)
OASIS-B Item: Current Number of Observable Stasis Ulcer(s) (M0470)
To be able to compare CARE items with the OASIS-B item Number of Observable Stasis
Ulcers that is used in HHA prospective payment system (PPS), it was necessary to combine two
CARE items. The Skin Integrity section of the CARE Item Set asks how many diabetic foot
ulcers (item III.G5c) and vascular ulcers (item III.G5d) were present during the 2-day admission
assessment window, while the OASIS-B identifies the current number of observable stasis ulcers
(M0470) in the day of the assessment visit. The definitions from the CARE and OASIS-B are
included below.
A new CARE variable was created to indicate the number of either diabetic foot ulcers
and/or vascular ulcers, with 4 representing four or more of these ulcers. This CARE variable
indicating Number of Diabetic or Vascular Ulcers Present (S03_G05DiabeticPlusVascular) was
compared to the OASIS-B M0470 Number of Current Observable Stasis Ulcer item responses.
CARE Definition:
G5c. Diabetic Foot Ulcer(s): Diabetic Foot Ulcer(s)
CARE Definition:
G5d. Vascular Ulcer(s): Arterial or venous, including diabetic ulcers not located on the
foot.
OASIS-B Definition:
M0470. Number of Observable Stasis Ulcer(s): Identifies the number of visible
(observable) stasis ulcers. [0] Zero; [1] One; [2] Two; [3] Three; [4] Four or more.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: Combined, items III.G5c and III.G5d on CARE are similar in
definition to the definition of M0470.

•

Scales: While the scales for the CARE items do not have an upper bound, the new
combined variable was scaled to match the OASIS-B item which is truncated at 4
(4 = four or more stasis ulcers).
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Implications
•

The OASIS-B and CARE assessments are not likely to indicate that a patient has
different numbers of stasis ulcers, including diabetic foot ulcers and vascular ulcers,
due to the difference in assessment time frame.

•

Additionally, category 4 on the OASIS-B tool (four or more ulcers) will incorporate
any score on CARE on III.G5c and III.G5d, combined, that is greater than or equal to
4.

•

Combining two items on CARE may result in higher counts than OASIS-B because
of the potential that clinicians double-counted wounds responding to each item, but
also because the more explicit list on the CARE Item Set might result in better
detection of existing wounds.

The overall frequencies for these items are shown in Tables 15-7a and 15-7b below,
followed by the cross-tabulation of the items in Table 15-7c.
Table 15-7a
CARE admission count of diabetic and vascular ulcers at assessment
CARE: Diabetic and vascular ulcers

Frequency

0
1
2
3
4 or more

4,442
82
23
+
16

+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 15.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Percent
96.8
1.8
0.5
+
0.4

Table 15-7b
OASIS-B start of care count of stasis ulcers at assessment
OASIS-B: Stasis ulcer

Frequency

Percent

Missing
0*

461
4,039
47
12
+
19

10.1
88.1
1.0
0.3
+
0.4

1
2
3
4 or more

+ Cells based on a sample size of n < 11 are not shown.
*Responses for patients with no current observable stasis ulcers (M0470 = 0) were coded as
zeros on this item.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Table 15-7c
CARE admission count of diabetic and vascular ulcers at assessment item by OASIS-B start
of care count of stasis ulcers
CARE: Diabetic
plus vascular

Missing

0

1

2

3

4 or
more

Total

0

10.4

89.1*

0.4

+

+

+

4,442

1

+

61.0

30.5*

+

+

+

82

2

+

47.8

+

+

+

+

23

3
4 or more

+

+

+

+

+

+

+

+

+

+

+

+

+

16

461

4,039

47

12

+

19

Total

4,587

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing CARE Item = 15. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
•

As indicated by the areas marked with an asterisk in Table 15-7c, there is a high level
of agreement between the CARE variable for number of diabetic foot ulcers or
vascular ulcers and the OASIS-B items for number of observable stasis ulcers.

•

CARE Item Set tended to have higher counts of ulcers than OASIS-B.
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•

Among patients with no diabetic or vascular ulcers on CARE Item Set, 89.1 percent
had no stasis ulcers reported in OASIS-B.

C. Cognitive Status, Mood, and Pain: Pain
CARE Item: Pain Effect on Activities (item IV.G05)
OASIS-B Item: Frequency of Pain Interfering with Patient’s Activity or Movement
(item M0420)
The Pain section of the CARE Item Set asks if the patient has limited his/her activities
because of pain during the 2-day admission assessment window (item IV.G5), while the
OASIS-B item identifies the frequency with which pain interferes with patient’s activity or
movement (M0420) during the visit. The definitions from the CARE and OASIS-B instruments
are included below.
CARE Definition:
G5. Pain Effect on Activities: During the past 2 days, have you limited your activities
because of pain?
OASIS-B Definition:
M0420. Frequency of Pain: Identifies frequency with which pain interferes with patient’s
activities, with treatment if prescribed. Frequency of Pain interfering with patient’s activity
or movement: [0] Patient has no pain or pain does not interfere with activity or movement;
[1] Less often than daily; [2] Daily, but not constantly; [3] All of the time.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit. Both tools employ interviews. The OASIS-B manual also suggests the use of
history and referral information if responses are not available through interviews.

•

Item Definitions: The CARE and OASIS-B definitions for the effect of pain on
activities are similar.

•

Scales: While the CARE scale assesses the patient with either no (0), yes (1), or
unable to answer or no response (8), the OASIS-B scale is more subdivided,
including patient has no pain or pain does not interfere with activity or movement (0),
less often than daily (1), daily, but not constantly (2), or all of the time (3).

Implications
•

The OASIS-B and CARE assessments may indicate that a patient has different effects
of pain on activities due to the difference in assessment time frame and sources of
information if referral information and history are used for OASIS-B items.

•

The OASIS-B items include responses indicating that the patient has pain daily,
which may be difficult to assess reliably in the span of the assessment window and
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therefore may result in increased variability between the OASIS-B responses and the
CARE responses.
•

Additionally, a score of 1 on the CARE Item Set may incorporate any score of 1, 2, or
3 on OASIS-B.

The overall frequencies for these items are shown in Tables 15-8a and 15-8b below,
followed by the cross-tabulation of the items in Table 15-8c.
Table 15-8a
CARE admission presence of pain effect on activities
CARE: Pain interview: Pain effect on activities
No pain or hurting in last 2 days or missing
0 = No
1 = Yes
8 = Unable to respond

Frequency

Percent

1,580
913
2,084
+

34.5
19.9
45.4
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Table 15-8b
OASIS-B start of care frequency of pain effect on activities
OASIS-B: Frequency of pain effect on activities

Frequency

Percent

0 = Patient has no pain or pain does not interfere with
activity or movement
1 = Less often than daily
2 = Daily, but not constantly
3 = All of the time

1,326

28.9

595
2,133
533

13.0
46.5
11.6

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-8c
CARE admission presence of pain effect on activities by OASIS-B start of care pain effect
on activities items

CARE: Pain effect on
activities

0 = Patient has no
pain or pain does not
interfere with
activity or
movement

1 = Less
often than
daily

2 = Daily,
but not
constantly

3 = All of
the time

Total

No pain or hurting in
last 2 days or missing

69.6*

14.8

14.2

1.4

1,580

0 = No

14.9*

18.3*

59.5

7.3

913

1 = Yes

4.3

9.2*

65.3*

21.3*

2,084

+
533

+
4,587

8 = Unable to respond
Total

+
1,326

+
595

+
2,133

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
•

As indicated by the areas marked with an asterisk in Table 15-8c, there was good
agreement between the CARE item for pain effect on activities and the OASIS-B
item for frequency of pain.

•

Note that only the patients who responded “Yes” to an initial question about the
presence of pain were assessed for pain’s effect on activities. Therefore, we have
viewed the 69.6 percent of patients with a missing value in CARE but no pain in
OASIS-B as a potential area of agreement.

•

A surprising finding is that among patients who responded “Yes” to any pain present
but who reported that pain does not limit their activities on CARE, the majority
(59.5 percent) had daily (but not constant) pain interfering with activity or movement
reported on OASIS-B.

•

Among patients who responded “Yes” to any pain present and reported that pain
limits their activities on CARE, 95.8 percent indicated that pain impacts their
movement or activities at some frequency (ranging from less often than daily to all of
the time) on OASIS-B.

•

The discrepancies between these items may result for multiple reasons. For example,
while the CARE item is an interview item, the OASIS-B item is not set up as a direct
interview item, although it may be assessed that way. In addition, differing item
definitions or differing assessment windows may also result in discrepancies, but
additional analyses may be undertaken to explore this further.
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D. Impairments: Bladder and Bowel Management
CARE Item: External or Indwelling Device or Require Intermittent Catheterization –
Bladder (item V.A02a)
CARE Item: Frequency of incontinence – Bladder (item V.A03a)
OASIS-B Item: Urinary Incontinence or Urinary Catheter Presence (item M0520)
The Bladder and Bowel Management section of the CARE Item Set asks if the patient
uses an external or indwelling device or requires intermittent catheterization for the bladder (item
V.A2a) and the frequency of incontinence (item V.A3a) during the 2-day admission assessment
window, while the OASIS-B asks about the presence of urinary incontinence or a condition that
requires urinary catheterization (M0520). The definitions from the CARE and OASIS-B are
included below.
CARE Definitions:
A2a. External or Indwelling Device or Require Intermittent Catheterization - Bladder:
Does the patient use an external or indwelling device or require intermittent catheterization?
A3a. Indicate the Frequency of Incontinence - Bladder: [0] Continent (no documented
incontinence); [1] Stress incontinence only (bladder only); [2] Incontinent less than daily
(only once during the 2-day assessment period); [3] Incontinent daily (at least once a day);
[4] Always incontinent; [5] No urine/bowel output (e.g., renal failure); [9] Not applicable
(e.g., indwelling catheter)
OASIS-B Definition:
M0520. Urinary Incontinence or Urinary Catheter Presence: Identifies presence of
urinary incontinence or condition that requires urinary catheterization of any type, including
intermittent or indwelling. The etiology of incontinence is not addressed in this item.
Urinary incontinence or urinary catheter presence: [0] No incontinence or catheter (includes
anuria or ostomy for urinary drainage); [1] Patient is incontinent; [2] Patient requires a
urinary catheter (i.e., external, indwelling, intermittent, suprapubic).
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The CARE item A2a is defined by the use of an external or
indwelling device or the requirement of intermittent catheterization while the
OASIS-B item is defined by urinary incontinence and the presence of a urinary
catheter.

•

Scales: The CARE scale assesses the patient with either no (0), or yes (1), the
OASIS-B scale is divided by no incontinence or catheter (0), patient is incontinent
(1), or patient requires a urinary catheter (2).
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Implications
•

The OASIS-B and CARE assessments are not likely to differ due to differences in
assessment time frames.

•

Because the OASIS-B item incorporates both incontinence and device use, it is not
possible to perfectly align the item scales.

The overall frequencies for these items are shown in Tables 15-9a(1), 15-9a(2), 15-9b(1),
and 15-9b(2) below, followed by the cross-tabulation of the items in Table 15-9c(1) and 159c(2).
Table 15-9a(1)
CARE admission presence of external or internal bladder device
CARE: Bladder: Device use
0 = No*
1 = Yes

Frequency
4,329
257

Percent
94.38
5.6

* Patients with no impairments in bowel or bladder management (V.A1) were coded
as having no bladder device use on this item.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 1.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-9a(2)
CARE admission frequency of bladder incontinence
CARE: Frequency of bladder incontinence
0 = Continent*
1 = Stress incontinence only
2 = Incontinent less than daily
3 = Incontinence daily
4 = Always incontinent
5 = No urine output
9 = Not applicable

Frequency
2,456
404
336
904
325
+
151

Percent
53.54
8.81
7.33
19.71
7.09
+
3.29

* Patients with no impairments in bowel or bladder management (V.A1) were coded as
continent on this item.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 1.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-9b
OASIS-B start of care urinary incontinence or catheter present
OASIS-B: Urinary incontinence

Frequency

Percent

2,382
2,022

51.93
44.08

183

3.99

0 = No incontinence or catheter (includes anuria or
ostomy for urinary drainage)
1 = Patient is incontinent
2 = Patient requires a urinary catheter (i.e., external,
indwelling, intermittent, suprapubic)

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-9c(1)
CARE admission presence of bladder device by OASIS-B start of care urinary incontinence
or catheter present

CARE: Presence of bladder
device
0 = No
1 = Yes
Total

0 = No incontinence
or catheter (includes
anuria or ostomy for
urinary drainage)

1 = Patient
is
incontinent

2 = Patient requires
a urinary catheter
(i.e., external,
indwelling,
intermittent,
suprapubic)

54.4*
9.3
2,382

45.3*
23.7
2,022

0.3
66.9*
183

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 1. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Total
4,329
257
4,587

Table 15-9c(2)
CARE admission frequency of urinary incontinence by OASIS-B urinary incontinence or
catheter present

CARE: Frequency of urinary
incontinence
0 = Continent
1 = Stress incontinence only
2 = Incontinent less than daily
3 = Incontinence daily
4 = Always incontinent
5 = No urine output
9 = Not applicable
Total

0 = No incontinence
or catheter (includes
anuria or ostomy for
urinary drainage)

1 = Patient
is
incontinent

2 = Patient requires
a urinary catheter
(i.e., external,
indwelling,
intermittent,
suprapubic)

92.5*
9.9
5.7
3.0
+
+
7.9
2,382

6.5
89.6*
93.5*
96.3*
94.8*
+
+
2,022

1.0
+
+
+
3.7
+
88.7*
183

Total
2,456
404
336
904
325
+
151
4,587

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 1. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
Comparison of CARE presence of external/internal device vs. OASIS-B frequency of
incontinence or catheter:
•

As indicated by the areas marked with an asterisk in Table 15-9c(1), there was a fair
amount of agreement where expected between the CARE item for presence of
internal or external bladder device and OASIS-B frequency of incontinence or urinary
catheter.

•

Among patients who were assessed as no external or internal urinary device on
CARE, 54.4 percent reported no urinary incontinence or catheter on OASIS-B.
Notably, an additional 45.3 percent who did not need a device on CARE were
recorded as incontinent but not requiring a catheter on OASIS-B. This suggests that
for patients without a bladder device recorded on the CARE Item Set, approximately
99.7 percent of responses were in agreement with the corresponding OASIS-B
assessment.

•

Among patients who were assessed as having an external or internal urinary device
on CARE, 66.9 percent were reported as requiring a urinary catheter on OASIS-B.
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•

The existence of some discrepancies between these items is not unexpected given that
the CARE item focuses exclusively on presence of a bladder device, while the
OASIS-B item combines information about incontinence and bladder devices. This
creates multiple areas of expected agreement as exhibited in Table 15-9c(1).

Comparison of CARE frequency of bladder incontinence vs. OASIS-B frequency of
incontinence or catheter:
•

As indicated by the areas marked with an asterisk in Table 15-9c(2), there was a high
amount of agreement between the CARE item for frequency of bladder incontinence
and OASIS-B frequency of incontinence or urinary catheter.

•

Among patients who were assessed as continent on the CARE Item Set, 92.5 percent
reported no urinary incontinence or catheter on OASIS-B.

•

Similarly, among patients who were assessed as either having stress incontinence,
incontinence less than daily, incontinence daily, or always incontinent, between
89.6 percent and 96.3 percent were reported to also be incontinent on OASIS-B,
indicating a high level of agreement.

•

In general, there were very few discrepancies between these items; those that
occurred may largely be due to differing item definitions. For example, while CARE
counts “stress incontinence” as a form of incontinence, this may not always be
considered incontinent in the OASIS-B though instructions state that if a patient is
incontinent at all (example given: “Sometimes I leak a bit”) the patient should be
included in the Incontinent category.

CARE Item: External or Indwelling Device or Require Intermittent Catheterization –
Bowel (item V.A02b)
OASIS-B Item: Ostomy for Bowel Elimination (item M0550)
The Bladder and Bowel Management section of the CARE Item Set asks if the patient
uses an external or indwelling device or requires intermittent catheterization for bowel
management (item V.A2b) during the 2-day admission assessment window, while the OASIS-B
asks about the presence of an ostomy for bowel elimination (M0550) and whether it is related to
a recent inpatient stay or a change in medical treatment plan in the last 14 days. The definitions
from CARE and OASIS-B are included below.
CARE Definition:
A2b. External or Indwelling Device or Require Intermittent Catheterization – Bowel:
Does the patient use an external or indwelling device or require intermittent catheterization?
OASIS-B Definition:
M0550. Ostomy for Bowel Elimination: Identifies whether the patient has an ostomy for
bowel elimination and, if so, whether the ostomy was related to a recent inpatient stay or a
change in medical treatment plan. Ostomy for Bowel Elimination: Does this patient have an
ostomy for bowel elimination that (within the last 14 days): a) was related to an inpatient
facility stay, or b) necessitated a change in medical or treatment regimen? [0] Patient does
not have an ostomy for bowel elimination; [1] Patient’s ostomy was not related to an
inpatient stay and did not necessitate change in medical or treatment regiment; [2] The
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ostomy was related to an inpatient stay or did necessitate change in medical or treatment
regimen.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit as well as the last 14 days.

•

Item Definitions: The CARE definition for item A2b is broader in scope than the
OASIS-B definition for M0550, incorporating both external and internal devices and
intermittent catheterization; OASIS-B subdivides the definition for ostomy as it is
related to an inpatient stay or a change in regimen.

•

Scales: The CARE item category of 1 (1 = yes) incorporates the OASIS-B item
categories of 1 (ostomy not related to an inpatient stay and did not necessitate change
in a medical or treatment program) and 2 (ostomy related to an inpatient stay or did
necessitate change in a medical condition).

Implications
•

The OASIS-B and CARE assessments may differ in reported use of an ostomy for
bowel elimination due to the difference in scales, and differences in the period of time
that the clinician can use to assess the patient. The longer assessment period on the
OASIS-B might result in a higher rate of use when examining the results from this
tool.

•

However, the CARE item is also more inclusive than the OASIS-B, including
intermittent catheterization in addition to both external and internal devices. It would
be expected that the data for these two items when compared would indicate patients
who have no ostomy use on the OASIS-B would show device use on the CARE item.

The overall frequencies for these items are shown in Tables 15-10a and 15-10b below,
followed by the cross-tabulation of the items in Table 15-10c.
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Table 15-10a
CARE admission presence of external or internal bowel device
CARE: Bowel: Device use
0 = No*
1 = Yes

Frequency
4,515
71

Percent
98.4
1.6

* Patients with no impairments in bowel or bladder management (V.A1) were coded as
having no bowel device use on this item.
NOTE: Missing = 1.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-10b
OASIS-B start of care presence of ostomy for bowel elimination
OASIS-B: Ostomy for bowel elimination
0 = Patient does not have an ostomy for bowel
elimination.
1 = Patient’s ostomy was not related to an inpatient stay
and did not necessitate change in medical or treatment
regimen.
2 = The ostomy was related to an inpatient stay or did
necessitate change in medical or treatment regimen.

Frequency

Percent

4,501

98.1

58

1.3

28

0.6

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-10c
CARE admission presence of external or internal bowel device by OASIS-B start of care
presence of device for bowel elimination

CARE: Bowel device
use

0 = Patient does not
have an ostomy for
bowel elimination

1 = Patient’s
ostomy was not
related to an
inpatient stay and
did not necessitate
change in medical
or treatment
regimen

2 = The ostomy
was related to an
inpatient stay or did
necessitate change
in medical or
treatment regimen

Total

0 = No

99.2*

0.6

0.2

4,515

1 = Yes

29.6

46.5

23.9

71

4,501

58

28

4,587

Total

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
NOTE: Missing = 1. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
•

As indicated by the areas marked with an asterisk in Table 15-10c, there was a
relatively high amount of agreement between the CARE item for presence of an
internal or external bowel device and OASIS-B presence of ostomy.

•

Among patients who reported no external or internal bowel device on the CARE Item
Set, 99.2 percent reported no ostomy on OASIS-B, which follows the expected
response pattern.

•

Similarly, it is also notable that the majority of patients reported to have an internal or
external bowel device on the CARE Item Set were assessed as having an ostomy that
either was (23.9 percent) or was not (46.5 percent) related to an inpatient stay or
change in treatment regimen on OASIS-B. As mentioned above, it is not unexpected
that patients with device use on the CARE Item Set are assessed in the data as having
“No ostomy” on OASIS-B, likely attributable to the more inclusive definition on the
CARE Item Set.

CARE Item: Indicate the Frequency of Incontinence – Bowel (item V.A03b)
OASIS-B Item: Bowel Incontinence Frequency (item M0540)
The Bladder and Bowel Management section of the CARE Item Set indicates the
frequency of bowel incontinence (item V.A3b) present during the 2-day admission assessment
window, while the OASIS-B asks about weekly frequency of bowel incontinence (M0540)
during the visit. The definitions from the CARE and OASIS-B instruments are included below.
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CARE Definition:
A3b. Indicate the Frequency of Incontinence – Bowel: Indicate the frequency of
incontinence – bowel.
OASIS-B Definition:
M0540. Bowel Incontinence Frequency: Identifies how often the patient experiences
bowel incontinence. Refers to the frequency of a symptom (bowel incontinence), not to the
etiology (cause) of that symptom. This item does not address treatment of incontinence or
constipation (e.g., a bowel program). Bowel Incontinence Frequency: [0] Very rarely or
never has bowel incontinence; [1] Less than once weekly; [2] One to three times weekly; [3]
Four to six times weekly; [4] On a daily basis; [5] More often than once daily; [NA] Patient
has ostomy for bowel elimination; [UK] Unknown.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The CARE definition for item A3b is equivalent to the OASIS-B
definition for M0550.

•

Scales: The CARE item categories of frequency, which are generally based on daily
units, differ in comparison to the categories of frequency for the OASIS-B, which are
based on weekly and daily units.

Implications
•

The OASIS-B and CARE assessments may indicate a difference in frequency of
bowel incontinence due to the difference in assessment scales and the assessment
time frame.

•

Additionally, most of the CARE item categories are equivalent to more than one
OASIS-B item category (i.e., a 2–Incontinent Less Than Daily on CARE is
equivalent to either a 1–Less Than Once Weekly or a 2–One to Three Times Weekly
for the OASIS-B item).

The overall frequencies for these items are shown in Tables 15-11a and 15-11b below,
followed by the cross-tabulation of the items in Table 15-11c.
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Table 15-11a
CARE admission frequency of bowel incontinence
CARE: Frequency of bowel incontinence
0 = Continent*
2 = Incontinent less than daily
3 = Incontinence daily
4 = Always incontinent
5 = No bowel output
9 = Not applicable

Frequency

Percent

3,886
335
156
114
+
88

84.72
7.30
3.40
2.49
+
1.92

* Patients with no impairments in bowel or bladder management (V.A1) were coded as
continent on this item (V.A2b).
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 1.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-11b
OASIS-B start of care frequency of bowel incontinence
OASIS-B: Bowel incontinence frequency
0 = Very rarely or never has bowel incontinence
1 = Less than once weekly
2 = One to three times weekly
3 = Four to six times weekly
4 = On a daily basis
5 = More often than once daily
NA = Patient has ostomy for bowel elimination
Unknown

Frequency

Percent

3,933
164
175
77
115
34
86
+

85.74
3.58
3.82
1.68
2.51
0.74
1.87
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-11c
CARE admission frequency of bowel incontinence by OASIS-B start of care frequency of bowel incontinence
0 = Very
rarely or
never has
bowel
incontinence

0 = Continent

Unknown

Total

+

+

1.0

+

3,886

8.1*

+

+

+

+

335

17.9

17.9*

33.3*

5.1*

+

+

156

+

9.6

14.0

40.4*

17.5*

9.6

+

114

+
+

+
+

+
+

+
+

+
+

+
39.8*

+
+

+
88

164

175

77

115

34

86

+

4,587

1 = Less
than once
weekly

3 = Four
to six
times
weekly

4 = On
a daily
basis

96.2*

1.6

0.7

+

2 = Incontinent less than
daily

29.9*

26.9*

31.9*

3 = Incontinence daily

19.9

+

4 = Always incontinent

+
+
53.4*

CARE: Frequency of
bowel incontinence

5 = No bowel output
9 = Not applicable
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5 = More
often than
once daily

NA = Patient
has ostomy
for
bowel
elimination

2 = One
to three
times
weekly

Total

3,933

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 1. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
•

As indicated by the areas marked with an asterisk in Table 15-11c, there was a high
amount of agreement between the CARE item for frequency of bowel incontinence
and OASIS-B frequency of bowel incontinence.

•

Specifically, there was a relatively high amount of agreement for patients who were
reported to have bowel incontinence less than daily on the CARE. Of patients with
incontinence less than daily indicated on the CARE Item Set, 96.8 percent were
reported to have OASIS-B responses that indicate incontinence less than daily: “No
or very rare bowel incontinence”, “Incontinence less than weekly”, “Incontinence one
to three times weekly” or “Incontinence four to six times weekly.”

•

Similarly, it is also notable that the majority of patients reported as always incontinent
of bowel on the CARE Item Set were assessed as incontinent either daily
(40.4 percent) or more than daily (17.5 percent) on OASIS-B.

•

The majority of patients (71.4 percent) assessed with “No bowel output” on the
CARE Item Set were reported as having no incontinence or very rare incontinence on
OASIS-B.

•

The “Not applicable” responses on the CARE Item Set were split between the “Very
rarely or never has bowel incontinence” and “Not applicable” on OASIS-B. There
were 53.4 percent of the 88 patients who were rated as “Very rarely or never has
bowel incontinence,” and 39.8 percent were coded as “Not applicable” on the
OASIS-B instrument.

E. Impairments: Hearing, Vision, and Communication
CARE Item: Ability to See in Adequate Light (item V.C1c)
OASIS-B Item: Vision (item M0390)
The Hearing, Vision, and Communication section of the CARE Item Set assesses the
patient’s usual ability to see in adequate light (item V.C1c), during the 2-day admission
assessment window. The OASIS-B similarly identifies the patient’s ability to see and function
within his/her environment. The definitions from the CARE and OASIS-B are included below.
CARE Definition:
C1c. Ability to See in Adequate Light (with Glasses or Other Visual Appliances).
OASIS-B Definition:
M0390. Vision: Identifies the patient’s ability to see and visually manage (function) within
his/her environment, wearing corrective lenses if these are usually worn. Vision with
corrective lenses if the patient usually wears them: [0] Normal vision: see adequately in most
situations; can see medication labels or newsprint; [1] Partially impaired: cannot see
medication labels or newsprint, but can see obstacles in path and the surrounding layout; can
count fingers at arm’s length; [2] Severely impaired: cannot locate objects without hearing or
touching them or patient nonresponsive.
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Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The CARE and OASIS-B definitions for ability to see in light or
vision are similar. Both include the use of corrective lenses; however, they do use
slightly different terminology to define the levels. The least impaired category on
CARE is defined as “adequate” as compared to “normal” on OASIS-B.

•

Scales: While the CARE item scale ascends to demonstrate the ability to see in
adequate light, the OASIS-B item scale ascends to demonstrate the impact of the
patient’s vision impairment on the ability to read or see objects.

Implications
•

The least impaired category on CARE, being defined as “adequate,” appears to be
more easily achieved than “normal” on OASIS-B, so we might anticipate some
discrepancies at this level, with more patients being assessed in the least impaired
category on the CARE Item Set than on the OASIS-B instrument.

The overall frequencies for these items are shown in Tables 15-12a and 15-12b below,
followed by the cross-tabulation of the items in Table 15-12c.
Table 15-12a
CARE admission ability to see in adequate light
CARE: Vision: Ability to see in adequate light
1 = Severely impaired
2 = Mildly to moderately impaired
3 = Adequate*
8 = Unable to assess
9 = Unknown

Frequency

Percent

117
890
3,536
38
+

2.6
19.4
77.1
0.8
+

* Patients with no impairments with hearing, vision, or communication (V.C1) were coded
as having adequate vision on this item (V.C1c).
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 1.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-12b
OASIS-B start of care vision ability
OASIS-B: Vision
0 = Normal vision: sees adequately in most situations;
can see medication labels, newsprint.
1 = Partially impaired: cannot see medication labels or
newsprint, but can see obstacles in path, and the
surrounding layout; can count fingers at arm’s length.
2 = Severely impaired: cannot locate objects without
hearing or touching them or patient nonresponsive.

Frequency

Percent

3,605

78.6

915

20.0

67

1.5

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-12c
CARE admission ability to see in adequate light by OASIS-B start of care ability to see

0 = Normal vision:
sees adequately in
most situations; can
see medication
labels, newsprint

1 = Partially
impaired: cannot
see medication
labels or newsprint,
but can see
obstacles in path,
and the surrounding
layout; can count
fingers at arm’s
length

2 = Severely
impaired: cannot
locate objects
without hearing or
touching them or
patient
nonresponsive

+

47.9

49.6*

2 = Mildly to moderately
impaired

28.8

70.9*

3 = Adequate

93.8*

6.2

8 = Unable to assess

68.4

OASIS-B: Vision
1 = Severely impaired

9 = Unknown
Total

+

Total
117
890
3,536

+

+
+

+
+
+

3,605

915

67

4,587

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 1. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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38

+

Summary Results
•

As indicated by the areas marked with an asterisk in Table 15-12c, there is a fairly
high degree of agreement between the CARE and OASIS-B items at the unimpaired
or slightly impaired levels, although this decreases to only moderate agreement at the
most severely impaired categories.

•

Among those with adequate vision reported in CARE, 93.8 percent also had normal
vision indicated in OASIS-B. Similarly, among those with mildly to moderately
impaired vision in CARE, 70.9 percent were assessed as partially impaired in
OASIS-B.

•

Notably, of the patients identified as severely impaired in CARE, there was an
approximately even distribution of responses between the expected OASIS-B
response, severely impaired (49.6 percent), and the next less severe category, partially
impaired (47.9 percent). Since the descriptions for “severely impaired” in CARE and
OASIS-B are quite similar, we would expect greater agreement in responses. The
scoring for these two categories of severity is the opposite in comparison to the other
instrument’s scoring. The unexpected result of the even distribution of responses for
these two items may be the result of clinical error when scoring these items.

F. Impairments: Respiratory Status
CARE Item: Respiratory Status – Short of Breath (item V.F1a-b)
OASIS-B Item: Short of Breath (item M0490)
The Respiratory Status section of the CARE Item Set assesses whether the patient is
dyspneic or noticeably short of breath with and without supplemental oxygen (item V.F1a-b)
during the 2-day admission assessment window. The OASIS-B similarly identifies the patient’s
level of shortness of breath during the time of the visit. The definitions from the CARE and
OASIS-B are included below. CARE assesses the patient on respiratory status with
supplemental oxygen and without supplemental oxygen separately, while the OASIS-B does not
differentiate whether the patient is on oxygen or not. Therefore, the use of an additional
respiratory status item on OASIS-B would allow stratification of the analyses to see how well the
items on the respective tools compare once the OASIS-B item for oxygen is controlled.
For this analysis, three distinct comparisons were conducted:
1. Comparison of CARE item F1a. Respiratory Status with Supplemental Oxygen with
the OASIS-B item M0490 Short of Breath using the full CARE–OASIS-B analytic
sample (see Table 15-13c(1)).
2. Comparison of CARE item F1a. Respiratory Status with Supplemental Oxygen with
the OASIS-B item M0490 Short of Breath using only patients from the CARE–
OASIS-B analytic sample who had “Oxygen Use” reported on OASIS-B item M0500
Respiratory Treatments (see Table 15-13c(2)).
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3. Comparison of CARE item F1b. Respiratory Status without Supplemental Oxygen
with the OASIS-B item M0490 Short of Breath including only those patients where
no oxygen use is indicated on the CARE–OASIS-B (see Table 15-13c(3)).
CARE Definition:
F1a. Respiratory Status with Supplemental Oxygen: Was the patient dyspneic or
noticeably short of breath?
CARE Definition:
F1b. Respiratory Status without Supplemental Oxygen: Was the patient dyspneic or
noticeably short of breath?
OASIS-B Definition:
M0490. Short of Breath: Identifies the patient’s level of shortness of breath. When is the
patient dyspneic or noticeably short of breath? [0] Never, patient is not short of breath; [1]
When walking more than 20 feet, climbing stairs; [2] With moderate exertion (e.g., while
dressing, using commode or bedpan, walking distances less than 20 feet); [3] With minimal
exertion (e.g., while eating, talking, or performing other activities of daily living (ADLs)) or
with agitation; [4] At rest (during the day or night).
OASIS-B Definition:
M0500. Respiratory Treatments Utilized at Home: Oxygen (intermittent or continuous),
ventilator (continually or at night), continuous airway pressure, or none of the above.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The CARE and OASIS-B definitions for respiratory status,
including whether the patient is dyspneic or short of breath, are similar.

•

Scales: The CARE and OASIS-B item scales are similar, but the OASIS-B category
of 4 (at rest during the day or night) incorporates the CARE categories of 5 (severe,
with evidence that patient is struggling to breathe at rest) and 4 (mild at rest during
day or night).

•

The scales between the CARE and OASIS-B also differ in that the CARE respiratory
status item has two assessment scores that are entered for the respiratory status of the
patient who requires oxygen.

•

The CARE’s first score is “with supplemental oxygen” and the second is “without the
use of supplemental oxygen.” Patients who might be assessed on both items include
those who can use oxygen intermittently or are actively being weaned.

•

The OASIS-B item M0490 Short of Breath requires the clinician to assess the
patient’s respiratory status without distinguishing the patient’s respiratory status with
or without the use of supplemental oxygen. The OASIS-B asks the clinician to
include the respiratory treatment the patient utilizes at home in a separate item
(M0500).
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Implications
•

Since the OASIS-B item does not specify whether the patient should be assessed with
or without oxygen, but the CARE items do, we controlled for oxygen use in the
comparison of the two assessments in the two sub-analyses by using the OASIS-B
item to stratify the cross-tabulation of the CARE and OASIS-B items by whether the
patient has oxygen use reported on the OASIS-B (M0500). We anticipate that the
agreement between the two assessments may be lower for these items than others
because patients who only intermittently use oxygen, or who are being weaned, may
or may not have been using oxygen when they were assessed on the OASIS-B
respiratory status item.

The overall frequencies for these items are shown in Tables 15-13a(1-3) and 15-13b(1-3)
below, followed by the cross-tabulation of the items in Tables 15-13c(1-3).
Table 15-13a(1)
CARE admission respiratory status with supplemental oxygen, all patients
CARE: Respiratory: With supplemental O2 was patient
dyspneic or short of breath
0 = Never
1 = When climbing stairs
2 = With moderate exertion
3 = With minimal exertion
4 = Mild at rest
5 = Severe
8 = Not assessed
9 = Not applicable*

Frequency

Percent

99
52
259
180
94
24
162
3,714

2.16
1.13
5.65
3.92
2.05
0.52
3.53
80.97

* Patients with no impairments with respiratory status (V.F1) were coded as “Not
applicable” on this item.
NOTE: Missing = 3.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-13a(2)
CARE admission respiratory status with supplemental oxygen, when oxygen use is
indicated on OASIS-B
CARE: Respiratory: With supplemental O2 was patient
dyspneic or short of breath
0 = Never
1 = When climbing stairs
2 = With moderate exertion
3 = With minimal exertion
4 = Mild at rest
5 = Severe
8 = Not assessed
9 = Not applicable*

Frequency
36
32
210
167
92
22
44
130

Percent
4.91
4.37
28.65
22.78
12.55
3.0
6.0
17.74

* Patients with no impairments with respiratory status (V.F1) were coded as “Not
applicable” on this item.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-13a(3)
CARE admission respiratory status without supplemental oxygen, when oxygen use is not
indicated on OASIS-B
CARE: Respiratory: Without supplemental O2 was
patient dyspneic or short of breath
0 = Never*
1 = When climbing stairs
2 = With moderate exertion
3 = With minimal exertion
4 = Mild at rest
5 = Severe
8 = Not assessed
9 = Not applicable

Frequency
2,170
285
946
348
46
+
+
43

Percent
56.31
7.39
24.55
9.03
1.19
+
+
1.16

* Patients with no impairments with respiratory status (V.F1) were coded as “Never”
dyspneic on this item.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 2.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-13b(1)
OASIS-B start of care when patient is dyspneic or noticeably short of breath, all patients
OASIS-B: Patient dyspneic/short of breath

Frequency

Percent

0 = Never, patient is not short of breath

1,389

30.28

1 = When walking more than 20 feet, climbing stairs

1,161

25.31

2 = With moderate exertion (e.g., while dressing, using
commode or bedpan, walking distances less than 20
feet)

1,331

29.02

3 = With minimal exertion (e.g., while eating, talking, or
performing other ADLs) or with agitation

565

12.32

4 = At rest (during day or night)

141

3.07

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-13b(2)
OASIS-B start of care when patient is short of breath, for patients where oxygen use is
indicated on OASIS-B
OASIS-B: Patient dyspneic/short of breath
0 = Never, patient is not short of breath

Frequency

Percent

22

3.00

1 = When walking more than 20 feet, climbing stairs

123

16.78

2 = With moderate exertion (e.g., while dressing, using
commode or bedpan, walking distances less than
20 feet)

261

35.61

3 = With minimal exertion (e.g., while eating, talking, or
performing other ADLs) or with agitation

228

31.11

99

13.51

4 = At rest (during day or night)

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-13b(3)
OASIS-B start of care when patient is short of breath, for patients where oxygen use is not
indicated on OASIS-B
OASIS-B: Patient dyspneic/short of breath

Frequency

Percent

0 = Never, patient is not short of breath

1,367

35.47

1 = When walking more than 20 feet, climbing stairs

1,038

26.93

2 = With moderate exertion (e.g., while dressing, using
commode or bedpan, walking distances less than 20 feet)

1,070

27.76

337

8.74

42

1.09

3 = With minimal exertion (e.g., while eating, talking, or
performing other ADLs) or with agitation
4 = At rest (during day or night)

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-13c(1)
CARE admission respiratory status with oxygen by OASIS-B start of care when patient is short of breath, all patients
3 = With minimal
exertion
(e.g., while eating,
talking, or
performing other
ADLs) or with
agitation

4 = At rest
(during day or
night)
+

0 = Never,
patient is not
short of breath

1 = When walking
more than 20 feet,
climbing stairs

2 = With moderate
exertion (e.g., while
dressing, using
commode or bedpan,
walking distances
less than 20 feet)

0 = Never

+

39.4

42.4

+

1 = When climbing stairs
2 = With moderate exertion

+
+

55.8*
17.0

34.6
58.7*

+
17.8

+
4.2

52
259

3 = With minimal exertion

+

6.7

16.1

61.7*

15.0

180

4 = Mild at rest

+

+

+

31.9

48.9*

94

5 = Severe

+

+

+

+

62.5*

24

8 = Not assessed

+

33.3

48.1

11.7

36.7

26.2

26.9

9.3

0.9

3,714

1,389

1,161

1,331

565

141

4,587

CARE: Admission
respiratory status with
oxygen
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9 = Not applicable
Total

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 3. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

+

Total
99

162

Table 15-13c(2)
CARE admission respiratory status with oxygen compared with OASIS-B start of care when patient is short of breath, where
oxygen use indicated on OASIS-B

CARE: Admission
respiratory status with
oxygen

2 = With moderate
exertion (e.g., while
dressing, using
commode or bedpan,
walking distances
less than 20 feet)

3 = With minimal
exertion (e.g.,
while eating,
talking, or
performing other
ADLs) or with
agitation

4 = At rest
(during day or
night)
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0 = Never,
patient is not
short of breath

1 = When walking
more than 20 feet,
climbing stairs

0 = Never

+

33.3

47.2

+

+

36

1 = When climbing stairs

+

56.3*

37.5

+

+

32

2 = With moderate exertion

+

15.2

59.0*

20.0

+

210

3 = With minimal exertion

+

+

15.6

62.9*

16.2

167

4 = Mild at rest

+

+

+

32.6

47.8*

92

5 = Severe

+

+

+

+

59.1*

22

8 = Not assessed

+

+

50.0

+

+

44

Total

9 = Not applicable

8.5

24.6

38.5

24.6

+

130

Total

22

123

261

228

99

733

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Table 15-13c(3)
CARE admission respiratory status without oxygen by OASIS-B start of care when patient is short of breath, where no oxygen
use is indicated on OASIS-B
3 = With minimal
exertion
(e.g., while eating,
talking, or
performing other
ADLs) or with
agitation

1 = When walking
more than 20 feet,
climbing stairs

2 = With moderate
exertion (e.g., while
dressing, using
commode or bedpan,
walking distances
less than 20 feet)

60.6*

23.3

13.6

2.2

+

2,170

6.0
2.4

83.2*
27.2

9.5
65.8*

1.4
4.3

+
+

285
946

1.1

6.6

25.6

64.4*

+

348

4 = Mild at rest

+

+

21.7

26.1

5 = Severe
8 = Not assessed

+
+

+
+

+
+

+
+

9 = Not applicable

+

+

46.5

11.6

14.8

43

1,367

1,038

1,070

337

42

3,854

CARE: Admission
respiratory status without
oxygen
0 = Never
1 = When climbing stairs
2 = With moderate exertion
3 = With minimal exertion

267

Total

0 = Never,
patient is not
short of breath

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 2. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

4 = At rest
(during day or
night)

34.8*
+*
+

Total

46
+
+

Summary Results
Table 15-13c(1) – Comparison of CARE Patient’s Respiratory Status Using Supplemental
Oxygen vs. When the OASIS-B Patient is Short of Breath (Who May or May Not Use Oxygen)
•

As indicated by the areas marked with an asterisk in Table 15-13c(1), there was a
moderate amount of agreement between the CARE and the OASIS-B items for
shortness of breath when any type of respiratory status impairment was present.
Table 15-13c(1) indicates that when the patient who was assessed using oxygen for
the CARE rating 1 (When climbing stairs) was compared to the OASIS-B rating 1
(When walking more than 20 feet, climbing stairs) the agreement level was
55.8 percent; CARE rating 2 (With moderate exertion) compared to OASIS-B
rating 2 (With moderate exertion) resulted in 58.7 percent agreement. The two
OASIS-B levels overlap with the CARE levels, demonstrating a moderate level of
agreement.

•

Also on Table 15-13c(1), among patients with more severe respiratory impairment on
the CARE tool ranging from 4–Mild at Rest to 5–Severe, the levels of agreement
with the corresponding OASIS-B response 4–At Rest (this is the most severe OASISB rating) were 48.9 percent to 62.5 percent, respectively.

Table 15-13c(2) – Comparison of CARE Patient’s Respiratory Status when Using
Supplemental Oxygen vs. OASIS-B Respiratory Status Item “When short of breath” (M0490)
Who Use Oxygen (per OASIS-B item M0500)
•

Approximately 16 percent of patients (n = 733) in the sample used oxygen in the
home.

•

Similar to the previous comparison, the areas marked with an asterisk in
Table 15-13c(2) indicate a moderate amount of agreement between the CARE and
OASIS-B items for shortness of breath when any type of impairment was present.
The sample size for the CARE and OASIS-B instrument rating of “Never short of
breath” was less that 11; therefore, it is not included in this table.

Table 15-13c(3) – Comparison of CARE Patient’s Respiratory Status without Supplemental
Oxygen vs. OASIS-B Item “When Short of Breath” for Patients Who Do Not Use Oxygen
•

As indicated by the areas marked with an asterisk in Table 15-13c(3), there was high
agreement between the CARE respiratory status item for patients assessed without
supplemental oxygen and the OASIS-B item for shortness of breath whether M0500
indicated oxygen was not used by the patient in the home. Indeed, the agreement
between these two items is much higher than that found in the other two comparisons
and the importance of the agreement is enhanced by the large number of patient
assessments included in the “never” through “severe/at rest” scale ratings.

•

The percentage of agreement in the areas of expected overlap ranged from
34.8 percent to 83.2 percent among CARE patients who were assessed with
respiratory impairment that included the levels “when climbing stairs” through
“severe/at rest” when compared to the corresponding OASIS-B responses.
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•

The lower agreement percentages (for expected cross-tabulation ratings) were
observed primarily between the two highest CARE impairment levels (mild at rest
and severe) and the correspondingly highest impairment level on OASIS-B (at rest).

•

In contrast to the other respiratory comparisons, there was also agreement at the “no
impairment” levels. Among patients who reportedly never had respiratory
impairment on the CARE Item Set, 60.6 percent were reported to never be short of
breath on OASIS-B.

G. Functional Status
The functional status section of the CARE Item Set is composed of three major sections:
Core Self Care (Section A), Core Functional Mobility (Section B), and Supplemental Functional
Ability (Section C). The results below are organized by these three CARE sections. Alignment
between the OASIS-B and CARE functional item scales is variable for multiple reasons:
1. Since the CARE functional items were patterned more closely after the science
underlying IRF-PAI/FIM® functional items, the CARE Item Set may align more
closely with the IRF-PAI/FIM® definitions.
2. The OASIS-B items have variable scales from one item to the next.
3. The CARE functional status rating scale includes two dimensions within the scale:
whether help was provided to the patient and, if so, the level of assistance provided.
The OASIS-B ADL/instrumental activities of daily living (IADL) items collect data on
patient’s prior functional status in addition to current; however, in these analyses, we are
focusing on the responses for patients' current functional status so the effects of time frame
differences are likely minimal. Similarities and differences between the CARE Item Set
functional items and the OASIS-B functional items are discussed below.
•

Functional rating scales:
–

CARE Functional Scale vs. OASIS-B ADL/IADL Functional Scale: The
CARE functional item rating is a six-category scale, ranging from 6-1, while the
OASIS-B ADL/IADL scale includes varied categories and can range from 0-2, 03, 0-4, or 0-5 per item. Each group of rating scales included UK–unknown.

▪ The item scale order in the two instruments is reversed. For example, a

patient who is independent is scored as a 6 on the CARE Item Set, whereas
the same patient is scored as a 0 on the OASIS-B instrument.

▪ Both instrument scales assess for usual performance.
▪ Scale category definition differences exist between the two instruments.

Specifically, the CARE Item Set discriminates between a level 3–
Partial/Moderate Assistance and a level 2–Substantial/Maximum Assistance
by assessing whether the helper did more than half the effort. The OASIS-B
does not distinguish between these two levels (recall the order is reversed) and
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only identifies if someone must help the patient to complete the activity. The
level descriptions that vary per item for the OASIS-B will be included in
detail below. Differences between the instruments (e.g., the assessment time
frame window and the rating scales) are important considerations in
interpreting the mapping results. Because the OASIS-B items vary, we have
not included a mapping here as in the prior comparisons with the MDS and
IRF-PAI.
Core Self Care and Supplemental Functional Ability – Usual Performance
CARE Item: Upper Body Dressing (item VI.A5)
OASIS-B Item: Ability to Dress Upper Body (item M0650)
The Functional Status section of the CARE Item Set assesses a patient’s usual
performance regarding upper body dressing (item VI.A5) during the 2-day admission assessment
period. The OASIS-B also assesses upper body dressing (M0650). The definitions from the
CARE and OASIS-B are also included below for easy reference.
CARE Definition:
A5. Upper Body Dressing: The ability to put on and remove shirt or pajama top. Includes
buttoning if applicable.
OASIS-B Definition:
M0650. Ability to Dress Upper Body: Identifies the patient’s ability to dress upper body,
including the ability to obtain, put on, and remove upper body clothing. The prior column
should describe the patient’s ability 14 days prior to the start (or resumption) of care visit.
The focus for today’s assessment—the “current” column—is on what the patient is able to do
today. Ability to dress upper body (with or without dressing aids) including undergarments,
pullovers, front-opening shirts and blouses, managing zippers, buttons, and snaps: [0] Able to
get clothes out of closets and drawers, put them on and remove them from the upper body
without assistance; [1] Able to dress upper body without assistance if clothing is laid out or
handed to the patient; [2] Someone must help the patient with upper body clothing; [3]
Patient depends entirely upon another person to dress the upper body; [UK] Unknown.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The CARE and OASIS-B definitions for upper body dressing are
similar.

•

Scales: The CARE scale for this item ascends to demonstrate independence, while the
OASIS-B scale for this item descends to demonstrate independence. In addition, the
CARE scale is more subdivided to demonstrate if helper assistance is required by the
patient and at what amount of assistance is required. The OASIS-B items vary in the
rating scale depending on the functional status or ADL/IADL. The rating scale does
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not always measure the specific amount of the helper’s physical assistance; rather, it
measures that physical assistance was needed. The OASIS-B uses a specific rating
scale to indicate a patient’s total dependence for the most dependent level of
assistance.
Implications
•

It is not likely that any differences in OASIS-B and CARE assessments on this item
would be due to the difference in assessment time frame.

•

Additionally for the upper body dressing item, there would be expected agreement
when comparing the OASIS-B single rating level 2, with three different CARE rating
levels 4, 3, and 2. To clarify, OASIS-B level 2 (Someone Must Help the Patient Put
On Upper Body Clothing) would be expected to map to CARE levels 4–Supervision
or Touching Assistance, 3–Partial/Moderate Assistance, and 2–Substantial/Maximal
Assistance for the upper body dressing item.

Item frequencies by instrument are shown in Tables 15-14a and 15-14b below, followed
by the cross-tabulation of the CARE and OASIS-B upper body dressing items in Table 15-14c.
Table 15-14a
CARE admission upper body dressing
CARE: Core self care: Upper body dressing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency

Percent

252
281
661
593
763
2,023
+
+
+
+

5.49
6.13
14.41
12.93
16.63
44.1
+
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 2.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-14b
OASIS-B start of care upper body dressing
OASIS-B: Current ability to dress upper body

Frequency

Percent

0 = Able to get clothes out of closets & drawers, put them
on, and remove them from the upper body w/out
assistance

1,664

36.28

1 = Able to dress upper body w/out assistance if clothing
is laid out or handed to the patient

1,323

28.84

2 = Someone must help the patient put on upper body
clothing

1,272

27.73

328

7.15

3 = Patient depends entirely upon another person to dress
the upper body

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Table 15-14c
CARE admission upper body dressing by OASIS-B start of care upper body dressing
0 = Able to get
clothes out of
closets &
drawers, put
them on and
remove them
from the upper
body w/out
assistance

1 = Able to
dress upper
body w/out
assistance if
clothing is
laid out or
handed to the
patient

2 = Someone
must help the
patient put on
upper body
clothing

1 = Dependent

+

+

12.7

86.1*

252

2 = Substantial assist.

+

+

70.5*

25.6

281

3 = Partial assist.

+

17.7

77.5*

3.5

661

4 = Supervision touching
assist.

6.4

40.8

51.8*

+

593

5 = Setup assist.

12.5

71.7*

15.1

+

763

6 = Independent

75.0*
+

19.8
+

5.0
+

+

2023

+

12

1,323

1,272

CARE: Upper body
dressing

L = Letter code
Total

1,664

3 = Patient
depends
entirely upon
another
person to
dress the
upper body

328

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 2. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Total

4,587

Summary Results
•

As indicated by the areas marked with an asterisk in Table 15-14c, overall there was a
high amount of agreement between the CARE and OASIS-B items for upper body
dressing.

•

Among patients who were assessed as Dependent on the CARE Item Set,
86.1 percent were similarly assessed as “Patient depends entirely on another person to
dress the upper body” on OASIS-B, which is the expected result.

•

Similarly high levels of agreement were observed between the other levels of the
CARE scale and their corresponding OASIS-B levels; indeed, in most cases it
exceeded 70.0 percent.

•

The expected agreement occurred between OASIS-B level 2 (Someone Must Help the
Patient Put On Upper Body Clothing) when compared to CARE levels 4–Supervision
or Touching Assistance, 3–Partial/Moderate Assistance, and 2–Substantial/Maximal
Assistance for the upper body dressing item (agreement percentages, respectively, are
70.5 percent, 77.5 percent, and 51.8 percent).

CARE Items: Lower Body Dressing (item VI.A6) and Putting On/Taking Off Footwear
(item VI.C6)
OASIS-B Item: Ability to Dress Lower Body (item M0660)
The Functional Status section of the CARE Item Set assesses a patient’s usual
performance regarding lower body dressing (item VI.A6) and ability to put on and take off
footwear (item VI.C6) during the 2-day admission assessment period. The corresponding
OASIS-B item combines the assessment of lower body dressing and putting on footwear by
grouping these two activities into one item. For this reason, both the CARE lower body dressing
and footwear items are compared individually with the OASIS-B item. The definitions from the
CARE and OASIS-B instruments are also included below for easy reference.
CARE Definition:
A6. Lower Body Dressing: The ability to dress and undress below the waist, including
fasteners. Does not include footwear.
CARE Definition:
C6. Putting On/Taking Off Footwear: The ability to put on and take off socks and shoes
or other footwear that are appropriate for safe mobility.
OASIS-B Definition:
M0660. Ability to Dress Lower Body: Identifies the patient’s ability to dress lower body,
including the ability to obtain, put on, and remove lower body clothing. The prior column
should describe the patient’s ability 14 days prior to the start (or resumption) of care visit.
The focus for today’s assessment—the “current” column—is on what the patient is able to do
today. Ability to dress lower body (with or without dressing aids) including undergarments,
slacks, socks, or nylons, shoes: [0] Able to obtain, put on, and remove clothing and shoes
without assistance; [1] Able to dress lower body without assistance if clothing is laid out or
handed to the patient; [2] Someone must help the patient on undergarments, slacks, socks,
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nylons, and shoes; [3] Patient depends entirely upon another person to dress the lower body;
[UK] Unknown.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The combined definitions for CARE items VI.A6 and VI.C6 is
approximately equivalent to the OASIS-B definition for lower body dressing. The
two items on CARE are combined to include the ability of putting on and taking off
shoes in the definition of lower body dressing. Both CARE and OASIS-B user
manuals direct the clinician to include lower extremity prostheses as lower extremity
apparel (if used).

•

Scales: The CARE scale order for this item ascends to demonstrate independence,
while the OASIS-B scale for this item descends to demonstrate independence. In
addition, the CARE’s six-level scale is more subdivided to demonstrate if helper
assistance is required by the patient and at what amount, while the OASIS-B’s scale
for this item considers four levels of assessing the patient’s ability to complete this
activity: independent, requires clothing laid out/handed to the patient, a helper assists
with this activity, or the patient is entirely dependent on another person for this
activity. Both instruments retain the same scores with or without the patient’s use of
dressing aides.

Implications
•

It is not likely that any differences in OASIS-B and CARE assessments on this item
would be due to the difference in assessment time frame.

•

Additionally, for the lower body dressing item, there would be expected agreement
when comparing the OASIS-B single rating level 2, with three different CARE rating
levels 4, 3, and 2. To clarify, OASIS-B level 2 (Someone Must Help the Patient Put
On Upper Body Clothing) would be expected to map to CARE levels 4–Supervision
or Touching Assistance, 3–Partial/Moderate Assistance, and 2–Substantial/Maximal
Assistance for the lower body dressing item.

•

We anticipated that agreement may be closer between the CARE footwear item and
the OASIS-B item (combines CARE’s lower body dressing and footwear items) than
the CARE’s lower body dressing item, as the footwear item is expected to be the
more difficult of these two CARE items.

Item frequencies by instrument are shown in Tables 15-15a(1-2) and 15-15b below,
followed by the cross-tabulation of the CARE and OASIS-B lower body dressing and footwear
items in Tables 15-15c(1-2).
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Table 15-15a(1)
CARE admission lower body dressing
CARE: Core self care: Lower body dressing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency

Percent

388
477
934
685
551
1,531
+
+
+
+

8.5
10.4
20.4
14.9
12.0
33.4
+
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 3.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-15a(2)
CARE admission put on/take off footwear
CARE: Supplemental function: Put on/take off footwear
Missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
E = Not attempted due to environmental constraints
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency
196
673
458
720
563
400
1,463
+
+
47
28
+
25

Percent
4.3
14.7
10.0
15.7
12.3
8.7
31.9
+
+
1.0
0.6
+
0.6

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-15b
OASIS-B start of care ability to dress lower body
OASIS-B: Current ability to dress lower body

Frequency

Percent

1,242

27.1

821

17.9

1,978

43.1

546

11.9

0 = Able to obtain, put on, and remove clothing and
shoes w/out assistance
1 = Able to dress lower body w/out assistance if
clothing and shoes are laid out or handed to the
patient
2 = Someone must help the patient put on
undergarments, slacks, socks or nylons, and shoes
3 = Patient depends entirely upon another person to
dress lower body

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-15c(1)
CARE admission put on/take off footwear by OASIS-B start of care lower body dressing

0 = Able to
obtain, put on,
and remove
clothing and
shoes w/out
assistance

1 = Able to
dress lower
body w/out
assistance if
clothing and
shoes are laid
out or handed
to the patient

2 = Someone
must help the
patient put on
undergarments,
slacks, socks
or nylons, and
shoes

1 = Dependent

+

+

12.6

86.1*

388

2 = Substantial assist.

+

+

71.1*

27.0

477

3 = Partial assist.

2.5

12.1

80.9*

4.5

934

4 = Supervision touching
assist.

6.1

22.9

67.3*

3.6

685

5 = Setup assist.

8.5

58.3*

32.7*

+

551

6 = Independent
L = Letter code

73.3*
+

14.1
+

12.0
+

+
+

1,531
18

821

1,978

546

4,587

CARE: Lower body
dressing

Total

1,242

3 = Patient
depends
entirely upon
another
person to
dress lower
body

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 3. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Total

Table 15-15c(2)
CARE admission putting on footwear by OASIS-B start of care lower body dressing

0 = Able to
obtain, put on,
and remove
clothing and
shoes w/out
assistance

1 = Able to
dress lower
body w/out
assistance if
clothing and
shoes are laid
out or handed
to the patient

2 = Someone
must help the
patient put on
undergarments,
slacks, socks
or nylons, and
shoes

34.7

14.8

44.4

6.1

196

1 = Dependent

+

1.8

42.9*

53.8*

673

2 = Substantial assist.

3.5

7.6

73.6*

15.3

458

3 = Partial assist.

5.0

16.4

74.9*

3.8

720

4 = Supervision touching
assist.

10.1

26.8

59.1*

3.9

563

5 = Setup assist.
6 = Independent

15.0
67.0*

47.5*
18.5

35.3
14.0

+
+

L = Letter code

13.2

13.2

41.2

32.5

114

1,242

821

1,978

546

4,587

CARE: Putting on/taking
off footwear
Missing

Total

3 = Patient
depends
entirely upon
another
person to
dress lower
body

Total

400
1,463

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
Table 15-15c(1) – Comparison of CARE Lower Body Dressing vs. OASIS-B Lower Body
Dressing Items
•

As indicated by the areas in Table 15-15c(1), overall there was a high amount of
agreement between the CARE lower body dressing and OASIS-B lower body
dressing items.

•

Among patients who were assessed as Dependent on the CARE Item Set,
86.1 percent were similarly assessed as “Patient depends entirely on another person to
dress the lower body” on OASIS-B, which is the expected result.

•

Similarly high levels of agreement were observed between the other levels of the
CARE scale and their corresponding OASIS-B levels, ranging from 58.3 percent for
agreement in “Setup” responses to 80.9 percent agreement between the CARE level
“Partial assistance” and OASIS-B level “Someone must help put on undergarment,
socks, and shoes.”
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Table 15-15c(2) – Comparison of CARE Putting On/Taking Off Footwear vs. OASIS-B Lower
Body Dressing Items
•

As indicated by the areas marked with an asterisk in Table 15-15c(2), overall there
was good agreement between the CARE putting on/taking off footwear and OASIS-B
lower body dressing items, although it was not quite as good as for the CARE versus
OASIS-B lower body dressing comparison.

•

Among patients who were assessed as Independent on the CARE Item Set,
67.0 percent were similarly assessed as “able to obtain, put on, and remove clothing
and shoes without assistance” on OASIS-B, which is the expected result.

•

Similarly, relatively high levels of agreement were observed between the other levels
of the CARE scale and their corresponding OASIS-B levels, ranging from
47.5 percent for agreement in “setup” responses to 74.9 percent agreement between
the CARE level “partial assistance” and OASIS-B level “someone must help put on
undergarment, socks, and shoes.”

•

There appears to be more agreement between the CARE lower body dressing item
and the OASIS-B item on identifying dependent patients than when looking at the
CARE footwear item. However, because the OASIS-B item includes lower body
dressing and footwear management, it was expected that more patients were rated as
dependent on the CARE footwear item than were not dependent on the OASIS-B
item (42 percent of patients dependent in CARE footwear item were only a level 2
[Someone Must Help the Patient Put On Undergarments, Slacks, Socks or Nylons,
and Shoes] on OASIS-B). This was expected because footwear is a more difficult
activity than lower body dressing, thus the 42.9 percent agreement seen in Table 1515c(2).

Core Functional Mobility and Supplemental Functional Ability – Usual Performance
CARE Item: Chair/Bed-to-Chair Transfer (item VI.B3)
OASIS-B Item: Transferring (item M0690)
The Functional Status section of the CARE Item Set assesses a patient’s usual
performance regarding a chair/bed-to-chair transfer (item VI.B3) during the 2-day admission
assessment period. The OASIS-B also assesses transferring (M0690). The definitions from the
CARE and OASIS-B are also included below for easy reference.
CARE Definition:
B3. Chair/Bed-to-Chair Transfer: The ability to safely transfer to and from a chair (or
wheelchair). The chairs are placed at right angles to each other.
OASIS-B Definition:
M0690. Transferring: Identifies the patient’s ability to safely transfer in a variety of
situations. The prior column should describe the patient’s ability 14 days prior to the start (or
resumption) of care visit. The focus for today’s assessment—the “current” column—is on
what the patient is able to do today. Transferring: Ability to move from bed to chair, on and
off toilet or commode, into and out of tub or shower, and ability to turn and position self in
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bed if patient is bedfast. [0] Able to independently transfer; [1] Transfers with minimal
human assistance or with use of an assistive device; [2] Unable to transfer self but is able to
bear weight and pivot during the transfer process; [3] Unable to transfer self and is unable to
bear weight or pivot when transferred by another person; [4] Bedfast, unable to transfer but is
able to turn and position self in bed; [5] Bedfast, unable to transfer and is unable to turn and
position self; [UK] Unknown.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The CARE and OASIS-B item definitions are moderately similar on
one of the four parts of the OASIS-B assessment item. The OASIS-B definition
combines several concepts that are measured as separate items on CARE. The
OASIS-B item includes the ability to transfer on and off toilet or commode, into and
out of the tub or shower, and ability to turn and position self in bed if patient is
bedfast. The OASIS-B item also includes the ability to bear weight. The CARE Item
Set includes the following as separate items: Chair/Bed to Chair Transfer, Toilet
Transfer, Rolling Left to Right. The CARE Item Set does not include shower/bath
transfers.

•

Scales: The CARE rating scale for this item ascends to demonstrate independence,
while the OASIS-B scale for this item descends to demonstrate independence. The
scales are generally not equivalent since the OASIS-B item includes use of an
assistive device, weight bearing, and turning/positioning self in bed as part of the
assessment scale. The OASIS-B ability to bear weight is related to patient transfer
rating scale, whereas the CARE does not include this task as a part of the rating scale
or the description of the transfer items comparable to the OASIS-B transfer item.

Implications
•

It is not likely that any differences in OASIS-B and CARE assessments on this item
would be due to the difference in assessment time frame.

•

Additionally, the OASIS-B scores may demonstrate a lower level of patient ability
since the assessment scale scores the patient on more functional tasks and several that
may be more difficult to perform than other tasks that are included in this one
OASIS-B item as compared to a similar CARE item.

Item frequencies by instrument are shown in Tables 15-16a and 15-16b below, followed
by the cross-tabulation of the CARE and OASIS-B ADL items in Table 15-16c.

279

Table 15-16a
CARE admission chair/bed-to-chair transfer
CARE: Core mobility: Chair/bed-to-chair transfer
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency

Percent

149
207
396
765
332
2,492
+
59
128
24
30

3.25
4.51
8.63
16.68
7.24
54.33
+
1.29
2.79
0.52
0.65

+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 2.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
Table 15-16b
OASIS-B start of care current transferring
OASIS-B: Current transferring
0 = Able to independently transfer
1 = Transfers with minimal human assistance or
with use of an assistive device

Frequency

Percent

898

19.58

3,086

67.28

2 = Unable to transfer self but is able to bear weight
and pivot during the transfer process

407

8.87

3 = Unable to transfer self and is unable to bear
weight or pivot when transferred by another
person

117

2.55

4 = Bedfast, unable to transfer but is able to turn
and position self in bed

25

0.55

5 = Bedfast, unable to transfer and is unable to turn
and position self

54

1.18

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-16c
CARE admission chair/bed-to-chair transfer by OASIS-B start of care current transferring

0 = Able to
independently
transfer

1=
Transfers
with
minimal
human
assistance
or with use
of an
assistive
device

1 = Dependent

+

+

30.2*

37.6*

2 = Substantial
assist.

+

35.7

51.2*

8.7*

+

+

207

3 = Partial assist.

0.3

72.5*

23.2*

3.5

0.3

0.3

396

4 = Supervision
touching
assist.

2.9

85.5*

10.5

+

+

765

5.4

0.9
+

+

+

332

+

+

+

2,492

+

10.2

244

54

4,587

CARE:
Chair/bed-tochair transfer

5 = Setup assist.

6.3

2 = Unable
to transfer
self but is
able to bear
weight and
pivot
during the
transfer
process

87.0*

3 = Unable
to transfer
self and is
unable to
bear weight
or pivot
when
transferred
by another
person

6 = Independent

32.6*

65.5*

1.6

L = Letter code

13.5

56.6

10.2

5.7

898

3,086

407

117

Total

4=
Bedfast,
unable to
transfer but
is able to
turn and
position
self in bed
7.4*

25

5=
Bedfast,
unable to
transfer and
is unable to
turn and
position
self

Total

14.1*

149

* Indicates area of anticipated overlap between the CARE and OASIS-B instrument responses.
+ Cells based on a sample size of n < 11 are not shown.
NOTE: Missing = 2. Values refer to row percents.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
•

Although there are substantial differences in item definitions, the trends exhibited in
Table 15-16c nonetheless indicate a high degree of agreement between these items,
suggesting they are measuring similar concepts.

•

Among patients who were assessed as Dependent on the CARE Item Set,
89.3 percent were assessed in one of several potential matching categories in
OASIS-B: 2–Unable to Transfer Self but Able to Bear Weight (30.2 percent), 3–
Unable to Transfer Self and Unable to Bear Weight (37.6 percent), 4–Bedfast but
Able to Position Self (7.4 percent), and 5–Bedfast and Unable to Position Self
(14.1 percent).

•

Similarly, patients who were assessed as either “partial assistance,” “supervision,” or
“setup” in CARE had approximately 73 percent to 87 percent of responses falling in
the expected OASIS-B category of 1–Transfers with Minimal Human Assistance.
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CARE Item: Shower/Bathe Self (item VI.C2)
OASIS-B Item: Bathing (item M0670)
The Functional Status section of the CARE Item Set assesses a patient’s usual
performance regarding the patient’s ability to shower and bathe self (item VI.C2) during the 2day admission assessment period. The OASIS-B also assesses bathing (M0670). The definitions
from the CARE and OASIS-B are also included below for easy reference.
CARE Definition:
C2. Shower/Bathe Self: The ability to bathe self in shower or tub, including washing,
rinsing, and drying self. Does not include transferring in/out of tub/shower.
OASIS-B Definition:
M0670. Bathing: Identifies the patient’s ability to bathe entire body and the assistance
which may be required to safely bathe in shower or tub. The prior column should describe
the patient’s ability 14 days prior to the start (or resumption) of care visit. The focus for
today’s assessment—the “current” column—is on what the patient is able to do today.
Bathing: Ability to wash entire body. Excludes grooming (washing face and hands only).
[0] Able to bathe self in shower or tub independently; [1] With the use of devices, is able to
bathe self in shower or tub independently; [2] Able to bathe in shower or tub with the
assistance of another person: (a) for intermittent supervision or encouragement or reminders,
(b) to get in and out of the shower or tub, or (c) for washing difficult-to-reach areas; [3]
Participates in bathing self in shower or tub, but requires presence of another person
throughout the bath for assistance or supervision; [4] Unable to use the shower or tub and is
bathed in bed or bedside chair; [5] Unable to effectively participate in bathing and is totally
bathed by another person; [UK] Unknown.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The CARE and OASIS-B item definitions are similar, but the
CARE definition is more detailed since it includes washing, rinsing, and drying. A
key difference between the two items, however, is that the OASIS-B item includes
getting in and out of the shower or tub, while the CARE item does not.

•

Scales: The CARE scale for this item ascends to demonstrate independence, while the
OASIS-B scale for this item descends to demonstrate independence. The scales are
generally not equivalent. Example of instrument differences: A score of 2 on the
OASIS-B assessment includes assistance of another person with getting in and out of
the shower or tub. The task of getting in and out of the shower or tub is not a task
included in the CARE item.
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Implications
•

It is not likely that any differences in OASIS-B and CARE assessments on this item
would be due to the difference in assessment time frame.

•

The OASIS-B item inclusion of getting in and out of the shower or tub makes the
OASIS-B item more difficult and therefore should result in patients having lower
levels of independence on the OASIS-B item than they have on the CARE’s
comparable item.

Item frequencies by instrument are shown in Tables 15-17a and 15-17b below, followed
by the cross-tabulation of the CARE and OASIS-B ADL items in Table 15-17c.
Table 15-17a
CARE admission shower/bathe self
CARE: Supplemental function: Shower/bathe self
Missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
E = Not attempted due to environmental constraints
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency

Percent

196
305
421
919
969
467
890
+
18
142
167
30
60

4.27
6.65
9.18
20.03
21.12
10.18
19.40
+
0.39
3.10
3.64
0.65
1.31

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-17b
OASIS-B start of care current bathing
OASIS-B: Current bathing
0 = Able to bathe self in shower or tub independently
1 = With the use of devices, is able to bathe self in
shower or tub independently
2 = Able to bathe in shower or tub with assistance of
another person: (a) for intermittent supervision or
encouragement or reminders, OR (b) to get in and out
of the shower or tub, OR (c) for washing difficult-toreach areas
3 = Participates in bathing self in shower or tub, but
requires presence of another person throughout the
bath for assistance or supervision
4 = Unable to use the shower or tub and is bathed in bed
or bedside chair
5 = Unable to effectively participate in bathing and is
totally bathed by another person

Frequency
296

6.45

641

13.97

1,286

28.04

1,351

29.45

800

17.44

213

4.64

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

284

Percent

Table 15-17c
CARE admission shower/bathe self by OASIS-B start of care bathing

0 = Able to
bathe self in
shower or tub
independently

1 = With the
use of
devices, is
able to bathe
self in shower
or tub
independently

2 = Able to bathe in
shower or tub with
assistance of another
person: (a) for
intermittent supervision
or encouragement or
reminders, OR (b) to
get in and out of the
shower or tub, OR
(c) for washing
difficult-to-reach areas

Missing

+

16.8

26.0

21.4

27.0

1 = Dependent

+

+

+

23.0

27.2*

47.2*

305

2 = Substantial assist.

+

+

9.3

62.9*

20.9

6.2

421

3 = Partial assist.

+

2.8

34.7*

50.3*

10.9

+

919

4 = Supervision touching
assist.

1.1

7.1

49.7*

34.1*

7.8

+

969

5 = Setup assist.

2.4

24.8

42.8*

18.8

10.9

+

467

6 = Independent

28.1*

42.0*

17.4*

6.2

6.2

+

890

L = Letter code

+

4.8

7.9

9.3

70.0

6.4

420

296

641

1,286

1,351

800

213

4,587

CARE: Supplemental
function: Shower/bathe self
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Total

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

3 = Participates
in bathing self in
shower or tub,
but requires
presence of
another person
throughout the
bath for
assistance or
supervision

4 = Unable to
use the shower
or tub and is
bathed in bed or
bedside chair

5 = Unable
to effectively
participate in
bathing and
is totally
bathed by
another
person
+

Total
196

Summary Results
•

As indicated by the areas marked with an asterisk in Table 15-17c, overall there was
fair to high agreement between the CARE shower/bathe self and OASIS-B bathing
items when combining percentages from expected agreement cross-tabulations (see
example below).

•

Among patients who were assessed as Dependent on the CARE Item Set,
74.4 percent were assessed as 5–Unable to Effectively Participate in Bathing and Is
Totally Bathed by Another Person or 4–Unable to Use the Shower or Tub and Is
Bathed in Bed or Bedside Chair, which are the predicted levels where agreement was
anticipated between the OASIS-B and CARE instrument levels.

•

Discrepancies on patients rated on CARE as needing 2–Substantial/Maximal
Assistance or 3–Partial/Moderate Assistance did tend to be skewed toward higher
dependency on the OASIS-B item. The higher percentage of agreement between the
instruments across the more assistance/dependency OASIS-B scales was predicted
due to the OASIS-B instrument’s inclusion of shower/bath transfer in the Bathing
item.

Similarly, high levels of agreement were observed between the other levels of the CARE
scale and their corresponding OASIS-B levels, ranging from 87.5 percent for agreement between
CARE “independent” and across the three OASIS-B levels (where agreement was anticipated
between the instruments) to 42.8 percent agreement between the CARE level “Setup” and
OASIS-B level “Able to bathe in shower or tub with assistance of another person” (the latter
includes help getting in and out of the shower or tub).
CARE Items: Mode of Mobility – Select the Longest Distance the Patient Walks and
Code Level of Independence (item VI.B5a)
OASIS-B Item: Ambulation/Locomotion (item M0700)
The Functional Status section of the CARE Item Set assesses a patient’s usual
performance regarding his/her mode of mobility depending if the patient primarily uses a
wheelchair (items VI.B5a-b) during the 2-day admission assessment period. The OASIS-B also
assesses a similar function item, ambulation and locomotion (M0700). The definitions from the
CARE and OASIS-B are included below for easy reference.
Considerations
The clinician using the CARE Item Set is instructed to choose the patient’s primary mode
of mobility, whereas the OASIS-B instructs clinicians to focus on the patient’s ability to
ambulate when determining how to score the patient. Even if the patient uses a wheelchair
75 percent of the time, the focus for the clinician using the OASIS-B instrument is the patient’s
ability to walk.
For the activity of mobility, the CARE Item Set has two distinct categories of assessment
items (walking or wheeling). On the CARE Item Set the clinician must choose either the
walking OR the wheelchair category, and then choose which one of the four distances is
appropriate to select when assessing the patient’s level of independence (6-1). For example, if
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the clinician selects the walking category, the clinician then chooses one of four CARE items
that best represents the farthest distance the patient walks (i.e., 150, 100, 50, or 10 feet). Finally,
the clinician assesses the amount of assistance the patient is required to walk, for that specifically
selected distance. The same method is also used for assessing the CARE wheelchair item if
chosen, instead of walking.
The challenge in presenting the data for this section was quite great due to there being a
single OASIS-B ambulation/locomotion item, whereas the CARE Item Set asks the clinician to
select between four separate mobility distances or four separate wheeling distances to measure
the patient’s walking or wheeling ability. In addition, the OASIS-B combines stair climbing and
walking on uneven surfaces with the OASIS-B ambulation/locomotion item, whereas the CARE
measures the patient’s ability for these as two separate and distinct items (ability to go up and
down steps and walking on uneven surfaces).
Ultimately, only two of the four CARE distances were chosen per walking and two
CARE distance items for wheeling were used in comparison to the single OASIS-B
ambulation/locomotion item. This resulted in individual frequency tables for the four chosen
CARE items (two for walking and two for wheeling) and one frequency table for OASIS-B
(shown twice) and four separate cross-tabulation tables to compare the agreement between the
four CARE variables and one OASIS-B variable.
In this comparison, both the responses to the CARE “Walk 150 feet” and “Walk in Room
Once Standing” items are compared to the OASIS-B ambulation/locomotion item.
CARE Definition:
B5a. Mode of Mobility: If the patient does not primarily use a wheelchair for mobility,
select the longest distance the patient walks and code his/her level of independence (Level 16) on that distance. Observe performance. (Select only one.) Walk 150 ft (45 m): Once
standing, can walk at least 150 feet (45 meters) in corridor or similar place. Walk 100 ft (30
m): Once standing, can walk at least 100 feet (30 meters) in corridor or similar space. Walk
50 ft (15 m): Once standing, can walk at least 50 feet (15 meters) in corridor or similar space.
Walk in Room Once Standing: Once standing, can walk at least 10 feet (3 meters) in room,
corridor, or similar space.
OASIS-B Definition:
M0700. Ambulation/Locomotion: Identifies the patient’s ability and the type of assistance
required to safely ambulate or propel self in a wheelchair over a variety of surfaces. The
prior column should describe the patient’s ability 14 days prior to the start (or resumption) of
care visit. The focus for today’s assessment—the “current” column—is on what the patient
is able to do today. Ambulation/Locomotion: Ability to safely walk, once in a standing
position, or use a wheelchair once in a seated position, on a variety of surfaces. [0] Able to
independently walk on even and uneven surfaces and climb stairs with or without railings
(i.e., needs no human assistance or assistive device); [1] Requires use of a device (e.g., cane,
walker) to walk alone or requires human supervision or assistance to negotiate stairs or steps
or uneven surfaces; [2]Able to walk only with the supervision or assistance of another person
at all times; [3] Chairfast, unable to ambulate but is able to wheel self independently; [4]
Chairfast, unable to ambulate and is unable to wheel self; [5] Bedfast, unable to ambulate or
be up in a chair; [UK] Unknown.
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Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The items have several important differences. The clinician using
the CARE Item Set must choose between assessing the patient’s walking or wheeling
ability, whereas the OASIS-B instructs clinicians to focus on the patient’s ability to
ambulate when determining how to score the patient. The OASIS-B item assesses the
patient’s abilities for both ambulation/locomotion within the single ambulation/
locomotion item. On the CARE Item Set, the clinician must choose either the
walking OR the wheelchair category, and then choose which one of the four distances
is appropriate to select when assessing the patient’s level of independence (6-1).

•

Rating Scales: The rating scales for the OASIS-B extend the definition of this item
beyond ambulation/locomotion and include several other items that are assessed
separately on the CARE Item Set.

•

The OASIS-B includes the item of stair climbing and walking on uneven surfaces,
whereas the ability to go up and down steps and walking on uneven surfaces are two
separate items on the CARE Item Set.

•

The CARE items assess the patient level of independence for a specific range of
distances. The clinician selects the distance (item) that reflects the greatest distance a
patient can ambulate safely, whereas OASIS-B does not specifically consider distance
within its rating scale.

Implications
•

The OASIS-B items will not differentiate levels of functioning in ambulation or
locomotion in as much detail as the CARE.

•

Because the OASIS-B item includes both walking and wheeling, we expect that the
CARE distribution of responses will not cover the full range of OASIS-B responses.
Patients rated as highly dependent on the CARE walking items will appear in the
more independent end of the OASIS-B scale because of the scale’s combination of
walking and wheeling items.

•

Because the OASIS-B item includes steps and stairs, in addition to the ability to walk
on uneven surfaces, we expect that many patients rated independent or at higher
levels of independence ratings on the CARE items will be rated with some level of
dependency on the OASIS-B items.

Item frequencies by instrument are shown in Tables 15-18a(1-2) and 15-18b below,
followed by the cross-tabulation of the CARE and OASIS-B ADL items in Tables 15-18c(1-2).

288

Table 15-18a(1)
CARE admission walk 150 feet once standing
CARE: Core mobility: Walk 150 feet
Selected another item or missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency
3,580
45
+
32
162
60
484
+
111
23
11
68

Percent
78.05
0.98
+
0.70
3.53
1.31
10.55
+
2.42
0.50
0.24
1.48

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Table 15-18a(2)
CARE admission walk in room once standing
CARE: Core mobility: Walk once standing
Selected another item or missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency
3,696
+
35
97
287
58
363
+
15
+
+
+

Percent
80.58
+
0.76
2.11
6.26
1.26
7.91
+
0.33
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-18b
OASIS-B start of care ambulation/locomotion
OASIS-B: Current ambulation/locomotion
0 = Able to independently walk on even and uneven
surfaces and climb stairs with or without railings
(i.e., needs no human assistance or assistive device)
1 = Requires use of a device to walk alone or requires
human supervision or assistance to negotiate stairs
or steps or uneven surfaces
2 = Able to walk only with the supervision or assistance
of another person at all times
3 = Chairfast, unable to ambulate but is able to wheel
self independently
4 = Chairfast, unable to ambulate and is unable to wheel
self
5 = Bedfast, unable to ambulate or be up in a chair

Frequency

Percent

339

7.39

2,564

55.90

1,256

27.38

212

4.62

180
36

3.92
0.78

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-18c(1)
CARE admission walk 150 feet by OASIS-B start of care ambulation/locomotion

CARE: Core
mobility: Walk 150
feet

0 = Able to
independently
walk on even
and uneven
surfaces and
climb stairs
with or
without
railings
(i.e., needs
no human
assistance or
assistive
device)

1=
Requires
use of a
device to
walk alone
or requires
human
supervision
or assistance
to negotiate
stairs or
steps or
uneven
surfaces

Selected another item
or missing

5.3

53.2

30.1

5.9

4.9

0.6

3,580

1 = Dependent

+

80.0

+

+

+

+

45

2 = Substantial assist.

+

+

+

+

+

+

3 = Partial assist.

+

56.3

40.6

+

+

+

32

4 = Supervision
touching assist.

+

64.8

32.7

+

+

+

162

5 = Setup assist.

+

73.3

+

+

+

+

60

6 = Independent

26.0

68.2

5.8

+

+

+

484

+

55.8

32.1

+

+

6

215

339

2,564

1,256

212

180

36

4,587

L = Letter code
Total

2 = Able to
3=
walk only
Chairfast,
with the
unable to
supervision ambulate but
or assistance is able to
of another
wheel self
person at all indepentimes
dently

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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4=
Chairfast,
unable to
ambulate
and is
unable to
wheel self

5=
Bedfast,
unable to
ambulate
or be up in
a chair

Total

+

Table 15-18c(2)
CARE admission walk in room once standing by OASIS-B start of care
ambulation/locomotion

CARE: Core
mobility: Walk once
standing

0 = Able to
independently
walk on even
and uneven
surfaces and
climb stairs
with or
without
railings (i.e.,
needs no
human
assistance or
assistive
device)

1 = Requires
use of a
device to
walk alone or
requires
human
supervision
or assistance
to negotiate
stairs or steps
or uneven
surfaces

Selected another item
or missing

8.1

56.2

1 = Dependent

+

2 = Substantial assist.

2 = Able to
walk only
with the
3 = Chairfast,
supervision
unable to
or assistance ambulate but
of another
is able to
person at all wheel self
times
independently

4=
5=
Chairfast,
Bedfast,
unable to
unable to
ambulate
ambulate
and is
unable to or be up in
a chair
Total
wheel self

24.6

5.6

4.7

0.8

3,696

+

+

+

+

+

+

+

+

91.4

+

+

+

35

3 = Partial assist.

+

25.8

72.2

+

+

+

97

4 = Supervision
touching assist.

+

40.1

57.1

+

+

+
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5 = Setup assist.

+

69

29.3

+

+

+

58

6 = Independent

8.8

78.8

12.4

+

+

+

363

L = Letter code

+

39

31.7

+

+

+

41

2,564

1,256

212

180

36

4,587

Total

339

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
Table 15-18c(1) – Comparison of CARE Walk 150 Feet vs. OASIS-B Ambulation/Locomotion
Items
•

As expected, Table 15-18c(1) shows that no patient who was able to walk 150 feet
was categorized as either chairfast or bedfast in OASIS-B (response levels 3, 4, and
5).

•

Among patients who were assessed as “independent” on the CARE Item Set,
94.2 percent were assessed as either “able to walk independently on even and uneven
surfaces” or “requires use of a device to walk alone” on OASIS-B, which are the
expected areas of overlap.

•

Similarly high levels of agreement were observed between the CARE “supervision”
category and the corresponding OASIS-B levels: 64.8 percent in the OASIS-B
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category of 1–Requires Use of Device or Requires Human Supervision and
32.7 percent in the OASIS-B category of 2–Able to Walk Only with the Supervision
or Assistance of Another Person at All Times.
Table 15-18c(2) – Comparison of CARE Walk In Room Once Standing vs. OASIS-B
Ambulation/Locomotion Items
•

As expected, Table 15-18c(2) shows that very few patients who were able to walk in
room once standing were categorized as either chairfast or bedfast in OASIS-B
(response levels 3, 4, and 5).

•

Among patients who were assessed as “independent” on the CARE Item Set,
87.6 percent were assessed as either “able to walk independently on even and uneven
surfaces” or “requires use of a device to walk alone” on OASIS-B, which are the
expected areas of overlap.

•

Similarly high levels of agreement were observed between the CARE “supervision”
category and the corresponding OASIS-B levels: 40.1 percent in the OASIS-B
category of 1–Requires Use of Device or Requires Human Supervision and
57.1 percent in the OASIS-B category of 2–Able to Walk Only with the Supervision
or Assistance of Another Person at All Times.

CARE Items: Mode of Mobility – Select the Longest Distance the Patient Wheels and
Code Level of Independence (item VI.B5b)
OASIS-B Item: Ambulation/Locomotion (item M0700)
The Functional Status section of the CARE Item Set assesses a patient’s usual
performance regarding his/her mode of mobility depending if the patient primarily uses a
wheelchair (items VI.B5a-b) during the 2-day admission assessment period. The OASIS-B also
assesses a similar function item, ambulation and locomotion (M0700). The definitions from the
CARE and OASIS-B are also included below for easy reference.
In this comparison, both the responses to the CARE “Wheel 150 Feet” and “Wheel in
Room Once Seated” items are compared to the OASIS-B Ambulation/Locomotion item.
CARE Definition:
B5b. Mode of Mobility: If the patient does primarily use a wheelchair for mobility, select
the longest distance the patient wheels and code his/her level of independence (Level 1-6) on
that distance. Observe performance. (Select only one.) Wheel 150 ft (45 m): Once sitting,
can wheel at least 150 feet (45 meters) in corridor or similar place. Wheel 100 ft (30 m):
Once sitting, can wheel at least 100 feet (30 meters) in corridor or similar space. Wheel 50 ft
(15 m): Once sitting, can wheel at least 50 feet (15 meters) in corridor or similar space.
Wheel in Room Once Sitting: Once sitting, can wheel at least 10 feet (3 meters) in room,
corridor, or similar space.
OASIS-B Definition:
M0700. Ambulation/Locomotion: Identifies the patient’s ability and the type of assistance
required to safely ambulate or propel self in a wheelchair over a variety of surfaces. The
prior column should describe the patient’s ability 14 days prior to the start (or resumption) of
care visit. The focus for today’s assessment—the “current” column—is on what the patient
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is able to do today. Ambulation/Locomotion: Ability to safely walk, once in a standing
position, or use a wheelchair once in a seated position, on a variety of surfaces. [0] Able to
independently walk on even and uneven surfaces and climb stairs with or without railings
(i.e., needs no human assistance or assistive device); [1] Requires use of a device (e.g., cane,
walker) to walk alone or requires human supervision or assistance to negotiate stairs or steps
or uneven surfaces; [2] Able to walk only with the supervision or assistance of another
person at all times; [3] Chairfast, unable to ambulate but is able to wheel self independently;
[4] Chairfast, unable to ambulate and is unable to wheel self; [5] Bedfast, unable to ambulate
or be up in a chair; [UK] Unknown.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the day of the assessment
visit.

•

Item Definitions: The items have several important differences. While the CARE
Item Set has separate items for those able to walk versus those who are primarily in a
wheelchair, in OASIS-B both are considered in the ambulation/locomotion item. As
well, while the CARE items assess levels of ability within a given distance (the
greatest distance a patient can walk safely), OASIS-B does not consider distance.

Implications
•

Because the OASIS-B item includes both walking and wheeling, we expect that the
CARE distribution of responses will not cover the full range of OASIS-B responses.

•

Patients rated as independent on the CARE wheeling items will still end up in the
more dependent end of the OASIS-B items because walking has been included in the
OASIS-B item.

Item frequencies by instrument are shown in Tables 15-19a(1-2) and 15-19b below,
followed by the cross-tabulation of the CARE and OASIS-B ADL items in Tables 15-19c(1-2).

294

Table 15-19a(1)
CARE admission wheel 150 feet
CARE: Core mobility: Wheel 150 feet
Selected another item or missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency

Percent

4,340
56
11
+
+
+
90
+
31
18
+
+

94.62
1.22
0.24
+
+
+
1.96
+
0.68
0.39
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Table 15-19a(2)
CARE admission wheel in room
CARE: Core mobility: Wheel in room
Selected another item or missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused
S = Not attempted due to safety concerns

Frequency

Percent

4,324
93
16
17
31
+
69
+
15
+
+
+

94.27
2.03
0.35
0.37
0.68
+
1.5
+
0.33
+
+
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Table 15-19b
OASIS-B start of care current ambulation
OASIS-B: Current ambulation/locomotion
0 = Able to independently walk on even and uneven surfaces
and climb stairs with or without railings (i.e., needs no human
assistance or assistive device)
1 = Requires use of a device to walk alone or requires human
supervision or assistance to negotiate stairs or steps or uneven
surfaces
2 = Able to walk only with the supervision or assistance of
another person at all times
3 = Chairfast, unable to ambulate but is able to wheel self
independently
4 = Chairfast, unable to ambulate and is unable to wheel self
5 = Bedfast, unable to ambulate or be up in a chair

Frequency

Percent

339

7.39

2,564

55.90

1,256

27.38

212
180
36

4.62
3.92
0.78

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
Table 15-19c(1) – Comparison of CARE Wheel 150 Feet vs. OASIS-B
Ambulation/Locomotion Items
•

As expected, Table 15-19c(1) shows that very few patients who were able to wheel
150 feet were categorized as bedfast in OASIS-B (response level 5).

•

Among patients who were assessed as “independent” in wheeling 150 feet on the
CARE tool, the majority (45.6 percent) were categorized as 3 (chairfast, unable to
ambulate but is able to wheel self independently) in OASIS-B. This is where the
majority of responses were expected to fall. Table 15-19c(1) revealed 25.6 percent
agreement between the instruments for patients who were independent in wheeling
150 feet and on the CARE Item Set were assessed as 1 (requires use of device to walk
alone or requires human supervision or assistance) on the OASIS-B. Sometimes it is
not clear why the data take unexpected patterns such as in this cross-tabulation.
Clinician error in reporting the data can also cause these unexpected patterns.

•

High levels of agreement (44.6 percent) were observed between the CARE
Dependent category and the OASIS-B category for 4 (chairfast, unable to ambulate
and is unable to wheel self), which was the expected area of overlap.
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Table 15-19c(1)
CARE admission wheel 150 feet by OASIS-B start of care ambulation/locomotion
0 = Able to
independently
walk on even
and uneven
surfaces and
climb stairs
with or without
railings (i.e.,
needs no
human
assistance or
assistive
CARE: Core mobility:
Wheel 150 feet
device)
Selected another item
or missing

1 = Requires
use of a
device to
walk alone or
requires
human
supervision
or assistance
to negotiate
stairs or steps
or uneven
surfaces

2 = Able to
walk only
3 = Chairfast,
with the
unable to
supervision
or assistance ambulate but
is able to
of another
person at all wheel self
independently
times

4=
Chairfast,
unable to
ambulate
and is
unable to
wheel self

5=
Bedfast,
unable to
ambulate
or be up in
a chair
Total

7.8

58.2

27.7

2.9

2.7

0.6

4,340

1 = Dependent

+

+

+

23.2

44.6

+

56

2 = Substantial assist.

+

+

+

+

+

+

11

3 = Partial assist.

+

+

+

+

+

+

+

4 = Supervision
touching assist.

+

+

+

+

+

+

+

5 = Setup assist.

+

+

+

+

+

+

+

6 = Independent

+

25.6

20

45.6

+

+

90

L = Letter code

+

+

20

30

37.1

+

70

1,256

212

180

36

4,587

Total

339

2,564

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Table 15-19c(2) – Comparison of CARE Wheel In Room Once Seated vs. OASIS-B
Ambulation/Locomotion Items
•

As expected, Table 15-19c(2) shows that very few patients who were able to wheel in
room once seated were categorized as bedfast in OASIS-B (response level 5).

•

Among patients who were assessed as “independent” in wheeling in room once seated
on the CARE Item Set, the majority (44.9 percent) were categorized as 3 (chairfast,
unable to ambulate but is able to wheel self independently) in OASIS-B. This is
where the majority of responses were expected to fall. Table 15-19c(2) revealed 18.8
percent agreement between the instruments for patients who were “independent in
wheeling in room once seated” on the CARE Item Set and patients who were assessed
as 1 (requires use of device to walk alone or requires human supervision or
assistance) on the OASIS-B. Sometimes it is not clear why the data take unexpected
patterns such as in this cross-tabulation. Clinician error in reporting the data can also
cause these unexpected patterns.
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•

High levels of agreement (64.5 percent) were observed between the CARE
Dependent category and the OASIS-B category for 4 (chairfast, unable to ambulate
and is unable to wheel self), which is the expected area of overlap.

Table 15-19c(2)
CARE admission wheel in room by OASIS-B start of care ambulation/locomotion

CARE: Core
mobility: Wheel in
room

0 = Able to
independently
walk on even
and uneven
surfaces and
climb stairs
with or without
railings (i.e.,
needs no
human
assistance or
assistive
device)

1 = Requires
use of a
device to
walk alone or
requires
human
supervision
or assistance
to negotiate
stairs or steps
or uneven
surfaces

Selected another item
or missing

7.8

58.6

27.3

3.7

2

0.6

1 = Dependent

+

+

15.1

+

64.5

+

93

2 = Substantial assist.

+

+

+

+

+

+

16

3 = Partial assist.

+

+

+

+

+

+

17

4 = Supervision
touching assist.

+

+

64.5

+

+

+

31

5 = Setup assist.

+

+

+

+

+

+

6 = Independent

+

18.8

29

44.9

+

+

69

L = Letter code

+

+

+

+

43.3

+

30

1,256

212

180

36

4,587

Total

339

2 = Able to
walk only
with the
3 = Chairfast,
supervision
unable to
or assistance ambulate but
of another
is able to
person at all wheel self
times
independently

2,564

4=
5=
Chairfast,
Bedfast,
unable to
unable to
ambulate
ambulate
and is
unable to or be up in
a chair
Total
wheel self
4,324

+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Supplemental Functional Ability – Usual Performance
CARE Item: Medication Management-Injectable Medications (item VI.C12)
OASIS-B Item: Management of Injectable Medications (item M0800)
The Functional Status section of the CARE Item Set assesses a patient’s usual
performance regarding the patient’s ability to manage injectable medications (item VI.C12)
during the 2-day admission assessment period. The OASIS-B also assesses the management of
injectable medications (M0800). The definitions from the CARE and OASIS-B are also included
below for easy reference.
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CARE Definition:
C12. Medication Management-Injectable Medications: The ability to prepare and take all
prescribed injectable medications reliability and safely, including administration of the
correct dosage at the appropriate times/intervals.
OASIS-B Definition:
M0800. Management of Injectable Medications: Identifies the patient’s ability to prepare
and take all injectable medications reliably and safely and the type of assistance required to
administer the correct dosage at the appropriate time/intervals. The focus is on what the
patient is able to do, not on the patient’s compliance or willingness. The prior column should
describe the patient’s ability 14 days prior to the start (or resumption) of care visit. The focus
for today’s assessment—the “current” column—is on what the patient is able to do today.
Management of Injectable Medications: Patient’s ability to prepare and take all prescribed
injectable medication reliably and safely, including administration of correct dosage at the
appropriate times/intervals. Excludes IV medications. [0] Able to independently take the
correct medication and proper dosage at the correct times; [1] Able to take injectable
medications at correct times if: (a) individual syringes are prepared in advance by another
person, or (b) given daily reminders; [2] Unable to take injectable medications unless
administered by someone else; [NA] No injectable medications prescribed; [UK] Unknown.
Key Item Differences
•

Assessment Windows: The assessment time frame for the CARE Item Set is 2
calendar days (if admitted before 12 noon) or 3 calendar days (for patients admitted
after 12 noon). The OASIS-B assessment time frame is the 24-hour period prior to
the visit and the time during the visit.

•

Item Definitions: The CARE and OASIS-B definitions for management of injectable
medications are similar.

•

Scales: The CARE scale for this item ascends to demonstrate independence, while the
OASIS-B scale for this item descends to demonstrate independence. The scales are
generally not equivalent since OASIS-B does not distinguish if someone provides
more than or less than half the assistance in the management of injectable
medications.

Implications
•

It is not likely that any differences in OASIS-B and CARE assessments on this item
would be due to the difference in assessment time frame.

•

Category 1–“Able to take injectable medications at correct times if (a) individual
syringes are prepared in advance by another person, or (b) given daily reminders” on
the OASIS-B tool will incorporate CARE categories 2–Substantial/Maximal
Assistance, 3–Partial/Moderate Assistance, 4–Supervision or Touching Assistance,
and 5–Setup or Clean-up Assistance.

Item frequencies by instrument are shown in Tables 15-20a and 15-20b below, followed
by the cross-tabulation of the CARE and OASIS-B ADL items in Table 15-20c.

299

Table 15-20a
CARE admission manage injectable medications
CARE: Supplemental function: Injectable drug
management

Frequency

Percent

Missing
1 = Dependent
2 = Substantial/maximal assistance
3 = Partial/moderate assistance
4 = Supervision or touching assistance
5 = Setup or clean-up assistance
6 = Independent
A = Task attempted but not completed
E = Not attempted due to environmental constraints
M = Not attempted due to medical restrictions
N = Not applicable
P = Patient refused

197
360
23
50
72
87
300
20
+
13
3,462
+

4.29
7.85
0.50
1.09
1.57
1.90
6.54
0.44
+
0.28
75.47
+

+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Table 15-20b
OASIS-B start of care manage injectable medications
OASIS-B: Current management of injectable
medications
0 = Able to independently take the correct oral
medication(s) and proper dosage(s) at the correct
times.
1 = Able to take medication(s) at the correct times if
(a) individual dosages are prepared in advance by
another person; OR (b) given daily reminders; OR
(c) someone develops a drug diary or chart.
2 = Unable to take medication unless administered
by someone else.
NA = No injectable medications prescribed.

Frequency
319

6.95

187

4.08

420

9.16

3,661

79.81

SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.
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Percent

Table 15-20c
CARE admission manage injectable medications by OASIS-B start of care manage
injectable medications

CARE: Supplemental
function: Injectable drug
management
Missing

1 = Able to take
medication(s) at the
0 = Able to
correct times if (a)
independently individual dosages are
take the correct prepared in advance
oral
by another person;
2 = Unable to
medication(s) and OR (b) given daily take medication
proper dosage(s)
reminders; OR (c)
unless
NA = No oral
at the correct
someone develops a administered by medications
times
drug diary or chart
someone else
prescribed

Total

5.6

+

7.1

84.8

197

1 = Dependent

+

5.3

80.3*

13.9

360

2 = Substantial assist.

+

+

65.2*

+

23

3 = Partial assist.

+

62.0

26.0*

+

50

4 = Supervision touching
assist.

20.8

50.0

18.1*

+

72

5 = Setup assist.

24.1

58.6*

+

12.6

87

6 = Independent

77.3*

7.0

+

12.7

300

L = Letter code

1.1

0.5

1.8

96.6

3,498

Total

319

187

420

3,661

4,587

*Expected areas of agreement are marked with an asterisk.
+ Cells based on a sample size of n < 11 are not shown.
SOURCE: RTI analysis of CARE and OASIS-B assessment data, 2008-2009.

Summary Results
•

As indicated by the areas marked with an asterisk in Table 15-20c, overall there was
relatively high agreement between the CARE and OASIS-B managing injectable
medications items.

•

Among patients who were assessed as “independent” on the CARE Item Set,
77.3 percent were assessed using the OASIS-B as “0–able to independently take the
correct medication and proper dosage at the correct times,” where agreement was
anticipated between the instruments.

•

A relatively high level of agreement (58.6 percent) was also observed between the
CARE level for “setup” and the OASIS-B level for “1–able to take injectable
medication at correct times if (a) individual syringes are prepared in advance by
another person OR (b) given daily reminders.”

•

The CARE levels for “substantial assistance” and “dependent” seemed to match most
closely with the OASIS-B level of “2–unable to take injectable medications unless
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administered by someone else,” at 65.2 percent and 84.8 percent of responses,
respectively.
15.4

Summary

While a direct one-to-one item comparison between the two instruments is not possible
due to differences in, for example, item scale categories, and the number of items and
combination of items per instrument activity assessed to assess function, this mapping of items
and associated scales presents an important examination of how CARE items compare to similar
OASIS-B items associated with current payment policy where equivalent items were available.
Assessment time frames are unlikely to have a large impact given that both instruments were
likely completed at the same time. Please note that some HHA PPS items were not possible to
evaluate because of the lack of an equivalent CARE item such as count of therapy visits, or an
indicator of which HHA episode it is for a patient who has a sequence of HHA episodes.
Preliminary findings indicate a medium level of agreement between the two assessment
instruments.
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SECTION 16
CONCLUSIONS
The findings in this report are critical to understanding the applicability of using
standardized versions of items in place of historical items on the three mandated patient
assessment tools: Inpatient Rehabilitation Facility Patient Assessment Instrument (IRF-PAI),
Minimum Data Set (MDS), and Outcome and Assessment Information Set (OASIS). The tools
measure similar concepts of medical, functional, and cognitive health status but use different
items to measure these concepts. The differences among these assessments make it impossible
to compare patients across settings, examine the adequacy of the access to care in different parts
of the country, and monitor the quality of care similar patients may receive in different settings.
The standardized items were based on an extensive stakeholder process that took into
account the existing items on the mandated assessment tools, the current scientific approaches
for determining patient complexity, and methodological issues in using items in different settings
with differing staff mix. The items tested in the Continuity Assessment Record and Evaluation
(CARE) assessment were based on the current science in each of the fields of care. Most of the
concepts were applicable to patients treated in more than one setting. For example, pressure
ulcers are present in patients across the continuum of provider types. While more severe
pressure ulcers may be more prevalent in one setting type than another, the approach for
measuring the pressure ulcer should be consistent. Using the input of the national pressure ulcer
experts to define the best way to measure a pressure ulcer, the CARE Item Set was able to test
one item’s use in different settings. The results showed that after training on an item, a
standardized measurement approach could be used that would allow patients to be measured
consistently across all settings.
Item selection was based on numerous technical expert panels to weigh the strengths and
weaknesses of current approaches and to determine the best items for measuring case complexity
across the continuum of care. Consideration of the granularity of an item and its ability to
measure changes at both the high end and the low end of severity was important if a standardized
item would be able to measure care across the continuum. The selection process also recognized
the importance of clinical input from each of the five settings—the acute and post-acute
settings—and the variation in the types of clinicians involved in each setting. Item development
was based on the expertise of the medical community, including the physicians, nurses,
respiratory therapists, and other specialists working with medical patients; the expertise of the
physical rehabilitation community in working with physical functional status, including
physiatrists, physical therapists, occupational therapists, speech pathologists, rehabilitation
nursing specialists, and others specializing in these areas; and the expertise of the cognitive
status community, including psychologists, geriatricians, speech pathologists, occupational
therapists, and others working in this area. These specialists were included from each of the
different levels of care to recognize that a clinician working in one setting may view a patient
differently or have different expectations regarding a patient’s status than those working in other
settings.
This multiclinical input was important for ensuring that all stages of the demonstration
and the use and testing of the reliability of the items could apply across all settings. The
reliability tests reported in Volume 2 of this work were important for determining the feasibility
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of using standardized items across settings. The results showed that most items, with the
exception of several instrumental activities of daily living, such as laundry and shopping, were
reliable, returning consistent results in paired interrater reliability testing and also when
clinicians across all participating setting types rated a set of standard video patients using the
CARE assessment. Comparisons with earlier tests of the mandated assessment items showed
that the standardized items were at least equal to, and in some cases more reliable than, items in
the existing assessment tools. The goal of these tests was to at least match the reliability of items
currently in use. The reliability tests included in Volume 2 showed that moving to standardized
items will not affect the reliability of the information collected in the different settings. Testing
also demonstrated that items elicited consistent responses across provider types and clinician
discipline when rating standard patients.
The work in Sections 13-15 helps explain some of the differences between the
standardized items and each of the analogous current assessment items on each tool. Each of the
three mandated tools had different rules that they followed in measuring the concepts. The
assessment windows and look-back periods differed across tools. For some concepts, entirely
different items were used to measure a concept, whereas for other concepts, the item definitions
varied only slightly. However, these differences resulted in broader or narrower definitions of
the condition being measured. In most cases, the CARE item used the most granular or most
focused item. In other cases, CARE was replacing a multidimensional item with two
unidimensional items to better define the factor being studied. For example, the toileting item in
CARE includes only toileting hygiene and excludes clothing or other factors more related to
mobility and self-care than perineal hygiene. Those skills are measured in their respective
physical function sections of dressing. In areas of major treatments and respiratory status, CARE
was designed to focus on patients with more complex needs than the average nursing needs seen
across post-acute care, rather than including items that covered the entire range of complex
impaired patients to noncomplex, unimpaired patients.
The comparisons in these later sections of the report are useful for helping understand
how patients were rated differently using the standardized and setting-specific mandated
assessment items. Differences between items on the two assessment items being compared were
provided, comparing assessment time frames, differences in rating scales if applicable, and
differences in item definitions and instructions, in addition to other potential sources of variation
between the two assessments. Paired ratings for cases in the CARE sample were shown as crosstabulations of the items being compared between the two assessments. Where items differed, the
differences were largely as expected, with existing assessment items collapsing some of the less
severe or less impaired cases with some of the more complex. CARE items were designed to
measure differences in complexity, especially those associated with differences in the intensity
of services needed. Some concepts had more than one measure in order to examine whether
certain measures of a concept worked better in certain populations.
The standardized item set tested in this volume from the CARE tool was selected to
reflect the basic items used in payment or case-mix measurement. Missing are more specific
items applicable to groups with specialized cognitive issues, such as the traumatic brain injury
populations or the more demented populations, to name a few. However, the items tested in the
Post-Acute Care Payment Reform Demonstration show that standardized items can be used
across the Medicare program to measure patient complexity. While every item may not be
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relevant for every patient, it is an important first step to have consistent ways of measuring items
that are relevant, independent of site of care. Having reliable standardized items is necessary to
allow examination of the patients’ clinical changes at different points in their episode, regardless
of site of care. This information is particularly important in today’s world as payers examine the
value of care provided in each setting and across a continuum of care.
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